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CHAPTER 1
Introduction and Aim of this
Work
1.1 Introduction and Objectives
In recent years, methodological advances have led to the development of numer-
ous colloidal carrier systems for an optimised delivery of active substances into the
skin. As a result of the increased consumer interest in environmental aspects and
health issues such as allergies, the focus of attention during formulation develop-
ment has steadily shifted towards the use of safe, biodegradable and skin-friendly
raw materials such as lecithin or sucrose ester mixtures. The growing number
of vehicles has instigated the need for reliable methods to characterise the skin
penetration potential of novel formulations. Accordingly, the main objectives of
this work can be divided into two interrelated fields: the development of topical
formulations and the optimisation of methods to characterise the skin penetration
of these formulations.
The first objective of this work was the development of optimised dermal for-
mulations for application of lipophilic drugs. Lecithin-based nanoemulsions should
be optimised to avoid the commonly used polyethoxylated co-surfactants that are
usually employed to obtain stable systems. To this end, sucrose ester surfac-
tants and natural cyclodextrins (CDs) were tested for their potential as additional
co-stabilising agents. Their influence on the long-term stability of lecithin-based
nanoemulsions, the interaction of the systems with model skin in vitro and on the
skin permeation of lipophilic model drugs was determined. These aspects were
investigated for both negatively and positively charged nanoemulsions.
Since lecithin itself exhibits certain drawbacks as an emulsifier, the next step of
this work was to develop nanoemulsions based on the investigated sucrose stearate
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mixture alone. A comparative study revealing the advantages and drawbacks of
lecithin and sucrose stearate emulsifier mixtures regarding formulation stability,
formulation morphology and skin permeation was conducted. Again, the effect of
additional CD in combination with these emulsifiers was evaluated to confirm the
previous results. Cryo transmission electron microscopy (cryo TEM) should be
employed for an exact characterisation of the different systems.
In the context of these studies, a peculiar rheological behaviour was observed
for certain sucrose stearate mixtures with intermediate hydrophilic-lipophilic bal-
ance. It was possible to create semi-solid oil-in-water emulsions stabilised solely
by sucrose stearate. Interestingly, these creamy systems were created merely by
modification of the production process and exhibited the exact same composition
as the corresponding nanoemulsions. Thus, comparative studies were performed
with these simple systems to investigate the potential of the novel emulsions as
dermal drug carriers. The obtained nanoemulsions and emulsions which differed
only in their mean droplet size and viscosity were characterised by dynamic light
scattering and laser diffraction measurements, respectively, as well as optical light
microscopy and cryo TEM. The long-term stability and morphology of both formu-
lation types was investigated and the influence of the different physical properties
of the otherwise identical systems on their skin permeation behaviour was inves-
tigated in vitro using diffusion cell setups. In further studies, the influence of the
exact sucrose stearate blend composition, the nature of the employed oil phase
and the exact processing conditions were investigated using thermoanalytical and
rheological techniques as well as fluorescence microscopy.
As a second major objective of this work, the tape stripping technique was
optimised for laboratory use using excised porcine ears to gain more accurate
data on the skin penetration behaviour of the novel vehicles. The tape stripping
technique is a well-established method to determine the skin penetration of active
substances in vivo. However, such in vivo studies require a lot of organisatorial
and legislative effort and cannot be performed in every lab. Thus, we decided to
validate in vitro tape stripping on excised porcine ears in combination with the
novel technique of near infrared (NIR) densitometry for the determination of the
skin penetration profiles of different model drugs. In this context, the assessment
of the transepidermal water loss (TEWL) by means of a closed condenser-chamber
system as well as skin hydration mapping with a capacitance-based sensor should
be adapted for skin integrity testing and monitoring of the changes in skin barrier
function during tape stripping.
Having established these experimental techniques for in vitro tape stripping
experiments, the skin penetration of different model drugs from the developed su-
crose stearate-based formulations should be investigated in comparative studies.
Likewise, the experimental setup should be employed to test the potential per-
meation enhancement effect of CDs under a finite dose in vitro setup. Finally,
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comparative tape stripping experiments with model formulations should be con-
ducted both in vivo on human forearm skin and in vitro on porcine ear skin to
confirm the validity of the porcine ear model for in vitro tape stripping.
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1.2 Einleitung und Zielsetzung
Die Entwicklung kolloidaler Arzneistoffabgabesysteme zur dermalen Applikation
wurde durch technologische Fortschritte während der letzten Jahrzehnte stark be-
günstigt. Aufgrund des verstärkten Interesses der Konsumenten an Umwelt- und
Gesundheitsaspekten liegt der Schwerpunkt bei der Entwicklung neuer Dermati-
ka heute auf der Verwendung von hautfreundlichen und bioabbaubaren Rohstof-
fen wie beispielsweise natürlichen Lezithin- oder Saccharoseester-Mischungen. Die
wachsende Anzahl an dermalen Arzneiformen bedingt eine stetige Entwicklung
verlässlicher Methoden zur Charakterisierung des Penetrationsvermögens neuer
Formulierungen. Dementsprechend bestanden die Ziele dieser Arbeit aus zwei mit-
einander verknüpften Teilgebieten: einerseits aus der Entwicklung neuer kolloidaler
Vehikel, andererseits aus der Optimierung von Methoden zur Charakterisierung der
Hautpenetration dieser Formulierungen.
Das erste Ziel dieser Arbeit bestand in der Entwicklung von dermalen Formu-
lierungen zur Verabreichung von lipophilen Arzneistoffen. Lezithin-basierte Nano-
emulsionen, die zumeist mittels polyethoxylierter Co-Tenside stabilisiert werden,
sollten mit Hilfe natürlicher Co-Stabilisatoren in Bezug auf Langzeit-Stabilität
und Hautpermeation optimiert werden. Daher sollte der Effekt von Saccharose-
ester-Tensiden und natürlichen Cyclodextrinen auf die physikalische Stabilität der
Lezithin-basierten Nanoemulsionen, auf deren Wechselwirkung mit Modellhaut in
vitro sowie auf die Hautpermeation lipophiler Modellarzneistoffe festgestellt wer-
den. Diese Aspekte wurden sowohl für positiv als auch für negativ geladene Nano-
emulsionen untersucht.
Da Lezithin bei alleiniger Verwendung als Tensid gewisse Nachteile aufweist,
wurde als nächster Schritt die Eignung der untersuchten Saccharoseester-Mischung
zur alleinigen Stabilisation von Nanoemulsionen untersucht. Eine Studie zum Ver-
gleich der Lezithin- und Saacharoseester-basierten Nanoemulsionen bezüglich phy-
sikalischer Stabilität, Morphologie sowie Hautpermeation sollte in diesem Rah-
men durchgeführt werden. Zudem wurde erneut der Effekt von zusätzlichem γ-
Cyclodextrin in Kombination mit diesen Tensiden untersucht, um die bisherigen
Ergebnisse zu bestätigen. Kryo-Transmissions-Elektronenmikroskopie wurde zur
exakten Charakterisierung der verschiedenen Systeme herangezogen.
Im Zuge dieser Studien legte die verwendete Saccharosestearat-Mischung mit
mittlerem Hydrophilie-Lipophilie-Wert ein ungewöhnliches rheologisches Verhal-
ten an den Tag. Es konnten halbfeste Öl-in-Wasser-Emulsionen hergestellt wer-
den, die lediglich mittels der Saccharoseester-Mischung stabilisiert wurden. Die
Herstellung dieser cremigen Formulierungen wurde interessanterweise durch ge-
ringfügige Modifikationen der Herstellungsbedingungen bewerkstelligt, während
die Zusammensetzung exakt jener der entsprechenden Saccharosestearat-basierten
Nanoemulsionen entsprach. Diese einfachen Systeme wurden in vergleichenden
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Studien in Hinsicht auf ihr Potential als dermale Arzneistoff-Carrier untersucht.
Die hergestellten Nano- und Makroemulsionen, die sich lediglich durch ihre Tröpf-
chengröße und Viskosität unterschieden, wurden mittels Dynamischer bzw. Sta-
tischer Laser-Lichtstreuungsmessung sowie Kryo-Transmissions-Elektronenmikro-
skopie bzw. Lichtmikroskopie charakterisiert.
Die Langzeitstabilität und Morphologie beider Systeme wurde untersucht und
der Einfluss der unterschiedlichen physikalischen Eigenschaften der ansonsten iden-
tisch zusammengesetzten Systeme auf die in vitro - Hautpermeation wurde mittels
Franz-Diffusionszellen analysiert. In weiterführenden Studien wurde der Einfluss
der genauen Zusammensetzung von Saccharosestearat-Mischungen, der verwende-
ten Ölphase und der genauen Herstellungsbedingungen mittels thermoanalytischer
sowie rheologischer Methoden und Fluoreszenz-Mikroskopie untersucht.
Als zweites Hauptziel dieser Arbeit sollte die Technik des Tape Stripping für
den Laborgebrauch an exzidierten porzinen Ohren optimiert werden, um exak-
tere Daten über das Hautpenetrationsverhalten der neuen Vehikel zu erhalten.
Die Tape Stripping - Methode ist eine etablierte Technik, um die Hautpenetration
verschiedener aktiver Substanzen in vivo zu bestimmen. In vivo - Studien an Pro-
banden erfordern jedoch einen erheblichen organisatorischen Aufwand und können
nicht in jedem Labor durchgeführt werden. Daher war es das Ziel dieser Arbeit, die
Technik des in vitro - Tape Stripping an exzidierten porzinen Ohren in Kombina-
tion mit der neuen Technik der Nah-Infrarot-Densitometrie zur Bestimmung der
Hautpenetration verschiedener Modellarzneistoffe zu validieren. In diesem Zusam-
menhang wurden der transepidermale Wasserverlust mittels Kondensor-Kammer
sowie die Hauthydratation mit Hilfe eines kapazitanzbasierten Sensors bestimmt.
Diese Methoden sollten für die Überprüfung der Hautintaktheit sowie zur Über-
wachung von Änderungen der Hautbarrierefunktion während des Tape Strippings
adaptiert werden.
Nach erfolgreicher Etablierung der in vitro Tape Stripping - Technik am por-
zinen Ohr sollte diese Methode zur Untersuchung der entwickelten Saccharose-
stearat-basierten Formulierungen herangezogen werden. Darüber hinaus wurde
diese Technik zur Überprüfung des potentiell permeationsfördernden Effektes von
γ-Cyclodextrin in Nanoemulsionen unter finite dose - Bedingungen eingesetzt.
Schließlich sollten vergleichende Tape Stripping - Experimente an Humanhaut in
vivo sowie porziner Ohrenhaut in vitro anhand von Modellformulierungen durch-
geführt werden, um die praktische Anwendbarkeit des porzinen Ohrenmodells für
in vitro - Tape Stripping zu überprüfen.

CHAPTER 2
Theoretical Background
2.1 Skin Morphology and Dermal Drug
Delivery
Structure and Function of the Skin
The human skin as our largest organ separates our organism from the external
environment. It protects us against chemical, physical or mechanical damages
and prevents the intrusion of microorganisms. It prevents dehydration, but allows
for a physiological evaporation of water from the skin surface. Apart from ther-
moregulation and mediating sensory impressions, it plays a role in immunological
processes [1-4].
The skin can largely be divided into the epidermis and the dermis (Figure 1).
The outermost skin layer is the epidermis, a comparatively thin epithelium that
is followed by the thicker dermis and the underlying subcutaneous fatty tissue.
Both hair follicles and eccrine glands are situated within the subcutis. The hair
shafts and eccrine gland ducts lead through the dermis and epidermis to the skin
surface. The subcutaneous vasculature and the finer dermal vasculature account
for the blood perfusion of the viable tissue [1, 3].
The epidermis itself is a dynamic tissue that consists of different cell layers
(Figure 2). The basement membrane, which represents the interface between the
epidermis and the underlying dermis, is followed by the stratum basale or germi-
nativum. Within this single basal layer of keratinocytes, new epidermal cells are
being produced by mitosis. Upon leaving this layer, the cells start to differentiate
and migrate in direction of the skin surface. The cells proceed through the stra-
tum spinosum (prickle cell layer) which exhibits large numbers of desmosomes and
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Figure 1: Schematic cross-sectional image of human skin after [1, 5]. (A) Full-
thickness skin (B) Expansion of the outermost 200 µm of the epidermis.
the stratum granulosum (granular layer). A thin intermittent layer, the stratum
lucidum (glossy layer), is most prominent within the palms of the hands and soles
of the feet. The cells are becoming wider and flatter as they move towards the
skin surface. The final differentiation at the interface to the outermost layer of the
epidermis, the stratum corneum (SC), transforms the viable cells into extremely
flattened dead cells filled with keratin. These non-viable cornified cells of the SC
are named corneocytes and are surrounded by an envelope of cross-liked proteins
as well as a lipid envelope [1, 3, 6].
The main barrier function of the skin, which prevents the loss of water and the
intrusion of xenobiotic substances, is attributed to the approximate 10 to 15 µm
of the SC. The overlapping corneocytes are held together by corneodesmosomes
and are embedded in lipid lamellae which are orientated parallel to the cell sur-
face. This intercellular lipid matrix consists primarily of ceramides, cholesterol,
cholesteryl esters, fatty acids and cholesterol sulphate. Unlike other biological
membranes, the skin does not contain any phospholipids. The outermost corneo-
cytes are eventually peeled off of the skin surface since the SC renews itself every
14 days; the average turnover time from the formation of new cells in the basal
layer to their shedding at the skin surface is approximately 28 days [6, 8-10]. The
arrangement of the corneocytes within the intercellular lipid matrix of the SC has
been described by means of the bricks and mortar model [11] (Figure 3).
2.1. SKIN MORPHOLOGY AND DERMAL DRUG DELIVERY 15
Figure 2: Life cycle of an epidermal cell and schematic cross-section through the
individual layers of the epidermis: stratum basale (1), stratum spinosum (2), stra-
tum granulosum (3), stratum corneum (4). Image reproduced with permission
from [7].
Mechanisms of Dermal Drug Delivery
The complex structural organisation of the SC constitutes the main rate-limiting
step against the penetration of active substances into the skin. The lipid bilayers
contain alternating hydrophilic and hydrophobic areas. To deliver therapeutically
relevant doses of an active agent into the skin (dermal drug delivery) or to achieve
permeation of a drug through the skin for a systemic effect (transdermal drug
delivery), this barrier has to be overcome. The penetration of active substances
across the SC may occur along different pathways (Figure 3): the transcellular
route, the intercellular route and the appendageal route, i.e. along skin appendages
such as eccrine gland ducts and hair follicles.
The precise mechanism of transport has not been unequivocally determined
despite years of discussion [12]. It was assumed earlier that lipophilic substances
permeate mostly via the intercellular pathway and hydrophilic drugs permeate via
the transcellular pathway [13]. The appendageal route was considered irrelevant
since hair follicles cover only about 0.1% of the skin surface [14]. More recent
studies have indicated that the intercellular pathway plays in fact an important role
for most substances [3, 12] and that the hair follicles may represent an important
long-term reservoir for topically applied substances [14-16].
The solubility of an applied drug is of major importance for its skin permeation
behaviour. Since areas of different polarity need to be overcome, the highest
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transcellular intercellular follicular
eccrine
Figure 3: Penetration pathways through the skin after [9]
skin permeation can be anticipated for drugs of intermediate polarity that possess
both a certain lipophilicity and hydrophilicity. Apart from the physicochemical
properties of the applied drug such as molecular mass and polarity, its permeation
is influenced by the applied concentration of drug, the partition coefficient of the
drug between the vehicle and the skin and the diffusion coefficient of the drug
within the SC [4].
The transport of substances across the skin can be regarded as a passive diffu-
sion process that can be approximated by Fick’s first law of diffusion:
J = DK∆c
h
J represents the steady-state flux of a permeant through the skin per unit area.
It is directly related to the diffusion coefficient D of the permeant within the skin,
the skin - vehicle partition coefficient K of the permeant and the concentration
difference ∆c across the skin. The flux is inversely correlated to the diffusional
pathlenght h. This simplified equation can be employed to describe or predict
drug diffusion across the skin [4, 9].
Penetration Enhancement Strategies
The penetration of active substances into the skin or their permeation across the
skin can be improved by different strategies. Drugs or pro-drugs with optimised
properties can be designed or their chemical potential can be enhanced by supersat-
uration within the vehicle. Alternatively, the active substances can be driven into
the SC by physical penetration enhancement methods. In this context, electrical
penetration enhancement methods such as iontophoresis, electroporation or ultra-
sound have been tested. In addition, micro needles can be employed to bypass the
SC. The most frequently employed penetration enhancement strategy, however,
involves modification of the SC by chemical enhancers. Chemical enhancers are
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substances which temporarily reduce the skin barrier function and thus improve
the flux of active substances into the skin. Extensive literature data exist on this
topic and numerous chemicals have been tested. Importantly, an enhancer itself
should be non-toxic to the skin, pharmacologically inactive and easily available
[17, 18].
Since hydration of the SC increases the penetration of most substances by
opening up the compact SC structure, water is among the safest and most effective
penetration enhancers. Occlusive films, hydrophobic ointments and patches all
enhance drug bioavailability in the skin due to enhanced skin hydration. Likewise,
vehicles containing moisturising factors or large amounts of water can temporarily
increase SC hydration [17, 19].
Among the most frequently investigated chemical penetration enhancers are
surfactants, alcohols, fatty acids, essential oils and terpens [18, 20]. The mecha-
nisms of action of penetration enhancers are often complex and difficult to elu-
cidate. Chemical penetration enhancers have been described to affect the intra-
cellular keratin within the corneocytes, to act on the desmosomes that maintain
corneocyte cohesion, to modify the intercellular lipid domains and disrupt the in-
tercellular lipid bilayers, e.g. by lipid extraction, or to increase the partitioning
of applied drugs, co-solvents or co-enhancers into the SC [20]. The use of most
chemical penetration enhancers thus involves an inherent skin irritation potential.
Since dermal toxicity is a limitation for practical application and consumer com-
pliance, there is increased interest in skin-friendly, safe and ideally bio-degradable
penetration enhancers. Thus, so-called green surfactants based on natural raw
materials are currently being investigated for the development of dermal drug
delivery systems with optimised skin penetration properties. Among those, alkyl
polyglucoside surfactants [21-24] and sucrose ester surfactants [25-27] are receiving
increased attention.
2.2 Emulsion Systems for Dermal Application
Definition of Emulsions and Nanoemulsions
An emulsion is a multiphase system consisting of at least two immiscible liquid
phases such as oil and water. One of the phases is dispersed within the other
phase by means of energy input, e.g. by mechanical shearing. Different types of
emulsions can be produced according to their composition, the chemical structures
of oil and surfactants as well as the processing conditions. An emulsion of oil
droplets surrounded by an aqueous bulk phase is termed oil-in-water emulsion
(o/w emulsion) while water droplets surrounded by an oily bulk phase represent
a water-in-oil system (w/o emulsion) [28]. Emulsions are metastable systems that
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are kinetically stabilised with the help of surfactants, polymers or other stabilising
agents that help to lower the interfacial tension between the phases. The inherent
thermodynamic instability of the systems will however eventually lead to physical
destabilisation [29, 30]. The considerate selection and combination of surfactants is
essential to minimise destabilisation phenomena such as aggregation, flocculation,
creaming, sedimentation or irreversible coalescence [31, 32]. Studies have shown
that mixed interfacial films composed of different surfactants usually result in
superior stability, presumably due to tighter molecular packing at the oil/water
interface [28].
The term nanoemulsion is generally employed to describe emulsions with drop-
let sizes in the lower submicron range. The main difference to emulsions with
droplets in the micrometer range lies in the superior physical stability of nano-
emulsions and their usually fluid nature. According to their particle size, nano-
emulsions can be transparent, translucent or milky white (Figure 4).
Liquid
Oil
Core
H2O
Figure 4: Optical appearance of a nanoemulsion (A, droplet diameters around
35 nm) and a conventional emulsion (B, droplet diameters around 1 µm). Image
reprinted from [33] with permission from Elsevier. The structure of a nano-sized
oil droplet is given on the right (modified after [34]).
The small oil droplets of o/w nanoemulsions can be kept suspended in the
aqueous bulk phase for prolonged periods of time since Brownian motion largely
prevents gravitationally driven sedimentation or creaming. If the oil phase pos-
sesses a certain solubility within the aqueous phase, Ostwald ripening may affect
the physical stability of the system. Due to solubility differences between large
and small emulsion droplets, the smaller droplets are incorporated into the larger
ones, thus further increasing their size. This process may be an issue for nano-sized
emulsions, but can be avoided by selecting appropriate excipients during formula-
tion development. If designed correctly, nanoemulsions exhibit excellent physical
stability [29].
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Strictly speaking, the definition nano applies only to systems with droplet sizes
below 100 nm, which is rarely achieved by conventional high-energy emulsification
methods. Alternatively, such systems have been termed submicron emulsions,
mini-emulsions, ultrafine emulsions or translucent emulsions [29, 35]. Irrespective
of the inconsistent terminology throughout literature, the overall properties of
nanoemulsions are accurately described by the term emulsion. Most importantly,
nanoemulsions should not be confused with microemulsions, which are thermody-
namically stable equilibrium systems that form spontaneously due to molecular
self-assembly. Microemulsions generally contain large amounts of surfactants and
co-surfactants or solvents and exhibit remarkable shelf lives. It should be kept in
mind that they bear no similarities to actual emulsions [29].
Emulsions are classical vehicles for the loctal treatment of skin disorders. Both
drug-loaded and drug-free systems can be designed for dermo-pharmaceutical or
cosmetic purposes. The usually semi-solid appearance of emulsions is advantageous
for practical application on skin and thus for patient compliance. Unlike microscale
emulsions, nanoemulsions are usually of a fluid nature that may require the use of
aerosol devices to facilitate application.
The present work was concerned with the development of both fluid nano-
emulsions and semi-solid emulsions. Separate investigations as well as comparative
studies were conducted to investigate the effect of the droplet size on the skin pene-
tration of incorporated drugs. Important physical parameters that were evaluated
in this context were the mean droplet size and polydispersity of the emulsions as
well as the droplet surface charge and pH value of the systems. The rheologi-
cal properties of dermal vehicles are of great importance for industrial processes,
practical application and stability and were therefore also investigated.
Lecithin-based Nanoemulsions
The first focus of this work was the optimisation of lecithin-based nanoemulsions
(see section 3.1). Lecithins are natural amphiphilic molecules that occur in cell
membranes of plants and animals. They are mixtures of phospholipids and have
important functions in the growth and functioning of cells. From a chemical view-
point, the term lecithin specifically refers to phosphatidylcholine, which is by far
the most abundant phospholipid. Thus, the name lecithin is commonly employed
for mixtures of phosphatidylcholine with related phospholipids [36].
Lecithins are among the most widely used natural emulsifying agents in phar-
maceutics, cosmetics and the food industry due to their excellent biocompatibility.
The polar structure of phospholipid molecules renders them useful non-ionic emul-
sifying agents (Figure 5).
However, phosphatidylcholine molecules alone are not ideally suited for the
formation of the curved surfaces of emulsion droplets due to their packing geometry
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Figure 5: Schematic structure of a phospholipid after [35]
at the interface. In addition, they lack electrical charges that are required for the
electrostatic stabilisation of colloidal systems. Substances that confer an electrical
charge to the surface of emulsion droplets contribute beneficially to the long-term
stability of the system by preventing aggregation and subsequent coalescence. In
case of the highly fluid nanoemulsions, physical destabilisation through Ostwald
ripening can likewise be prevented or decelerated [30, 37].
Thus, different strategies were followed for the development of nanoemulsions
with optimised stability. Firstly, lecithin mixtures were employed as emulsifiers in-
stead of the pure phosphatidylcholine. Natural lecithin mixtures contain different
phospholipids such as phosphatidic acid, phosphatidylserine, phosphatidylinositol
and small amounts of free fatty acids, all of which are able to confer a negative
electrical charge to the droplet surface of nanoemulsions and lead to improved
molecular packing at the interface [30, 37]. In addition, the physiological base
phytosphingosine was employed to develop positively charged nanoemulsions for
comparison. We likewise tested natural sucrose stearate mixtures and natural
CDs as additives to promote the formation of mixed interfacial films for improved
droplet stabilisation. Since sucrose stearate mixtures of intermediate hydrophilic-
lipophilic balance (HLB) were found highly suitable for emulsion formation, they
were investigated separately in extensive follow-up studies (see section 3.2 and
3.4). The conclusions derived from these studies as well as from an extensive liter-
ature research were summarised in a review article supplemental to this work [35]
(see chapter 8).
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Sucrose Stearate-based Nanoemulsions and Emulsions
Sucrose fatty acid esters are natural non-ionic surfactants that are increasingly
employed in nutrition, cosmetics and pharmaceutics. These amphiphilic surface-
active molecules consist of a sucrose molecule as hydrophilic group and different
fatty acids as lipophilic groups. Since sucrose possesses 8 hydroxy groups, it may
form esters with up to 8 fatty acid moities (Figure 6). The nature and the number
of fatty acid residues may be varied and thus a wide range of surfactant mixtures
with different HLB values can be obtained. Due to their biocompatible and skin-
friendly nature, sucrose ester mixtures are approved as food additives in many
countries and are raw materials for dermal applications such as personal care
products, cosmetics and pharmaceutical products [38, 39].
R = fatty acid ester moiety or H 
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Figure 6: Chemical structure of sucrose esters after [39]
In terms of emulsion development, sucrose esters of different HLB values have
been investigated for their potential to form o/w nanoemulsions [26, 40] and to
influence the skin permeation of drugs [41, 42].
Since sucrose stearate mixtures were found to be highly suitable emulsifiers for
nanoemulsion development, comparative studies on lecithin-based nanoemulsions
and sucrose stearate-based nanoemulsions were performed (see section 3.2). The
results revealed that the latter systems exhibited smaller droplet sizes, a highly ho-
mogeneous morphology, better electrochemical stabilisation and overall improved
physical and chemical stability.
In addition, novel semi-solid sucrose stearate-based emulsions were developed
thanks to serendipity findings during the development of the different nanoemuls-
ions. The peculiar rheological behaviour of sucrose stearate mixtures with interme-
diate HLB values allowed for the production of fluid nanoemulsions and semi-solid
emulsions of identical composition. In a first study (section 3.4), we focused on
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the influence of the physical properties of these systems on the in vitro skin per-
meation and penetration of different incorporated model drugs. Interestingly, the
skin penetration potential of the incorporated drugs in vitro was the same for both
vehicle types. This was confirmed in subsequent in vivo tape stripping experiments
(see section 3.5). In a follow-up study (section 3.8), the focus was placed on the
influence of the sucrose ester blend composition, the employed oil type and the
production conditions on the properties of the semi-solid emulsions.
Although the novel semi-solid emulsions exhibited complex physical proper-
ties and very exact processing conditions were required to obtain reproducible
results, it should again be emphasised that an appealing semi-solid appearance
was obtained without the use of additional gelling agents or stabilisers. Since
these emulsions only contained 5% w/w of surfactant, high skin-friendliness may
be anticipated. Thus, further research in this field might be of interest.
Characterisation of Nanoemulsions and Emulsions
The physical and chemical stability of dermal emulsions is, besides an inherent
skin-friendliness, among the primary interests in formulation development. Dif-
ferent techniques can be employed for the initial characterisation of emulsions
and the subsequent stability monitoring. When regarding the physical stability
of emulsions, the mean droplet size and droplet size distribution are among the
most interesting parameters. In case of nanoemulsions, these parameters can be
determined by dynamic light scattering (DLS, photon correlation spectroscopy)
measurements. This technique analyses the intensity fluctuations of light that is
scattered by the particles in a sample. The droplets of nanoemulsions are sub-
jected to Brownian motion. If they are illuminated with a laser, the droplets
scatter the light according to their size. Smaller droplets move more rapidly and
thus cause different fluctuations in light intensity than large droplets. By employ-
ing the Stokes-Einstein equation, the hydrodynamic diameters of the droplets can
be calculated once the velocity of the Brownian motion has been deduced from the
intensity fluctuations [43]. This technique is recommended for droplet diameters
between approximately 3 nm and 10 µm depending on the manufacturer specifica-
tions of the respectively employed device. The most accurate results, however, are
certainly obtained for monodisperse samples with droplet sizes in the submicron
range. For conventional emulsions with droplet sizes in the higher micrometre
range, laser diffraction (LD, static light scattering) is the method of choice. This
technique determines droplet size distributions by comparing the scattering pat-
tern of a sample to an appropriate optical model with the help of a mathematical
inversion process. All light scattering techniques are based on certain assumptions
depending on the underlying mathematical theory. Calculations employing the
Mie theory are based on the assumption that the analysed particles are spherical
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and homogeneous in nature [43]. Detailed information about the morphology of the
analysed nanoemulsions is therefore required to verify the accuracy of DLS results.
Besides, the DLS technique exhibits certain limitations regarding the character-
isation of nano-sized emulsions. Small populations of large droplets, surfactant
aggregates as well as lamellar or vesicular structures may remain undetected and
may bias DLS calculations due to their non-spherical nature. The sample dilution
that is generally required for DLS measurements may conceal reversible destabil-
isation phenomena such as flocculation or the appearance of aggregates [44, 45].
At the moment, electron microscopy in combination with different cryo prepa-
ration techniques represents one of the most informative approaches towards a
thorough characterisation of nanoemulsion morphology [45, 46]. In the context of
the present work, cryo TEM was repeatedly employed to characterise the devel-
oped nanoemulsions and to determine the effect of the different surfactants and
additives on the morphology of the produced systems. The overall insights that
were gathered during these studies were summarised in a recent review article
supplemental to this work [45] (see chapter 8).
Apart from the droplet size distribution, the electrochemical stabilisation of
the nanoemulsion droplets can be investigated. The technique of laser Doppler
electrophoresis (laser Doppler anemometry) delivers information about the zeta
potential (ZP), which characterises the droplet surface charge of the emulsion
droplets within the aqueous bulk phase. The nanoemulsion sample is subjected to
an electrical field. If the droplet surface is charged, the droplets migrate towards
the electrode of the opposite charge. Their velocity is directly proportional to the
magnitude of their surface charge, i.e. their ZP. When a laser beam is scattered
by the moving droplets, a frequency or phase shift of the laser light results and
is measured as the droplet mobility. The ZP is derived from this mobility and
the dispersant viscosity, e.g. by employing the Smoluchowski theory. For nano-
emulsions with high absolute ZP values above 30 mV, satisfying electrochemical
stabilisation can be anticipated [47]. If necessary, appropriate charge-inducing ad-
ditives can be employed to confer a high absolute charge to the droplet surfaces,
thus preventing their aggregation and subsequent coalescence [35].
The DLS technique in combination with laser Doppler electrophoresis is the
most frequently employed approach for investigating the physical stability of nano-
emulsions. The required dilution of the sample may conceal reversible aggregation
phenomena, but will otherwise exert little influence on the properties of the in-
vestigated nanoemulsion. In case of semi-solid emulsions with droplet sizes in
the micrometer range, LD can be employed after extensive dilution and careful
homogenisation of the creamy samples. However, the obtained results may be af-
fected by the specific steps of sample preparation before the analysis, especially if
a complex internal morphology is involved. More accurate information about the
physical properties of semi-solid emulsions can be obtained by rheological mea-
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surements. The reaction of a formulation to an applied shear, i.e. its resistance to
deformation, may provide valuable information about its internal structure. The
flow behaviour of emulsions and their viscoelastic properties depend on different
factors, such as the oil volume fraction, the mean droplet size, the droplet surface
charge and colloidal interactions [48]. Both linear and oscillatory measurements
can be conducted to elucidate the formulation properties. In addition, optical light
microscopy may assist to visualise the emulsion morphology. Due to the dense na-
ture of semi-solid emulsions, additional techniques of sample preparation might
be necessary to clarify the nature of the observed formulation structures. In the
present studies, fluorescence marking of the respective oil or water phase and sub-
sequent fluorescence microscopic analysis served to clarify previous uncertainties
(see section 3.8).
The chemical stability of emulsions can be compromised during storage due
to degradation processes that may not immediately affect the physical stability
of the entire system. However, the progressive chemical degradation of emulsion
compounds such as surfactants, incorporated drugs or natural oils will eventually
affect the entire system due to an increasing drop in pH value. Accordingly, the
pH value represents a useful indicator for monitoring the chemical stability of an
emulsion. In the context of the present studies, lecithin-based systems generally
appeared to be more prone to oxidative and hydrolytical degradation than sucrose
stearate-based systems (see section 3.2).
2.3 Cyclodextrins in Dermal Formulations
Definition, Properties and Application of Cyclodextrins
CDs are cyclic oligosaccharides consisting of several α-D-glucopyranose units joined
through an α-1,4 bond. These dextrose units form a torus-shaped molecule with
a hydrophilic outer surface and a lipophilic central cavity. CDs with six, seven or
eight dextrose units have been named α-, β- and γ-CD [43] (Figure 7).
Apart from these natural CDs, a large number of CD derivatives with improved
aqueous solubility or other properties of interest have been developed for various
applications. CDs are well-established pharmaceutical compounds due to their
ability to form non-covalent inclusion complexes with suitable lipophilic molecules
or molecule structures. These inclusion complexes may exhibit completely differ-
ent physical, chemical and biological properties than either the parent drug or the
CD and can be employed for various beneficial purposes. The main applications
of CDs in pharmaceutical technology are the stabilisation or solubilisation of ac-
tive molecules of poor aqueous solubility. Complexation with CDs can thus be
employed to increase the solubility and the dissolution of drugs, to protect volatile
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Figure 7: Molecular structure of the natural cyclodextrins α, β and γ (reprinted
with courtesy of M. Chaplin, London Southbank University)
or unstable compounds, to alter drug release rates or to minimise local irritation.
In addition, CDs can affect the skin permeation of drugs [49-51].
Cyclodextrins in Dermal Formulations
CDs can be incorporated in dermal drug delivery systems to improve the solubil-
ity and dispersion of drugs. In addition, they can influence the skin permeation
rates of drugs. When applied as additives in dermal formulations, CDs may act
as permeation enhancers by keeping lipophilic drugs in solution and consequently
delivering them to the skin surface. However, this effect strongly depends on the
complexation affinity between drug and CD and may lead to decreased skin perme-
ation rates as well [49, 50]. In addition, the emulsifying potential of natural CDs
has been recently discussed and employed for formulation development [52-55].
CDs can act as emulsifying agents in emulsions by forming inclusion complexes
with fatty acid residues of the oil phase. If appropriate excipients are employed,
these molecule complexes exhibit surface active properties and can lower the in-
terfacial tension of the resulting systems. These amphiphilic supermolecules can
thus contribute to the stabilisation of emulsions [55]. Due to their large molecu-
lar weight, CDs cannot permeate the skin themselves and can thus be considered
as comparably eudermic stabilising agents [56]. Although the concept of using
CDs as emulsifying agents in multiphase systems was introduced some time ago
[57, 58], it has only been investigated to a limited extent in simple or multiple
emulsions [59-61]. Thus, the practical applicability of CDs as co-stabilising agents
in complex nanoemulsion systems should be investigated within the present work
(see section 3.1 and 3.2). At the same time, the effect of the natural CDs on the
skin permeation of incorporated model drugs was analysed. Repeated diffusion
cell studies revealed a particularly pronounced enhancement effect for steroidal
drugs when combined with γ-CD. Thus, an additional methodological study was
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performed to elucidate the underlying mechanisms (see section 3.6).
2.4 The Tape Stripping Technique
In Vivo vs. in Vitro Tape Stripping
Different in vitro setups have been developed to investigate the permeation or
penetration of active substances into the skin, such as different diffusion cell setups
[62], the bovine udder skin model [63] and the Saarbruecken penetration model
[64, 65]. The tape stripping technique is a classical in vivo technique to investigate
the skin penetration of applied substances [66, 67], but has likewise been adapted
for in vitro experiments using excised human skin [68]. During the tape stripping
process, a defined amount of drug-loaded formulation is applied to a marked skin
area, usually by means of a saturated glove finger. After a specific interval of
residence time, the outermost corneocyte layers of the SC as well as the penetrated
formulation are successively removed with the help of adhesive tapes. Each tape is
pressed firmly onto the skin surface for a short interval of time and is subsequently
pulled off in a single rapid movement. Preferably, the pressure application is
performed with a rolling movement to minimise the influence of wrinkles. Each
individual adhesive tape is then analysed for the removed corneocyte mass and
the amount of penetrated drug to obtain the skin penetration profile of the active
substance [69, 70]. This technique is most frequently performed on human forearm
skin in vivo (Figure 8).
Figure 8: Preparations for the tape stripping technique on human forearm skin in
vivo
Although tape stripping can be performed using excised human skin or even
heat-separated human epidermis, these model skins are not entirely representa-
tive for the in vivo situation. In particular, the follicular penetration pathway
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within the excised human skin is largely blocked due to the contraction of elastic
fibres of the excised skin tissue. In this respect, it was suggested that porcine ear
skin might represent a superior in vitro model for mimicking the skin penetra-
tion of drugs into human skin. The porcine ear skin remains on the cartilage of
the excised ear. Thus, non-physiological contraction of the tissue is avoided [14].
Despite the larger size of the porcine hair follicles, this in vitro model represents
a promising approach to investigate the skin penetration of novel formulations
with different model drugs. We therefore decided to optimise this technique to
obtain reproducible and accurate in vitro skin penetration data. In particular, the
quantification of the removed corneocytes should be facilitated by adapting the
technique of NIR-densitometry for this task (see section 3.3).
Methods of Corneocyte Quantification
The accuracy of the skin penetration profiles obtained by the tape stripping tech-
nique depends strongly on the accuracy of the employed methods of corneocyte
quantification. Different methods have been proposed for this task, such as col-
orimetric protein assays [68, 71, 72], differential weighing [66, 73, 74] and optical
light microscopy [75]. More recently, optical approaches of corneoycte quantifica-
tion have been introduced for the analysis of human SC cells both in vivo and
in vitro, such as UV/Vis spectroscopy [66, 76, 77] and NIR-densitometry [68,
78]. These methods rely on the determination of the optical pseudo-absorption of
the removed adhesive tapes. Since NIR-densitometry had not yet been validated
for the quantification of porcine corneocytes, this objective was included in the
present work for optimisation of the tape stripping technique on excised porcine
ear skin. The employed device was the NIR-densitometer SquameScan® 850A
(Heiland Electronic GmbH, Wetzlar, Germany) as shown in Figure 9.
2.5 Skin Integrity Testing in Vitro
Apart from a standardised working procedure and reliable methods of corneocyte
quantification, constant high quality of the employed porcine ear skin is essential
to obtain reproducible results during in vitro tape stripping. Porcine ear skin
may be of variable nature depending on the breed and upbringing of the sacrificed
animal. The preferred area for tape stripping experiments is the central part of
the dorsal ear side [79, 80], which may be damaged due to tags or injuries. Skin
diseases or small lesions may remain unnoticed to the naked eye. Thus, additional
techniques for quality control of the employed skin are required. In the context
of the present work, the assessment of the TEWL and skin hydration imaging
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Figure 9: The SquameScan® 850A near infrared-densitometer
with a capacitance-based fingerprint sensor were investigated and tested for the
characterisation of porcine ear skin in vitro (see section 3.7).
Transepidermal Water Loss
An important homeostatic function of the skin is to regulate the loss of water to
the external environment. For both human and porcine skin, this task is fulfilled
by the outermost 10 to 20 µ of the epidermis, the SC, which allows for a certain
physiological water loss by passive diffusion and from sweat glands [81]. The
magnitude of the physiological TEWL of healthy human skin depends strongly
on the respective skin area. Typical basal values for different skin regions have
been determined [82-84]; for instance, the typical TEWL of human forearm skin
may range from 9 to 16 g m-2 h-1. If the skin barrier function is compromised by
physical or chemical damages or by skin disorders, the TEWL is increased. Thus,
the determination of the TEWL represents an effective method to characterise the
state of the skin barrier function in vivo and is an established tool for skin integrity
testing during in vivo tape stripping experiments [81]. Areas of increased TEWL
can be identified and excluded from tape stripping experiments.
The TEWL can be determined by measuring the water vapour flux density.
Both open- and closed-chamber devices based on different measurement principles
have been developed [85-88]. Open-chamber devices require an exact climatisation
and still ambient air; the results may be influenced by external factors. Closed-
chamber instruments are easier to handle and result in smaller experimental scat-
tering of the obtained data [89].
In the context of this work, the closed-chamber device Aquaflux® (Biox® Sys-
tems Ltd., London, UK) was employed since it prevents environmental factors
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from directly influencing the measurement results. The measurement principle is
the condenser-chamber method (Figure 10) [90].
Figure 10: The Aquaflux® closed-chamber device and its measurement principle
(courtesy of B. Imhof, Biox® Ltd.)
The measurement head is placed onto the skin, thereby creating a closed envi-
ronment between the skin surface and the aluminium condenser at the top of the
chamber that is maintained below the freezing temperature of water. At the skin
surface, the water vapour emerging from the skin creates an area of high humidity
while the condenser converts water vapour to ice and thus acts as humidity sink.
Due to this humidity gradient, the water vapour migrates from the skin to the
condenser by passive diffusion and the water vapour flux in g m-2 h-1 is calculated
from the measured humidity gradient [87, 90, 91].
For in vitro studies, determination of the TEWL does of course not offer the
same applicability as for in vivo experiments since excised porcine ears lack an
active circulation. The skin and the underlying tissue may dehydrate during pro-
longed experiment times and the TEWL thus largely depends on the state of the
ear. Nevertheless, determination of the TEWL in vitro can be employed to char-
acterise the state of fresh porcine ears, to assess the skin barrier function and to
monitor the defrosting process if frozen porcine ears are employed. The hydra-
tion of porcine ears within a set of experiments can be determined with satisfying
accuracy and diseased skin areas or lesions with increased TEWL values can be
identified and excluded [92, 93].
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Capacitance-based Fingerprint Sensor Imaging
A capacitance-based sensor was tested for its suitability to characterise the skin
surface properties of porcine ear skin in vitro. Skin capacitance is an electrical
property of the skin that can be measured at the level of the SC. The obtained
values are related to the moisture content of the tissue. Thus, skin hydration
mapping can be employed to visualise and quantify the water content of the skin
[94].
Skin capacitance imaging is a non-optical and non-invasive method that can
distinguish different levels of SC hydration. This capacitive pixel-sensing technol-
ogy is based on a silicone image sensor technology that was initially developed for
fingerprint assessment in biometric security procedures. The technique allows to
record capacitance images of the skin surface in relation to the skin surface hydra-
tion at 50 µm intervals. Changes in the SC structure may be related to its water
holding capacity and alterations of the barrier function that affect the electrical
properties of the skin can thus be detected. Sites of dermal inflammation and
subclinical irritation, lesions or sweat gland disturbances can be identified in vivo
[95-97].
In addition, capacitance mapping of the skin was found highly useful to inves-
tigate the skin relief or surface topography in vivo due to its simplicity and speed
of data acquisition [98, 99]. Capacitive skin images give a representation of the
skin topography in terms of wrinkles and cells. In dermatology and cosmetics, the
characterisation of the skin surface topography can serve to investigate the effect
of dermatological or cosmetic formulations or to evaluate the ageing process of
the skin. Primary and secondary lines and wrinkles as well as skin pores can be
visualised [94, 100-102].
The capacitance-based sensor employed for skin hydration imaging and surface
analysis during this work is a novel, hand-held probe that uses fingerprint array
sensors (MBF 200, Fujistu Ltd.) [103] (Figure 11). Advantages of this technique
are its non-invasive nature and its rapid and simple use. The device is briefly
applied onto the skin to assess the current skin hydration properties. Specifically
designed algorithms calculate skin hydration maps, skin micro relief images and
even 3D surface profiles of the skin. The skin surface pattern of hydration and to-
pography is viewed as high-resolution real-time non-optical images. Skin hydration
maps of 256 x 300 pixels with a spatial resolution of 50 x 50 µm are automatically
generated. Each pixel is represented by an 8-bit greyscale value on a scale from
0 to 255. High greyscale values, i.e. dark pixels, represent hydrated areas of high
capacitance while low greyscale values, i.e. bright pixels, represent dry spots or
depressions and lines in the micro relief which impede the contact between the
probe and the SC. Areas where skin moisture is lost via the SC via sweat glands
or damaged skin areas can be detected [95, 96, 103].
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Figure 11: Capacitance-based fingerprint sensor (MBF 200, Fujistu Ltd.)
Since this technique had not been employed for skin integrity testing in con-
text with tape stripping experiments on either human or porcine skin, we decided
to investigate the applicability of capacitance-based imaging for quality control
of porcine ear skin and monitoring of the changes in skin barrier function dur-
ing tape stripping. Comparison of the obtained data with corresponding TEWL
values should reveal whether the two techniques deliver comparable results and
are equally suitable for the initial control of porcine ear skin and a subsequent
in-process control during in vitro tape stripping.

CHAPTER 3
Publications
The fundamental concepts of this work are presented in the following publications:
• Lecithin-based Nanoemulsions: ‘Enhancement of stability and skin perme-
ation by sucrose stearate and cyclodextrins in progesterone nanoemulsions’,
Int. J. Pharm. 393 (2010), 152–160
• Sucrose Stearate-based Nanoemulsions: ‘Development of sucrose stearate-
based nanoemulsions and optimisation through γ-cyclodextrin’, Eur. J.
Pharm. Biopharm. 79 (2011), 58–67
• Facilitating in Vitro Tape Stripping: ‘Facilitating in vitro tape stripping:
application of infrared densitometry for quantification of porcine stratum
corneum proteins’, Skin Pharmacol. Physiol. 24 (2011), 256–268
• Semi-solid Sucrose Stearate Emulsions: ‘Semi-solid Sucrose Stearate-Based
Emulsions as Dermal Drug Delivery Systems’, Pharmaceutics 3 (2011), 275-
306
• In Vivo/in Vitro - Correlation: ‘In Vitro vs in Vivo Tape Stripping: Valida-
tion of the Porcine Ear Model and Penetration Assessment of Novel Sucrose
Stearate Emulsions’, Eur. J. Pharm. Biopharm., in press
The remaining publications augment previous findings and allow a more detailed
insight into specific aspects of the established results.
• Effect of γ-Cyclodextrin: ‘Effect of γ-cyclodextrin on the in vitro skin per-
meation of a steroidal drug from nanoemulsions: Impact of experimental
setup’, Int. J. Pharm., in press
33
34 CHAPTER 3. PUBLICATIONS
• Skin Integrity Testing: ‘Skin integrity testing and monitoring of in vitro tape
stripping by capacitance-based sensor imaging’, Skin Res. Technol., submit-
ted Nov 18th 2011 - under review
• Optimisation of Sucrose Stearate Emulsions: ‘Semi-solid O/W emulsions based
on sucrose stearates: influence of oil and surfactant type on morphology and
rheological properties’, J. Disp. Sci. Technol., accepted for publication
International Journal of Pharmaceutics 393 (2010) 152–160
Contents lists available at ScienceDirect
International Journal of Pharmaceutics
journa l homepage: www.e lsev ier .com/ locate / i jpharm
Enhancement of stability and skin permeation by sucrose stearate and
cyclodextrins in progesterone nanoemulsions
Victoria Klanga, Nadejda Matskob, Anna-Maria Zimmermanna, Emina Vojnikovica, Claudia Valentaa,∗
a University of Vienna, Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Life Sciences, Althanstraße 14, 1090 Vienna, Austria
b Graz University of Technology and Centre for Electron Microscopy Graz, Institute for Electron Microscopy and Fine Structure Research, 8010 Graz, Austria
a r t i c l e i n f o
Article history:
Received 14 January 2010
Received in revised form 20 April 2010
Accepted 21 April 2010
Available online 29 April 2010
Keywords:
Nanoemulsion
Submicron emulsion
Cyclodextrin
Progesterone
Sucrose stearate
a b s t r a c t
Lecithin-based nanoemulsions are colloidal drug delivery systems which offer fundamental advantages
in topical therapy, such as excellent skin permeation of lipophilic drugs; however, their physicochem-
ical long-term stability is usually rather poor without the use of additional synthetic surfactants such
as polysorbates. In a novel approach negatively and positively charged formulations were developed
without the use of conventional synthetic surfactants. Natural substances such as sucrose esters and
different cyclodextrins were additionally used as stabilising agents. Emphasis was laid on optimisation
of the homogenisation process and formulation properties. The optimised formulations were tested for
their potential as drug delivery systems for progesterone. Furthermore, crucial formulation parameters
such as particle size and zeta potential were monitored for more than a year. In this context, the effect
of the natural excipients sucrose stearate and cyclodextrins ,  and  on in vitro skin permeation was
investigated; the inﬂuence of the positive particle surface charge induced by incorporation of the cationic
phytosphingosine was evaluated as well. The results showed that in particular the cyclodextrins seemed
to induce fundamental changes in formulation microstructure as conﬁrmed by cryo TEM, thus leading to
remarkably increased skin permeation rates of progesterone compared to the control.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Multicomponent systems with particle sizes in the submicron
range play an important role as drug delivery systems today.
In topical drug delivery, colloidal multiphase systems such as
nanoemulsions offer fundamental advantages in terms of per-
meation enhancement for lipophilic drugs and skin-compatibility
(Tadros et al., 2004). However, their widespread use is limited by
their comparatively poor long-term stability when compared to
thermodynamically stable systemssuchasmicroemulsions (Tadros
et al., 2004).
Nanoemulsions aremetastable systemscharacterisedbyamean
droplet diameter below 100nm (Sonneville-Aubrun et al., 2004).
However, the term is widely used to describe formulations with
particle sizes in the submicron range below 500nm (Porras et al.,
2004). Hence for the sake of simplicity, the submicron-sized formu-
lationsdeveloped in this studywill be referred toasnanoemulsions.
A major amount of research has been devoted to the
development of lecithin-based nanoemulsions with acceptable
physicochemical stability (YilmazandBorchert, 2005;Hoeller et al.,
2009). The small content of mostly eudermic surfactants in these
formulations renders them highly suitable for dermal application.
∗ Corresponding author. Tel.: +43 1 4277 55 410; fax: +43 1 4277 9554.
E-mail address: Claudia.valenta@univie.ac.at (C. Valenta).
Both negatively and positively charged nanoemulsions have
been developed in order to overcome the barrier posed by the stra-
tum corneum of the skin (Piemi et al., 1999; Yilmaz and Borchert,
2005; Hoeller et al., 2009). Literature suggests that formulations
with positive droplet surface charge yield higher permeation rates
for drugs because of better interaction with negatively charged
residues of skin proteins (Piemi et al., 1999; Hoeller et al., 2009)
or lipids (Michniak-Kohn et al., 2005). The cationic base phytosph-
ingosine (PS) has already been incorporated into nanoemulsions
successfully (Yilmaz and Borchert, 2005; Hoeller et al., 2009) and
was therefore selected as additional compound to induce a positive
particle surface charge.
So far, however, additional synthetic surfactants such as
polysorbates (Tweens) were generally necessary to stabilise such
nanoemulsions for a longer period of time (Yilmaz and Borchert,
2005; Hoeller et al., 2009). Polysorbates are ethoxylated tensides
which supposedly cause skin irritation and contact dermatitis
(Bergh et al., 1998a,b). They might therefore impair the skin-
friendliness of the developed nanoemulsion systems.
In this context, natural emulsiﬁers offer an appropriate alter-
native to conventional synthetic surfactants. Apart from lecithin
mixtures, various carbohydrates have been shown to possess
interesting properties in terms of stabilising multiphase systems.
In recent years, the so-called “sugar surfactants” have enjoyed
increasedattention in formulationdevelopment. This termnotonly
refers to alkylpolyglucosides, but also to the less frequently investi-
0378-5173/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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gated sucrose esters such as sucrose stearate (SS). These non-ionic
surfactants are fatty acid esters of sucrose which exhibit differ-
ent HLB values according to the type and number of their fatty
acid residues (Csoka et al., 2007). Certain sucrose esters have been
shown to increase skin permeation of drugs (Ayala-Bravo et al.,
2003;Cazares-Delgadillo et al., 2005;Calderilla-Fajardoet al., 2006;
Csoka et al., 2007). Therefore, these natural surfactants were cho-
sen as co-emulsifying agents to be tested for their suitability in
formulation development and their effect on skin.
Another class of carbohydrates which has recently (Duchene
et al., 2003; Bochot et al., 2007; Inoue et al., 2008; Rother, 2009)
been investigated in terms of emulsifying properties are the cyclic
oligosaccharides called cyclodextrins (CDs). These well-known
pharmaceutical compounds are able to form non-covalent inclu-
sion complexes with suitable lipophilic molecule structures. They
are therefore frequently used to stabilise or solubilise lipophilic
drugs (Challa et al., 2005). Their rather poor water-solubility has
led to the development of a large number of chemically modi-
ﬁed derivatives with improved physicochemical properties. The
present study, however, focuses on the use of the common natural
CDs ,  and .
In drug delivery systems used on skin, CDs have been reported
to improve the dispersion of drugs and inﬂuence their skin perme-
ation rates (Loftsson et al., 2007). In addition, they can be used to
stabilise emulsion systems by complexation of fatty acid residues
of the oil phase. Thus, new surface active molecule complexes are
formed which lower interfacial tension and stabilise the systems
(Duchene et al., 2003; Inoue et al., 2008). These newly formed
amphiphilic “supermolecules” (Rother, 2009) representhighlyeud-
ermic emulsifying agents as the CDs themselves cannot permeate
the skin due to their large molecular weight (Loftsson and Masson,
2001).
The concept of using CDs as emulsifying agents in multiphase
systems was ﬁrst introduced by Shimada et al. (1991, 1992). How-
ever, it has only been investigated to a limited extent in simple
emulsion or multiple emulsion systems (Yu et al., 2003; Hashizaki
et al., 2007; Inoue et al., 2008). To date few approaches have been
made to test the feasibility of using CDs as additional stabilising
agents in complex multicomponent systems such as lecithin-based
nanoemulsions. Hence, the natural CDs ,  and  were chosen
as respective co-stabilising excipients in order to investigate their
effect on formulation properties and skin permeation of the model
drug progesterone.
In conclusion, the primary aim of the present study was
the development of stable nanoemulsions as delivery systems
for progesterone without the use of possibly skin-irritating syn-
thetic surfactants such as polysorbates. To this end, lecithin-based
nanoemulsions with negative or positive particle surface charge
were developed and optimised with the help of additional stabilis-
ing agents such as sucrose esters and CDs. The second objective
of this study was the investigation of the effect of aforemen-
tioned excipients, in particular the CDs, on formulation properties
and microstructure as well as skin permeation of the model drug
progesterone in vitro. In this context, the hypothesis of superior
skin permeation from positively charged formulations containing
phytosphingosine in comparison to their negatively charged coun-
terparts was evaluated as well.
2. Materials and methods
2.1. Materials
Cyclodextrin  (Cavamax® W6 Pharma) and  (Cavamax® W8
Pharma) were obtained from Wacker Chemie AG (Munich, Ger-
many); cyclodextrin  (Kleptose) was kindly donated by Roquette
frères (Lestrem, France). Progesterone (CAS: 57-83-0) was pur-
chased from Sigma–Aldrich (St. Louis, USA). Phytosphingosine was
kindly provided by Degussa (Cosmoferm BV, NL). Lipoid E-80 was
donated by Lipoid GmbH (Ludwigshafen, Germany), containing
81.8% phosphatidylcholine, 8.2% phosphatidylethanolamine and
2.0% lysophosphatidylcholine according to manufacturers’ speci-
ﬁcations. Sucrose stearate (Ryoto Sugar Ester® S-970) and sucrose
laureate (Ryoto Sugar Esters® L-595 and L-1695) were supplied by
Mitsubishi-Kasei FoodCorporation (Tokyo, Japan). Propyleneglycol
(1,2-propanediol) and the antioxidant -tocopherol were pur-
chased from Pauli GmbH & Co. KG (Vienna, Austria). The preserving
agent potassium sorbate was obtained from Herba Chemosan
Apotheker-AG (Vienna, Austria). PCL-liquid (cetearyl ethylhex-
anoate, isopropyl myristate) was provided by Symrise GmbH &
Co. KG (Holzminden, Germany). All other chemicals used were
of analytical reagent grade and used as received without further
puriﬁcation.
2.2. Preliminary tests and solubility studies
2.2.1. Optimisation of formulation composition
Different sugaresters S-970, L-595andL-1695were testedas co-
emulsiﬁers; to this end, they were incorporated (1%, w/w) into the
basic formulations. Furthermore, different concentrations of CDs
were incorporated into the basicmixtures both alone and in combi-
nation with sucrose esters; the most suitable concentration of CDs
in terms of formulation properties was selected for further studies.
2.2.2. Solubility of progesterone
An important aspect of skin permeation studies in vitro is the
choice of the receptor ﬂuid. Progesterone is almost insoluble in
water (3.79×10−5 Mat 25 ◦C) (Zoppetti et al., 2007); since awholly
aqueous receptor medium like phosphate buffer is unsuitable for
drugs with a water solubility lower than 10g/ml (Brain et al.,
1998), propylene glycol/water (40+60, w/w) was chosen as recep-
tor phase. The solubility of progesterone in this acceptor medium
hasalreadybeenestablishedandhasbeen found tobe suitable for in
vitro skin diffusion studies (Valenta et al., 2001; Biruss and Valenta,
2006).
2.3. Formulations
Nanoemulsions were prepared as previously described (Hoeller
et al., 2009); process parameters were optimised. The aqueous
and oily phases were prepared separately. The aqueous phase,
consisting of freshly distilled water and potassium sorbate, was
stirred at 50 ◦C. In the respective formulations, sucrose ester and
CD ,  or  were incorporated into the aqueous phase. The
oil phase consisted of PCL-liquid, Lipoid E-80, propylene glycol
and -tocopherol; phytosphingosine and progesterone were dis-
solved in the oil phase as well in the respective formulations. The
two phases were mixed and pre-homogenised for 4min with an
ultra-turrax (Omni 500) at 2500 rpm. Afterwards, the mixture was
stirred and heated to 50 ◦C before it was further homogenised
with a high-pressure homogeniser (EmulsiFlex C3, Avestin) for 16
homogenisation cycles at 750bar. Table 1 shows the different for-
mulations as well as their composition and abbreviations.
2.4. Nanoemulsion characterisation
2.4.1. Particle size
All formulations were analysed for their particle size and par-
ticle size distribution by photon correlation spectroscopy using a
Zetasizer Nano ZS (Malvern, UK) at 25 ◦C. Samples were diluted
with freshly distilled water 1:100 (v/v) to diminish opalescence.
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Table 1
Composition of optimised nanoemulsion formulations with negative particle surface charge and abbreviations. The corresponding positively charged formulations were
created by addition of the cationic phytosphingosine (PS, 0.1%, w/w) and marked with “+”. Drug-loaded formulations were created by incorporation of progesterone (1%,
w/w) and marked with “prog”.
Excipients Nanoemulsion composition (% w/w)
   Control -SS -SS -SS Control-SS
Lipid phase
PCL-liquid 20 20 20 20 20 20 20 20
Lipoid E80 4 4 4 4 4 4 4 4
Propylene glycol (PG) 3 3 3 3 3 3 3 3
-Tocopherol 1 1 1 1 1 1 1 1
Aqueous phase
Sucrose stearate S-970 (SS) – – – – 1 1 1 1
Cyclodextrin  (-CD) 0.5 – – – 0.5 – – –
Cyclodextrin  (-CD) – 0.5 – – – 0.5 – –
Cyclodextrin  (-CD) – – 0.5 – – – 0.5 –
Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Distilled water to 100 100 100 100 100 100 100 100
The obtained polydispersity index (PDI) values represent the parti-
cle size distribution within the formulations. PDI values below 0.2
indicate a narrow size distribution; this indicates good long-term
stability due to reduction of degradation processes like Ostwald
ripening (Yilmaz and Borchert, 2005). The parameters of interest
were measured immediately after preparation of the formulations;
the obtainednanoemulsionswere stored at 4 ◦Candmeasurements
were performed every fortnight over a period of more than 12
months. Thus, information about the long-term stability of the for-
mulations was gained.
2.4.2. Particle surface charge (zeta potential)
The particle surface charge of the formulations was deter-
mined by laser Doppler electrophoresis using a Zetasizer Nano
ZS (Malvern, UK). Zeta potential (ZP) values of the formulations
were determined at 25 ◦C. Samples were diluted with distilled
water (1:100, v/v) containing sodium chloride (0.01mmol) in order
to ensure constant conductivity below 0.05mS/cm. As distilled
water alone might lead to ﬂuctuating conductivity as solvent,
addition of electrolytes ensures reproducible measurement con-
ditions (Mueller, 1996; Yilmaz and Borchert, 2005). The ZP roughly
characterises the surface charge of the emulsion particles. High
absolute values lead to repulsive forces between particles which
might improve the stability of multiphase systems. Absolute val-
ues higher than 30mV generally indicate good long-term stability
(Mueller, 1996). Zeta potential values were measured immediately
after preparation of the formulations and were continuously anal-
ysed every fortnight over the observation period of more than 12
months.
2.4.3. Cryo transmission electron microscopy (Cryo TEM)
Standard nanoemulsion samples containing -CD were com-
pared to a control nanoemulsion without CD in order to establish
differences inparticle formationandmicrostructureof the formula-
tions. The samples were dissolved (1:10, v/v) in distilled water (pH
6.7); then a 4mdrop of each solutionwas placed on a TEM copper
grid coveredwith aperforated carbonﬁlm (Pelco International) and
blotted with a ﬁlter paper to form a thin liquid ﬁlm of the sample
(thickness of 100–250nm). The thinned sample was plunged into
liquid ethane at its freezing temperature (−183 ◦C) to form a vitri-
ﬁed specimen, and then transferred to liquid nitrogen (−196 ◦C) for
storage until examination. Vitriﬁed specimens were examined in a
Philips T12 transmission electronmicroscope (Philips) operating at
an accelerating voltage of 120kV using an Oxford CT3500 (Oxford
Instruments) cryo holder that maintained the vitriﬁed specimens
at −160 ◦C during sample observation. Images were recorded dig-
itally on a cooled Gatan BioScan CCD camera (Gatan) using the
DigitalMicrograph 3.4 software (Gatan) in low-dose imaging mode
to minimise beam exposure and electron beam radiation damage.
2.5. Chemical stability
In order to investigate a possible inﬂuence of the CDs on stability
and distribution of progesterone, stability studies were performed
for all drug-loaded formulations. The drug content was analysed
immediately after preparation and set as 100%. The nanoemul-
sions were stored at 4 ◦C. Samples were taken every fortnight for
6 months. Brieﬂy, 10mg of nanoemulsion were dissolved in 1ml
of methanol, centrifuged for 6min at 12,000 rpm (Hermle Z323K,
MIDSCI, USA) and analysed by HPLC. Samples were taken at least
in triplicate (n≥3).
2.6. Skin permeation experiments
In vitro skin permeation studies were performed using standard
Franz-type diffusion cells (Permegear, USA). Porcine abdominal
skin was chosen as model membrane because of its morphol-
ogy and permeability, which are similar to those of human skin
(Cazares-Delgadillo et al., 2005; Michniak-Kohn et al., 2005). The
porcine abdominal skin was freed from hair and treated with a der-
matome (GB 228R, Aesculap) set at 1.2mm. The obtained skin was
stored at −20 ◦C until use. The samples were defrosted 2h prior to
the experiment.
Appropriate skin patches were clamped between the donor and
the receptor chamber of the diffusion cells having a permeation
area of 1.13 cm2. The receptor compartment was ﬁlled with 2ml of
propylene glycol/water (40+60, w/w) to provide sink conditions
for progesterone, as previously reported (Valenta and Wedenig,
1997; Biruss and Valenta, 2006).
The diffusion cells were kept at skin surface temperature (32 ◦C)
and stirredwithmagnetic bars for 48h. The formulation (0.6 g)was
placed on the excised skin in the donor chamber. Samples of 200l
were removed at deﬁned time intervals for analysis and replaced
by fresh receptor medium. At least ﬁve parallel experiments were
performed for each formulation (n≥5). The sampleswere analysed
for their drug content byHPLC. Permeation proﬁles of progesterone
were constructed by plotting time (hours) against the cumulative
amount of the drug (g/cm2) measured in the receptor solution.
In addition, the steady state ﬂux (J,g cm−2 h−1) was calculated by
linear regression after 8h of lag-time.
2.7. HPLC analysis of progesterone
Samples were analysed for their drug content by HPLC
(PerkinElmer, USA), consisting of an auto sampler (ISS-200), a
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Table 2
Physicochemical properties of different nanoemulsions: comparison of blank versus drug-loaded formulations containing -CD. Values are means± SD of at least three
formulations (n≥3). Measurements were performed in triplicate on a Zetasizer Nano ZS (Malvern, UK) at 25 ◦C. Samples were diluted with distilled water (1:100, v/v)
containing sodium chloride (0.01mmol) before the experiments to ensure constant conductivity around 0.025mS/cm. Parameters shown are mean particle size (MPS),
polydispersity index (PDI) and zeta potential (ZP).
MPS (nm) PDI ZP (mV) Conductivity (mS/cm)
 149.58 ± 10.05 0.07 ± 0.01 −23.54 ± 3.38 0.023 ± 0.002
 prog 194.62 ± 13.18 0.07 ± 0.01 −20.82 ± 4.47 0.025 ± 0.003
-SS 140.35 ± 6.40 0.08 ± 0.01 −41.96 ± 2.67 0.025 ± 0.002
-SS prog 174.33 ± 13.86 0.08 ± 0.01 −37.51 ± 4.57 0.024 ± 0.003
+ 258.80 ± 56.56 0.19 ± 0.06 55.20 ± 3.238 0.028 ± 0.005
+prog 316.59 ± 20.42 0.24 ± 0.04 52.90 ± 3.64 0.023 ± 0.005
-SS+ 175.37 ± 12.43 0.11 ± 0.02 46.33 ± 3.46 0.031 ± 0.006
-SS +prog 266.67 ± 22.65 0.20 ± 0.03 44.75 ± 3.61 0.023 ± 0.002
pump (lc pump, ISS-200) and an UV-diode array detector (235C).
A previously reported method was used with slight adaptations
(Biruss and Valenta, 2006), using a Nucleosil 100-5 C18 column
(250mm×4mm, Macherey-Nagel, USA) plus pre-column (SS 8/4).
The mobile phase consisted of methanol/water (70+30, w/w). The
detection wavelength was set at 255nm and the retention time
was approximately 7min at a ﬂow rate of 1.0ml/min. A calibration
curve was calculated based on peak area measurements of diluted
standard solutions ranging from0.79 to101.30g/ml. Theobtained
correlation coefﬁcient was 0.9999.
2.8. Differential scanning calorimetry (DSC)
Skin samples were analysed with a differential scanning
calorimeter (PerkinElmer DSC-7) according to an established
method in order to investigate the thermal transitions of the
porcine skin used for the experiments (Valenta et al., 2001; Hoeller
et al., 2009). In short, about 25mg of porcine skin were impreg-
nated with 3ml of nanoemulsion for 24h. Control samples were
treated with 3ml of distilled water in the same fashion. The skin
samples were then blotted dry, sealed within an aluminium holder
and heated from 30 to 120 ◦C at a heating rate of 5 ◦C/min. The
obtained DSC curves were compared to the control samples in
terms of linear onset and transition temperature (peak maximum)
of the obtained endothermic peak. Gravimetric analysis of the sam-
ples prior to DSC experiments showed an average water content of
55.61±1.82% (w/w).
2.9. Statistical data analysis
Statistical data analysis was performed with the software pro-
gram GraphPadPrism using the Student’s t-test with P<0.05 as
minimum level of signiﬁcance. Results are expressed as means of
at least three experiments± SD.
3. Results
3.1. Formulations
Based on previous studies, basic lecithin-based nanoemulsions
were optimised in terms of composition and production condi-
tions. Blank and drug-loaded nanoemulsions were created using
an established method (Hoeller et al., 2009). Table 2 shows the
physicochemical properties of the different formulations. It was
also possible to introduce a positive surface charge by addition of
PS; a concentration of 0.1% (w/w) proved to be most suitable.
Preliminary studies with different concentrations of CDs
showed an amount of 0.5% (w/w) to be appropriate for creating sta-
ble nanoemulsions with acceptable solubilising capacity for other
compounds.
Three saccharose esters were tested as co-surfactants. Sucrose
laureateL-595 led to systemswithhigh lipophilicity, thus rendering
incorporation of lipophilic drugs impossible. Sucrose laureate L-
1695 led to unstable formulations with quick increase in particle
size and ﬂuctuating zeta potential. Sucrose stearate S-970 (SS) led
to satisfying results; it was therefore chosen as most suitable co-
surfactant for all further studies.
3.2. Nanoemulsion characterisation
Visual inspection revealed whitish, homogenous formulations
of low viscosity in all cases. As the droplet size is above 100nm, the
formulations appear white due to signiﬁcant multiple scattering of
light (Mason et al., 2006).
3.2.1. Particle size, polydispersity index and zeta potential
All formulations were analysed directly after production. Crit-
ical parameters such as particle size, PDI and zeta potential were
determined. Since properties of corresponding formulations were
similar irrespectiveof the typeofCDused,nanoemulsionproperties
are demonstrated only on formulations containing -CD as rep-
resentative example. Table 2 demonstrates their physicochemical
properties after 16 homogenisation cycles.
Negatively charged blank nanoemulsions showed particle sizes
between140and195nmwhileparticle sizesofdrug-loaded formu-
lations were slightly increased. Formulations containing additional
SS exhibited lower particle sizes. As Table 2 clearly shows, PDI val-
ues of all negatively charged formulationswere far below0.2which
indicates high homogeneity within the formulations. Addition of
PS led to positively charged nanoemulsions with increased particle
sizes of at least 170nmup to over 300nm. As expected, the PDIwas
slightly deteriorated, thus affecting storage stability of the formu-
lations. The additional incorporation of SS again decreased particle
sizes in most cases. In contrast, the addition of progesterone led to
strongly increased particle sizes.
The particle surface charge (zeta potential, ZP) values were
determined for all formulations. Conductivity was kept constantly
below 0.05mS/cm, thus ensuring reproducible measurement con-
ditions. Average conductivity of the diluted samples was around
0.025–0.030mS/cm for all measurements. Negatively charged
nanoemulsions showed average ZP values around −20mV. Addi-
tion of SS led to an increase in absolute ZP values from around −20
to −40mV, thereby increasing electrochemical stability. Addition
of PS led to formulations with positive ZP values between +44 up
to +55mV. In these positively charged nanoemulsions, incorpora-
tion of SS only induced minor changes in surface charge; ZP values
were not inﬂuenced or even decreased in some cases. Incorpora-
tion of progesterone generally led to a slight decrease of absolute
ZP values.
The physicochemical long-term stability of the formulations
was monitored over 12 months and investigations are still ongo-
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Table 3
Inﬂuence of cyclodextrins on long-term stability: effect of -cyclodextrin on positively charged drug-loaded formulations with (a) or without (b) sucrose stearate (SS).
Parameters shown are mean particle size (MPS) in nm, polydispersity index (PDI) and zeta potential (ZP) in mV. Measurements were performed at least in triplicate (n≥3;
Zetasizer Nano) every 2 weeks for 12 months or until phase separation occurred (*). Numbers are means± SD.
(a)
Time (weeks) +prog Control +prog
MPS± SD PDI± SD ZP± SD MPS± SD PDI± SD ZP± SD
0 316.59 ± 20.42 0.24 ± 0.04 52.90 ± 3.64 465.47 ± 70.66 0.35 ± 0.04 54,45 ± 4.60
2 320.89 ± 41.49 0.25 ± 0.02 53.39 ± 2.16 472.32 ± 50.50 0.32 ± 0.04 50,02 ± 1.55
4 314.20 ± 28.87 0.24 ± 0.05 50.37 ± 4.70 524.64 ± 95.74 0.37 ± 0.05 44.78 ± 5.02
6 307.57 ± 13.54 0.21 ± 0.03 49.33 ± 3.42 * * *
8 325.35 ± 34.64 0.21 ± 0.01 49.65 ± 1.58 * * *
10 312.77 ± 7.78 0.24 ± 0.03 50.41 ± 2.51 * * *
12 334.74 ± 25.82 0.23 ± 0.09 46.60 ± 3.82 * * *
14 350.15 ± 52.30 0.22 ± 0.07 41.11 ± 1.80 * * *
16 362.41 ± 48.32 0.26 ± 0.08 40.72 ± 6.06 * * *
18 336.06 ± 17.83 0.26 ± 0.04 48.52 ± 1.80 * * *
20 352.01 ± 36.34 0.28 ± 0.06 38.08 ± 2.78 * * *
22 375.77 ± 55.26 0.23 ± 0.07 37.93 ± 4.74 * * *
24 326.45 ± 10.36 0.23 ± 0.05 33.97 ± 9.36 * * *
52 465.41 ± 56.76 0.34 ± 0.06 34.24 ± 6.79 * * *
(b)
Time (weeks) -SS +prog Control-SS +prog
MPS± SD PDI± SD ZP± SD MPS± SD PDI± SD ZP± SD
0 266.67 ± 22.65 0.20 ± 0.03 44.75 ± 3.61 504.36 ± 81.79 0.32 ± 0.04 56.54 ± 3.93
2 274.04 ± 21.78 0.18 ± 0.04 45.46 ± 1.75 487.41 ± 136.26 0.34 ± 0.12 46.80 ± 2.96
4 287.23 ± 49.09 0.162 ± 0.07 40.65 ± 1.33 511.18 ± 85.54 0.34 ± 0.02 46.79 ± 1.50
6 326.66 ± 57.14 0.21 ± 0.03 40.18 ± 1.21 * * *
8 353.21 ± 74.78 0.21 ± 0.05 38.15 ± 6.71 * * *
10 381.09 ± 102.43 0.19 ± 0.01 34.92 ± 3.83 * * *
12 474.67 ± 188.08 0.24 ± 0.01 35.35 ± 4.73 * * *
14 516.09 ± 199.21 0.25 ± 0.02 29.54 ± 8.13 * * *
16 630.00 ± 307.00 0.24 ± 0.03 31.63 ± 10.20 * * *
18 * * * * * *
ing. For negatively charged nanoemulsions, particle sizes and ZP
values remained almost constant for both blank and drug-loaded
formulations. Fig. 1 clearly illustrates that incorporation of pro-
gesterone hardly inﬂuenced formulation properties of negatively
charged formulations. However, its effect on the corresponding
positively charged formulationswasmorepronounced. Thedroplet
sizes of positively charged nanoemulsions showed a more rapid
increase and ZP values generally showed a stronger decrease, indi-
cating amore rapid destabilisation process (data not shown). These
effects were aggravated in the presence of progesterone (Table 3).
However, the degree of destabilisation caused by incorporation
of progesterone was dependent on the CD incorporated. In this
context, formulations containing - or -CD showed acceptable
particle sizes between 250 and 350nm, followed by -CD. Control
formulations without any CD, however, were completely unsta-
ble with particle sizes soon deteriorating far beyond 500nm. In
addition, the respective PDI values were increased. Table 3a and
b distinctly show the physical destabilisation of the control for-
mulations caused by agglomeration of particles. As can be seen
in Table 3b, no positive inﬂuence of the additional SS was notice-
able here. This indicates that it is the presence of CD alone that
contributes to the enhanced physical stability of the respective
formulations.
3.2.2. Cryo TEM
As illustrated in Fig. 2, the nanoemulsion droplets appeared
mostly spherical, if slightly deformed; this observation is in accor-
dance with previous studies (Mason et al., 2006; Shakeel et al.,
2007). The observed droplet size is in good correspondence with
the results achieved by photon correlation spectroscopy measure-
ments. However, the incorporated CD apparently leads to the
formation of additional multilamellar structures, as can be seen
Fig. 1. Inﬂuence of progesterone incorporation on long-term stability of nanoemul-
sions: development of mean particle size (bars) and zeta potential (lines) over an
observation period of 12 months as observed on negatively charged formulations,
shown on systems containing -cyclodextrin. Measurements were performed at
least in triplicate (n≥3) every 2 weeks for over a year, again using a Zetasizer Nano.
For reasons of clarity, the time frame is shortened in these graphs. Indicated values
are means± SD. -SS (white bars () and white dots (©), respectively); -SS prog
(black bars () and black dots (), respectively).
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Fig. 2. Cryo TEM photographs of the microstructure of nanoemulsions (a) with -cyclodextrin and (b) without cyclodextrin. The white arrows indicate the multilamellar
structures detected in formulations containing cyclodextrin. The magniﬁcation is illustrated by the scale bars.
in Fig. 2a. None of these structures were observed in the control
formulation without CD (Fig. 2b).
3.3. Chemical stability
The chemical stability of all drug-loaded formulations was
analysed by HPLC every fortnight during 6 months or until decom-
position. The average content of progesterone remained around
80% for most nanoemulsions during the observation period (data
not shown). Variations in drug contentwere rather due toproblems
in analysis than to instability of the steroid hormone, as literature
suggests (Kunze, 2006). No degradation products could be detected
by HPLC. The incorporation of CDs apparently did not inﬂuence the
recovered drug content.
3.4. Skin permeation experiments
Permeation proﬁles of progesterone from different nanoemul-
sions are shown in Fig. 3. Comparison of the cumulative amounts
permeated after 48h revealed a signiﬁcant inﬂuence of the CDs
on skin diffusion rates of progesterone compared to the control
(P<0.05). In negatively charged formulations, all CDs led to an
increase in skin permeation of progesterone despite the differ-
ent sizes of their lipophilic cavities. The highest permeation rates
were achieved with -CD, which was up to 5-fold compared to
the control (Table 4) in terms of the cumulative amount of pro-
gesterone. These permeation rates were followed by formulations
containing -CD and -CD. Interestingly, the same ranking of per-
meation enhancementwas observedboth in presence or absence of
SS, namely -CD>-CD>-CD> control. An additional effect of SS
as permeation enhancer was noticed in all formulations irrespec-
tive of the type of CD used (Table 4). The sugar surfactant led to
increased skin permeation from negatively charged formulations,
acting in synergy with the CDs used. Furthermore, Table 4 clearly
indicates that the drug ﬂuxes obtained by linear regression are in
good accordance with the conclusions derived from analysis of the
cumulative amounts permeated. A comparison of the mean drug
ﬂuxes shows a signiﬁcant if slightly smaller effect of the different
CDs with a 3.5-fold increase for formulations with -CD and SS.
In positively charged formulations, similar tendencies were
observed. The addition of PS led to a further increase of skin per-
meation, especially in formulations containing -CD (Fig. 3). In
formulations containing - and -CD the effect was not as pro-
nounced in all cases. Further studies are being conducted to achieve
consistent results.
3.5. Differential scanning calorimetry (DSC)
DSC studies were performed using a single piece of porcine
skin, which showed one endothermic peak at around 78 ◦C. This
peak corresponds to intracellular lipid layers and is in good accor-
dance with literature (Golden et al., 1987). All negatively charged
formulations led to a signiﬁcant change in peak maximum and
linear onset of the peak compared to the control samples which
were pre-impregnatedwithwater (P<0.05) (Table 5). Both of these
parameters were shifted to lower values. This indicates changes
Table 4
Inﬂuence of cyclodextrin ,  and  on cumulative amounts permeated and mean drug ﬂux J of progesterone; indicated values are means (n≥5)± SD. The calculated
enhancement factor highlights the effect of the cyclodextrins alone or in synergy with sucrose stearate (SS) compared to the control formulation.
Formulation Cumulative amount± SD
(g/cm2, after 48h)
Enhancement factor
versus control
Mean drug ﬂux± SD
(J, g cm−2 h−1)
Control prog 9.57 ± 3.56 1.00 0.35 ± 0.08
 prog 18.06 ± 2.22 1.89 0.58 ± 0.14
 prog 25.05 ± 2.29 2.62 0.63 ± 0.06
 prog 41.86 ± 4.46 4.37 1.04 ± 0.10
-SS prog 24.53 ± 5.37 2.56 0.72 ± 0.08
-SS prog 34.16 ± 5.00 3.57 0.86 ± 0.12
-SS prog 48.63 ± 5.08 5.08 1.21 ± 0.11
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Fig. 3. Effect of cyclodextrin ,  and  alone (a) and in combination with sucrose
stearate (SS) (b) on in vitro skin permeation rates of progesterone from negatively
and positively charged nanoemulsions; positively charged formulations are marked
with “+”. Drug permeation through porcine skin was determined by HPLC. At least
ﬁve experiments were performed for each formulation (n≥5) using Franz-type dif-
fusion cells. Indicated values are means± SD. Abbreviations: (a)  prog ();  prog
(); prog ();+prog (); control prog (©). (b)-SS prog ();-SS prog ();-SS
prog (); -SS +prog (); control prog (©).
in thermal transition of the skin lipids, as previously observed in
similar investigations (Hoeller et al., 2009). In addition, negatively
charged formulations containing -, - or -CD showed a slightly
stronger inﬂuence on skin lipids than the control nanoemulsion.
However, only minor differences between the effects of the indi-
vidual CDs were detected. For more distinguished analysis of
the different formulations a more sensitive method should be
employed.
In positively charged formulations, the changes in terms of peak
maximumand linear onsetwere smaller, if signiﬁcant inmost cases
(Table 5)when compared to thewater-impregnated control. This is
in accordancewith previous data (Hoeller et al., 2009); it can there-
fore be assumed that the positive effect of PS on skin permeation
is caused by other interactions than those with skin lipids. How-
ever, a slightly stronger effect on skin lipids could be achieved than
with previously developed formulations containing PS (Hoeller et
al., 2009).
4. Discussion
The primary objective of this study was the development of
stable formulations without the use of conventional synthetic sur-
Table 5
Thermal transition changes of porcine skin induced by pre-impregnation with pos-
itively and negatively charged nanoemulsions containing progesterone (1%, w/w)
for 24h. Porcine skin pre-impregnated with water served as a control. Experiments
were performed at least in quadruplicate (n≥4). Indicated values are means± SD.
Tm indicates the temperature of the transition’s maximum. Gravimetric analysis of
the samples prior to DSC measurements showed average water content of about
55% (w/w).
Treatment (n≥4) DSC Tm (◦C) Linear onset (◦C)
Skin treated with water (control) 79.64 ± 0.75 65.83 ± 0.28
Formulations
Control prog 75.99 ± 0.48 63.06 ± 0.66
 prog 73.63 ± 0.58 62.53 ± 0.44
 prog 74.39 ± 0.94 62.83 ± 0.48
 prog 75.22 ± 0.66 62.53 ± 0.74
-SS prog 74.53 ± 0.29 62.97 ± 0.33
-SS prog 74.49 ± 0.71 62.64 ± 0.06
-SS prog 75.13 ± 0.38 62.74 ± 0.55
+prog 79.51 ± 0.53 64.48 ± 0.73
+prog 78.85 ± 0.45 64.40 ± 0.55
+prog 77.04 ± 0.72 63.74 ± 0.52
-SS +prog 77.74 ± 0.91 63.89 ± 1.15
-SS +prog 77.32 ± 0.64 63.65 ± 0.28
-SS +prog 76.07 ± 0.68 63.12 ± 0.62
factants like polysorbates. Emphasis was laid on the use of natural
products; hence, the applicability of different sucrose esters aswell
asCDswas testedextensively. Thepositiveeffects inducedby incor-
poration of CDs clearly show that not all possible beneﬁts of CDs as
compounds in topical drug delivery systems have been thoroughly
investigated yet. The effect of CDs on formulation microstructure
might offer applications apart from drug solubilisation or stabilisa-
tion. However, it should be brought to mind that the effect of CDs
on a complexmultiphase systemcannot be generally predicted, but
has to be investigated separately for every novel formulation. It is
of utmost importance to perform CD formulation studies in media
that closely resemble the ﬁnal drug-loaded formulation (Jansook
and Loftsson, 2009). The present study is the ﬁrst evaluation of the
effect of CDs on complex nanoemulsion systems on a long-term
basis.
First off, we succeeded in developing basic negatively charged
formulations stabilised by lecithin only. Corresponding nanoemul-
sions with positive particle surface charge were created with the
help of the cationic phytosphingosine. However, incorporation of
progesterone led to destabilisation and skin permeation rates were
rather poor. Therefore, CDs and sucrose esters were tested as addi-
tional stabilising agents. This strategy proved to be successful. In
particular, a stabilising effect of the incorporated CDs was notice-
able in positively charged formulations containing progesterone.
The addition of CD ,  or  led to increased physicochemical sta-
bility compared to the control nanoemulsion, which was unstable
soon after production. This stabilising effect, however, was not as
pronounced in negatively charged formulations during the obser-
vation period; it was possibly obscured by the effects of the other
surfactants. All of the negatively charged formulations were stable
for over 1.5 years and stability evaluations are still ongoing.
In order to visualise the differences in formulation properties
caused by incorporation of CDs, the nanoemulsion microstruc-
ture was analysed by cryo TEM. Indeed, additional multilamellar
structures were found in nanoemulsions containing -CD while
none of these were detected in the control formulation without
CD. Furthermore, formulations with CD seemed to exhibit stronger
surface tension and their freezing behaviour was completely dif-
ferent from the behaviour of formulations without CD. These two
phenomena are most certainly related as carbohydrate containing
solutespossesshigher cohesionandacertain cryoprotective ability.
3.1. LECITHIN-BASED NANOEMULSIONS 41
V. Klang et al. / International Journal of Pharmaceutics 393 (2010) 152–160 159
Therefore, vitriﬁcation of larger volumes of formulations stabilised
by carbohydrates, such as the additional cyclodextrins, is possi-
ble. In contrast, crystallisation of water almost always occurred in
the control nanoemulsions before the cryoﬁxation was completed.
The stronger surface tension of the CD containing formulation
also might be related to the presence of the additional multil-
amellar structures. A possible explanation for these formations
could be the tendency of lecithin to self-aggregate and form mul-
tilamellar structures or other structural units (Shchipunov, 1997;
Meier and Schreiber, 2005). These multilamellar layers formed
by lecithin molecules can be regarded as an effective structural-
mechanical barrier (Shchipunov, 1997). After all, an important issue
in terms of destabilisation of lecithin-based emulsions is the sep-
aration into an aqueous layer and a concentrated emulsion phase
(Shchipunov, 1997). During the present study, this phenomenon
was only observed in positively charged nanoemulsions and could
be delayed by addition of CDs. In negatively charged formulations,
sufﬁcient stabilitywasapparentlyachieved irrespectiveof theaddi-
tional CDs. In this case only extended studies might reveal a more
distinctive stabilising effect of the CDs in the long term.
Why the observed multilamellar structures were only formed
in the presence of CDs remains to be investigated. Possibly, occu-
pation of interfacial regions by CDs leads to an excess of free
lecithin molecules which consequently form said vesicles. It is a
well-known fact that amphiphilic molecules like lecithin tend to
form higher structural units when dispersed in water at high con-
centrations; the formation of multiple bilayer membranes can lead
to ﬂat lamellar phases or vesicles (Shchipunov, 1997; Meier and
Schreiber, 2005). It might be assumed that larger CDs displace
more lecithin molecules and therefore lead to increased forma-
tion of additional multilamellar structures. The sugar ester present
in the investigated formulations might contribute to the forma-
tion of these multilamellar or perhaps even micelle-like structures.
Literature reports that similar phenomena have been observed in
formulations containing elastic vesicles based on a sucrose ester
(Bouwstra et al., 2003).
As a second aim of this study, the inﬂuence of CDs as well as
sucrose stearate on skin permeation of progesterone was evalu-
ated. Indeed, these compounds led to enhanced skin permeation
rates of the drug. The enhancement effect of a positive particle
surface charge induced by phytosphingosine was not consistent
throughout the studies and will be further investigated. Overall,
the achieved skin permeation rates from both positively and nega-
tively charged formulations were satisfying. The permeation rates
of progesterone from nanoemulsions with -CD exceeded those of
previously developed formulations such as liposomes when tested
under similar conditions (Biruss and Valenta, 2006).
The sucrose ester S-970, namely sucrose stearate, was found to
enhance skin permeation from all formulations. In consideration
of its HLB value, even stronger permeation enhancement effects
might have been achieved with sucrose esters of higher HLB val-
ues, such as sucrose laureate L-1695, if they had led to stable
formulations in the ﬁrst place. Previous studies show a satisfy-
ing enhancement effect of sucrose stearate S-970 for the release
of metoprolol from transdermal therapeutic systems. However,
sucrose esters with higher HLB values of around 15–16 which are
esteriﬁed with short chain fatty acids performed even better in this
respect (Csoka et al., 2007). Within the scope of the present study,
theuseof sucrose stearateS-970seemedtoconstitute thebest com-
promise to achieve satisfying results both in terms of formulation
stability and skin permeation.
In this context it has to be recollected that the HLB value of
lecithin is comparable to that of sucrose stearate S-970. It can there-
fore be concluded that the addition of sucrose stearate S-970 did
not alter theHLBvalueof approximately 9of the emulsifying agents
within the system. Consequently, the observed enhancement of
skin permeation can rather be ascribed to the additional presence
of sucrose stearate than to a change in overall HLB value of the
emulsiﬁer system used.
Interestingly, the observed skin permeation enhancement was
correlated to the cavity size of the incorporated CDs. The mecha-
nismofpermeationenhancement throughCDs is normally ascribed
to the complexation and thus better dispersion of drug molecules
within the formulation (Loftsson and Bodor, 1995). In the present
formulations, however, it is rather unlikely that the permeation
enhancement is caused only by solubilisation of progesterone as
the molar amount of CD is very low when compared to the molar-
ity of the drug. It might therefore be assumed that the CDs do not
mainly solubilise the drug, but rather contribute to the stabilisation
of the interfacial regions between oil droplets and water. Accord-
ing to recent studies, insertion of CD-oil complexes as additional
surfactants in this interfacial ﬁlm can lead to increased release of
drugs (Rother, 2009). The amphiphilicmolecule complexes suppos-
edly lead to areas of decreased thickness within the interfacial ﬁlm
through which drug molecules can permeate more rapidly. Fur-
thermore, the additional multilamellar structures might promote
interactions between skin and formulation in general and could
thus exert a positive inﬂuence on skin permeation.
5. Conclusion
The results of the present study show that it is possible to
develop eudermic nanoemulsions with optimised long-term sta-
bility without the use of conventional synthetic tensides. In this
respect, emulsifying additives such as sucrose esters are highly rec-
ommendable both in terms of stabilisation and skin permeation.
Furthermore, the natural CDs ,  and  proved to be of great
interest as additional compounds. TheCDs seemed to induce funda-
mental changes in formulation structure as conﬁrmed by cryo TEM,
thus leading to increased skin permeation rates of progesterone.
In addition, a positive effect of CD incorporation on formulation
stability was noticed for certain formulations.
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a b s t r a c t
Nanoemulsions aimed at dermal drug delivery are usually stabilised by natural lecithins. However, leci-
thin has a high tendency towards self-aggregation and is prone to chemical degradation. Therefore, the
aim of this study was to develop nanoemulsions with improved structure and long-term stability by
employing a natural sucrose ester mixture as sole surfactant. A thorough comparison between the novel
sucrose stearate-based nanoemulsions and corresponding lecithin-based nanoemulsions revealed that
the sucrose ester is superior in terms of emulsifying efﬁciency, droplet formation as well as physical
and chemical stability. The novel formulations exhibited a remarkably homogeneous structure in cryo
TEM investigations, as opposed to the variable structure observed for lecithin-based systems. The
in vitro skin permeation rates of lipophilic drugs from sucrose stearate nanoemulsions were comparable
to those obtained with their lecithin-based counterparts. Furthermore, it was observed that addition of c-
cyclodextrin led to enhanced skin permeation of the steroidal drug ﬂudrocortisone acetate from
9.99 ± 0.46 to 55.10 ± 3.67 lg cm2 after 24 h in the case of sucrose stearate-based systems and from
9.98 ± 0.64 to 98.62 ± 24.89 lg cm2 after 24 h in the case of lecithin-based systems. This enhancement
effect was signiﬁcantly stronger in formulations based on lecithin (P < 0.05), which indicates that syner-
gistic mechanisms between the surfactant and the cyclodextrin are involved. Cryo TEM images suggest
that the cyclodextrin is incorporated into the interfacial ﬁlm, which might alter drug release rates and
improve the droplet microstructure.
 2011 Elsevier B.V. All rights reserved.
1. Introduction
Classical O/W nanoemulsions can be produced by high-pressure
homogenisation using small amounts of natural lecithin as emulsi-
ﬁer, which accounts for their high skin friendliness [1–3]. Although
particle sizes below 100 nm are hardly reached with lecithin-type
emulsiﬁers, the term nanoemulsion is commonly used for such
systems with droplet sizes in the lower submicron range. Since
phospholipid mixtures possess superior emulsifying properties
compared to puriﬁed phosphatidylcholine, they are preferred for
nanoemulsion production [4,5]. However, these classical nano-
emulsion surfactants pose certain problems in formulation devel-
opment. On the one hand, phospholipids are prone to oxidative
and hydrolytical degradation [6], which results in an unfavourable
visual and olfactory appearance after a certain storage time. On the
other hand, lecithin mixtures have a high potential for self-aggre-
gation phenomena, which leads to the formation of vesicular or
multilamellar structures during the production of nanoemulsions
[4]. Although numerous studies report the presence of liposomal
vesicles in lecithin-based O/W nanoemulsions [7–11], few proposi-
tions have been made on how to avoid such by-products of high-
pressure homogenisation. Despite decades of research in this ﬁeld,
it is still unclear whether these structures can be entirely avoided
[6]. Moreover, it has not been fully clariﬁed whether the presence
of such structures has a negative effect on the formulations’ long-
term stability. Micelle-mediated transport of oil and the occur-
rence of liposomes have been reported to impair nanoemulsion
stability due to increased Ostwald ripening [12–15]. Technological
issues aside, the occurrence of liposomes in parenteral nanoemul-
sion systems is held responsible for dyslipidemias and embolisms
[6,16]. The development of homogeneous, vesicle-free O/W nano-
emulsions might therefore be desirable to achieve reproducible
properties and storage stability.
Although many aspects of lecithin behaviour are hard to pre-
dict, few studies discuss the issue of nanoemulsion homogeneity.
Common particle size measurement techniques such as dynamic
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light scattering fail to distinguish between oil droplets and other
nano-sized structures. In addition, information on how to avoid
the formation of unwanted surfactant aggregates is scarce. While
lecithin molecules have a pronounced tendency towards self-
aggregation, other natural and eudermic emulsiﬁers might be more
suitable to form reproducible O/W droplets. Hardly any informa-
tion on the disposition of different emulsiﬁer types to form these
by-products of high-pressure homogenisation can be found. The
present investigation addresses this shortcoming by a thorough
comparison of a commonly used lecithin mixture and a sucrose es-
ter mixture. It has been shown recently that sucrose esters can suc-
cessfully be employed as co-surfactants in nanoemulsions [17–19].
However, the use of these natural emulsiﬁer mixtures as main sur-
factants for classical nanoemulsion systems has not been thor-
oughly investigated yet. Especially, sucrose stearate S-970 has
been shown to exert positive effects on stability and skin perme-
ation of lecithin-based nanoemulsions [20]. Its HLB value of around
9 is comparable to that of lecithin; therefore, it should be deter-
mined whether the previously employed natural lecithin mixture
lecithin E-80 could be replaced as sole emulsiﬁer. To this end, a
thorough characterisation of blank and drug-loaded nanoemul-
sions in terms of physicochemical formulation parameters, micro-
scopic appearance and long-term stability was conducted.
As a second major focus of this study, the in vitro skin perme-
ation of four model drugs from the novel sucrose stearate-based
nanoemulsions was investigated and compared to the permeation
from lecithin-based systems. Although O/W nanoemulsions are
generally more suitable for the delivery of lipophilic drugs, hydro-
philic drugs were also included for reasons of comparison. More-
over, the effect of additional c-cyclodextrin (CD) was
investigated to conﬁrm a previously reported enhancement effect
on the skin permeation of a lipophilic steroidal drug [20]. Thus, fur-
ther insights into the suitability of natural CDs as additives in
nanoemulsions are gained.
2. Materials and methods
2.1. Materials
Egg lecithin Lipoid E-80 was donated by Lipoid GmbH (Ludwig-
shafen, Germany). Sucrose stearate (Ryoto Sugar Ester S-970) was
supplied by Mitsubishi-Kagaku Food Corporation (Tokyo, Japan).
Cyclodextrin c (Cavamax W8 Pharma) and cyclodextrin a (Cava-
max W6 Pharma) were obtained from Wacker Chemie AG (Mu-
nich, Germany). Cyclodextrin b (Kleptose) was donated by
Roquette frères (Lestrem, France). Fludrocortisone acetate (CAS:
514-36-3, Batch No. 075K1029) was purchased from Sigma Aldrich
(St. Louis, USA). Fluconazole (CAS: 86386-73-4, Batch No. 050418),
and ﬂufenamic acid (CAS: 530-78-9, Batch No. 1619) was obtained
from Kemprotec Limited (Middlesbrough, UK). Minoxidil (CAS:
38304-91-5, Batch No. 81835129) was purchased from Caesar &
Loretz GmbH (Hilden, Germany). The preserving agent potassium
sorbate was obtained from Herba Chemosan Apotheker-AG (Vien-
na, Austria). PCL-liquid (cetearyl ethylhexanoate, isopropyl myris-
tate) was purchased from Dr. Temt Laboratories (Vienna, Austria).
All other chemicals used were of analytical reagent grade and used
without further puriﬁcation.
2.2. Preliminary investigations and solubility studies
2.2.1. Optimisation of formulation composition
Preliminary studies were conducted to optimise formulation
composition and processing parameters. Different surfactant con-
centrations between 1% and 5% (w/w) were tested. Likewise, the
most suitable oil volume fraction for particle size reduction was
determined. Oil concentrations of 10%, 15% and 20% (w/w) were
investigated. Finally, the natural CDs a, b and c were incorporated
(1% w/w) in order to investigate their inﬂuence on formulation
properties.
2.2.2. Solubility of model drugs: choice of the receptor medium
The suitability of the chosen phosphate buffer (pH 7.4, 0.012 M)
as acceptor medium for in vitro skin diffusion studies has already
been established for all employed model drugs in previous work
by our group; details on solubility studies can be found in the lit-
erature [17,21,22]. The use of propylene glycol or ethanol as addi-
tives to enhance the solubility of the lipophilic drugs in the
aqueous buffer was avoided to prevent solvent effects. For reasons
of comparison both within this study and with previous results, the
same phosphate buffer was employed for all investigated drugs
even if the permeation of the lipophilic drugs might be compara-
tively lower than under actual in vivo conditions due to their low
solubility.
2.3. Formulations
Nanoemulsions were prepared as previously described [17,20].
The aqueous phase, consisting of freshly distilled water and potas-
sium sorbate, was stirred at 50 C. Sucrose stearate S-970 was
incorporated into the aqueous phase, while lecithin E-80 was dis-
solved in the oil-phase PCL-liquid of the respective formulations.
Additional c-CD was incorporated into the aqueous phase where
appropriate. The lipophilic drugs ﬂudrocortisone acetate and ﬂu-
fenamic acid were dissolved in the oil phase, while the hydrophilic
drugs ﬂuconazole and minoxidil were dissolved in the aqueous
phase. The two phases were mixed and pre-homogenised for
4 min with an ultra-turrax (Omni 500) at 2500 rpm. Afterwards,
the mixture was stirred and heated to 50 C before further homog-
enisation with a high-pressure homogeniser (EmulsiFlex C3, Aves-
tin) for 20 homogenisation cycles at 750 bars. Longer
homogenisation times led to an increase in particle size due to
overprocessing. Table 1 shows the optimised formulations as well
as their composition and abbreviations.
2.4. Nanoemulsion characterisation
2.4.1. Particle size
All formulations were analysed for their particle size and parti-
cle size distribution by dynamic light scattering (DLS, photon cor-
relation spectroscopy) using a Zetasizer Nano ZS (Malvern, UK) at
25 C. Samples were diluted with freshly distilled water 1:100 (v/
v) to diminish opalescence. The obtained polydispersity index
(PDI) values represent the particle size distribution within the for-
mulations. PDI values below 0.2 indicate a narrow size distribution
Table 1
Composition of basic optimised nanoemulsion formulations and abbreviations. Drug-
loaded formulations were created by incorporation of 1% w/w of ﬂudrocortisone
acetate (ﬂud), ﬂufenamic acid (ﬂuf), ﬂuconazole (ﬂuc) and minoxidil (min). Abbre-
viations: LN, lecithin-based nanoemulsion; SN, sucrose stearate-based nanoemulsion;
c-LN, lecithin-based nanoemulsion with c-CD; c-SN, sucrose stearate-based nano-
emulsion with c-CD.
Excipients Nanoemulsion composition (% w/w)
LN SN c-LN c-SN
PCL-liquid 20 20 20 20
Lipoid E-80 2.5 – 2.5 –
Sucrose stearate S-970 – 2.5 – 2.5
Potassium sorbate 0.1 0.1 0.1 0.1
c-Cyclodextrin – – 1.0 1.0
Model drug 1.0 1.0 1.0 1.0
Distilled water to 100 100 100 100
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and thus good long-term stability due to reduction in degradation
processes like Ostwald ripening [23]. The formulation parameters
of interest were measured immediately after preparation. The ob-
tained nanoemulsions were stored at 4 C, and consecutive mea-
surements were performed in regular intervals over a period of 6
months.
2.4.2. Particle surface charge (zeta potential)
The particle surface charge of the formulations was determined
by laser Doppler electrophoresis using a Zetasizer Nano ZS (Mal-
vern, UK). Zeta potential (ZP) values of the formulations were
determined at 25 C. Samples were diluted with distilled water
(1:100 v/v) containing sodium chloride (0.01 mmol) in order to en-
sure constant conductivity below 0.05 mS/cm. As distilled water
alone might lead to ﬂuctuating conductivity, addition of electro-
lytes ensures reproducible measurement conditions [23,24]. The
ZP roughly characterises the surface charge of the emulsion parti-
cles. High absolute values lead to repulsive forces between parti-
cles, which may improve the physical stability of multiphase
systems. Absolute values higher than 30 mV generally indicate
good stability, while values above 60 mV indicate excellent long-
term stability [24]. Zeta potential values were determined after
production and in regular intervals over 6 months.
2.4.3. Cryo transmission electron microscopy (cryo TEM)
Standard nanoemulsion samples containing either 2.5% of leci-
thin or 2.5% of sucrose stearate were compared in order to estab-
lish differences in particle formation and microstructure of the
formulations. Corresponding nanoemulsions containing additional
c-CD (1% w/w) were investigated as well to investigate the effect of
the CD on the nanoemulsion structure. The samples were dissolved
(1:10 as well as 1:5 v/v, respectively) in distilled water (pH 6.7);
then, a 4-lm drop of each solution was placed on a TEM copper
grid covered with a perforated carbon ﬁlm (Pelco International)
and blotted with a ﬁlter paper to form a thin liquid ﬁlm of the sam-
ple (thickness of 100–250 nm). The thinned sample was plunged
into liquid ethane at its freezing temperature (183 C) to form a
vitriﬁed specimen and then transferred to liquid nitrogen
(196 C) for storage until examination. Vitriﬁed specimens were
examined in a Philips T12 transmission electron microscope (Phi-
lips) operating at an accelerating voltage of 120 kV using an Oxford
CT3500 (Oxford Instruments) cryo holder that maintained the vit-
riﬁed specimens at 160 C during sample observation. Images
were recorded digitally on a cooled Gatan BioScan CCD camera
(Gatan) using the DigitalMicrograph 3.4 software (Gatan) in low-
dose imaging mode to minimise beam exposure and electron beam
radiation damage.
2.5. Chemical stability
2.5.1. Chemical stability of incorporated drugs
Both the drug content and the chemical stability of all drug-
loaded formulations were investigated. Potential differences be-
tween the emulsiﬁers in terms of drug solubilisation and of the
long-term stability of the incorporated drugs should be revealed
in this fashion. The results should, however, rather be regarded
as an overview than as a comprehensive stability study since the
latter would require far more sophisticated methods of analysis
which are validated for the detection of anticipated degradation
products. The drug content was analysed immediately after prepa-
ration and set as 100%. The nanoemulsions were stored at 4 C.
Samples were taken in regular intervals over 6 months. Brieﬂy,
10 mg of nanoemulsion was dissolved in 1 ml of methanol, centri-
fuged for 6 min at 12,000 rpm (Hermle Z323K, MIDSCI, USA) and
analysed by HPLC. Samples were taken at least in triplicate (nP 3).
2.5.2. Chemical stability of the formulations
Oil components as well as surfactants may be affected by chem-
ical degradation through hydrolysis or oxidation. Since such phe-
nomena result in a decrease in pH [6], pH values of all
nanoemulsionswere determined in regular intervals over 6months.
At least three formulations (nP 3) were investigated at room tem-
perature (25 C) with a pH meter (Orion 420A, Bartelt, Austria).
2.6. Skin permeation experiments
In vitro skin permeation studies were performed using standard
Franz-type diffusion cells (Permegear, USA). Porcine abdominal
skin was chosen as model membrane because of its morphology
and permeability, which are similar to those of human skin
[25,26]. The porcine abdominal skin was freed from hair and trea-
ted with a dermatome (GB 228R, Aesculap) set at 1.2 mm. The skin
was stored at 20 C until use and thawed prior to the experi-
ments. Appropriate skin patches were clamped between the donor
and the receptor chamber of the diffusion cells having a perme-
ation area of 1.13 cm2. The receptor compartment was ﬁlled with
2 ml of phosphate buffer (pH 7.4). The diffusion cells were kept
at skin surface temperature (32 C) and stirred with magnetic bars
for 24 h. The formulation (0.6 g) was placed on the excised skin in
the donor chamber. Samples of 200 ll were removed at deﬁned
time intervals for analysis and were replaced by fresh receptor
medium. In the case of minoxidil, the whole acceptor ﬂuid of
2 ml was removed and replaced in order to ensure sink conditions.
At least ﬁve parallel experiments were performed for each formu-
lation (nP 5). The samples were analysed for their drug content by
HPLC. Permeation proﬁles of the drugs were constructed by plot-
ting time (hours) against the cumulative amount of the drug (lg/
cm2) as measured in the receptor solution. In addition, the stea-
dy-state ﬂux (J, lg cm2 h1) was calculated by linear regression
after the respective lag times.
2.7. HPLC analysis
All samples were analysed for their drug content by HPLC (Ser-
ies ISS-200, Perkin Elmer, USA), consisting of an autosampler, an lc
pump and an UV-diode array detector (235C). Previously reported
methods were used using a Nucleosil 100-5 C18 column
(250 mm  4 mm, Macherey–Nagel, USA) plus a Nucleosil 100-5
C18 pre-column (CC8/4, 40 mm  4 mm, Macherey–Nagel, USA).
For all analyses, the oven temperature was set at 50 C and the
injection volume was 20 ll. The analysis of the data was performed
using the TotalChrom Navigator 6.2.0 software. Standard solutions
of the drugs were prepared, and calibration curves were calculated
by plotting the analysed drug concentrations against the obtained
peak area values. The limit of quantiﬁcation, set well above the
limit of detection in all cases, is represented by the respective low-
est point of the standard solution measurements for each drug as
given below.
The quantiﬁcation of ﬂudrocortisone acetate was performed as
previously described [21,27].The mobile phase consisted of aceto-
nitrile and water (40/60 v/v). The detection wavelength was
240 nm, and the retention time was around 11 min at a ﬂow rate
of 0.8 ml/min. The concentration range of the standard solutions
was between 1.84 lg/ml and 1340.0 lg/ml with a coefﬁcient of
determination of R2 = 0.9999.
The quantiﬁcation of ﬂufenamic acid and minoxidil was con-
ducted according to previously described methods with slight
adaptations [21,22]. In both cases, the mobile phase consisted of
methanol/water (75/25 w/w); glacial acetic acid was added until
a pH value of 3.2 was reached. The ﬂow rate was 1.0 ml/min. For
ﬂufenamic acid, the detection wavelength was set at 245 nm with
a retention time of 4.5 min. A calibration curve was calculated
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based on peak area measurements of diluted standard solutions
ranging from 0.82 lg/ml to 104.40 lg/ml with R2 = 0.9990. In case
of minoxidil, the detection wavelength was set at 255 nm with a
retention time of 4 min. The calibration curve was calculated using
standard solutions from 0.6 lg/ml to 207.10 lg/ml. The obtained
coefﬁcient of determination was R2 = 1.00.
The quantiﬁcation of ﬂuconazole was performed as reported
[21]. The mobile phase consisted of freshly prepared phosphate
buffer (0.012 M, pH 7.4) and methanol (55/45 v/v) with addition
of 1 mmol of octanesulfonic acid. The detection wavelength was
set at 260 nm with a retention time around 4.5 min and a ﬂow rate
of 1.0 ml/min. The concentration range of the standard solutions
was between 17.3 lg/ml and 548.0 lg/ml with R2 = 0.9999.
2.8. Statistical data analysis
Results are expressed as means of at least three experi-
ments ± SD. Statistical data analyses were performed with the soft-
ware program GraphPadPrism3. Parametric data were analysed
using the Student’s t-test with P < 0.05 as minimum level of signif-
icance, while non-parametric data were analysed using the Mann–
Whitney test with P < 0.05.
3. Results
3.1. Formulation optimisation
The ﬁrst aim of the study was to develop a stable nanoemulsion
system with one or more sucrose esters as emulsifying agents.
Since satisfying results could already be obtained with S-970 as
sole emulsiﬁer, no co-surfactants were necessary. Further preli-
minary studies were thus conducted with either sucrose stearate
S-970 or lecithin E-80 as individual emulsiﬁers in simple nano-
emulsions. Different amounts of 1%, 2.5% or 5% (w/w) of the respec-
tive surfactant were incorporated. The results are given in Table 2.
The particle size measurements revealed that sucrose stearate is a
superior emulsifying agent when compared to lecithin. Smaller
particle sizes could be obtained especially at low concentrations.
The ZP values obtained with the different emulsiﬁers showed that
sucrose stearate is likewise superior in terms of electrochemical
stability. Overall, the ZP values of sucrose stearate-based nano-
emulsions were higher than those of their lecithin-based counter-
parts at all concentrations and increased concomitantly with
increasing surfactant concentration. In contrast, the ZP of leci-
thin-based nanoemulsions remained at low values for 1% and
2.5% (w/w) of surfactant and only increased when higher amounts
of 5% (w/w) of lecithin were added. This tendency is in good agree-
ment with the changes in particle size at the respective surfactant
concentrations.
At increasing surfactant-to-oil ratios, the emulsifying efﬁciency
of both surfactants increased and smaller particle sizes were ob-
tained. At 5% (w/w) of surfactant, the performance of lecithin im-
proved notably, if not enough to compete with sucrose stearate.
Since high-pressure homogenisation of nanoemulsions with 5%
(w/w) of sucrose stearate proved to be hardly feasible due to its in-
creased viscosity, the formulations with 2.5% (w/w) of surfactant
were chosen for all further studies.
Different oil volume fractions were investigated as well.
Although literature reports otherwise [28], no particle size reduc-
tion was achieved by reducing the oil content from 20% to 15% or
10% (w/w). Quite the contrary, a slight increase in particle sizes
with a concomitant decrease of ZP values was observed. Therefore,
the oil content was maintained at 20% (w/w), which is advanta-
geous in terms of solubilising capacity for lipophilic drugs.
Finally, the inﬂuence of the natural CDs a, b and c on formula-
tion properties was investigated. Neither of these CDs affected for-
mulation parameters such as particle size or ZP in a negative way
when included at 1% (w/w), as can be seen in Table 3 for c-CD.
Since previous studies had shown that c-CD had the strongest
enhancement effect on the skin permeation of a steroidal drug
[20], it was chosen as additive for further investigations.
3.2. Formulations
Blank and drug-loaded nanoemulsions were created using an
established method [17]. Table 3 shows the physicochemical prop-
erties of the different nanoemulsions. The effect of drug incorpora-
tion was comparable for all investigated drugs. Therefore, only
systems with ﬂudrocortisone acetate and ﬂuconazole are shown
as representative examples for a lipophilic and a hydrophilic drug.
The incorporation of c-CD did not alter formulation properties
notably except for systems with minoxidil, which could not be
homogenised due to viscosity alterations and were therefore ex-
cluded from further investigations.
3.3. Nanoemulsion characterisation
All formulations were highly ﬂuid and homogeneous upon vi-
sual inspection. Their optical appearance was translucent to whit-
ish. A bluish touch was noticeable for formulations based on
sucrose stearate due to Rayleigh scattering, an optical effect caused
by the nano-sized emulsion droplets [29].
Table 2
Physicochemical properties of basic blank nanoemulsions investigated in preliminary
studies: comparison of different surfactant concentrations. Values are means ± SD of
three formulations (n = 3). Measurements were performed in triplicate on a Zetasizer
Nano ZS (Malvern, UK) at 25 C. Samples were diluted with distilled water (1:100 v/v)
containing sodium chloride (0.01 mmol) before the experiments to ensure constant
conductivity below 0.05 mS/cm. Parameters shown are mean particle size (MPS),
polydispersity index (PDI), zeta potential (ZP) and conductivity (Cond).
Parameters Mean particle
size (nm)
PDI Zeta potential
(mV)
Conductivity
(mS/cm)
Lecithin
1.0% (w/w) 281.40 ± 02.92 0.180 ± 0.027 25.20 ± 02.20 0.016 ± 0.007
2.5% (w/w) 231.39 ± 14.28 0.269 ± 0.012 26.33 ± 02.43 0.030 ± 0.005
5.0% (w/w) 132.52 ± 26.03 0.118 ± 0.024 56.43 ± 03.81 0.027 ± 0.001
Sucrose stearate
1.0% (w/w) 193.79 ± 01.76 0.065 ± 0.003 48.36 ± 01.19 0.014 ± 0.003
2.5% (w/w) 141.56 ± 09.02 0.075 ± 0.007 57.28 ± 05.77 0.016 ± 0.008
5.0% (w/w) 120.39 ± 09.15 0.134 ± 0.017 70.81 ± 13.25 0.020 ± 0.006
Table 3
Physicochemical properties of different nanoemulsions after 20 homogenisation
cycles: comparison of blank versus drug-loaded formulations shown on systems
containing ﬂudrocortisone acetate or ﬂuconazole. Values are means ± SD of at least
three formulations (nP 3). Measurements were performed in triplicate on a Zetasizer
Nano ZS (Malvern, UK) at 25 C. Samples were diluted with distilled water (1:100 v/v)
containing sodium chloride (0.01 mmol) before the experiments to ensure constant
conductivity below 0.05 mS/cm. Parameters shown are mean particle size (MPS),
polydispersity index (PDI), zeta potential (ZP) and conductivity (Cond).
Parameters Mean particle
size (nm)
PDI Zeta potential
(mV)
Conductivity
(mS/cm)
LN blank 186.41 ± 11.06 0.13 ± 0.05 21.72 ± 1.83 0.023 ± 0.002
LN ﬂud 183.13 ± 05.50 0.11 ± 0.04 26.64 ± 4.86 0.027 ± 0.002
LN ﬂuc 156.87 ± 09.73 0.05 ± 0.01 24.70 ± 3.41 0.029 ± 0.004
c-LN ﬂud 175.82 ± 00.47 0.09 ± 0.04 30.19 ± 4.12 0.027 ± 0.003
c-LN ﬂuc 155.60 ± 07.96 0.07 ± 0.02 22.50 ± 2.20 0.022 ± 0.002
SN blank 141.21 ± 08.73 0.08 ± 0.02 57.28 ± 5.77 0.016 ± 0.008
SN ﬂud 146.66 ± 08.53 0.13 ± 0.03 63.38 ± 9.14 0.020 ± 0.001
SN ﬂuc 136.79 ± 04.49 0.09 ± 0.03 56.68 ± 0.05 0.022 ± 0.005
c-SN ﬂud 144.77 ± 10.61 0.11 ± 0.02 63.77 ± 6.22 0.020 ± 0.008
c-SN ﬂuc 135.74 ± 04.57 0.08 ± 0.01 65.19 ± 5.50 0.016 ± 0.007
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3.3.1. Particle size, polydispersity index and zeta potential
The different nanoemulsions were analysed directly after pro-
duction. Critical formulation parameters such as particle size, PDI
and ZP were determined (Table 3). Blank lecithin-based nanoemul-
sions exhibited a mean particle size of around 180 nm, which re-
mained unchanged or was even slightly decreased upon
incorporation of the different drugs. In the case of sucrose ester-
based nanoemulsions, the mean particle size was found to be very
consistently around 140 nm for blank as well as for all drug-loaded
formulations. The incorporation of c-CD had no impact on the par-
ticle size of either of the nanoemulsion systems (P > 0.05 in all
cases). The PDI values of all systems were far below 0.2. Overall,
the mean particle size of sucrose stearate-based nanoemulsions
was signiﬁcantly smaller for all systems (P < 0.05).
The particle surface charge values were determined for all for-
mulations. Nanoemulsions containing lecithin showed average ZP
values around 20 to 30 mV irrespective of the nature of the
incorporated drugs. In contrast, nanoemulsions stabilised by su-
crose stearate exhibited signiﬁcantly higher ZP values of over
50 mV up to 65 mV, which indicates an improved electrochem-
ical stability (P < 0.05).
The physicochemical long-term stability of the formulations
was monitored over 6 months. The particle size of blank formula-
tions with either lecithin or sucrose stearate remained largely con-
stant during the whole observation period. However, Fig. 1 clearly
demonstrates that the mean ZP values remained only constant in
the case of sucrose stearate-based nanoemulsions. The lecithin-
based systems showed a noticeable increase in absolute ZP values
from around 20 to 40 mV.
The incorporation of the model drugs hardly inﬂuenced the
destabilisation process of either nanoemulsion system. Although
drug-loaded lecithin-based nanoemulsions generally exhibited lar-
ger particle sizes and a more pronounced increase in mean particle
size over the course of 6 months, none of the observed changes
were statistically signiﬁcant (P > 0.05). Table 4 shows the develop-
ment of the mean particle size as well as PDI and ZP values of for-
mulations with ﬂudrocortisone acetate. The particle sizes of all
drug-loaded systems remained largely constant, while the ZP in-
creased in lecithin-based systems due to chemical degradation. Su-
crose stearate-based nanoemulsions showed a slow decrease in
absolute ZP values as commonly observed during the ageing pro-
cess of nanoemulsions.
3.3.2. Cryo transmission electron microscopy (cryo TEM)
Blank nanoemulsions stabilised with lecithin or sucrose stea-
rate were investigated by cryo TEM. This technique is frequently
used to visualise colloidal systems such as nanoemulsions or lipo-
somes [7]. Fig. 2a and b illustrates the effect of the different emul-
siﬁers on the nanoemulsion structure. It was found in several
rounds of analysis that the lecithin-based formulations were far
from homogeneous in their microstructure. The left-hand side of
Fig. 2a shows not only irregularly shaped nanoemulsion oil drop-
lets but also large numbers of vesicular structures such as various
types of liposomes and multilamellar phospholipid layers. These
images conﬁrm that a large variety of such structures emerge dur-
ing high-pressure homogenisation if lecithin E-80 is used as a sur-
factant. In contrast, the nanoemulsions stabilised by sucrose
stearate S-970 as shown on the right-hand side of Fig. 2b had a per-
fectly reproducible structure. Several consecutive rounds of analy-
sis revealed that these formulations consisted almost exclusively of
perfectly spherical oil droplets.
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Fig. 1. Inﬂuence of surfactant on long-term stability in the case of lecithin (LN) or
sucrose stearate (SN): development of mean particle size in nm and zeta potential
in mV over a storage time of 6 months as observed on blank formulations with
lecithin or sucrose stearate. The bars represent the particle size as indicated on the
left-hand scale (black bars j: LN, white bars h: SN). The lines show the
development of the mean zeta potential (black symbol —N—: LN, white symbol —
s—: SN) as indicated on the right-hand scale of the ﬁgure. The drug-loaded
formulations showed a highly similar trend. Measurements were performed at least
in triplicate (nP 3; Zetasizer Nano) every two weeks. Numbers are given ±SD. For
the sake of clarity, only monthly measurements are shown.
Table 4
Physical stability of drug-loaded nanoemulsions with either lecithin (LN) or sucrose
stearate (SN) shown on systems containing ﬂudrocortisone acetate (ﬂud) (3a). The
corresponding systems with additional c-CD are shown for comparison (3b).
Experiments were performed in triplicate (n = 3) in regular intervals over an
observation period of 6 months. The indicated parameters are the mean particle
size (MPS), polydispersity index (PDI) and zeta potential (ZP). Numbers are given as
means ± SD.
(4a)
Time (weeks) MPS (nm) ± SD PDI ± SD ZP (mV) ± SD
LN ﬂud
0 183.13 ± 05.50 0,11 ± 0.04 26.64 ± 04.86
4 184.01 ± 05.44 0.11 ± 0.06 26.62 ± 02.18
8 188.66 ± 08.03 0.13 ± 0.08 31.06 ± 03.03
12 185.87 ± 09.61 0.09 ± 0.04 33.40 ± 00.58
16 186.01 ± 04.57 0.08 ± 0.02 39.38 ± 03.91
20 197.73 ± 25.50 0.09 ± 0.04 35.92 ± 03.70
24 189.58 ± 18.77 0.09 ± 0.04 41.51 ± 03.70
SN ﬂud
0 146.66 ± 08.53 0.13 ± 0.03 63.38 ± 09.14
4 144.10 ± 06.00 0.09 ± 0.02 55.81 ± 05.79
8 143.26 ± 05.83 0.10 ± 0.03 52.88 ± 01.13
12 143.24 ± 07.08 0.08 ± 0.01 55.38 ± 06.74
16 141.89 ± 07.38 0.08 ± 0.02 54.99 ± 02.40
20 147.08 ± 07.35 0.10 ± 0.05 54.89 ± 08.56
24 142.88 ± 08.24 0.11 ± 0.02 51.77 ± 12.36
(4b)
c-LN ﬂud
0 175.82 ± 00.47 0.09 ± 0.04 30.19 ± 04.12
4 179.17 ± 08.76 0.05 ± 0.01 30.34 ± 00.84
8 182.80 ± 13.11 0.06 ± 0.02 35.98 ± 07.11
12 185.27 ± 16.82 0.07 ± 0.02 34.21 ± 03.82
16 187.20 ± 21.36 0.07 ± 0.06 37.07 ± 03.01
20 185.02 ± 17.28 0.11 ± 0.05 36.18 ± 01.95
24 184.59 ± 14.70 0.09 ± 0.07 34.91 ± 06.01
c-SN ﬂud
0 144.77 ± 10.61 0.11 ± 0.02 63.77 ± 06.22
4 154.44 ± 04.43 0.07 ± 0.02 58.36 ± 02.23
8 155.86 ± 05.66 0.10 ± 0.01 60.26 ± 03.69
12 163.24 ± 03.68 0.12 ± 0.04 62.41 ± 13.26
16 158.72 ± 03.67 0.09 ± 0.03 62.80 ± 04.67
20 159.20 ± 02.05 0.11 ± 0.04 64.60 ± 01.95
24 161.93 ± 00.87 0.10 ± 0.02 59.74 ± 06.14
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Interestingly, the addition of c-CD to these emulsion systems
apparently had a remarkable inﬂuence on the process of emulsion
formation in the case of lecithin (Fig. 2c). A much more homoge-
neous emulsion structure was observed than for the nanoemulsion
based on lecithin alone. The sample contained remarkably less
vesicular structures, and the shape of the oil droplets was more
regular and spherical, if slightly rough on the surface. The images
were analysed with the help of the DigitalMicrograph 3.4 software
(Gatan) for their content of oil droplets and vesicular structures. In
case of lecithin-based formulations without c-CD (Fig. 2a), a total
of 62.45 ± 33.12% of vesicular structures were observed per image
(n = 3 analysed images, total number of structures n = 981). In case
of the lecithin-based formulations with additional c-CD (Fig. 2c),
merely 13.39 ± 10.76% of vesicles were found per image (n = 5 ana-
lysed images, total number of structures n = 701). In contrast, no
visual differences in the highly homogeneous structure of sucrose
stearate-based nanoemulsions were noticeable after addition of
c-CD (Fig. 2d).
3.4. Chemical stability
3.4.1. Chemical stability of incorporated drugs
After the initial determination of the drug content, the chemical
stability of all incorporated drugs was analysed in regular intervals
over 6 months. The average content of all drugs remained between
80% and 116% of the initial value for all nanoemulsions during the
observation period (data not shown). The slight ﬂuctuations in
drug content are rather due to inhomogeneous drug dispersion
and methodological issues in analysis than to any actual degrada-
tion processes. Indeed, no degradation products were detected by
HPLC. Neither the type of surfactant nor the presence of c-CD ex-
erted a noticeable inﬂuence on the recovered drug content. How-
ever, it has to be kept in mind that more sophisticated analytical
methods are needed to give a full insight into the individual drugs’
actual fate within the formulations over the course of time. The
presented data merely serve to give an overview about the basic
quality of the formulations.
3.4.2. Chemical stability of the formulations
Additional information about the physicochemical stability of
the nanoemulsions was derived from the change in pH value over
the course of time. A continuous decrease in pH over the course of
6 months was observed. The inﬂuence of the surfactant type on the
chemical stability of the nanoemulsions was assessed on all blank
and drug-loaded formulations. Although both types of nanoemul-
sion exhibited a signiﬁcant decrease in pH value after 6 months
(P < 0.05), lecithin-based nanoemulsions showed a more pro-
nounced change from 6.98 ± 0.31 to 5.81 ± 0.36 (n = 18) when com-
Fig. 2. Cryo TEM photographs of the microstructure of blank nanoemulsions (a) with 2.5% lecithin E-80 and (b) with 2.5% sucrose stearate S-970 as sole emulsifying agent.
The corresponding formulations containing additional c-cyclodextrin are shown below for lecithin (c) as well as for sucrose stearate (d). The magniﬁcation is illustrated by
the black scale bars. Dark spheres represent nanoemulsion oil droplets. Other vesicular structures such as uni- or bilamellar liposomes (light spheres) or multilamellar
structures (light lamellar layers) are indicated by white arrows. Occasional dark crystals are due to ice formation during cryo preparation of the sample.
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pared to sucrose stearate-based systems with a drop from
6.75 ± 0.33 to 6.26 ± 0.24 (n = 19). Apparently, lecithin molecules
have a stronger disposition towards chemical degradation than
the sucrose ester surfactant. The formation of lyso-lecithin and free
fatty acids through hydrolysis of lecithin molecules not only in-
creases the negative ZP values but also causes a drop in pH and
promotes further degradation [6].
3.5. Skin permeation experiments
Permeation proﬁles of all drugs from lecithin-based and sucrose
stearate-based nanoemulsions were established after 24 h. A com-
parison of the cumulative drug amounts clearly shows that the
hydrophilic drugs permeate through the model skin more rapidly
and to a larger extent. The permeated amounts of lipophilic drugs
were conﬁned to percentages between 0.2% and 0.8% of the applied
dose. In contrast, around 30–40% of the applied hydrophilic drug
amounts were recovered from the receptor medium. Although
nanoemulsions are generally recommended for the incorporation
of lipophilic drugs, they may also be employed for the delivery of
hydrophilic drugs. Table 5 shows the mean cumulative permeated
drug amounts after 24 h as well as the corresponding mean drug
ﬂuxes for all investigated formulations. The concentrations of ﬂu-
drocortisone acetate and ﬂufenamic acid that were able to perme-
ate through the porcine skin were comparatively small. The
released amounts of both ﬂuconazole and minoxidil are around
20–40 times higher than the corresponding amounts of the lipo-
philic drugs.
What can be further derived from these data is the fact that
incorporation of c-CD inﬂuenced mainly the skin permeation rate
of the steroidal drug ﬂudrocortisone acetate. The effect of c-CD
on skin permeation was investigated for ﬂudrocortisone acetate,
ﬂufenamic acid and ﬂuconazole. The incorporation of the addi-
tional compound c-CD led to signiﬁcantly enhanced skin perme-
ation rates of the lipophilic ﬂudrocortisone acetate (P < 0.05)
(Fig. 3). Interestingly, this was not the case for the lipophilic ﬂufen-
amic acid although a slight trend was noticeable. As expected, the
skin permeation rate of the hydrophilic drug ﬂuconazole was not
increased by incorporation of the CD. In fact, the skin permeation
was even slightly decreased for both lecithin-based and sucrose
stearate-based nanoemulsions.
A comparison of the skin permeation efﬁciency of the different
emulsiﬁers shows that the skin permeation of the hydrophilic
drugs ﬂuconazole and minoxidil was signiﬁcantly higher from lec-
ithin-based nanoemulsions (P < 0.05). The skin permeation of the
lipophilic drugs ﬂudrocortisone acetate and ﬂufenamic acid was
the same for both types of surfactant (P > 0.05). A statistical analy-
sis was performed for the cumulative permeated drug amounts as
well as for the corresponding drug ﬂuxes. Both evaluations led to
consistent results.
4. Discussion
4.1. Comparison of emulsifying efﬁciency: sucrose stearate versus
lecithin
Although the surfactants lecithin E-80 and sucrose stearate S-
970 possess similar HLB values, the produced formulations differed
in their physicochemical properties. The novel sucrose stearate-
based systems exhibited smaller mean droplet sizes and a higher
electrochemical stability. This tendency was observed for both
blank and drug-loaded formulations. Likewise, these systems were
less prone to chemical degradation, as both visual observation and
monitoring of the pH indicated. The nanoemulsion production pro-
cess was more reliable and controllable in the case of sucrose stea-
rate since lecithin is more sensitive to changes in temperature. The
storage of lecithin-based nanoemulsions at room temperature
leads to changes in colour and odour. This destabilisation was
decelerated by refrigerated storage but was nevertheless notice-
able after 6 months. The chemical degradation of the emulsiﬁer
rendered the system less appealing despite the largely constant
particle size. In contrast, sucrose ester nanoemulsions showed a
clean white colour and no changes in odour after 6 months. The
PDI of all systems remained below or around 0.2, which indicates
a very homogeneous droplet size distribution and high physical
stability [20].
The high negative ZP of sucrose stearate-based systems was di-
rectly correlated with the amount of sucrose ester. This might be
ascribed to the presence of larger amounts of residual, non-esteri-
ﬁed fatty acids in the sucrose ester mixture. An observed decrease
in pH at increasing sucrose stearate concentrations as well as a
comparison of the manufacturers’ product speciﬁcations supports
Table 5
Skin permeation rates of ﬂudrocortisone acetate (ﬂud), ﬂufenamic acid (ﬂuf),
ﬂuconazole (ﬂuc) and minoxidil (min) from both lecithin-based nanoemulsions (LN)
and sucrose stearate-based nanoemulsions (SN) expressed as cumulative permeated
drug amounts (lg cm2) and mean drug ﬂuxes (J, lg cm2 h1). At least ﬁve
experiments were performed for each formulation (nP 5); indicated values are
means ± SD.
Formulation Cumulative drug amount after
24 h ± SD (lg cm2)
Mean drug ﬂux ± SD (J,
lg cm2 h1)
SN ﬂud 9.99 ± 0.46 0.55 ± 0.02
LN ﬂud 9.98 ± 0.64 0.55 ± 0.04
c-SN ﬂud 55.10 ± 3.67 2.56 ± 0.14
c-LN ﬂud 98.62 ± 24.89 4.53 ± 0.99
SN ﬂuf 48.88 ± 18.27 1.55 ± 0.87
LN ﬂuf 42.22 ± 20.47 1.21 ± 0.62
c-SN ﬂuf 56.62 ± 17.35 1.83 ± 0.87
c-LN ﬂuf 45.97 ± 18.63 1.42 ± 0.69
SN ﬂuc 1993.45 ± 256.77 88.39 ± 9.40
LN ﬂuc 2481.67 ± 297.86 109.55 ± 11.30
c-SN ﬂuc 1885.14 ± 132.48 81.74 ± 5.92
c-LN ﬂuc 2157.13 ± 108.32 93.63 ± 3.80
SN min 1957.93 ± 296.12 84.27 ± 11.99
LN min 2402.55 ± 236.00 102.56 ± 9.41
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Fig. 3. Effect of c-cyclodextrin on the in vitro skin permeation proﬁle of ﬂudro-
cortisone acetate from lecithin-based nanoemulsions (LN ﬂud) and sucrose
stearate-based nanoemulsions (SN ﬂud). The drug permeation through porcine
abdominal skin over the course of 24 h was determined by HPLC. The cumulative
permeated drug amounts are plotted versus time. At least ﬁve experiments were
performed for each formulation (nP 5) using Franz-type diffusion cells. Indicated
values are means ± SD. Abbreviations: LN ﬂud: dashed line (- -d- -); SN ﬂud: dashed
line (- -4- -); c-LN ﬂud: full line (AdA); c-SN ﬂud: full line (A4A).
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this theory. While lecithin E-80 contains a maximum of 0.05% of
free fatty acids, sucrose stearate S-970 may contain up to 10% of
residual fatty acids, free sucrose, moisture and ash.
In terms of long-term stability, the ZP of sucrose stearate-based
systems remained stable while the negative droplet surface charge
of lecithin-based systems increased. This increase was most likely
caused by hydrolysis of lecithin molecules. The chemical degrada-
tion of the surfactant results in increasing concentrations of lyso-
lecithin and free fatty acids, which confer more negative charges
to the droplets’ surfaces [30]. This phenomenon has therefore to
be considered a sign of physicochemical destabilisation.
Since the analysis of particle size distributions through DLS
alone may provide incomplete information [31,32], additional cryo
TEM investigations were performed. Thus, the exact nature of the
measured structures and remarkable differences caused by the
use of the different surfactants were visualised. Systems stabilised
by sucrose stearate exhibited perfectly homogeneous nanoemul-
sion droplets, while systems stabilised by lecithin had a variable
morphology. Sucrose stearate apparently possesses a better pack-
ing geometry at the O/W interface and is therefore more suitable
for the formation of curved surfaces. In terms of droplet sizes,
the images conﬁrmed the results obtained by DLS.
Previously conducted cryo TEM analyses of lecithin-based
nanoemulsions showed more regular droplet shapes, most likely
due to the presence of additional emulsiﬁers and stabilisers [20].
The presented results conﬁrm that the lecithin mixture alone is
less efﬁcient in nanoemulsion formation and that co-surfactants
should be employed. In this context, it was shown that c-CD might
serve as a co-stabilising agent.
4.2. Effect of c-CD on the nanoemulsion structure
Further cryo microscopic images revealed that addition of c-CD
to the lecithin-based system remarkably improved the homogene-
ity of the formulation. This indicates that the CD might be involved
in the formation of the interfacial ﬁlm which apparently became
more suitable to form curved surfaces. Neither composition nor
production process were altered in any other way; thus, the effect
can only be ascribed to the presence of additional surface-active
molecule complexes formed by CD molecules and fatty acid resi-
dues of the oil phase [33–37]. Since the rather voluminous CD mol-
ecules represent the hydrophilic region of the newly formed
‘‘surfactants’’, the resulting surface-active agents may have a suit-
able interfacial packing parameter to promote the formation of
droplets. These observations are in good agreement with recent
data [20]. It may be assumed that the previously detected excess
of lecithin aggregates in the bulk water phase was caused by CD
molecules which were inserted into the interfacial ﬁlm of the O/
W droplets, thus forcing surplus lecithin molecules into the aque-
ous phase. No such effect was observed in the present study since
the overall amount of surfactant was low.
4.3. Effect of c-CD on nanoemulsion stability
An additional aspect of the stability monitoring was the incor-
poration of c-CD. The results showed that emulsion stability was
not impaired by the presence of the CD. Cyclodextrins have a high
potential for undesired interactions with various excipients. A high
afﬁnity of the CD towards lipophilic moieties of surfactant mole-
cules may lead to complexation and subsequent inactivation
[38]. Likewise, the decomposition of certain drugs may be acceler-
ated by CDs [39]. It is therefore of utmost importance to investigate
the speciﬁc effect of CD incorporation on every new system. Previ-
ous investigations have shown that CDs may have a stabilising ef-
fect on nanoemulsions [20]. In the present case, the addition of c-
CD seemed to stabilise ZP values of lecithin-based systems, thus
conferring increased electrochemical stability to the nano-sized
droplets.
4.4. Effect of the different emulsiﬁers and c-CD on skin permeation
Since the skin permeation of drugs is inﬂuenced by factors such
as their molecular mass and their log P value, the skin permeation
of the investigated drugs differed considerably. The skin perme-
ation rates of minoxidil were highest, followed by ﬂuconazole
and ﬂudrocortisone acetate as well as ﬂufenamic acid. Although
nanoemulsions are aimed at the incorporation of lipophilic drugs,
larger amounts of hydrophilic drugs could be delivered by incorpo-
ration into the aqueous phase. In the present experimental setup,
this is probably related to the higher solubilities of the hydrophilic
drugs in the aqueous receptor medium. In addition, the increased
hydration of the skin in the experimental setting may have contrib-
uted to the enhanced permeation of the hydrophilic drugs [40].
Apart from these general aspects, the performance of sucrose stea-
rate-based nanoemulsions in terms of skin permeation was evalu-
ated and compared to that of lecithin-based systems. In case of
both lipophilic drugs, similar skin permeation rates were achieved
with lecithin- and sucrose stearate-based nanoemulsions
(P > 0.05). Interestingly, the skin permeation of both hydrophilic
drugs was higher from lecithin-based nanoemulsions than from
their sucrose ester-based counterparts (P < 0.05), possibly due to
the presence of liposomes as conﬁrmed by cryo TEM. The hydro-
philic drugs might be incorporated into the liposomal structures
to a certain extent, which may enhance their skin permeation from
lecithin-based systems. In addition, lecithin molecules themselves
are known to interact with skin lipids and promote the skin perme-
ation of actives [1,41,42].
In the context of the skin permeation studies, the enhancement
effect of c-CD on various drugs was investigated. A highly signiﬁ-
cant permeation enhancement was found for ﬂudrocortisone ace-
tate (P < 0.05), which conﬁrmed previous results [20]. This
indicates that c-CD can indeed be employed to enhance the skin
permeation of steroidal drugs from O/W nanoemulsions. No such
effect was observed for the lipophilic ﬂufenamic acid. Interestingly,
the release of ﬂuconazole from lecithin-based nanoemulsions was
signiﬁcantly decreased by the addition of c-CD (P < 0.05). This
might be explained by the observed strong decrease in liposomal
structures through addition of c-CD. It may thus be concluded that
the superior release of hydrophilic drugs from lecithin-based sys-
tems was indeed caused by the additional liposomes.
In summary, the lack of permeation enhancement for drugs
other than steroidal ones leads to certain useful conclusions. It
can be assumed that the extraction of cholesterol or other skin
components by the CD [43,44] can be excluded as a possible mech-
anism of action since such an effect would have affected the skin
permeation of all drugs. Accordingly, an occlusion effect [45,46]
through increased ﬁlm-building capacity of the CD-containing for-
mulations can be ruled out as well. However, it is well known that
CDs can enhance the skin permeation of drugs by forming an inclu-
sion complex and thus increasing drug solubility and dispersion
within the formulation [43,47,48]. Hence, more drug is available
at the skin surface to enter the stratum corneum through diffusion.
However, such an effect appears unlikely if only small molar
amounts of CD are incorporated, such as the presented amount
of CD/drug of around 1:3.
It is particularly interesting that the permeation enhancement
effect of c-CD was linked to the nature of the employed emulsiﬁer.
The effect was signiﬁcantly higher in lecithin-based nanoemul-
sions than in sucrose stearate-based systems (P < 0.05). This leads
to the conclusion that some kind of underlying synergistic mecha-
nism must be taken into account. As previously mentioned, the CD
molecules can complex fatty acid residues of the oil phase, thus
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forming new surface-active molecule complexes [33–37]. It is most
likely that the CDs are incorporated into the interfacial ﬁlm in this
fashion, as the cryo TEM images suggest. The insertion of such
additional emulsiﬁers may facilitate drug release [49]. It is com-
monly known that mixed interfacial ﬁlms are more ﬂexible and
thus more suitable to form spherical droplets [50]. It might be de-
duced that this structural ﬂexibility might also promote the release
of speciﬁc drugs from the oil core, especially if they have an afﬁnity
for the CD cavities. Such a dynamic system might lead to an accel-
erated release of the incorporated drug, as is obviously the case for
steroidal drugs in the presence of c-CD. The complexation afﬁnity
between drug and CD may play a signiﬁcant role in this context.
The release of compounds from structures like solid lipid nanopar-
ticles or nanoemulsion droplets is slower from the core than from
the surface of the phospholipid layer [51]. If the CD acts as a ‘‘trans-
porter’’ and enhances the afﬁnity of the drug to leave the oil core
through complexation, accelerated skin permeation may result.
However, the exact mechanism behind the enhancement effect re-
mains to be investigated. It has to be kept in mind that the involved
processes are of a dynamic nature. In any case, the addition of c-CD
represents a skin-friendly way to promote the permeation of ste-
roidal drugs without affecting the skin barrier function.
5. Conclusion
Sucrose stearate is a highly suitable emulsiﬁer for nanoemul-
sion production and superior to lecithin in several aspects. Excel-
lent skin friendliness can be expected from the novel
formulations which contain only 2.5% of the mild surfactant. In
addition, it was found that the formation of nano-sized droplets
could be promoted by the addition of c-CD in the case of lecithin
while the number of vesicular structures was decreased. The con-
comitantly enhanced release of a steroidal drug from the oil core
might be associated with its complexation afﬁnity to the CD, which
will be subject of further investigations.
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 Introduction 
 In the field of dermatopharmacokinetics, tape strip-
ping is employed to establish skin penetration profiles 
of substances that are applied onto the skin in various 
vehicles. After a defined application time, the upper-
most layers of stratum corneum (SC) are consecutively 
removed with adhesive tapes. Subsequently, all adhesive 
films are analyzed for their drug content as well as for 
the amount of removed corneocyte aggregates. Quanti-
fication of the latter is necessary to obtain an accurate 
penetration depth of the applied substances  [1] . Former-
ly, time-consuming methods for the analysis of these SC 
proteins were employed, such as gravimetric determina-
tion  [2–8] , microscopic evaluation  [9] , or extraction and 
subsequent analysis with protein assays  [10, 11] . More 
recently, optical methods for protein analysis on adhe-
sive films have been developed. The UV absorption of 
proteins, directly reflecting the amount of corneocytes, 
was found to be too weak as opposed to the light scat-
tering observed for the horny layer particles  [6] . In con-
trast, optical spectroscopy in the visible range was found 
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 Abstract 
 Infrared (IR) densitometry is a highly practical method re-
cently proposed for protein analysis during in vivo tape strip-
ping. However, this method has not yet been validated for 
the quantification of porcine stratum corneum (SC) proteins. 
Therefore, the aim of this study was to establish calibration 
curves for the analysis of adhesive tapes removed from por-
cine ear skin. To this end, the protein absorption (as deter-
mined via IR densitometry) was correlated with the protein 
content determined with the Micro BCA TM protein assay after 
extraction of the tapes. The obtained linear regressions con-
firm that IR densitometry is suitable for the quantification of 
not only human, but also porcine, SC proteins. The pattern 
of protein removal observed with porcine skin differs from 
that of human skin due to more pronounced corneocyte 
clustering and deep ‘canyons’, which necessitates specific 
evaluation of porcine skin samples and a working protocol 
that takes this into account. The presented data will facilitate 
future analysis of porcine SC proteins during in vitro tape 
stripping.  Copyright © 2011 S. Karger AG, Basel 
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to be a suitable tool for protein quantification on tapes 
in a manner that is undisturbed by other skin compo-
nents  [1, 5, 12–14] . The so-called pseudo-absorption of 
the proteins – which is composed of reflection, scatter-
ing and diffraction of the light by corneocytes – can be 
used to indirectly quantify the protein mass on the tapes 
 [1, 5] .
 Recently, the compact infrared (IR) densitometer 
SquameScan  850A was introduced as an efficient and 
simple quantification tool for adhesive tapes obtained 
from human volunteers in vivo  [15] and in vitro  [16] . The 
optical pseudo-absorption of SC tape strippings was 
shown to correlate linearly with the respective protein 
content. Calibration curves were obtained which can be 
used for the rapid and non-destructive quantification of 
human SC proteins.
 However, no data have so far been presented to vali-
date this method for the analysis of tape strippings ob-
tained from porcine skin in vitro. Clinical trials per-
formed on human volunteers often involve considerable 
effort in terms of logistics and time, as well as permission 
from an ethical committee. Furthermore, excised human 
skin is not always available. Therefore, in vitro tape strip-
ping using porcine skin represents a suitable alternative 
to obtain basic information about the penetration behav-
ior of new vehicles and drugs. Numerous studies have 
investigated the suitability of the porcine skin model for 
in vitro studies  [7, 8, 17–19] . It is a well-accepted substitute 
for human skin due to similarities in epidermal thick-
ness, lipid composition and permeability  [8] . In context 
with tape stripping, porcine ear skin was found to be the 
most suitable in the in vitro model  [8, 20] . Therefore, 
there is a need for efficient and accurate quantification 
methods to analyze porcine corneocytes on adhesive 
tapes.
 The present publication aims to establish the method 
of IR densitometry for quantification of porcine SC pro-
teins obtained by in vitro tape stripping. Two different 
brands of standardized adhesive films, Corneofix  and 
D-Squame  tapes, were investigated for their suitability 
to homogeneously remove the corneocytes of the upper 
skin layers. The primary objective of the study was to 
generate calibration curves for the quantification of 
porcine SC proteins. The validation of IR densitometry 
for this application is an important step towards paving 
the way for future in vitro experiments with porcine 
skin.
 Materials and Methods 
 Chemicals 
 Sodium hydroxide (CAS No. 1310-73-2, Lot No. 437415/2) was 
purchased from Sigma-Aldrich Chemie GmbH (Steinheim, Ger-
many). Hydrochloric acid (CAS No. 7647-01-0, Lot No. 41240) 
was obtained from Sigma-Aldrich Laborchemikalien GmbH 
(Seelze, Germany). Sodium chloride (CAS No. 7647-14-5, Lot No. 
082409) was purchased from Herba Chemosan Apotheker AG 
(Vienna, Austria). The Micro BCA TM Protein Assay Kit was ob-
tained from Pierce Biotechnology Inc. (Rockford, Ill., USA). The 
kit consisted of reagent A (alkaline tartrate-carbonate buffer), re-
agent B (bicinchoninic acid solution) and reagent C (copper sul-
fate solution), which were mixed according to the manufacturer’s 
instructions. The protein standards employed were bovine   -
globulin (BGG; 2.0 mg/ml, product No. 23212, Lot No. LC142488) 
and bovine serum albumin (BSA; 2.0 mg/ml, product No. 23209, 
Lot No. LC143026) as purchased from Pierce Biotechnology Inc. 
Standard D-Squame adhesive tapes with a diameter of 22 mm and 
an area of 3.8 cm 2 were purchased from CuDerm Corp. (Dallas, 
Tex., USA). Standard Corneofix adhesive films with a square area 
of 4.0 cm 2 were obtained from Courage + Khazaka GmbH (Co-
logne, Germany).
 Preparation of Porcine Skin 
 Fresh porcine ears were donated by the Clinic for Swine,
University of Veterinary Medicine, Vienna. Preliminary studies 
showed that different storage conditions did not alter the skin 
barrier function or the SC properties. Tape-stripping results ob-
tained with fresh porcine ear skin were comparable to those of 
refrigerated or deep-frozen material. Recently published findings 
confirmed these observations  [16] . In order to ensure logistic fea-
sibility and reproducibility of the experiments, all porcine ears 
used in this study were stored at –24   °   C and thawed prior to the 
respective experiments. After defrosting, the ears were cleaned 
carefully with purified water and blotted dry with soft tissue. The 
skin was subsequently freed from hair with scissors, and intact 
representative skin areas were indicated with a permanent mark-
er. In addition, the transepidermal water loss (TEWL) of the skin 
was determined using the closed-chamber device AquaFlux  
(Biox Ltd., London, UK) to confirm an intact skin barrier func-
tion and to monitor the defrosting process. When the TEWL 
reached values between 15 and 20, the tape stripping procedure 
was started. The TEWL measurements were performed before 
and after tape stripping on the respective skin areas, and the soft-
ware program AquaFlux V6.2 was used for data analysis.
 In vitro Tape Stripping 
 The tape stripping procedure was conducted with 20 sequen-
tial adhesive films for each experiment. Two different brands of 
adhesive tape, D-Squame and Corneofix tapes, were investigated 
separately. For each type of adhesive film, 12 individual experi-
ments (n = 240, respectively) were conducted by the same techni-
cian to minimize variations  [15, 21] . The in vitro tape stripping 
was carried out under standardized conditions, which were 
adapted to the different types of adhesive film. Since various fac-
tors – such as the intensity and duration of pressure application 
as well as the velocity of tape removal – may have a significant 
influence on the amount of removed SC proteins  [5, 19] , care was 
taken to ensure a reproducible working procedure. The porcine 
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ears were stretched out on Styrofoam plates and fixed with nee-
dles if necessary. After placing the first adhesive film on the skin, 
its outline was indicated with a permanent marker to ensure sub-
sequent tape stripping on the exact same skin area. In order to 
apply pressure while ensuring a rolling movement to minimize 
the influence of wrinkles  [14] , pressure was applied with the 
thumb covered in a vinyl glove as previously described  [19, 22] . 
The experiment was performed on a balance to ensure a constant 
pressure of 49 N (5 kg) in the case of Corneofix and 19 N (2 kg) 
in the case of D-Squame. This comparatively high pressure was 
a prerequisite for obtaining reproducible amounts of SC proteins, 
especially in the case of Corneofix tapes which possess a lower 
adhesive power  [19] . Similar working protocols were reported for 
D-Squame tapes on human skin in vitro  [16, 21] . A critical con-
tact time and pressure are necessary to obtain the maximum 
‘tackiness’ of the adhesive film  [23] , i.e. the maximum adhesive 
power, to promote reproducible removal of proteins. After apply-
ing the respective pressure for 3 s, the tape was removed in a 
single rapid movement. The amount of adherent SC proteins was 
subsequently determined by IR densitometry and the Micro BCA 
protein assay. The cumulative amount of SC proteins was em-
ployed to establish the depth of the complete SC as previously 
described  [5] .
 Infrared Densitometry 
 The amount of corneocytes on each removed tape strip was 
determined using the infrared densitometer SquameScan TM 850A 
(Heiland Electronic GmbH, Wetzlar, Germany)  [15] . This device 
measures the decrease in light intensity over an area of 15 mm. 
The optical pseudo-absorption of the adhesive films at a wave-
length of 850 nm serves to indirectly quantify the amount of SC 
proteins on the tapes. The analysis is non-destructive and rapid. 
The absorption values (%) can be read from the display after an 
equilibrium time of 3 min. The linear working range of the device 
is between 0 and 40% of absorption with a resolution of 0.1%, as 
indicated by the manufacturer  [15, 16] .
 The instrument was calibrated prior to the experiments. An 
empty sample holder was set as 0% of absorption, while an ambi-
ent light filter with a defined absorption of 39.0% was used to 
control the functionality of the device. The absorption of an emp-
ty tape was used as a reference to account for the background 
noise. After the tape stripping procedure, the removed tapes were 
placed in the sample holder with the adhesive side facing upwards 
and subsequently analyzed  [15, 16] . The homogeneous distribu-
tion of the corneocyte aggregates on each tape strip was checked 
visually after removal. The existence of non-homogeneous areas 
was noted in the protocol as previously reported  [5] .
 Micro BCA Protein Assay 
 The quantification of the porcine SC proteins removed with 
each tape strip was carried out according to the microplate work-
ing protocol of the Micro BCA protein assay as previously de-
scribed  [15] . The colorimetric reaction is based on the formation 
of a chelate complex of bicinchoninic acid (BCA) and cuprous 
ions.
 After the pseudo-absorption at 850 nm of each tape strip was 
analyzed via IR densitometry the adhesive tapes were transferred 
into 1.5-ml Eppendorf tubes and incubated with 750   l of 1  M so-
dium hydroxide solution to extract the proteins. To this end, the 
tubes were placed into an Eppendorf Thermomixer comfort (Ep-
pendorf AG, Hamburg, Germany) and shaken at 37  °  C and 1,400 
rpm for 1 h. After the appropriate cooling time, 500   l of the re-
sulting protein solutions were neutralized with 500   l of 1  M hy-
drochloric acid. After mild homogenization, 100   l of each sam-
ple was replicated into a 96-well microplate. Subsequently, 100   l 
of standardized Micro BCA Protein Assay working reagent were 
added. The covered microplate was shaken at 300 rpm for 60 s and 
then incubated at 37  °  C for 2 h. After appropriate cooling time, the 
absorbance of the samples at   = 550 nm was determined at room 
temperature with a UV/VIS microplate reader (Tecan Infinite TM 
200, Tecan Ltd., Maennedorf, Switzerland). The protein content 
of each removed adhesive tape was analyzed in triplicate (n = 3), 
and the mean value was used for further evaluation. Five blank 
adhesive tapes (n = 5) were respectively extracted in exactly the 
same fashion as the protein-covered tapes, and analyzed with ev-
ery round of analysis. The mean value of these blank tapes served 
as the respective control to account for background noise.
 The quantification of the protein samples was performed with 
the help of calibration curves created by diluting protein standard 
solutions which were freshly prepared and analyzed with each 
microplate. The standard employed for this study was BGG as 
previously reported  [15] . For reasons of comparison, standard so-
lutions of BSA were prepared and analyzed as well. The standard 
solutions were prepared in the range of 2.5–40   g/ml, which is 
the recommended linear working range of the employed assay. A 
solution of 1  M sodium chloride was employed as a solvent, which 
corresponds to a mixture of equal parts of 1  M sodium hydroxide 
and 1  M hydrochloric acid. The same solution without BGG served 
as a control. This blank solution was determined in triplicate on 
each microplate. The mean value was subtracted from the results 
of the standard solutions to account for the background noise.
 Protein values above the linear working range of the assay can 
be determined via extrapolation of the calibration curve. How-
ever, the slope rather follows a linear correlation of the second 
order, which will lead to inaccurate results for higher protein val-
ues ( fig. 1 ). Therefore, samples where a high protein content was 
anticipated due to the obtained IR densitometric values were di-
luted with 1  M NaCl solution (1: 3 v/v) prior to analysis with the 
Micro BCA assay.
 Statistical Data Analysis 
 The linear regressions as well as the coefficients of determina-
tion R 2 , the correlation coefficients R, the mean values and the 
standard deviations were calculated using the software program 
Microsoft Office Excel 2003. The linear regression analysis was 
performed to determine the relationship between two properties 
of the corneocytes: the pseudo-absorption at 850 nm as deter-
mined via IR densitometry and the amount of corneocytes as de-
termined with the Micro BCA protein assay. All other statistical 
tests such as the Student’s t test were performed using the software 
program GraphPad Prism 3.
 The calibration curves of the protein standards were separate-
ly evaluated both as linear correlations of the first order (linear 
function) and linear correlations of the second order (square 
function), as indicated in the Micro BCA working protocol. Since 
the protein values calculated with these curves were highly com-
parable (p  1 0.05), it was decided that the conventional linear cal-
ibration curve provided sufficient linearity in the range of the 
investigated protein concentrations.
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 Results 
 Skin Barrier Function and TEWL 
 Determination of the TEWL was employed to assess 
the intactness of the skin barrier function. Mean TEWL 
values of 17.09  8 2.20 g    m –2    h –1 (n = 24) were reached 
after approximately 1.5 h of thawing. At this point, the 
tape stripping procedure was started to avoid dehydra-
tion of the thawed tissue. Removal of 20 tape strips lead 
to a variable increase in TEWL to values around 51.22  8 
15.63 g    m –2    h –1 (n = 24). This might be due to interindi-
vidual differences in SC thickness  [7] , variable SC cohe-
sion  [23] , as well as variable or decreased hydration of the 
in vitro tissue  [8] . After 20 tapes, a large part of the bar-
rier of the porcine ear SC had been removed  [8] . Tape 
stripping of the whole SC with respectively 80–130 tapes 
led to a more pronounced increase in TEWL, with values 
up to around 70.17  8 3.84 g    m –2    h –1 for Corneofix tapes 
and 78.78  8 4.36 g    m –2    h –1 for D-Squame tapes (n = 7, 
respectively). The higher increase caused by D-Squame 
tapes is in agreement with data presented in the literature 
 [19] , and may be ascribed to the stronger adhesive force 
which leads to a more pronounced disruption of the skin 
barrier.
 Protein Analysis with the IR Densitometer 
 All analyzed tape strips gave absorption values well 
within the linear working range. The limit of quantifica-
tion was not reached. Since the device allows for a calibra-
tion prior to every series of measurements – thus elim-
inating the influence of the tapes’ background absorp-
tion – no further correction of the obtained values was 
necessary.
 Protein Analysis with the Micro BCA Protein Assay 
 Since previous investigations had employed different 
protein standards for comparable tasks  [15, 16] , both 
BGG and BSA were tested as possible standards for the 
quantification of porcine SC proteins. The protein ab-
sorption of the diluted standard solutions was deter-
mined at 550 nm with a microplate reader.  Figure 2 shows 
the results of the linear regression analysis between pro-
tein content and absorption for the diluted standard solu-
tions of BGG and BSA. Comparable calibration curves 
could be obtained with both protein standards. In case of 
BGG, the mean coefficient of determination R² was 0.999 
 8 0.002 (n = 37), while in the case of BSA, R 2 was 0.999 
 8 0.001 (n = 8). In order to provide a basis for compari-
son with previously published results for human skin 
 [15] , the BGG standard was employed for evaluation of all 
porcine protein samples. The standard curves deter-
mined for each experiment provided a linear correlation 
between the protein absorption at 550 nm and the protein 
content in the range of 2.5–40   g/ml. Since the protein 
amounts obtained after removal of adhesive films were 
never below this concentration, no extrapolation of the 
data towards the lower limit of quantification was neces-
sary.
 Every microplate was evaluated separately with the 
respective blank tape samples and the protein standard 
solutions as recommended by the manufacturer. In 
 order to examine the reproducibility of the individual 
experiments, an overall regression analysis was per-
formed over all individual data points of the employed 
BGG standard solutions, which corresponded to 37 in-
dividually prepared samples for each concentration (n = 
185).  Figure 3 shows the results of the regression analysis 
for the absorption at 550 nm and the protein content of 
the BGG standard. The overall coefficient of determina-
tion R 2 was 0.9932 with a confidence interval of 95%, 
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 Fig. 1. Impact of the polynomial nature of protein calibration 
curves shown on data obtained with BGG (number of calibration 
series = 37). The mean protein values obtained with the standard 
solutions were set into correlation with the respective absorption 
values by linear regression using either a linear correlation curve 
(A; –– U ––) or a polynomial correlation of the second order (B; 
 –– S –– ), as suggested by the manufacturer’s working protocol. The 
analyzed working range was between 2.5 and 200   g/ml BGG for 
the polynomial correlation curve. The linear working range em-
ployed for the microplate working protocol was between 2.5 and 
40   g/ml. 
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which confirms that the described working protocol
is suitable for obtaining reproducible results with the 
Micro BCA assay.
 The absorption of the SC proteins extracted from the 
tapes was determined with the help of the individual cal-
ibration curves established with BGG as a protein stan-
dard. The amount of proteins extracted from each tape 
was quantified in this fashion, and the obtained values 
were employed for the linear regression analysis.
 Linear Regression Analysis: Pseudo-Absorption versus 
Protein Content 
 Summarizing the experiment: tape stripping, visual 
control of the protein coverage on the tapes and IR den-
sitometric analysis were performed, followed by extrac-
tion and analysis of the protein content with the Micro 
BCA protein assay. Despite an accurate working proce-
dure, the porcine SC proteins were generally removed in 
large polygonal aggregates. Therefore, no tapes were a 
priori excluded from analysis in order to determine 
whether the specific clustering behavior of porcine SC 
proteins would affect the IR densitometric quantifica-
tion. Inhomogeneous protein coverage was noted in the 
protocol for separate evaluation procedures  [5, 14] .
 The obtained protein content of the samples as deter-
mined with the Micro BCA assay was then plotted against 
the previously determined IR densitometric absorption 
values. The regression analysis revealed a linear correla-
tion between these data, both for Corneofix and D-
Squame tapes ( fig. 4 ; n = 240, respectively). The obtained 
coefficients of determination were in the same order of 
magnitude as previously reported for human SC proteins 
 [15, 16] , namely R 2 = 0.812 for Corneofix and R 2 = 0.732 
for D-Squame tapes. An analysis of all obtained protein 
values irrespective of the type of adhesive film showed a 
similar trend (n = 480, R 2 = 0.729). A large number of ex-
periments were included in the correlation to give an 
overview about the reproducibility of the tape stripping 
method using porcine ear skin. The obtained correlations 
confirm that quantification of porcine SC proteins is pos-
sible in the course of an everyday experimental setup 
without having to exclude tapes from the final evaluation. 
A certain variability of the data has to be anticipated for 
experiments conducted with biological material  [24] .
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 Fig. 3. Linear regression over all individual data points of 37 cali-
bration curves obtained with BGG as a protein standard (n = 185). 
The confidence intervals set at 95% were within the range of 
0.0089 to 0.0091 for the slope and –0.0057 to –0.0012 for the Y-
intercept with a mean correlation of y = 0.0090  8 0.0001 to 0.0035 
 8 0.0012. The protein absorption values of defined standard so-
lutions were determined with a microplate reader at room tem-
perature. 
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 Fig. 2. Comparison of BGG and BSA as external standards for 
protein analysis with the Micro BCA protein assay. Defined pro-
tein solutions were employed to establish a linear correlation be-
tween protein concentration (  g/ml) and protein absorbance. 
The diluted protein solutions were analyzed at 550 nm with a TE-
CAN Infinite  microplate reader. The presented values are means 
 8 SD of individually determined calibration curves: n = 8 curves 
for BSA (– –    – –); n = 37 curves for BGG (–– U ––). 
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 Determination of Porcine SC Mass 
 Despite the good overall correlation between IR den-
sitometric values and the protein content of the tapes, the 
presented calibration curves might yield inaccurate re-
sults for adhesive films with low protein coverage. Since 
the amount of corneocytes removed from deeper layers 
of the SC becomes smaller with increasing tape numbers, 
higher uncertainties in quantification have to be expect-
ed  [5] . Moreover, it was shown that a reliable linear re-
gression analysis should only be conducted with selected 
pairs of data not disturbed by any methodological or an-
alytical effects  [1] . Otherwise, methodological limitations 
will lead to skewed correlations  [11, 24] .
 Therefore, a more restrictive evaluation of the data 
was performed for the individual experiments following 
the recommendations of Weigmann et al.  [1, 5] . The in-
dividual data sets were checked for experimental arti-
facts as previously noted during the experiment. Poten-
tially biased samples, i.e. adhesive films with strongly 
inhomogeneous protein coverage and/or risk of a stack 
effect  [5] , were subsequently excluded from the linear
regression analysis. Individual calibration curves for 
each experiment were calculated and extrapolated to the 
total SC depth which is represented by additional zero 
values for pseudo-absorption and protein content.  Fig-
ure 5 shows representative examples for individual cali-
bration curves obtained with either Corneofix or D-
Squame (n = 13, respectively). The individual correla-
tions were performed for 12 data sets for each tape brand. 
Since important skin parameters such as SC thickness 
and cohesion may vary significantly for different indi-
viduals, the data obtained for each individual were eval-
uated separately to obtain representative mean values of 
12 experiments  [5, 13] . The number of samples in the in-
dividual experiments remaining after exclusion of ex-
perimental artifacts ranged from 13 to 19 for Corneofix 
(34 out of 240 tapes excluded) and from 9 to 19 for D-
Squame (59 out of 240 tapes excluded). It is noteworthy 
that the number of excluded tapes was by far larger for 
D-Squame than for Corneofix.
 All experiments were evaluated in this fashion and 
highly comparable correlation curves were achieved. In 
the case of Corneofix, the mean R 2 was 0.940  8 0.019 
while in the case of D-Squame, a mean R 2 of 0.934  8 
0.022 was obtained (n = 12, respectively). The slopes k 
were 0.438  8 0.054 for Corneofix and 0.385  8 0.069 for 
D-Squame tapes. No statistical differences between the k 
values obtained for Corneofix and D-Squame tapes were 
found (p  1 0.05). Therefore, a mean calibration curve to 
be used for the evaluation of undisturbed data was estab-
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 Fig. 4. Linear regression analysis of individual protein samples 
obtained through sequential tape stripping of porcine ear skin 
with either Corneofix ( a ) or D-Squame tapes ( b ). For each type of 
adhesive film, 12 experiments were conducted during each of 
which 20 sequential adhesive films were removed (n = 240 for 
each type of adhesive film). The protein content as determined 
with the Micro BCA assay was plotted against the corresponding 
IR densitometric data. 
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lished including all experiments irrespective of the tape 
brand used. The mean overall correlation was found as
y = 0.41x with a mean coefficient of determination R 2 of 
0.937  8 0.021 (n = 24). The obtained slope k represents 
the mean factor of proportionality between pseudo-ab-
sorption and protein content, which was 0.41  8 0.07 for 
all experiments (n = 24). This value can be employed to 
calculate the mass of SC proteins ( m ) after determination 
of their pseudo-absorption at 850 nm ( A ) for a normal-
ized tape area of 1 cm 2 by employing the equation  m = 
 A /0.41 (in   g/cm 2 ).
 As previously discussed  [5] , the highest accuracy in 
protein quantification is surely obtained with individual 
correlation curves which have to be established for every 
volunteer or every skin sample. In the case of porcine ear 
skin, this would be a rather time-consuming quest con-
sidering the fact that only a limited number of experi-
ments can be performed on a single porcine ear. The use 
of the established overall correlation will save time while 
still providing sufficiently accurate results.
 Determination of Porcine SC Thickness in vitro 
 Additional tape stripping experiments (n = 7 for D-
Squame, n = 7 for Corneofix) were conducted in which 
the complete horny layer was removed. The number of 
adhesive films required for this task varied between 80 
and 130 strips. The end of tape stripping was set at the 
limit of quantification of the IR densitometer. When the 
values remained constant around 0.0  8 0.1%, the strip-
ping procedure was stopped.
 The cumulative value of pseudo-absorption was 
327.44  8 133.55 % (n = 14). The mean SC thickness was 
calculated using the mean proportionality factor of 
0.41. The mean protein density of the tissue was as-
sumed with 1 g    cm –3 , as previously proposed for calcu-
lating the thickness of both porcine  [8] and human skin 
 [5] . The resulting mean SC thickness was found to be 
7.96  8 3.25   m. These values are in agreement with 
recent data published for porcine SC thickness  [7, 8, 25] . 
Higher values for SC thickness have been reported as 
well  [20, 26] . This expected variability may be due to 
interindividual differences – such as the exact age and 
breed of the pigs  [7] , the general skin state as well as the 
exact location of tissue sampling and the different tech-
niques of analysis. Various techniques such as histolog-
ical sectioning after freezing  [26] , TEWL measurements 
in combination with tape stripping  [8] , light microsco-
py  [20] and fluorescence microscopy  [25] were pro-
posed.
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 Fig. 5. Representative linear regression curves of individual pro-
tein samples obtained through 1 sequential tape stripping exper-
iment of porcine ear skin with either Corneofix ( a ) or D-Squame 
tapes ( b ). Adhesive films with inhomogeneous protein coverage 
which would lead to biased results were excluded. The analyzed 
values represent undisturbed adhesive films (n = 13, respectively) 
with visually homogeneous protein coverage. Extrapolation of the 
regression curve was performed in order to allow an accurate de-
termination of low protein values. 
3.3. FACILITATING IN VITRO TAPE STRIPPING 61
 Facilitating in vitro Tape Stripping  Skin Pharmacol Physiol 2011;24:256–268 263
 The accuracy of the obtained results was confirmed by 
correlating the SC thickness as determined by the two 
employed methods against the respective tape strip num-
ber ( fig. 6 ). In the case of Corneofix tapes ( fig. 6 a), an al-
most identical SC thickness was calculated using the pro-
tein amounts determined via the protein assay and the 
corresponding values determined via IR densitometry. 
This supports the validity of the applied extrapolation of 
the correlation curves as previously reported  [5] . In the 
case of D-Squame tapes ( fig. 6 b), a slight discrepancy be-
tween the values was observed. This again confirms that 
tapes of lower adhesive power are more suitable for the 
use on porcine skin since a smaller risk of the stack effect 
and relatively smaller uncertainties due to inhomoge-
neous protein coverage occur.
 It is well known that the amount of corneocytes re-
moved with single tapes and the thickness of the horny 
layer can vary considerably for different individuals  [1, 
22, 27] . Hence during skin penetration studies, the abso-
lute horny layer thickness should either be established for 
every tested individual or for a sufficiently large number 
of individuals for which a representative mean thickness 
can be calculated.
 Discussion 
 Peculiarities of Porcine Skin during Tape Stripping 
 Many of the observations made during this investiga-
tion are linked to the specific properties of porcine skin 
and its distribution on adhesive films. In pig skin, the 
cells are organized in polygonal clusters or columns that 
comprise the whole of the epidermis and are separated by 
intercluster regions or ‘canyons’. This structure as de-
scribed and graphically demonstrated by Carrer et al.  [25] 
might explain the distinct pattern of porcine corneocyte 
removal. As  figure 7 a, b clearly shows, the corneocytes 
are removed in large polygonal clusters. Since the inter-
cluster regions start as wrinkles on the skin surface, the 
corresponding areas on the tape will exhibit a lower cor-
neocyte density – thus appearing as separating barriers 
between the SC clusters fixed to the tape. High protein 
density as primarily observed for the first tape strips re-
moved will therefore lead to comparatively inhomoge-
neous protein coverage. The following adhesive films 
showed a more homogeneous protein coverage, especial-
ly in the case of Corneofix tapes. Due to their higher ad-
hesive power, the D-Squame tapes generally showed a 
more irregular pattern of protein removal. In contrast, 
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 Fig. 6. Depth of the SC reached after removal of 20 sequential tape 
strips using Corneofix ( a ) or D-Squame tapes ( b ). The black sym-
bols ( + ,  d ) represent the SC depth as calculated from the protein 
values obtained by direct analysis with the Micro BCA protein 
assay. The white symbols ( _ ,  o ) represent the SC depth as calcu-
lated after indirect protein quantification by IR densitometry us-
ing the presented factor of proportionality k = 0.41. The values are 
means  8 SD of 12 experiments. 
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the first tape strips removed from human skin in vivo 
( fig. 7 c, d; courtesy of the experimenter) show a finely dis-
tributed network of small corneocyte aggregates.
 However, the distribution of the porcine protein clus-
ters and intercluster regions is apparently of a sufficient-
ly homogeneous nature to allow for a reasonably accurate 
analysis of the pseudo-absorption by IR densitometry. 
Previous studies have reported the successful quantifica-
tion of porcine SC proteins via assessment of the pseudo-
absorption by UV/VIS spectroscopy  [13] . Despite the 
presence of the described trans-epidermal shunt path-
ways  [25] , the penetration behavior of different sun-
screens was found to be nearly identical for human skin 
in vivo and porcine ear skin in vitro  [13] . A substantial 
amount of research confirms the suitability of the por-
cine ear model as a substitute for human skin despite the 
inherent structural differences. A slightly higher perme-
ability of the porcine skin has been reported  [28, 29] , 
which may be related to the presented canyons or the 
larger orifices of porcine hair follicles  [13] . The reported 
observations are thus in accordance with previous opin-
ions. In vitro tissue shows different properties compared 
to living skin which may affect the amount of removed 
SC. The presence of wrinkles may have a different effect 
during in vitro tape stripping even if a rolling movement 
is used to apply pressure  [14] .
 Linear Regression Analysis and Tape Stripping 
 In recent years, various methods have been introduced 
for the quantification of proteins removed with adhesive 
films. Most of these methods have been validated by sim-
ply correlating the obtained data with the values deter-
mined by a classical protein analysis method, such as pro-
tein assays  [10, 11, 15, 16] or weighing  [1, 2, 6] . In this 
context, disturbing influences connected with the tape 
stripping procedure have been described in detail  [1, 14] . 
The main challenge is to obtain a homogeneous distribu-
tion of corneocyte aggregates fixed on the individual 
tapes. Inhomogeneous protein coverage may be caused 
by the inherent heterogeneity of the skin, and might 
therefore not be entirely avoided  [11] . On the other hand, 
errors caused during the working procedure can be con-
trolled – such as incorrect positioning of the tapes or in-
consistent removal – otherwise the obtained absorption 
values might not be representative of the amount of cor-
neocytes on the tape  [1] . To prevent such disturbing ef-
fects from biasing the correlation, the homogeneous dis-
tribution of the horny layer particles on each tape should 
be checked visually. If obvious disturbances are detected, 
the corresponding data pair should be excluded from the 
linear regression analysis  [1, 19] . However, the distribu-
tion of the horny layer particles of porcine skin on the 
tapes was found to be generally more irregular than for 
tapes strips removed from human skin. Thus, all ob-
tained tape strips were used for establishing an overall 
correlation as previously demonstrated  [15, 16] . Nonethe-
less, discrepancies concerning the protein coverage were 
noted. Evaluation of the data showed that despite the ir-
regular pattern of protein removal of porcine skin, the 
overall correlations obtained for the summarized 240 
samples were highly satisfying when compared to data 
obtained with human skin  [15, 16] .
a b
c d
 Fig. 7. Representative examples of first adhesive films to be re-
moved from the skin surface of porcine skin ( a ,  b ) and human 
skin ( c ,  d ). 
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 IR Densitometry: Influence of Different Tape Brands 
and Protein Coverage 
 The two investigated brands of adhesive film led to 
successive protein removal from the skin surface. The D-
Squame tapes generally led to higher amounts of removed 
protein than the Corneofix tapes, despite the adapted 
working protocol. In addition, the protein removal pro-
cess proceeded quite differently with increasing tape 
numbers according to the brand of adhesive film. The D-
Squame tapes produced similarly high amounts of re-
moved protein irrespective of the tape number. In con-
trast, the Corneofix tapes led to the removal of large 
amounts of protein especially on the first and second tape 
while subsequent tapes showed a consistent decrease in 
protein content. Similar observations have been reported 
in context with comparative studies using D-Squame and 
Tesafilm tapes  [16] .
 The results of the different methods of analysis, name-
ly the IR densitometric absorption values and protein 
content determined with the Micro BCA assay, are plot-
ted against the respective tape strip number ( fig. 8 ). The 
curves help visualize the change in protein content dur-
ing the tape stripping procedure. Moreover, the correla-
tion of the absorption and the protein content to the re-
spective tape number illustrates the effect of potential 
disturbances. The units of the respective measurement 
quantities are given on the scales to the left and to the 
right. The curves show that both types of measured quan-
tities, i.e. pseudo-absorption and actual protein content, 
correlate very well for Corneofix tapes ( fig. 8 a). In case of 
D-Squame, the high protein values on the first tape lead 
to slightly inconsistent results since the absorption values 
are comparatively low ( fig. 8 b).
 Although the two methods deliver largely corre-
sponding results in both cases, it becomes clear that the 
results obtained for the first tape strip may vary slightly, 
especially in the case of D-Squame. This might be as-
cribed to the discrepancy between the measurement area 
of the IR densitometer and the extracted tape strip area. 
While the IR densitometer assesses only around 45% of 
the tape strip area, the protein assay accounts for the 
whole area. Irregular protein coverage on the adhesive 
film outside the measurement area remains unnoticed 
during IR densitometry, but will influence the results of 
the protein assay. The potential discrepancies will in-
crease with increasing protein content, as is occasionally 
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 Fig. 8. Progression of the removed protein content as observed 
with Corneofix ( a ) and D-Squame ( b ) tapes during the tape strip-
ping process on porcine ear skin. The presented values are the 
means of 12 independent experiments (means  8 SD) during each 
of which 20 sequential tape strips were removed. The mean pro-
tein absorption at 850 nm (%; –– U ––) as well as the mean protein 
density (  g/cm 2 ; – –      – –) were plotted against the respective 
tape strip number. 
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obtained with the first adhesive film of Corneofix, but 
more frequently with D-Squame tapes. This method-
ological issue might result in slightly inconsistent data 
and explains the outliers which bias the overall correla-
tion of all samples. Even if the tape stripping procedure 
is conducted correctly, slight variability in protein cover-
age of the tapes cannot be entirely avoided when using 
porcine ear skin.
 In addition, high protein coverage might cause an ad-
ditional stack effect due to overlapping corneocyte aggre-
gates, which might lead to erroneously low protein ab-
sorption values. The stack effect was described for UV/
VIS spectroscopy  [1, 5] , but may affect other optical meth-
ods such as IR densitometry as well. If the density of cor-
neocytes on the tapes is very high, cells may be piled upon 
each other and thus remain undetected. This leads to 
comparatively lower absorption values in relation to the 
actual protein content.
 The described discrepancy between absorption and 
actual protein content was primarily observed for the 
first D-Squame tapes which possess higher adhesive 
power. This explains the slightly lower coefficient of de-
termination of the original correlation obtained with D-
Squame tapes. Similar observations of inhomogeneous 
protein coverage were reported for in vivo studies on 
human volunteers with D-Squame tapes  [11] . The inho-
mogeneities were highest for the first tape strips, and 
decreased progressively with SC depth. It may be as-
sumed that ideal homogeneity of the protein coverage 
may not be reached due to the inherent heterogeneity of 
SC properties, particularly for the loosely bound outer 
SC layers  [11] . As is well known, the structure of the SC 
is not homogeneous in its entire thickness  [2] . Likewise, 
it is a common experience during tape stripping that 
higher amounts of particles may be suddenly removed 
with an individual tape  [1] . However, different studies 
indicate that accurate protein quantification is possible 
if both the skin material used and the working protocol 
are chosen with care  [5, 14] . Inhomogeneous protein 
coverage of Tesafilm tapes occurred rarely for human 
skin in vivo and did not represent a significant source of 
error for protein quantification through UV/VIS spec-
troscopy  [5] . It remains to be investigated whether the 
higher adhesive power of D-Squame tapes is indeed un-
favorable in this context. In any case, attention should 
be paid to a consistent quality of the employed adhesive 
films. Unfavorable or prolonged storage conditions 
might impair the tackiness of the tapes and should thus 
be avoided.
 In consideration of all discussed aspects, the obtained 
coefficients of determination show all the more that the 
correlation between pseudo-absorption and protein con-
tent of the tapes is actually of a remarkably robust nature.
 Methodological Aspects Concerning the Micro BCA 
Protein Assay 
 Protein analysis with ready-to-use test kits is a practi-
cal and reliable method for evaluating the performance 
of a new analysis method such as IR densitometry. Im-
portant aspects that should not be neglected are the 
choice of the right assay that will deliver accurate results 
for the analyzed range of protein concentrations. In the 
present case, the Micro BCA assay was the method of 
choice since protein concentrations below 20   g/ml were 
frequently observed. Since high protein values above 40 
  g/ml will be determined with decreasing accuracy 
( fig. 1 ), such samples should either be diluted beforehand 
or excluded from the linear regression analysis. The al-
ternative method of bisecting the respective tapes with a 
scalpel for separate analysis may be a source of error  [11] . 
In addition, the first adhesive films frequently have to be 
discarded from the final evaluation due to comparatively 
larger inhomogeneities in protein coverage  [19] .
 IR Densitometry: Differences between Human and 
Porcine Skin 
 The obtained correlations differed from those report-
ed for human skin  [15, 16] . A comparison of the calibra-
tion curves shows that the slope of the presented porcine 
correlations is less steep. This might be explained by two 
phenomena. Firstly, porcine skin might behave different-
ly when subjected to radiation at 850 nm, leading to a dif-
ferent pattern in terms of light scattering, reflection and 
diffraction. Since protein absorption was previously re-
ported to differ significantly between male and female 
human volunteers  [30] , it is not unlikely that porcine SC 
proteins exhibit a different pattern of pseudo-absorption 
as well. Differences between porcine and human keratin 
have been reported  [31] . Secondly, porcine skin appears 
rather rough in comparison to human skin and behaves 
differently when subjected to the adhesive force of a tape 
strip. While human corneocytes are removed as a consis-
tent layer of finely distributed protein aggregates, the por-
cine corneocytes are removed in large clusters or patches. 
On the one hand, this might lead to an increased occur-
rence of the stack effect  [5, 14] . On the other hand, the 
pseudo-absorption of the proteins may be a different one 
for this specific pattern of protein removal.
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 Summarizing these findings, it can be concluded that 
the presented correlation curves are a useful prerequisite 
for rapid and efficient quantification of porcine SC pro-
teins during in vitro tape stripping studies. The results 
indicate that tape strips with lower adhesive power are 
more suitable for IR densitometric analysis of porcine SC 
proteins. Although IR densitometry should be primarily 
employed for homogenous skin samples, it was shown 
that it is possible to obtain satisfyingly accurate results for 
porcine ear skin despite significant protein clustering. 
The pseudo-absorption measured by IR densitometry 
was found to be suitable for quantification of corneocyte 
aggregates on individual tapes.
 Conclusion 
 It may be concluded that despite the obvious challeng-
es that occur during tape stripping of porcine skin, repro-
ducible and accurate results can be obtained if the tape 
stripping procedure is conducted correctly. IR densitom-
etry as an optical method for protein quantification can 
be used to rapidly and efficiently determine the penetra-
tion profiles of applied substances without destroying the 
respective tapes. Further studies are being conducted to 
investigate the porcine ear model in tape stripping ex-
periments in combination with IR densitometric protein 
analysis.
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Abstract: Mild non-ionic sucrose ester surfactants can be employed to produce lipid-based 
drug delivery systems for dermal application. Moreover, sucrose esters of intermediate 
lipophilicity such as sucrose stearate S-970 possess a peculiar rheological behavior which 
can be employed to create highly viscous semi-solid formulations without any further 
additives. Interestingly, it was possible to develop both viscous macroemulsions and fluid 
nanoemulsions with the same chemical composition merely by slight alteration of the 
production process. Optical light microscopy and cryo transmission electron microscopy 
(TEM) revealed that the sucrose ester led to the formation of an astonishing hydrophilic 
network at a concentration of only 5% w/w in the macroemulsion system. A small number 
of more finely structured aggregates composed of surplus surfactant were likewise detected 
in the nanoemulsions. These discoveries offer interesting possibilities to adapt the low 
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viscosity of fluid O/W nanoemulsions for a more convenient application. Moreover, a 
simple and rapid production method for skin-friendly creamy O/W emulsions with 
excellent visual long-term stability is presented. It could be shown by franz-cell diffusion 
studies and in vitro tape stripping that the microviscosity within the semi-solid 
formulations was apparently not influenced by their increased macroviscosity: the release 
of three model drugs was not impaired by the complex network-like internal structure of 
the macroemulsions. These results indicate that the developed semi-solid emulsions with 
advantageous application properties are highly suitable for the unhindered delivery of 
lipophilic drugs despite their comparatively large particle size and high viscosity.  
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1. Introduction  
Sucrose fatty acid esters have been known as additives in the fields of nutrition, cosmetics and 
pharmacy for a long time [1-4]. However, it is only recently that their potential as mild non-ionic 
surfactants in the production of topical lipid-based drug delivery systems has been investigated more 
thoroughly. Different sucrose esters of various HLB values have been investigated for their potential to 
form O/W nanoemulsions [5-7] and to increase [8-10] or retard [11] the skin permeation of 
incorporated drugs. We have recently demonstrated the superiority of sucrose stearate S-970 over a 
comparable lecithin mixture to produce highly stable and homogeneous O/W nanoemulsions for 
dermal application [7]. In this context we found that the employed emulsifier sucrose stearate S-970 
exhibited a peculiar rheological behavior when processed in a specific way. The astonishing gel-
forming ability of sucrose stearate mixtures of intermediate hydrophilic/lipophilic balance (HLB value) 
around 9 to 11 has been reported in earlier literature [12,13] as well as recently [11,14,15]. However, 
no attempt has been made so far to design semi-solid multiphase vehicles which are stabilized in this 
fashion and can be used for incorporation of lipophilic drugs. The properties of a sucrose stearate/water 
dispersion were recently investigated [15], but no approach to incorporate additional excipients has 
been reported. However, incorporation of oil or model drugs may have a significant effect on the 
gelling properties of the sucrose ester and thus the microstructure of the resulting vehicles. Likewise, 
the drug release properties of such viscous sucrose ester-stabilized formulations have not been 
explored yet. Since these aspects are of great practical interest for the development of new 
formulations, the present work addresses these points.  
A simple and skin-friendly sucrose stearate-based O/W emulsion was developed. Optical light 
microscopy, cryo transmission electron microscopy, rheological investigations and laser diffractometry 
were employed to characterize the microstructure of the novel system. Three lipophilic model drugs 
were incorporated and the effect of formulation microstructure and viscosity on the release profile of 
the system was investigated in vitro using franz-type diffusion cells and tape stripping experiments on 
porcine ears. Since a large particle size and high viscosity of a topically applied formulation are 
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frequently associated with decreased or sustained drug release, we decided to compare the novel 
systems to corresponding O/W nanoemulsions. Through a slight alteration of the production process 
and subsequent high-pressure homogenization it was possible to develop fluid O/W nanoemulsions of 
the exact same composition as the novel macroemulsions and the same content of sucrose stearate, 
namely 5% (w/w). Microscopic and rheological investigations were performed on these systems as 
well. Dynamic light scattering and laser Doppler electrophoresis were employed to further characterize 
the nanoemulsions.  
Overall, the aim of the present study was to explore the astonishing gel-forming properties of 
sucrose stearate S-970 in colloidal multiphase drug delivery systems and to characterize the nature of 
the resulting semi-solid vehicles. In addition, the drug release profile of these novel O/W emulsions 
was evaluated by comparing them to fluid nano-sized emulsions of identical chemical composition.  
 
2. Experimental Section  
2.1. Materials 
Sucrose stearate (Ryoto Sugar Ester® S-970) was supplied by Mitsubishi-Kagaku Food Corporation 
(Tokyo, Japan). PCL-liquid (cetearyl ethylhexanoate, isopropyl myristate) was purchased from 
Dr.Temt Laboratories (Vienna, Austria). The preserving agent potassium sorbate was obtained from 
Herba Chemosan Apotheker-AG (Vienna, Austria). Flufenamic acid (CAS: 530-78-9, Batch No. 1619) 
and diclofenac acid (CAS: 15307-86-5, Batch No. 080304) were obtained from Kemprotec Limited 
(Middlesbrough, UK). Curcumin (CAS: 458-37-7, Batch No. 079K1756) was purchased from Sigma 
Aldrich (St. Louis, USA). Standard Corneofix® adhesive films with a square area of 4.0 cm² were 
obtained from Courage + Khazaka GmbH (Cologne, Germany). All further chemicals used were of 
analytical reagent grade and used without further purification.  
 
2.2. Formulations 
Different concentrations of 1 to 5% w/w sucrose stearate S-970 were tested for their emulsifying 
potential in O/W emulsions. An increase in viscosity in dependence of the preparation method had 
been noticed especially for 5% w/w of sucrose stearate. At surfactant concentrations above 5% w/w, 
highly viscous creamy emulsions had been obtained irrespective of the preparation method, i.e. the 
emulsion microstructure had been too viscous to pass it through a high-pressure homogenizer even if 
heated. Therefore, an amount of 5% w/w of sucrose stearate was chosen for the final formulations.   
The produced viscous macroscopic emulsions and the corresponding fluid nanoemulsions were 
identical in their composition, which is given in Table 1.  
The preparation of a separate water and oil phase was the same in both cases. The aqueous phase, 
consisting of freshly distilled water and potassium sorbate, as well as the oil phase, consisting of the 
cosmetic oil PCL-liquid, were respectively stirred at 50 °C. Blank and drug-loaded formulations were 
prepared. The lipophilic model drugs flufenamic acid, diclofenac acid and curcumin were respectively 
dissolved in the oil phase at a concentration of 0.5% (w/w).  
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Table 1. Basic composition of macroemulsions (E) and nanoemulsions (NE).  
Excipients Emulsion composition (% w/w) 
  
E = NE 
PCL-liquid 20 
Sucrose stearate S-970 5.0 
Potassium sorbate 0.1 
Model drug 0.5 
Distilled water to 100 
In case of the macroemulsions, sucrose stearate S-970 was dissolved in the oil phase. A highly 
viscous macroemulsion was obtained upon slow admixture of the aqueous phase, further stirring for  
10 minutes and subsequent treatment with an ultra-turrax (Omni 500, 2500 rpm, 4 minutes). 
Refrigerated storage appeared to favor the observed gelling effect.  
In case of the nanoemulsions, sucrose stearate S-970 was dissolved in the aqueous phase in order to 
maintain low viscosity of the system. The oil phase was subsequently added slowly to the aqueous 
phase for the same reason. The mixture was stirred for further 10 minutes, then pre-homogenized with 
an ultra-turrax (Omni 500, 2,500 rpm, 4 minutes). The mixture was stirred and heated to 50 °C before 
homogenization with a high-pressure homogeniser (EmulsiFlex C3, Avestin) for 16 homogenization 
cycles at 750 bars. Process parameters such as homogenization pressure and homogenization time had 
been optimized during previous studies [7]. Care was taken to process the mixture under mildly pre-
heated conditions to avoid any sudden cooling and associated gelling within the device.  
 
2.3. Emulsion Characterization 
2.3.1. Visual characterization  
Both macroemulsions and nanoemulsions were investigated for the presence of structures visible to 
the eye as well as for their texture and skin feeling.  
 
2.3.2. Particle size  
The macroemulsions were investigated for their particle size and particle size distribution by laser 
diffractometry (laser diffraction, static laser light scattering). Measurements were performed in 
triplicate on a Mastersizer 2000 (Malvern, UK). The instrument was operated with the HydroS 2000 
sample dispersion unit (Malvern, UK) and software version 5.60 at 25 °C. The samples were diluted 
with distilled water (1:1000 v/v) and stirred slightly prior to analysis. All samples were analyzed in 
triplicate (n = 3). No sonification of the samples was performed prior or during the measurements to 
avoid the destruction of possible aggregates which may provide information about the microstructure 
as well as destabilization phenomena [16,17]. Laser diffraction measurements yield volume-weighted 
diameters as results for droplet sizes up to 2000 µm [16]. The parameters obtained in the present 
experiments were the d(v, 0.1), d(v, 0.5) and d(v, 0.9). Likewise, the volume weighted mean D [4,3] 
and the surface weighted mean D [3,2] were obtained. The d(v, 0.5) or volume median diameter marks 
the size where 50% of the distribution is above and 50% is below this value. The d(v, 0.1) represents 
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the point where 10% of the volume distribution is below this value. In analogy, the d(v, 0.9) marks the 
point where 90% of the volume distribution is below this value. The d(v, 0.9) can be employed to 
quantify larger droplets which might be present in the sample such as aggregates formed due to internal 
processes or destabilization [16]. The volume weighted mean or volume mean diameter D [4,3] 
corresponds to the mean diameter of spheres with the same volume as the analyzed droplets and is 
calculated by d4,3 = ∑ni di4 / ∑ ni di3, where ni is the number of particles with diameter di [17]. In 
analogy, the surface weighted mean D [3,2] represents the mean diameter of the spheres with the same 
surface area as the analyzed droplets. In addition, the span was automatically calculated for all samples. 
This dimensionless number represents the width of the droplet size distribution based on the 10%, 50% 
and 90% quantile. A wide particle size distribution will yield a comparatively large span. All 
parameters were calculated automatically using the Mie theory with a refractive index of 1.52 and a 
particle absorption value of 0.1. Measurements were conducted immediately after production and after 
six months of storage time.  
The nanoemulsions were investigated for their particle size and particle size distribution by 
dynamic light scattering (DLS, photon correlation spectroscopy) using a Zetasizer Nano ZS (Malvern, 
UK) at 25 °C. Samples were diluted with freshly distilled water 1:100 (v/v) to diminish opalescence. 
The obtained parameters were the hydrodynamic diameter expressed as z-average value of the samples 
as well as the polydispersity index (PDI). The z-average value is an intensity weighted mean diameter 
of the bulk population of the sample while the PDI represents the particle size distribution within the 
formulations. PDI values below 0.2 indicate a narrow size distribution and thus good long-term 
stability [18]. The approximate measuring range of this instrument is from 3 nm to 3 µm [19]. All 
samples were analyzed in triplicate (n = 3). Each individual result was automatically calculated as the 
average of 3 measurements with 20 sub-measurements each. The particle size and PDI of the 
nanoemulsions were measured immediately after preparation and in regular intervals over a period of 
six months. In order to detect the presence of potential larger droplets or aggregates, both optical light 
microscopy and cryo TEM were employed.  
 
2.3.3. Particle surface charge (zeta potential)  
The particle surface charge of the nanoemulsions was determined by laser Doppler electrophoresis 
using a Zetasizer Nano ZS (Malvern, UK). The electrophoretic mobility of the droplets was determined 
and automatically converted into the zeta potential using the Helmholtz-Smoluchowski equation by the 
Malvern data analysis software [16]. Zeta potential (ZP) values of the formulations were determined at 
25 °C. Samples were diluted with distilled water (1:100 v/v) containing sodium chloride (0.01 mmol) 
in order to ensure constant conductivity below 0.05 ms/cm and thus reproducible measurement 
conditions [16,18,20]. The ZP roughly characterizes the surface charge of the emulsion droplets in 
solution. High absolute values above 30 mV lead to repulsive forces between the droplets which may 
improve the physical stability of multiphase systems [20]. Absolute ZP values above 60 mV indicate 
excellent electrochemical stability [16]. Zeta potential values were determined in triplicate for all 
nanoemulsions (n = 3) after production and in regular intervals over six months.  
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2.3.4. Physical stability   
The physical stability of both macroemulsions and nanoemulsions was compared by determination 
of the particle size after an observation period of six months. All formulations were stored at 4 °C. A 
visual control was regularly performed to detect any signs of instability. In case of the nanoemulsions, 
additional control measurements were performed in regular intervals over the whole observation period 
as well.  
 
2.3.5. Drug content, chemical stability and pH value 
The drug content of all formulations was analyzed immediately after preparation to ensure 
appropriate drug incorporation. Briefly, 10 mg of the emulsion were dissolved in 1 mL of methanol, 
centrifuged for 6 minutes at 12,000 rpm (Hermle Z323K, MIDSCI, USA) and analyzed by HPLC or 
UV/Vis spectroscopy. Samples were taken at least in triplicate (n ≥ 3). In case of flufenamic acid and 
diclofenac acid, further samples were taken in regular intervals over three months to obtain a rough 
overview about the chemical stability of the acidic drugs and their homogeneous dispersion within the 
systems. Since curcumin is known to undergo a variety of degradation processes which would require 
more specific methods of analysis, no attempt was made to cover this aspect in the scope of the present 
work. The obtained data should merely ensure the use of representative and intact formulations for all 
further studies.  
The pH value of the formulations was determined using a pH meter (Orion 420A, Bartelt, Austria). 
The pH of all formulations was determined at room temperature (25 °C) in regular intervals to detect 
destabilization phenomena induced by chemical degradation through hydrolysis or oxidation, which 
result in a decrease of pH [21].  
 
2.3.6. Optical light microscopy  
Optical light microscopy was employed to obtain an overview about the presence of structures 
within the micrometer size range, which was especially interesting in the case of the macroemulsion 
morphology. In case of nanoemulsions, optical light microscopy served as a quality control to ensure 
the absence of larger structures. The microscopic analysis was carried out using a photo microscope 
(Zeiss Axio Observer.Z1 microscopy system, Carl Zeiss, Oberkochen, Germany) equipped with phase 
contrast and differential interference contrast (DIC) and using LD Plan-Neofluar objectives. A small 
amount of fresh or stored sample of the macroemulsions and nanoemulsions was respectively placed 
on an object slide, covered and analyzed immediately. Images were taken in conventional bright field 
mode, with phase contrast and with DIC while 5, 10, 20 and 40-fold magnifications were employed for 
all samples.  
 
2.3.7. Transmission electron microscopy (TEM): Cryo TEM and negative staining for conventional 
TEM 
The structure of blank macroemulsions and nanoemulsions containing 5% (w/w) sucrose stearate 
was visualized using cryo TEM. To this end, several vitrified specimens were prepared for each 
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formulation type. In case of the macroemulsion, a fresh glow-discharge copper grid covered with a 
perforated carbon film was placed on the sample, polished by filter paper in order to remove excess 
material and immediately plunged into liquid ethane. The macroemulsion samples were observed in an 
undiluted state so as not to destroy the internal structure. In case of the nanoemulsion, the sample was 
dissolved in distilled water (1:10 v/v). Subsequently, a 4 µm drop of the solution was placed on a fresh 
glow-discharge TEM copper grid covered with a perforated carbon film (Pelco International) and 
blotted with a filter paper to form a thin liquid film of the sample (thickness of 100–250 nm). The 
thinned sample was plunged into liquid ethane at its freezing temperature (−183 °C) to form a vitrified 
specimen, and was then transferred to liquid nitrogen (−196 °C) for storage until examination. Vitrified 
specimens were examined in a Philips T12 transmission electron microscope (Philips) operating at an 
accelerating voltage of 120 kV using an Oxford CT3500 (Oxford Instruments) cryo holder that 
maintained the vitrified specimens at −160 °C during sample observation. Images were recorded 
digitally on a cooled Gatan BioScan CCD camera (Gatan) using the DigitalMicrograph 3.4 software 
(Gatan) in low-dose imaging mode to minimize beam exposure and electron beam radiation damage. 
In addition, conventional TEM analysis was performed for both samples after negative staining with 
uranyl acetate as previously described [22]. To this end, a carbon coated mesh was hydrophilized by 
glow discharge and a drop of the respective undiluted emulsion was deposited on the mesh. An 
aqueous solution of 1% (v/v) of the negative staining agent uranyl acetate was subsequently applied on 
the mesh to facilitate observation.  
 
2.3.8. Rheological characterization 
The rheological properties of both macroemulsions and nanoemulsions were investigated. All 
experiments were performed on a Bohlin CVO Rheometer (Malvern Instruments, UK) with a 
thermostatic control system (Bohlin KTB30, Malvern, UK). The employed rheometer tools were a 
thermostatically controlled cone and plate tool with 40 mm in diameter and a 4° angle (CP 4°/40 mm) 
for the macroemulsions and a coaxial cylinder system with 25 mm in diameter (cup and bob C25) for 
the nanoemulsions. The temperature for both tools was maintained at 25 ± 0.5 °C throughout all 
experiments. The applied amount of sample was around 2 g for macroemulsions and around 15 g for 
nanoemulsions. Both blank and drug-loaded formulations were investigated. All measurements were 
performed at least in triplicate (n ≥ 3). Values given in figures and tables are the average values.  
Flow curves were established for all systems. The flow properties of both blank and drug-loaded 
macroemulsions and nanoemulsions were investigated by measuring the dynamic viscosity η (in Pa·s) 
under shear stress. Rheological experiments in a controlled-rate mode were performed. A controlled 
shear rate γ was employed at a constant temperature of 25 ± 0.5 °C to determine the viscosity of the 
samples as a function of the shear rate ranging from 0.1 s−1 to 100 s−1. The obtained flow curves of 
both macroemulsions and nanoemulsions were compared to the power law model (Ostwald model) 
defined as η = m γ (n-1) where η represents the shear viscosity, m equals the consistency coefficient, γ 
represents the shear rate and n is the flow behavior index. Values of n = 1 are indicative for Newtonian 
fluids while values of n < 1 are representative for shear-thinning, i.e. pseudoplastic fluids. Values of  
n > 1 are found for shear-thickening dilatant fluids [23,24].  
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Moreover, oscillatory shear experiments were performed for all systems. In the oscillatory mode, a 
sinusoidal stress is applied to the sample and the response in form of the induced strain is measured 
[25,26]. To this end, the rheometer tool is moved forward and backward in a defined sinusoidal 
motion. After identification of the linear viscoelastic region the samples were investigated over a 
frequency of 1–10 Hz. Crucial parameters were determined as a function of the oscillatory frequency 
(v, in Hz). The parameters obtained in this fashion are the elastic modulus G’, the viscous modulus 
G’’, the complex modulus G* and the dynamic viscosity η’.  
The elastic modulus or storage modulus G’ is defined as G’ = G* cos (δ) and describes the 
recoverable energy that is stored within an elastic system. The viscous modulus or loss modulus G´´ is 
calculated by G´´ = G* sin (δ) and represents the energy that is dissipated in the viscous flow and 
transformed into heat. These moduli represent the real and imaginary parts of the complex dynamic 
shear modulus G* [25-27]. The dynamic viscosity η’ is defined as η’ = G’’/ω, where ω is the angular 
velocity of the oscillatory stress which is in turn related to the oscillatory frequency by the relationship 
ω=2πν. The related phase angle is expressed as δ [25,26].  
 
2.4. Skin permeation experiments using franz-type diffusion cells 
In vitro skin permeation studies were performed using standard franz-type diffusion cells 
(Permegear, USA). Thus, the potential influence of the different formulation properties of 
macroemulsions and nanoemulsions on the skin permeation of the three model drugs flufenamic acid, 
diclofenac acid and curcumin was investigated. Porcine abdominal skin was chosen as model 
membrane because of its morphology and permeability, which are similar to those of human skin 
[9,28]. The porcine abdominal skin was freed from hair and treated with a dermatome (GB 228R, 
Aesculap) set at 1.2 mm. The skin was stored at −20 °C until use and thawed prior to the experiments. 
Appropriate skin patches were clamped between the donor and the receptor chamber of the diffusion 
cells having a permeation area of 1.13 cm2. The receptor compartment was filled with 2 mL of 
phosphate buffer (pH 7.4, 0.012M) in case of flufenamic acid and diclofenac acid [29]. In case of 
curcumin, a mixture of distilled water/ethanol (50/50 % v/v) was employed to ensure sink conditions 
[30,31]. The diffusion cells were kept at skin surface temperature (32 °C) and stirred with magnetic 
bars for 24 hours. The formulation (0.6 g) was placed on the excised skin in the donor chamber. 
Samples of 200 µL were removed at defined time intervals for analysis and were replaced by fresh 
receptor medium. At least five parallel experiments were performed for each formulation (n ≥ 5). The 
samples were analyzed for their drug content by HPLC in case of flufenamic acid and diclofenac acid 
or by UV/Vis spectroscopy in case of curcumin. Permeation profiles of the drugs were constructed by 
plotting time (hours) against the cumulative amount of the drug (µg/cm²) as measured in the receptor 
solution. In addition, the steady state flux (J, µg·cm−2·h−1) was calculated by linear regression after the 
respective lag-times.  
 
2.5. Skin penetration experiments via in vitro tape stripping  
In order to obtain penetration profiles of the three model drugs from both macroemulsions and 
corresponding nanoemulsions at least six individual tape-stripping experiments were performed for 
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each formulation (n ≥ 6) on porcine ear skin. Fresh porcine ears were donated by the Clinic for Swine, 
University of Veterinary Medicine, Vienna. Since previous studies had shown that frozen storage does 
not alter the skin barrier function or the stratum corneum properties in the context of tape stripping 
experiments [32,33], the ears were stored at −24 °C and thawed prior to the respective experiments. 
After defrosting, the ears were cleaned carefully with purified water and blotted dry with soft tissue. 
The skin was subsequently freed from hair with scissors and intact, representative skin areas were 
indicated with a permanent marker. In addition, the transepidermal water loss (TEWL) of the skin was 
determined using the closed-chamber device AquaFlux® (Biox Ltd., London, UK) to confirm an intact 
skin barrier function and to monitor the defrosting process [33]. The software program AquaFlux® 
V6.2 was used for analysis of these data. When the TEWL reached values between 15 and 20 g m−2 h−1 
the experiment was started. To this end, the porcine ears were stretched out on styrofoam plates and 
fixed with needles if necessary. The respective formulation was applied onto the marked skin area at a 
concentration of 6 mg·cm−2 with a saturated vinyl glove finger and was gently distributed and 
massaged for 30 seconds. After a penetration time of 1 hour the tape stripping procedure was started. 
The adhesive films employed to remove the superficial stratum corneum layers were standard 
Corneofix® tapes. Care was taken to ensure a reproducible working procedure. After placing the first 
adhesive film on the skin its outline was indicated with a permanent marker to ensure subsequent tape 
stripping on the exact same location. Pressure was applied with the thumb covered in a vinyl glove as 
previously reported [34] to ensure a rolling movement and thus minimize the influence of wrinkles 
[35]. The experiment was performed on a balance to ensure a constant pressure of 49 N (5 kg) which is 
a prerequisite for the removal of reproducible amounts of stratum corneum proteins [33]. After 
applying pressure for 3 seconds, the tape was removed in a single rapid movement. In this fashion, 20 
sequential adhesive films were removed per experiment. The amount of adherent corneocytes was 
subsequently determined by IR-densitometry using the infrared densitometer SquameScanTM 850A 
(Heiland electronic GmbH, Wetzlar, Germany) [36]. Briefly, the optical pseudo-absorption of the 
adhesive films at a wavelength of 850 nm is employed to quantify the amount of stratum corneum 
proteins on the tapes. The absorption values in % can be read from the display and the corresponding 
mass of proteins can be determined using the correlation factor of 0.41 which was previously 
established for analysis of porcine ear skin [33]. This value can be employed to calculate the mass of 
SC proteins (m) after determination of their pseudo-absorption at 850 nm (A) for a normalized tape 
area of 1 cm² by employing the equation m = A / 0.41 (in µg·cm−2).  
The mean cumulative amount of removed stratum corneum proteins was employed to establish the 
penetration depth of the applied drugs in relation to the complete stratum corneum thickness. The latter 
was determined by continuous stripping of the complete stratum corneum in four of the experiments  
(n = 4) until the detection limit of the IR-densitometer was reached.  
 
2.6. HPLC analysis  
The formulations or samples containing flufenamic acid or diclofenac acid were analyzed for their 
drug content by HPLC (Series ISS-200, Perkin Elmer, USA), consisting of an auto sampler, a lc pump 
and an UV-diode array detector (235C). Previously reported methods were used using a Nucleosil 100-
5 C18 column (250 mm × 4 mm, Macherey-Nagel, USA) plus a Nucleosil 100-5 C18 pre-column 
3.4. SEMI-SOLID SUCROSE STEARATE EMULSIONS 77
Pharmaceutics 2011, 3                   
 
 
284
(CC8/4, 40 mm × 4 mm, Macherey-Nagel, USA). For all analyses, the oven temperature was set at  
50 °C and the injection volume was 20 µL. The analysis of the data was performed using the 
TotalChrom Navigator 6.2.0 software. Standard solutions of the drugs were prepared and calibration 
curves were calculated by plotting the analyzed drug concentrations against the obtained peak area 
values.  
The quantification of flufenamic acid and diclofenac acid was conducted according to previously 
described methods [29,37]. For both drugs, the mobile phase consisted of methanol/water (75/25 w/w); 
glacial acetic acid was added until a pH value of 3.2 was reached. The flow rate was 1.0 mL/min in 
both cases. For flufenamic acid, the detection wavelength was set at 245 nm with a retention time of 
4.5 minutes. A calibration curve was calculated based on peak area measurements of diluted standard 
solutions ranging from 0.09 µg/mL to 110.50 µg/mL with a coefficient of determination R2 = 0.9999. 
The limit of detection for flufenamic acid was found to be around 0.04 µg/mL; the limit of reasonable 
quantification was set at 0.09 µg/mL. For diclofenac acid, the detection wavelength was set at 280 nm 
with a retention time of 10 minutes. The measurement range of the diluted standard solutions 
employed for the calibration curve was between 0.06 µg/mL and 28.97 µg/mL with R2 = 1. The limit 
of detection for diclofenac acid was, likewise, around 0.04 µg/mL; the limit of quantification was set at 
0.06 µg/mL.  
2.7. UV/VIS spectroscopic analysis 
The quantification of curcumin was performed as previously reported [30] using a double beam 
UV/Vis spectrophotometer (Spectrophotometer U-3010, Hitachi, Japan). A correlation curve was 
established for standard solutions of curcumin in pure ethanol (96% v/v) ranging from 0.31 µg/mL to 
5.01 µg/mL with R2 = 0.9952. The curcumin content of the samples filled into quartz cuvettes was 
determined at 425 nm. Samples containing a higher curcumin content were diluted prior to the analysis 
until values within the linear range of the calibration curve were obtained. This was frequently the case 
for samples extracted from the first two adhesive films of the tape stripping experiments.  
2.8. Statistical data analysis 
Results are expressed as means of at least three experiments ± SD. Statistical data analyses were 
performed with the software program GraphPadPrism3. Parametric data were analyzed using the 
Student’s t-test with P < 0.05 as minimum level of significance while non-parametric data were 
analyzed using the Mann-Whitney test or the Wilcoxon signed rank test with P < 0.05, respectively.  
3. Results and Discussion  
3.1. Formulations and production aspects 
The optimal surfactant concentration to produce both highly viscous macroemulsions and fluid 
nanoemulsions was found to be 5% w/w. Despite the increasing viscosity, considerate sample 
preparation still allowed for high-pressure homogenization of the mixture in case of the 
nanoemulsions. Thus, the physicochemical properties of emulsions stabilized by 5% w/w of sucrose 
stearate could be varied by modification of the production process. 
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As anticipated, conductivity measurements confirmed the nature of the obtained emulsions as being 
of the O/W type. The temperature seemed to play a crucial role during processing of the sucrose 
stearate-based emulsions. If the fluid mixture was kept at 40–50 °C, further homogenization was 
feasible. If the mixture was cooled, some sort of gelling effect took hold and transformed the system 
into a semi-solid emulsion. This was especially pronounced if the mixture was cooled down rapidly. 
Similar behavior has been reported for aqueous sucrose stearate dispersions [15]. Moreover, the 
different ways of emulsion preparation as described in the literature [22] may have had an additional 
influence on the properties of the resulting mixture and thus either allowed for further high-energy 
processing or not. The variation in the mixing protocol of the compounds apparently influenced the 
viscosity of the pre-emulsion, which plays an important role for later processing [19].  
3.2. Visual characterization 
Creamy, thick macroemulsions were produced by dissolving the sucrose ester in the oil phase. The 
low density of the emulsions suggested that large amounts of air were incorporated to provide a fluffy 
appearance. All formulations had an appealing, homogeneous appearance which was retained over the 
whole observation period.  
In contrast, fluid if slightly gel-like nanoemulsions were produced by dissolving the surfactant in the 
aqueous phase and subsequent high-pressure homogenization. Figure 1 shows the visual appearance of 
the viscous macroscopic emulsions in contrast to the fluid nanoemulsions. Upon closer inspection, 
small white aggregates could be detected in the otherwise homogeneous whitish to bluish 
nanoemulsions. These were most likely composed of surfactant aggregates formed during or after high-
pressure homogenization and can be ascribed to the comparatively high surfactant concentration as 
opposed to our previous studies [7]. These structures did however not impair the performance or 
physical stability of the formulations in any way. Upon cooled storage at 4 °C, they appeared to 
contribute to the increasingly gel-like texture of the nanoemulsions. Indeed, low storages temperatures 
have previously been reported to cause gelation of nanoemulsions of certain compositions [38].  
Figure 1. Visual appearance of a sucrose stearate-based macroemulsion (E) and a 
corresponding nanoemulsion (NE). Age of the presented formulations: 9 months. 
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3.3. Particle size 
In case of the macroemulsions, the mean particle sizes were in the micrometer range as shown in 
Table 2A and 2B.  
Table 2. Physicochemical properties of fresh (2A) and stored (2B) blank and drug-loaded 
macroemulsions (E) after high-shear dispersion with an ultra-turrax. Measurements were 
performed in triplicate on a Mastersizer 2000 (Malvern, UK) at 25 °C. The samples were 
diluted with distilled water (1:1000 v/v) and stirred slightly prior to analysis. The 
parameters shown are the mean particle size expressed as volume weighted mean D [4,3], 
surface weighted mean D [3,2] and volume median diameter d(0.5) as well as the d(0.1) 
and d(0.9) values and the span. All values represent the mean of three formulations (n = 3) 
in µm and are given ± SD. 
(2A) Freshly prepared samples 
Parameters E blank E curc E fluf E diclo 
D [4,3] 06.94 ± 0.97 09.72 ± 1.92 08.56 ± 0.05 11.80 ± 0.42 
D [3,2] 03.70 ± 0.15 04.14 ± 0.04 04.46 ± 0.02 05.43 ± 0.36 
d (v, 0.1) 01.74 ± 0.04 01.73 ± 0.01 01.72 ± 0.01 02.04 ± 0.16 
d (v, 0.5) 05.16 ± 0.26 06.80 ± 0.07 08.26 ± 0.04 11.29 ± 0.45 
d (v, 0.9) 12.58 ± 2.25 14.55 ± 0.41 15.44 ± 0.09 22.09 ± 0.42 
Span 02.09 ± 0.31 01.89 ± 0.04 01.66 ± 0.01 01.78 ± 0.05 
(2B) After 6 months of storage 
Parameters E blank E curc E fluf E diclo 
D [4,3] 25.81 ± 2.44 26.46 ± 08.27 35.33 ± 2.35 33.03 ± 3.89 
D [3,2] 08.71 ± 0.38 06.57 ± 00.72 11.25 ± 0.88 08.79 ± 0.41 
d (v, 0.1) 04.18 ± 0.25 02.56 ± 00.25 06.88 ± 0.65 03.41 ± 0.18 
d (v, 0.5) 20.04 ± 2.29 13.41 ± 02.57 21.53 ± 1.49 23.54 ± 1.57 
d (v, 0.9) 55.31 ± 5.96 49.66 ± 16.30 77.37 ± 3.01 73.61 ± 6.74 
Span 02.55 ± 0.05 03.45 ± 00.51 03.28 ± 0.13 02.98 ± 0.08 
All parameters of importance are given, namely the D [4,3], D [3,2], d(v, 0.1), d(v, 0.5) and d(v, 
0.9) values as well as the span. The span, which describes the width of the particle size distribution, 
was comparatively large for both blank and drug-loaded formulations. This indicates that various 
emulsion droplet sizes, ranging from the nanometer up to the micrometer scale, were present in the 
mixture. This could also be derived from a visual observation of the obtained distribution curves, 
which indicated a highly polydisperse nature of the samples with droplet sizes ranging from 0.7 up to 
several hundred micrometers. This was especially pronounced after 6 months of storage. In particular 
the strong increase in d(v, 0.9) values points to a small population of increasingly large individual 
droplets.  
Since the samples were diluted prior the measurements, it is unclear whether these data merely give 
an overview about the oil droplet size distribution within the emulsion, or also about remnants of the 
hydrophilic network which provides the basis for the high viscosity of the systems. Likewise, since the 
results obtained with this technique are volume-based, the presence of a few individual larger droplets 
may skew the correlation considerably since the presence of very small droplets may easily be 
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outweighed by the far more voluminous larger droplets. Thus, an additional microscopic analysis was 
performed.  
In case of the nanoemulsions, the mean particle sizes as determined by DLS were in the lower 
submicron range for both blank and drug-loaded formulations (Table 3).  
Table 3. Physicochemical properties of blank and drug-loaded nanoemulsions (NE) after 
16 cycles of high-pressure homogenization. Measurements were performed in triplicate on 
a Zetasizer Nano ZS (Malvern, UK) at 25 °C. Samples were diluted with distilled water 
(1:100 v/v) containing sodium chloride (0.01 mmol) before the experiments to ensure 
constant conductivity below 0.05 ms/cm. Parameters shown are mean particle size (MPS), 
zeta potential (ZP), conductivity (cond) and polydispersity index (PDI). Values represent 
the mean of at least three formulations (n ≥ 3) and are given ± SD. 
Parameters NE blank NE curc NE fluf NE diclo 
Particle size (nm) 116.40 ± 10.22 124.69 ± 2.58 128.33 ± 11.34 114.44 ± 2.42 
Zeta potential (mV) −58.89 ± 14.48 −47.11 ± 1.49 −51.36 ± 2.71 −54.12 ± 4.83 
Conductivity (mS/cm) 0.024 ± 0.005 0.017 ± 0.004 0.025 ± 0.005 0.023 ± 0.003 
PDI 0.11 ± 0.03 0.25 ± 0.03 0.09 ± 0.01 0.11 ± 0.02 
 
The narrow intensity-based distribution curves indicated a monodisperse nature of the samples. The 
PDI values were below 0.2 except for curcumin-loaded formulations, which indicates a narrow droplet 
size distribution and thus good long-term stability. Individual whitish aggregates detected among visual 
inspection were not detected with these measurements since they were most likely dissolved upon 
dilution of the samples. It is likewise known that DLS alone may fail to detect the presence of 
individual larger oil droplets or vesicles and may thus provide incomplete information [39]. Therefore, 
as for the macroemulsions, an emphasis was placed on microscopic examination techniques to obtain 
more accurate information about the actual microstructure of the formulations.  
In context with the DLS measurements it has to be mentioned that the highly lipophilic drug 
curcumin was rather dispersed than dissolved within the oil phase. The presence of undissolved drug 
did not disturb the particle size measurements, as previously reported [40]. Merely a slight increase of 
the PDI value was noticed. Homogeneous distribution of the drug could be obtained after re-
homogenization of the system by slight shaking. In case of the corresponding macroemulsions with 
curcumin the drug was homogeneously distributed within the system and no dispersed drug aggregates 
were visible within the homogeneous orange emulsion.   
Overall, the droplet size in equilibrated emulsions is mainly determined by the intensity of 
mechanical agitation, the amount and interfacial properties of the surfactants, the interfacial tension 
and the physical properties of the oil and aqueous phases [17,41]. The properties of an emulsion will 
change significantly with the type of emulsification process used [41], as was impressively 
demonstrated in the present study. Thus, care should be taken to ensure an exact mixing procedure, 
since any irregularity may lead to changes in formulation microstructure. 
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3.4. Particle surface charge of nanoemulsions 
The ZP values of blank and drug-loaded nanoemulsions are given in Table 3. The surface charge of 
sucrose stearate-based nanoemulsions was in the range around −50 to −60 mV, which indicates high 
electrochemical stabilization of the system. These high negative values are most likely caused by the 
presence of residual free fatty acids at the interface [7].  
 
3.5. Physical stability 
The physical long-term stability of all systems was highly satisfying. As anticipated in case of the 
macroemulsions, a notable increase in mean particle size after six months was observed (Figure 2A). 
However, the formulation remained visually stable and showed no signs of phase separation or 
microbial contamination upon conventional storage at 4 °C in a receptacle for ointments.  
In case of the nanoemulsions (Figure 2B), the mean particle sizes remained highly constant in the 
course of six months as confirmed by regular measurements.  
Figure 2. Mean droplet size of blank and drug-loaded macroemulsions (E, 2A) and 
corresponding nanoemulsions (NE, 2B) as determined immediately after production and 
after 6 months. The diluted samples were analyzed in triplicate at 25 °C on a Mastersizer 
2000 (Malvern, UK) in case of the macroemulsions and a Zetasizer Nano ZS (Malvern, 
UK) in case of the nanoemulsions. The parameters shown are the volume weighted mean D 
[4,3] for macroemulsions and the mean droplet diameter as z-average for nanoemulsions. 
Values represent the mean of at least three formulations (n ≥ 3) and are given ± SD. 
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Figure 2. Cont. 
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As can be seen in Table 4, this was the case for both blank and drug-loaded nanoemulsions, shown 
on representative formulations containing flufenamic acid. The mean ZP values of the nanoemulsions 
increased slightly (Table 4A and 4B), most likely due to chemical changes within the formulations 
such as hydrolysis of surfactant molecules or excipients of the oil phase. This process results in the 
release of free fatty acids and thus an increased amount of negative charges at the interface. Since a 
certain surplus of surfactant was employed, the chemical degradation of the latter may have been more 
apparent than in our previous studies [7]. At the same time, this surplus of surfactant might be 
responsible for the individual whitish aggregates that were observed within the nanoemulsions. The 
number of these aggregates visible to the eye increased over time.  
In summary, particle size measurements of submicron-sized emulsions by light scattering 
techniques are not always sufficient to monitor the actual physical stability of such formulations. 
Visible destabilization phenomena such as separation of oil droplets or formation of a precipitate might 
remain undetected [40]. Thus, carefully visual inspection of the samples is necessary. Additional and 
more precise information can be gained by microscopic investigations.  
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Table 4. Physical stability of blank (4A) and drug-loaded nanoemulsions (4B, shown on 
systems containing flufenamic acid). Similar results were obtained for all drug-loaded 
formulations. Experiments were performed in triplicate (n = 3) in regular intervals over an 
observation period of six months. The indicated parameters are the mean particle size 
(MPS), polydispersity index (PDI) and zeta potential (ZP). Numbers are given as 
means ± SD. 
(4A)    
time   NE blank   
(weeks) MPS (nm) ± SD  PDI ± SD ZP (mV) ± SD 
0 116.40 ± 10.22 0.11 ± 0.03 −61.73 ± 10.50 
4 116.07 ± 09.93 0.12 ± 0.03 −64.13 ± 07.10 
8 116.53 ± 08.56 0.13 ± 0.02 −60.91 ± 04.08 
12 118.31 ± 08.28 0.12 ± 0.02 −61.27 ± 16.41 
16 117.28 ± 08.05 0.13 ± 0.01 −60.70 ± 06.09 
20 120.11 ± 08.93 0.13 ± 0.02 −64.69 ± 04.00 
24 121.71 ± 09.61 0.15 ± 0.04 −64.76 ± 06.03 
(4B)    
time   NE fluf   
(weeks) MPS (nm) ± SD PDI ± SD ZP (mV) ± SD 
0 128.28 ± 09.61 0.09 ± 0.01 −49.03 ± 00.37 
4 128.01 ± 10.01 0.10 ± 0.01 −49.86 ± 02.05 
8 125.06 ± 10.06 0.10 ± 0.01 −49.73 ± 04.38 
12 126.55 ± 09.16 0.09 ± 0.01 −50.77 ± 04.64 
16 129.94 ± 10.47 0.09 ± 0.01 −52.16 ± 05.13 
20 132.92 ± 11.46 0.09 ± 0.02 −48.38 ± 02.13 
24 129.12 ± 10.78 0.08 ± 0.01 −55.20± 04.40 
 
3.6. Drug content, chemical stability and pH value 
The initially determined drug contents of all formulations as well as the chemical stability of 
flufenamic acid and diclofenac acid remained satisfying over the course of a limited observation period 
of three months. No further attention was devoted to this topic since a more thorough analysis of the 
chemical stability of the incorporated drugs, especially in case of curcumin, was not an emphasis of 
this study.  
The pH values of blank formulations were around 6.80 ± 0.04 for macroemulsions and 6.89 ± 0.01 
for nanoemulsions (n = 3, respectively). Drug incorporation led to slightly lower pH values in case of 
flufenamic acid and diclofenac acid (data not shown). However, all pH values were in an acceptable 
range for dermal application.  
Interestingly, chemical degradation processes appeared to affect the nanoemulsions to a greater 
extent than the corresponding macroemulsions irrespective of drug incorporation. After a storage time 
of 6 months, the overall mean pH value of all formulations was 6.40 ± 0.20 in case of the 
macroemulsions and 6.01 ± 0.11 in case of the nanoemulsions (n = 13, respectively). This observation 
is in agreement with previously reported data which indicate that lipid oxidation in nanoemulsions 
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proceeds more rapidly than in conventional emulsions due to the increased surface area of the  
nano-sized droplets [17].  
 
3.7. Optical light microscopy  
Optical light microscopy was conducted to obtain an overview about larger structures present in the 
different formulations. The images were in good agreement with the visual observations of the samples 
as well as the particle size measurements. 
Figure 3. Images of fresh as well as stored macroemulsions as observed by optical light 
microscopy. Images 3A, 3B and 3C show a blank macroemulsion directly after preparation 
while the corresponding images 3D, 3E and 3F show the same formulation after 6 months 
of storage. The employed microscopic modes were 10x magnification/bright field (3A, 
3D), 20x magnification/DIC (3B, 3E and 3G, 3H, 3I) and 40x magnification/bright field 
(3C, 3F). The indicated scale bars represent 50 µm. Images 3G, 3H and 3I represent 
artefacts of fresh macroemulsions obtained after 20 minutes of storage of the object slide.  
 
 
In case of freshly prepared blank macroemulsions a complex network of hydrophilic spherical 
structures presumably composed of sucrose ester/water aggregates was observed (Figure 3A to 3C). 
Large spherical interconnected aggregates formed a net-like structure which surrounded the darker oil 
droplets. In between the large “meshes” of this network, smaller spherical aqueous structures were 
observed which filled up the space. Likewise, it may be assumed that large amounts of air are 
incorporated as well. Overall, the particle sizes observed for the different surfactant aggregates varied 
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from around 30 µm for the large network-forming structures down to 0.6 µm for the smaller aggregates 
filling up the spaces in between. The oil droplets were of variable size and their diameter ranged 
mostly within the micrometer range, as already indicated by the laser diffraction measurements. 
Although these particle size measurements were conducted with highly diluted samples, it is unclear 
whether the sucrose ester aggregates were included in the analysis. If this was the case, it would 
account for the high polydispersity of the analyzed samples. Particle sizes as small as 600 nm have 
likewise been reported for the structural compounds of aqueous gel-like dispersions of sucrose stearate 
[15]. However, the values reported by Ullrich and co-workers were based on DLS analysis of highly 
polydisperse and undiluted samples, which renders an interpretation difficult.  
Interestingly, the nature of the viscous macroemulsions changed upon storage. Images that were 
taken after a storage time of over 6 months revealed an increasingly dense aggregate network with less 
free space between the aggregate “meshes” of the network (Figure 3D to 3F). This increase in density 
of the network might have been caused by a minor separation of water condensation on the lid of the 
storage receptacle. Likewise, the influence of gravity might have caused incorporated air to escape 
from the emulsion bulk phase. As anticipated by particle size measurements, the average size of the 
dispersed oil droplets showed a definite increase with oil droplet diameters frequently larger than 30 
µm. Individual oil droplets of up to 160 µm in diameter were observed as well. It may be assumed that 
the presence of such individual large droplets remained undetected in the laser diffraction 
measurements due to methodological limitations [42]. Despite this obvious change in the internal 
formulation structure, the visual appearance of the semi-solid vehicles remained intact.  
Interesting additional information was gained from observation of changes in formulation 
microstructure upon manipulation on an object plate. After prolonged presence of the macroemulsions 
on the object plate, a dried network became visible which covered the dried out area around residual 
water droplets (Figure 3G). In addition, the potential of the sucrose ester mixture to form liquid 
crystalline structures became more apparent as increasingly large areas, also along the dried network 
structure, showed birefringence under polarized light (Figure 3G, 3H, 3I). These observations indicate 
that the network structure of the viscous formulation might be at the margin of a weak liquid 
crystalline matrix.  
Overall, the observed network of unilamellar vesicles bears a certain resemblance to a cubic gel 
phase observed in previous studies [43,44]. Despite the apparent differences in formulation 
composition and size range when compared to our macroemulsions, similar general observations were 
reported. A system of high viscosity was obtained with no other compounds than a dispersed phase 
fraction of 5–15% w/w. The vesicular unilamellar spheres responsible for the system’s properties 
consisted of amphiphilic material only. Dilution of the gel phase led to the formation of a viscous, but 
not gel-like phase which was unfortunately not further characterized. The fact that the macroemulsion 
structure is not as ordered as the cubic gel structure might be due to the fact that much larger amounts 
of water and less surfactant are present. Our system might thus be comparable to the described diluted 
cubic phase system. Another explanation might point to a resemblance to self-standing gel-like 
emulsions. However, larger amounts of internal phase are usually reported for such systems [45]. 
In case of the freshly prepared nanoemulsion (Figure 4A), constant background movement indicated 
the presence of nano-sized oil droplets subjected to Brownian motion [22]. The samples were highly 
86 CHAPTER 3. PUBLICATIONS
Pharmaceutics 2011, 3                   
 
 
293
homogeneous except for a few larger vesicular structures and individual surfactant aggregates. These 
structures which were visible to the naked eye as whitish flakes appeared as irregularly shaped 
“islands” within the formulation. However, their number was highly limited after production. These 
aggregates remained undetected during the DLS measurements of the diluted samples.  
Figure 4. Images of fresh, as well as stored, nanoemulsions as observed by optical light 
microscopy. All images were taken with 40 x magnification/DIC. Image 4A shows the 
blank nanoemulsion directly after preparation. Figure 4C shows the same formulation after 
6 months of storage. Image 4B shows an artefact obtained with a fresh nanoemulsion 
sample due to evaporation effects on the object slide. The indicated scale bars represent  
50 µm.  
 
 
The nature of the fluid nanoemulsions changed upon storage. Images that were taken of samples 
after 6 months of storage time (Figure 4C) revealed a much larger number of the described shapeless 
aggregates. It may be assumed that these aggregates represent separated fractions of surplus sucrose 
ester. For blank nanoemulsions, the viscosity of the sample appeared to be increased as compared to 
the fresh one due to gelling effects of the surfactant. No such gelling effect upon storage was observed 
for the more fluid nanoemulsions with flufenamic acid and diclofenac acid. This aspect is currently 
being investigated in rheological studies over prolonged observation periods and will be reported in a 
separate context. Overall, nanoemulsions apparently suffered notable changes in formulation 
microstructure despite the fact that the particle size measurements suggested otherwise.  
Again, observation of the sample’s behavior on the object plate provided useful information. The 
nanoemulsion droplet started gelling immediately upon application on the plate. After covering of the 
sample, a structured dispersed film remained at the edges of the droplet (Figure 4B). Again, this rather 
ordered structural network may be situated at the margin of a weak liquid crystalline network [15]. 
Similar behavior can be observed upon positioning of a microemulsion on an object plate, where 
growth of liquid crystals can be observed at the margin of the sample due to evaporation of volatile 
compounds.  
Although the peculiar rheological behavior of colloidal sucrose ester suspensions in water has 
recently attracted attention [11,14], the microstructure of these systems is still somewhat unclear [15]. 
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Microscopic data exists mostly for suspensions with higher concentrations of sugar surfactant, which 
consequently contain increasing amount of liquid crystalline structures [13]. Interestingly, for a 
suspension of another sucrose stearate mixture with a slightly higher HLB value of 12, liquid 
crystalline structures were already observed at a concentration of 4% w/w [46]. Although information 
on the structure of O/W emulsions co-stabilized by alkylpolyglucosides, a frequently employed type of 
sugar surfactant, can be found [47], no such data exist for O/W emulsions stabilized by a sucrose ester 
mixture alone.  
 
3.8. Cryo TEM and TEM after negative staining 
Cryo TEM investigations of freshly prepared formulations were additionally performed to visualize 
the structural differences between the two original systems on a nano-scale level. In case of the 
macroemulsion (Figure 5A), a dense structural network was observed which appeared to consist of 
closely located or connected spherical aggregates with mean diameters as small as a few hundred 
nanometers (marked areas). These aggregates formed the larger droplets which had been visualised by 
light microscopy. Since the sample was observed in its original state without dilution and the TEM 
image is merely a 2D projection, the borders of the smaller aggregates could not be clearly 
distinguished. However, the images serve to confirm the rich internal structure of the macroemulsion. 
The structural network appeared to be remarkably homogeneous, since the ice crystals commonly 
observed during cryo-preparation emerged in a highly ordered and regular fashion. Additional analysis 
with conventional TEM sample preparation and negative staining confirmed these observations (Figure 
5B). Droplets of various sizes could be distinguished.  
Figure 5. Analysis of the microstructure of blank macroemulsions by cryo TEM (5A) and 
conventional TEM after negative staining with uranyl acetate (5B). The magnification is 
illustrated by the black scale bars.  
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In case of the nanoemulsion, a common if highly crowded internal structure was revealed despite 
the dilution of the sample (Figure 6A). The nano-sized oil droplets appeared to be partially deformed 
or collapsed, which is not entirely unexpected given the high surfactant concentration and resulting 
high viscosity of the formulation. Likewise, the shape of the deformable nanodroplets can be 
influenced by the oil volume fraction [48]. At high oil volume fractions, the surfaces of the crowded 
droplets strongly repel each other. This can cause the droplets to deform and become non-spherical 
[49]. In addition, individual shapeless aggregates most likely composed of sucrose stearate/water were 
detected in the nanoemulsion sample, which confirmed the optical light microscopy data. The 
rheological properties of the sample influence the processing conditions during high-pressure 
homogenization. The equilibrium between the rupturing of oil droplets and coalescence events which 
occur within the device are governed by the viscosity of the processed colloidal system [50,51]. In 
terms of viscosity, the employed pre-homogenized mixture surely resides at the margin of the device’s 
working capacity. The surplus of surfactant which is subjected to the high-pressure homogenization 
procedure is apparently united in the described shapeless aggregates. Conventional TEM analysis after 
negative staining confirmed the above observations (Figure 6B). A noteworthy observation regarding 
the conventional TEM analysis is the fact that a largely intact emulsion structure could be visualized 
despite the high vacuum and the potential risk of beam damage imminent to this technique. This aspect 
will be the subject of further investigations.  
Figure 6. Analysis of the microstructure of blank nanoemulsions by cryo TEM (6A) and 
conventional TEM after negative staining with uranyl acetate (6B). The magnification is 
illustrated by the black scale bars.  
 
 
Summarizing the main conclusions of the microscopic observations, it may be assumed that the 
highly viscous and dense structure of the macroemulsions is caused by a network of excess surfactant. 
In case of the nanoemulsion, smaller droplet sizes are created which possess a larger surface area 
covered by surfactant molecules. Thus, only a small amount of surplus surfactant is left after 
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production which subsequently leads to the observed aggregates which increase in number and size 
during storage. In case of the macroemulsion, the droplet sizes remain in the micrometer range, thus 
providing less surface area to be covered by surfactant molecules. Consequently, a larger amount of 
free surfactant is left which then forms the network-like structure via self-assembly into vesicles or 
similar structures, possibly approaching a weak liquid crystalline state.  
3.9. Rheological investigations 
The rheological properties of a colloidal system strongly depend on its composition and, more 
importantly in this case, on the processing conditions. The analysis of these properties is a simple tool 
to characterize the macroscopic properties of a formulation in an objective way and thus to confirm 
visual observations [52]. The rheological properties of emulsions are crucial for their application on 
skin as well as their physical stability. Especially in case of the presented macroemulsions, it may be 
assumed that the coalescence of oil droplets or other potential destabilization phenomena strongly 
depend on the rheological properties of the system. These properties are influenced by the oil volume 
fraction, the droplet size and particle charge as well as by colloidal interactions [53]. In order to obtain 
an overview about the rheological properties of the different systems, the flow behavior as well as the 
viscoelastic properties of both blank and drug-loaded systems were analyzed.  
In case of the macroemulsions, the flow curves revealed that the dynamic viscosity of the systems 
decreased with increasing shear rates. This pseudoplastic or shear-thinning flow behavior was found 
for both blank and drug-loaded macroemulsions. The incorporation of the model drugs led to an 
increase in viscosity at all shear rates. Figure 7 demonstrates the advantageous effect of drug 
incorporation on the viscosity of the macroemulsions in an exemplary manner at a shear rate of 15 s−1. 
The apparent viscosity of the macroemulsions at this shear rate was between 2.26 ± 0.10 and 
7.92 ± 0.02 Pa·s.  
Figure 7. Comparison of the apparent viscosity of macroemulsions (E) and corresponding 
nanoemulsions (NE) with and without incorporated drug at a shear rate of 15 s−1. The effect 
of the incorporated drugs curcumin (cu), flufenamic acid (fl) and diclofenac acid (di) is 
demonstrated. Values represent the mean of three formulations (n = 3) and are given ± SD.  
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A minor shear-thinning effect was also observed for blank nanoemulsions and nanoemulsions with 
curcumin. As already indicated, curcumin was partly dispersed in the system, thus changing its overall 
properties and leading to an increased viscosity and shear-thinning behavior of the nanoemulsion. For 
all other drug-loaded nanoemulsions, the dynamic viscosity was entirely independent of the applied 
shear rate which is characteristic for Newtonian flow behavior. Except in the case of curcumin, the 
incorporation of drugs into the sucrose stearate nanoemulsion led to a decrease of viscosity at all shear 
rates (Figure 7): nanoemulsions with flufenamic acid and diclofenac acid exhibited an apparent 
viscosity of 0.01 ± 0.001 Pa·s at all shear rates.  
Overall, it was apparent that the viscosity of the macroemulsions was several orders of magnitude 
higher than that of the nanoemulsions. The apparent viscosity of the blank nanoemulsion was  
0.03 ± 0.001 Pa·s at the presented shear rate, while the viscosity of the corresponding blank 
macroemulsion was 2.26 ± 0.10 Pa·s, which corresponds to a 64-fold increase in viscosity.  
An analysis of the flow curves of both macroemulsions and nanoemulsions using the power law 
model confirmed the above discussed observations. In case of the nanoemulsions, the value of the flow 
behavior index n was in the order NE diclo > NE fluf > NE blank > NE curc, where especially the 
values of the nanoemulsions with diclofenac acid and flufenamic acid were close to 1 (n = 0.98 ± 0.03 
and n = 0.92 ± 0.08), thus confirming Newtonian flow behavior. In contrast, the flow behavior index n 
of blank macroemulsions was 0.10 ± 0.01 and was decreased further by incorporation of either drug. A 
value of n close to zero indicates pronounced shear-thinning behavior of the samples.  
Overall, the shear-thinning effect observed for macroemulsions and, to a minor extent, for blank and 
curcumin-loaded nanoemulsions is consistent with literature. The pseudoplastic nature of the 
macroemulsions can be explained by the deformation of the emulsion droplets under increasing shear 
which facilitates their flow. Likewise, nanoemulsions may exhibit shear-thinning behavior due to 
changes in the droplet shape along the flow channel [22]. In this case, the incorporation of flufenamic 
acid and diclofenac acid apparently eliminated any such effect by lowering the viscosity of the blank 
nanoemulsion system, possibly by interacting with surplus amounts of surfactant.  
In addition, oscillatory measurements were performed. In case of the macroemulsions, the elastic 
modulus G’ was strongly dominating over the viscous modulus G’’ at all oscillatory frequencies, which 
is favorable in terms of physical stability. A comparison of G’ and G’’ for all systems at a frequency of 
1 Hz is given in Figure 8. The elastic modulus G’ ranged from approximately 250 to 1300 Pa while the 
viscous modulus G’’ ranged from 70 to 380 Pa. Drug incorporation generally increased the values of 
G’ and G’’. The only exception was the curcumin-loaded formulation where G’’ was decreased. 
Overall, both parameters increased at an increasing oscillatory frequency. An increase in the elastic 
modulus with increasing frequency has been related to the closer packing of microgelled colloidal 
particles and the resulting larger friction forces between the droplets subjected to shear [54].  
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Figure 8. Comparison of the elastic modulus G’ (black bars) and the viscous modulus G’’ 
(grey bars) of macroemulsions (E) and corresponding nanoemulsions (NE) with and 
without incorporated drug at an oscillatory frequency of 1 Hz. The effect of the 
incorporated drugs curcumin (cu), flufenamic acid (fl) and diclofenac acid (di) is 
demonstrated. Values represent the mean of three formulations (n = 3) and are given ± SD. 
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In case of the nanoemulsions, the viscous modulus G’’ clearly dominated over the elastic modulus 
G’ (Figure 8). In case of flufenamic acid and diclofenac acid, drug incorporation led to a decrease of 
the viscous modulus G’’, thus confirming their fluidizing effect on the nanoemulsions. In case of 
curcumin, incorporation led to an increase of the viscous modulus G’’ due to undissolved drug. The 
elastic modulus G’ was increased by drug incorporation in all cases. Again, both parameters G’’ and 
G’ increased with increasing oscillatory frequency. Needless to say, both the elastic and viscous 
modulus were again several orders of magnitude larger for macroemulsions than for nanoemulsions. 
While the elastic modulus G’ of blank nanoemulsions was 0.06 ± 0.01 Pa, the corresponding value for 
blank macroemulsons was 248.01 ± 14.97 Pa. This corresponds to a 4409-fold increase in the 
formulation’s elasticity. Likewise, the viscous modulus G’’ of blank macroemulsions was 256 times 
larger than for blank nanoemulsions (0.40 ± 0.05 versus 101.83 ± 3.68 Pa).  
Overall, the rheological data confirmed that the employed sucrose stearate mixture led to the 
formation of entirely different emulsion bulk structures by alteration of the production process. A 
thorough understanding of the bulk structure of an emulsion is necessary to accurately describe its 
macroscopic mechanical properties. If the droplets within an emulsion are concentrated enough to be 
deformed, as is obviously the case for the present systems, the mechanical properties of the system can 
change from viscous to elastic during production due to increased deformation through osmotic 
pressure [55]. The application of a small shear strain works against the interfacial tension and causes 
the packed droplets to deform, thereby creating additional interfacial area and storage energy [55]. 
Likewise, as indicated by the cryo TEM experiments, the macroemulsion structure appeared to be 
highly symmetrical in terms of distribution of water and oil phase, which may contribute to increasing 
viscosity and elasticity [56].  
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The potential of the sucrose ester mixture to stabilize highly elastic macroemulsions is worthy of 
further investigation. So far, it may be assumed that the ability of the employed sucrose ester to 
increase the viscosity of emulsions may be related to its potential to self-assembly and the ability of 
sucrose to form hydrogen bonds and bind water [17].  
 
3.10. In vitro skin permeation: franz-cells 
The cumulative permeated drug amounts after 24 hours as well as the corresponding drug fluxes for 
all three model drugs are given in Table 5.  
Table 5. Skin permeation rates of curcumin (curc), flufenamic acid (fluf) and diclofenac 
acid (diclo) from macroemulsions (E) and nanoemulsions (NE) expressed as cumulative 
permeated drug amounts (µg·cm−2) and mean drug fluxes (J, µg·cm−2·h−1). At least 
five experiments were performed for each formulation (n ≥ 5); indicated values are 
means ± SD. 
Formulation Cumulative drug amount  Mean drug flux ± SD 
  after 24h ± SD (µg·cm¯²) (J, µg·cm−²·h−¹) 
E curc n.d. n.d. 
NE curc 0.71 ± 0.96 0.04 ± 0.06 
E fluf 27.27 ± 7.18 1.28 ± 0.34 
NE fluf 24.48 ± 5.13 1.15 ± 0.24 
E diclo 140.30 ± 27.36 6.66 ± 1.28 
NE diclo 147.37 ± 31.05 6.92 ± 1.44 
As can be seen, the corresponding macroemulsions and nanoemulsions performed equally well in 
this experimental setup, leading to highly similar release profiles in all three cases. No statistically 
significant differences between the different formulation types were obtained in terms of either 
cumulative drug amounts or drug fluxes (P > 0.05, respectively). In case of curcumin, the achieved 
permeation rates were negligible despite the adapted acceptor medium. This can be ascribed to the high 
lipophilicity of curcumin, which is known to be problematic in terms of formulation development and 
drug delivery [30,31]. However, the skin permeation experiments were not perpetuated for a longer 
time span so as not to allow maceration effects to take hold.  
The small droplet size of the nanoemulsions is associated with a large surface area, which has 
frequently been reported to result in an enhanced or accelerated release of incorporated drugs and thus 
an increased biological effect [51,57,58]. Interestingly, no such effect was observed in the present 
experiments. Indeed, literature shows that a smaller particle size is not necessarily associated with 
improved drug delivery [59]. In this case, the skin penetration of the model drugs rather appears to be 
governed by the employed excipients.  
Another interesting aspect in this context is the fact that the skin permeation rates of the drugs were 
not influenced by the strongly increased viscosity of the macroemulsion systems. The microviscosity of 
the macroemulsions appeared to be comparable to that of the fluid nanoemulsions despite the 
significant difference in macroviscosity. This phenomenon has been investigated and confirmed in a 
recent study dealing with gel-like colloidal dispersions of a comparable sucrose stearate mixture [15]. 
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It may thus be assumed that the loose interconnected hydrophilic network observed for the 
macroemulsions in our study is of a similar nature despite the presence of additional oil droplets. The 
release of all three model drugs remained impaired by the complex network-like macroemulsion 
structure.  
 
3.11. In vitro skin penetration: tape stripping 
The results of the tape stripping experiments were in good agreement with the results obtained with 
the franz-cell studies. In summary, neither the particle size nor the viscosity appeared to exert any 
influence on the penetration behavior of the three model drugs. The penetration depth of the drugs was 
found to be highly similar for corresponding macroemulsions and nanoemulsions in case of all three 
model substances (P > 0.05, respectively). The same tendency was observed for the accumulated 
amounts of drug in the SC as determined by summarizing the drug quantities recovered from the 
individual tape strips (P > 0.05, respectively). Merely in case of diclofenac acid, slightly if significantly 
larger drug amounts were recovered from the skin treated with the macroemulsion due to a surplus of 
drug on the first adhesive film (P < 0.05). Table 6 shows a comparison of the macroemulsions and 
nanoemulsions in terms of penetrated drug amounts and the penetration depth of the drugs. The latter is 
expressed both in absolute values (µm) and as percentage of the entire SC thickness, which was found 
to be 6.59 ± 0.47 µm for the employed porcine ears after removal of the entire SC via tape stripping (n 
= 4).  
 
Table 6. Skin penetration data of curcumin (curc), flufenamic acid (fluf) and diclofenac 
acid (diclo) from macroemulsions (E) and nanoemulsions (NE) as determined by tape 
stripping. At least six experiments were performed for each formulation (n ≥ 6); indicated 
values are means ± SD. 
Formulation 
 
Penetrated drug amount 
[µg/cm²] 
Penetration 
[µm] 
depth 
[% of SC] 
E curc 45.22 ± 6.61 3.75 ± 0.53 56.79 ± 08.01 
NE curc 51.07 ± 4.17 3.21 ± 0.81 48.61 ± 12.24 
E fluf  21.93 ± 6.29 3.08 ± 1.29 46.65 ± 19.62 
NE fluf  24.02 ± 7.03 3.61 ± 0.95 54.67 ± 14.36 
E diclo 27.98 ± 4.43 5.62 ± 0.65 85.22 ± 09.83 
NE diclo 20.72 ± 2.58 4.79 ± 0.95 72.70 ± 14.40 
A graphical illustration of the penetration profiles for flufenamic acid from both macroemulsions 
and nanoemulsions is given in Figure 9A/9B as a representative example.  
The highest skin penetration depth was achieved by by diclofenac acid, which was in good 
agreement with the results of the franz-cell studies. Concerning curcumin it is interesting to note that 
unlike the results derived from the franz-cell diffusion studies, satisfying skin penetration was reached 
in this experimental setup which was comparable to that of flufenamic acid. It may thus be assumed 
that in vitro tape stripping is a more suitable approach to investigate the skin penetration of highly 
lipophilic drugs such as curcumin. Additional in vivo tape stripping studies will be conducted with the 
curcumin-loaded formulations to confirm these results.  
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Figure 9. In vitro skin penetration profiles of flufenamic acid applied topically in 
macroemulsions (9A) and nanoemulsions (9B). The data were obtained via tape stripping 
using porcine ear skin (n = 8, respectively).  
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3.12. Comparison of in vitro studies: franz-cells vs. tape stripping  
Since the classical experimental set-up using franz-type diffusion cells may be influenced by 
interactions between the receptor medium and the model skin which may affect the barrier properties 
[60], additional tape stripping experiments were performed to avoid the influence of the receptor 
medium and to provide a more practically orientated experimental setup with a short finite-dose 
application.  
Under in vivo conditions, there is of course a high tissue clearance due to the bloodstream which 
cannot be simulated with the excised porcine ear. However, the results of our study showed that in the 
case of curcumin, hardly any skin diffusion was obtained with franz-type diffusion cells over the 
course of 24 hours despite the presence of a large amount of ethanol in the receptor medium, which 
offers a high solubilizing capacity for curcumin. In contrast, a penetration profile similar to that of the 
other drugs was achieved by in vitro tape stripping.  
As expected, the skin penetration and skin permeation data obtained by the different experimental 
setups were not entirely comparable in terms of numerical values. In case of curcumin, a reasonable 
penetration into the stratum corneum was determined by tape stripping (around 50 µg cm−2) while no 
transdermal permeation was observed with franz-type diffusion cells despite the adapted receptor 
medium. In case of flufenamic acid, the amounts detected in the skin by tape stripping and in the 
receptor medium after 24 hours were of a similar order of magnitude (around 25 µg cm−2, 
respectively). In case of diclofenac acid, a comparatively smaller amount of drug was obtained by tape 
stripping (around 25 µg cm−2) than was recovered from the receptor medium (around 145 µg cm−2). 
Since it is well-known that diclofenac as an acid is difficult to deliver, it may be assumed that as for 
curcumin, the results obtained with franz-type diffusion cells are not representative of the in vivo 
situation. In case of curcumin, an underestimation of the skin penetration potential resulted while in 
case of diclofenac, an overestimation was obtained. The inconsistent experimental results for 
diclofenac might be related to the different types of setup, the different types of skin employed for the 
experiments and related differences in pH gradients across the skin [61]. Overall, it may be concluded 
that tape stripping experiments deliver by far more realistic data than franz-type diffusion cell studies. 
Comparative in vivo tape stripping experiments are envisioned in order to confirm the relevance of the 
data obtained by in vitro tape stripping.  
 
4. Conclusions  
Sucrose stearate of an intermediate HLB value can be employed to design innovative lipid-based 
drug delivery systems which possess improved texture for dermal application while at the same time 
providing unimpeded drug release properties. The exact nature of the fluffy hydrophilic network 
surrounding the O/W emulsion droplets of various sizes should be subject to further investigations in 
order to specifically create desired properties of similar new vehicles. In the context of our 
investigations, additional in vivo tape stripping experiments are planned to gain a more realistic 
estimation of the penetration behavior of the newly developed formulations.    
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a b s t r a c t
Porcine ear skin is frequently used as a substitute for human skin in dermatological research and is espe-
cially useful for tape stripping experiments where the penetration of active substances into the upper-
most skin layers is investigated. However, certain differences between the surface properties of these
skin types exist, and reports on the comparability of tape stripping data obtained in vitro using porcine
ear skin and data obtained in vivo on human forearm skin are scarce. Thus, we performed comparative
tape stripping experiments in which the skin penetration of curcumin and ﬂuorescein sodium from con-
ventional microemulsions and hydrogels was investigated. In this context, the skin penetration potential
of novel semi-solid macroemulsions and ﬂuid nanoemulsions based on sucrose stearate was evaluated as
well. The removed corneocytes were quantiﬁed by NIR-densitometry using recent correlation data for
human and porcine proteins. The trends observed for the skin penetration into porcine ear skin were
highly representative for the in vivo situation on human skin, conﬁrming that the porcine ear is an excel-
lent in vitro model for tape stripping experiments. Moreover, the validity of the NIR-densitometric
approach for the quantiﬁcation of both human and porcine stratum corneum proteins was conﬁrmed
in this study for the ﬁrst time.
 2011 Elsevier B.V. All rights reserved.
1. Introduction
Tape stripping is a well-established method to investigate the
skin penetration of topically applied substances. The superﬁcial
layers of the stratum corneum (SC) are removed with adhesive
ﬁlms, which are subsequently analysed for their drug and protein
content. Thus, the amount of penetrated drug and the penetration
depth into the skin can be determined [1,2]. Recently, near-
infrared densitometry (NIR-densitometry) has been shown to
possess great potential for the analysis of the SC proteins removed
with each tape and has subsequently been validated for in vivo [3]
and in vitro [4] tape stripping on human skin. However, in vivo
studies may be associated with signiﬁcant organisational and
legislative issues, and the sources for excised human skin for
in vitro studies are limited. In tape stripping experiments, the ex-
cised porcine ear has been shown to be a suitable skin substitute
for human skin in vivo [2] since the ear skin, which remains on
the cartilage during the experiments, does not contract [5]. In fact,
this renders porcine ear skin even more suitable for in vitro tape
stripping than excised human skin or excised porcine skin from
other areas [6]. Thus, the NIR-densitometric method of protein
quantiﬁcation has been validated for this application as well [7].
Valuable information on the porcine ear skin model in general
can be found [5]. However, only few reports deal with the use of
porcine ear skin for in vitro tape stripping [8,9] and quantiﬁcation
of the porcine proteins removed with the tapes [2,10]. There is a
surprising lack of comparative studies, which deal with conven-
tional vehicles applied in a non-occluded fashion, although it
may be assumed that a vast majority of topical formulations is
applied in this manner. Validation of the porcine ear model under
these conditions using different formulations of practical relevance
seems essential to legitimate its use for in vitro tape stripping.
0939-6411/$ - see front matter  2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.ejpb.2011.11.009
Abbreviations: SC, stratum corneum; NIR-densitometry, near-infrared densi-
tometry; TEWL, transepidermal water loss.
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Detailed comparative information should be obtained through
parallel tape stripping on human and porcine skin with substances
of different logP values.
Thus, the aim of this study was to compare the skin penetration
of two well-established model substances, namely the lipophilic
dye curcumin and the hydrophilic dye ﬂuorescein sodium, from
different formulations applied on porcine ear skin in vitro and
human skin in vivo. Classical formulations such as a microemul-
sion and an alcoholic hydrogel were employed as vehicles for this
task. Recently developed skin-friendly O/W macroemulsions and
nanoemulsions were additionally tested for their drug delivery po-
tential in vivo. Interestingly, these formulations of identical com-
position had yielded highly comparable skin penetration rates
in vitro despite signiﬁcant differences in particle size and viscosity
[11]. Thus, in vivo tape stripping should reveal whether this phe-
nomenon was conﬁned to the realms of in vitro set-ups or would
be observed in vivo as well.
In summary, the present work aims to validate the porcine ear
skin model for in vitro tape stripping experiments while using the
novel technique of NIR-densitometry for protein quantiﬁcation of
both porcine and human skin. Since differences in the pattern of
wrinkles, the corneocyte distribution and the pseudo-absorption
at 850 nm of porcine and human corneocytes have been reported
[7,12], the present study should elucidate whether these factors
would impair the comparability of porcine and human skin pene-
tration proﬁles. Determination of the transepidermal water loss
(TEWL) as a biophysical skin analysis technique was additionally
employed to ensure integrity of the skin of both volunteers and por-
cine ears. Long-term monitoring of the TEWL of human volunteers
was conducted to determine the physiological TEWL range and to
ensure representative skin properties for later tape stripping.
2. Materials and methods
2.1. Materials
Standard Corneoﬁx adhesive ﬁlms with a square area of
4.0 cm2 were obtained from Courage + Khazaka GmbH (Cologne,
Germany). Curcumin (CAS: 458-37-7), ﬂuorescein sodium salt
(CAS: 518-47-8) and potassium sorbate (CAS: 24634-61-5) were
purchased from Sigma Aldrich (St. Louis, USA). Sucrose stearate
(Ryoto Sugar Ester S-970) was supplied by Mitsubishi-Kagaku
Food Corporation (Tokyo, Japan). PCL-liquid (cetearyl ethylhexano-
ate/isopropyl myristate, CAS: 90411-68-0) and propylene glycol
(1,2-propanediol, CAS: 57-55-6) were purchased from Dr. Temt
Laboratories (Vienna, Austria). Oleic acid (CAS: 112-18-1), carbo-
pol 940 polymer (CAS: 9063-87-0) and TRIS (tris(hydroxy-
methyl)-aminomethane 2% w/w buffer solution, CAS: 77-86-1)
were obtained from Herba Chemosan Apotheker-AG (Vienna, Aus-
tria). The lecithin mixture lipoid S-75 was kindly donated by Lipoid
GmbH (Ludwigshafen, Germany). Ultraphil amphiphilic cream
was purchased from Intendis Austria GmbH (Vienna, Austria).
According to the manufacturer, the compounds of this cream are
glycerol distearate, glycerol monostearate, liquid parafﬁn, polyoxy-
ethylene 100 stearate, polyoxyethylene 2 and 21 stearyl alcohol,
white vaseline, distilled water, benzyl alcohol and perfume oil.
The traditional Austrian product spiritus vini gallici 60% (Fran-
zbranntwein) was prepared according to the Codex Alimentarius
Austriacus (Chapter B33) by diluting an extract (Urkörper Gallhu-
ber 60%, Herba Chemosan Apotheker-AG, Vienna, Austria) with
appropriate amounts of ethanol, menthol and distilled water
(1:10/0.2/10 w/w). All further chemicals such as the solvents eth-
anol (CAS: 64-17-5) and isopropanol (CAS: 67-63-0) used were of
analytical reagent grade and used as obtained from Sigma Aldrich
(St. Louis, USA).
2.2. Formulations
Established formulations were employed for the comparative
tape stripping experiments on porcine ear skin in vitro and human
skin in vivo, namely a lecithin-based microemulsion [13] and an
alcoholic hydrogel. The amphiphilic cream ultraphil was em-
ployed for preliminary in vitro studies. The novel sucrose stea-
rate-based emulsions were evaluated only by in vivo tape
stripping since their penetration behaviour in vitro had already
been established [11]. The composition of the individual formula-
tions is given in Table 1.
The microemulsion was prepared by dissolving the lecithin
mixture in isopropanol, ethanol and oleic acid. Distilled water
was slowly added during magnetic stirring.
The hydrogel was prepared by dissolving the polymer carbopol
940 in a mixture of spiritus vini gallici, propylene glycol and iso-
propanol. A homogeneous gel network was formed upon addition
of the TRIS buffer solution under mild mechanical stirring.
The sucrose stearate-based macroemulsions and corresponding
nanoemulsions were prepared as described [11]. The separate oil
and aqueous phases were mixed and stirred with an ultra-turrax
(Omni 500, 2500 rpm, 4 min). In case of the ﬂuid nanoemulsions,
the mixture was further treated with a high-pressure homogeniser
(EmulsiFlex C3, Avestin) for 20 cycles at 750 bars.
The model drug curcumin was incorporated into all above men-
tioned formulations at 0.5% (w/w), respectively. The hydrophilic
model drug ﬂuorescein sodium was dissolved in the microemul-
sion for comparative investigation at 0.5% (w/w). The drug content
of all formulations was determined after preparation to conﬁrm
drug incorporation. In case of curcumin, 10 mg of the respective
formulation was dissolved in 1 ml of ethanol (96% v/v). The sam-
ples were homogenised in an ultrasonic bath at 30 kHz (US Star-
sonic 60, Liarre, Italy) for 20 min and then centrifuged for 6 min
at 12,000 rpm (Hermle Z323 K, MIDSCI, USA). Subsequently,
0.5 ml of each sample was further diluted with ethanol (96% v/v,
1:10) and analysed by UV/Vis spectroscopy as described in Section
2.10. In case of ﬂuorescein sodium, the same procedure was con-
ducted with phosphate buffer (pH 7.4, 0.012 M) instead of ethanol.
For drug quantiﬁcation, 100 ll of the diluted samples was trans-
ferred into a microtiter plate in triplicate and analysed by ﬂuores-
cence spectroscopy as described in Section 2.11. Samples were
always taken at least in triplicate (nP 3).
2.3. Skin tissue
Fresh porcine ears were obtained from the Clinic for Swine at
the University of Veterinary Medicine Vienna, Austria. The age of
the slaughtered pigs was around 6 months. To ensure integrity of
the skin barrier, the ears were removed before the carcass was ex-
posed to any high-temperature cleaning procedure [9]. The ears
were washed carefully under cold running water and blotted dry
with soft tissue. All ears were stored at 20 C and thawed prior
to the experiments since the main penetration barrier, the non-
vital superﬁcial SC layer, is not inﬂuenced by frozen storage
[4,14]. All experiments were carried out at room temperature.
The skin remained on the isolated ear. In addition, porcine abdom-
inal skin was tested in preliminary studies, but was found unsuit-
able for tape stripping experiments. The SC of porcine abdominal
skin is thinner than that of the dorsal side of porcine ears [15], thus
rendering the acquisition of accurate skin penetration data
difﬁcult.
2.4. Test persons and experimental conditions
Long-term evaluation of the TEWL on the volar forearms and
the forehead of human volunteers was performed on a population
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of 26 male and female volunteers aged between 18 and 44. Written
informed consent for this non-invasive procedure was obtained
from all participants. Measurements were taken over 4 months.
For the tape stripping experiments, twelve healthy volunteers
aged 18–44 were included after giving their written informed
consent. They did not suffer from skin diseases or allergies. The
study was approved by the ethics committee of the medicinal
university of Vienna (EK-Nr. 503/2011). All experiments were
performed according to the same protocol. The volunteers were
required not to apply cosmetic or skin care products up to 12 h
prior to the experiment and to avoid excessive consumption of
coffee, tea or alcohol [16]. Furthermore, they were asked not to
engage in physical activity prior to the experiments and to re-
main seated for 15 min after entering the test area with constant
ambient temperature (24 ± 1 C) and humidity (50 ± 4% relative
humidity).
The steps of the working protocol for in vitro and in vivo exper-
iments were the same: after application of a formulation, the pen-
etration behaviour of the respective model drug was determined
by tape stripping and subsequent analysis of both protein content
and drug amounts found on the individual tape strips. The tape
stripping procedure in combination with sensitive analytical meth-
ods allows an exact localisation of the applied drugs in the SC [17].
2.5. Transepidermal water loss (TEWL)
The TEWL of the skin was determined using the closed-chamber
device AquaFlux (Biox Ltd., London, UK) and the AquaFlux V6.2
program for data analysis. In case of porcine ear skin, TEWL mea-
surements were taken as a quality control to exclude areas with al-
tered skin barrier function. Although the TEWL of excised porcine
ears is hardly representative of the in vivo situation, it can serve
to monitor the defrosting process and to ensure a standardised
working protocol [7,8,18]. The presence of small lesions and scars
can be detected since such areas exhibit noticeably higher TEWL
values.
Prolonged storage of fresh or defrosted porcine ears at ambient
conditions will inevitably lead to dehydration of the tissue and
thus to a constant decrease in the TEWL. However, there is a sufﬁ-
ciently long time frame for fresh or defrosted porcine ears with
average TEWL values around 15 g m2 h1 that represents a suit-
able starting point for tape stripping experiments. Therefore, the
TEWL of the porcine ears was determined for all samples before
the tape stripping procedure. Assessment of the TEWL after tape
stripping provided additional information about changes in skin
barrier function [15].
In case of human skin in vivo, determination of the TEWL is an
established method for skin integrity testing [19,20]. Substantiated
TEWL monitoring of human volunteers was performed to establish
a database of physiologically acceptable TEWL values for different
skin areas such as the volar forearms and the forehead. These data
served to provide a basis for comparison to identify unsuitable skin
areas or skin types prior to the tape stripping experiments.
Measurements were taken in regular intervals over a period of
4 months. Volunteers were advised not to treat their skin
differently than usual and not to use skin care products immedi-
ately before the measurements. The inﬂuence of parameters such
as age, sex, the frequent use of skin care products, inclination to
sweat, skin type and the season on the skin barrier function was
evaluated in this context. Information on subjective parameters,
such as the use of skin care products and the inclination to sweat
of the individual volunteers, was gained by means of a question-
naire.
2.6. Preliminary experiments: optimisation of tape stripping working
protocol
Preliminary experiments were performed to identify the most
suitable working protocol for in vitro tape stripping. The effect of
different application times was investigated. To this end, tape
stripping was performed after 1 and 4 h following the application
of the respective formulation. The selected model formulations
used were the microemulsion, the hydrogel and the amphiphilic
cream ultraphil with curcumin.
2.7. In vitro tape stripping
In vitro skin penetration proﬁles were established for the curcu-
min-loaded microemulsion, hydrogel and ultraphil cream as well
as for the microemulsion with ﬂuorescein sodium. At least six indi-
vidual tape stripping experiments were performed for each formu-
lation on porcine ear skin (nP 6, respectively). After defrosting
and cleaning, the skin was blotted dry with soft tissue and freed
from visible hair with scissors. The ears were stretched out on
styrofoam plates and ﬁxed with needles. Intact, representative skin
areas of 15 cm2 were indicated with a permanent marker. The
TEWL of the skin was determined with the AquaFlux device (Biox
Ltd., London, UK) to conﬁrm an intact skin barrier function [7].
When the TEWL reached values between 15 and 20 g m2 h1,
the respective formulation was applied onto the skin by means
of a saturated glove ﬁnger at a concentration of 2 mg cm2 and
gently distributed for 30 s. After an application time of 1 or 4 h,
the tape stripping procedure was started.
The adhesive ﬁlms employed to remove the superﬁcial SC lay-
ers were standard Corneoﬁx tapes. Care was taken to ensure a
reproducible working procedure [3,21]. The outline of the ﬁrst
adhesive ﬁlm was indicated with a permanent marker to facilitate
subsequent tape stripping on the same location. Pressure was ap-
plied with the thumb covered in a vinyl glove [22] to ensure a
rolling movement and thus minimise the inﬂuence of wrinkles
[1]. While a roller is among the most suitable devices to ﬂatten
out the skin during in vivo tape stripping, the skin of excised
pig ears provides less space for handling a roller. Experience
has shown that a rolling movement performed by the thumb
leads to the most efﬁcient and homogeneous removal of porcine
corneocytes in vitro [7,22]. Thus, this working protocol was
Table 1
Composition of all investigated formulations in % (w/w) and abbreviations.
Microemulsion Hydrogel Macroemulsion/nanoemulsion
Excipients % (w/w) % (w/w) % (w/w)
Lipoid S-75 40 Propylene glycol 10 PCL-liquid 20
Isopropanol 35 Isopropanol 10 Sucrose stearate 5
Oleic acid 9.5 TRIS 2% 5.1 Potassium sorbate 0.1
Ethanol 96% v/v 5 Carbopol 940 0.6 Model drug 0.5
Model drug 0.5 Model drug 0.5 Distilled water 74.4
Distilled water 10 Spiritus vini gallici 73.8
Abbreviations: ME microemulsion; GE hydrogel; E macroemulsion; NE nanoemulsion.
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adopted for the in vitro experiments. A piece of paper was placed
between the tape and the thumb to avoid a transfer of emulsion
from the adjacent skin parts to the adhesive ﬁlm [23]. The exper-
iment was performed on a balance to ensure a constant pressure
of 49 N (5 kg) [7]. After applying pressure for 3 s, the tape was re-
moved in a single rapid movement. In case of curcumin-loaded
formulations, 20 sequential tape strips were removed. Since a
higher penetration depth was anticipated for ﬂuorescein sodium,
40 tape strips were removed in this case.
2.8. In vivo tape stripping
In vivo skin penetration experiments were performed on 12
healthy test persons. The penetration proﬁles were established
for the curcumin-loaded microemulsion and hydrogel as well as
for the microemulsion with ﬂuorescein sodium. Moreover, the no-
vel curcumin-loaded macroemulsion and nanoemulsion were
investigated in the same fashion. Six individual experiments on
the human ﬂexor forearm were performed for each formulation
(n = 6, respectively).
Representative intact skin areas of 15 cm2 were indicated with a
permanent marker. The TEWL of the skin was determined as de-
scribed above. The respective formulation was then applied onto
the skin by means of a saturated glove ﬁnger at a concentration
of 2 mg cm2 and gently distributed for 30 s. After an application
time of 30 min, the tape stripping procedure was conducted. In this
case, pressure was applied with a roller [1,23]. Except for the
means and intensity of pressure application and the application
time, the working procedure was identical to that employed for
the porcine ears.
2.9. Protein quantiﬁcation by NIR-densitometry
We recently validated NIR-densitometry for the quantiﬁcation
of porcine skin during in vitro tape stripping [7]. In the present
work, we tested the proposed method for in vitro tape stripping
experiments on porcine skin for comparison with in vivo data,
for the ﬁrst time using different formulations.
The amount of corneocytes removed with the individual adhe-
sive ﬁlms was analysed using the infrared densitometer Squame-
Scan™ 850A (Heiland electronic GmbH, Wetzlar, Germany). The
removed tape strips were measured at a wavelength of 850 nm
as previously described using an empty tape strip as a reference
[3,4]. Thus, the optical pseudo-absorption of the adhesive ﬁlms
that is caused by an interaction of the corneocyte aggregates with
light via scattering, diffraction and reﬂection was determined [23].
Since the device has been validated separately for porcine and hu-
man skin, the respective calibration data were used for protein
quantiﬁcation. In case of porcine skin, the mass of SC proteins
(m) can be calculated after determination of their pseudo-absorp-
tion (A) for a normalised tape area of 1 cm2 by employing the equa-
tion m = A /0.41 (in lg cm2) [7]. In case of human proteins, the
equation derived from the respective calibration curve can be em-
ployed for this task, namelym = (A  2.703)/0.623 (in lg cm2) [3].
The mean cumulative amount of removed SC proteins was em-
ployed to establish the penetration depth of the applied drugs in
relation to the complete SC thickness. Experience has shown that
the SC thickness of both human forearm skin and pig ear skin
can vary considerably for each individual [7,9]. Since removal of
the entire SC in each case is too much organisational effort and
an additional strain for the volunteers, we employed well-estab-
lished reference values for the entire SC thickness in accordance
with the literature [9]. Thus, the thickness of the SC of porcine
ear skin was assumed with 8.2 lm and the thickness of human
SC of the volar forearm with 11.0 lm.
2.10. Curcumin quantiﬁcation by UV/Vis spectroscopic analysis
After NIR analysis, the individual tapes containing corneocytes
and curcumin were dissolved in 4 ml of ethanol (96% v/v). The
samples were homogenised in an ultrasonic bath at 30 kHz (US
Starsonic 60, Liarre, Italy) for 20 min and centrifuged for 6 min at
12,000 rpm (Hermle Z323K, MIDSCI, USA). The resulting curcumin
solutions were analysed by UV/Vis spectroscopy. The quantiﬁca-
tion was performed as previously reported [17,24] using a double
beam UV/Vis spectrophotometer (Spectrophotometer U-3010, Hit-
achi, Japan). A calibration curve was established for standard solu-
tions of curcumin in ethanol (96% v/v) ranging from 0.31 lg/ml to
5.01 lg/ml with R2 = 0.9952. The curcumin content of the samples
ﬁlled into quartz cuvettes was determined at 425 nm against a
control sample of an extracted blank tape strip. Samples containing
higher curcumin content were diluted prior to analysis until values
within the linear range of the calibration curve were obtained. This
was occasionally the case for samples extracted from the ﬁrst
adhesive ﬁlm of the experiments.
2.11. Fluorescein sodium quantiﬁcation by ﬂuorescence spectroscopy
After NIR analysis, the tapes containing corneocytes and ﬂuo-
rescein sodium were dissolved in 4 ml of phosphate buffer (pH
7.4, 0.012 M). As described above for curcumin, the samples were
homogenised and centrifuged. The resulting ﬂuorescein sodium
solutions were analysed by ﬂuorescence spectroscopy. The quanti-
ﬁcation was conducted using a microplate reader (Tecan™ inﬁnite
200, Tecan Ltd., Maennedorf, Switzerland) at an excitation wave-
length of 485 nm, an emission wavelength of 535 nm and a con-
stant gain of 78. A calibration curve was established for standard
solutions of ﬂuorescein sodium in phosphate buffer (pH 7.4,
0.012 M) ranging from 0.04 lg/ml to 5.07 lg/ml with R2 = 0.9992
to quantify the drug content of the samples. Samples containing
a higher content of ﬂuorescein sodium were diluted prior to anal-
ysis. For drug quantiﬁcation, 100 ll of the diluted samples was
pipetted into a microtiter plate in triplicate and analysed against
control solutions of extracted blank adhesive ﬁlms.
2.12. Statistical data analysis
Results are generally expressed as means of three or more
experiments ± SD. Statistical data analyses were performed with
the program GraphPadPrism3 while using P < 0.05 as a minimum
level of signiﬁcance in all cases. Parametric data were analysed
using the Student’s t test or ANOVA, while non-parametric data
were analysed using the Mann–Whitney test or the Kruskal–Wallis
test.
3. Results and discussion
In summary, both visual inspection and analysis of the drug
content of the formulations conﬁrmed their suitability for the sub-
sequent experiments (data not shown). The following sections deal
with the results of the in vitro experiments, followed by the results
obtained in vivo and conclusive remarks on the similarities and dif-
ferences between the data.
3.1. In vitro experiments: porcine ear skin
3.1.1. Transepidermal water loss (TEWL)
The TEWL of fresh or defrosted porcine ear skin in vitro can be
employed as an indicator for the intactness of the SC barrier func-
tion [25,26]. Since the excised ear does not possess any metabo-
lism, the determined values will of course differ from those
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in vivo. Nevertheless, experience has shown that lesions or irregu-
larities in the SC barrier function can be identiﬁed. The results of
the TEWL measurements conducted during in vitro tape stripping
are given in Fig. 1. The TEWL value of intact porcine ear skin before
tape stripping was always between 10 and 20 g m2 h1. The
experiments were then started immediately to prevent dehydra-
tion of the tissue. Upon removal of 20 adhesive ﬁlms from un-
treated skin regions, the TEWL increased signiﬁcantly (P < 0.05).
However, as can be derived from the large standard deviation, this
increase can vary to a large extent due to inter-individual differ-
ences. Such differences tend to become negligible upon further
tape stripping of the same area. After the removal of 40 tapes from
the untreated skin site, the TEWL values reached a peak around
80 g m2 h1. It may be assumed that the majority of the SC was
removed at this point. Removal of further tapes until the complete
SC was removed only led to minor increase in the TEWL after this
point (data not shown). These ﬁndings conﬁrm previous data [7].
Apart from these observations regarding the TEWL of untreated
tape stripped skin, the effect of the different formulations applied
before tape stripping was investigated (Fig. 1). Apparently, the dif-
ferent formulations inﬂuenced the extent of SC barrier disruption
during tape stripping in accordance with the employed excipients.
The microemulsion, containing large amounts of surfactant and
solvents, led to a signiﬁcantly larger increase in the TEWL after
the removal of 20 tapes when compared to the corresponding
control site (P < 0.05). In contrast, the TEWL values obtained after
the removal of 20 tapes from skin sites treated with the hydrogel
were comparable to the control (P > 0.05). The lowest increase in
TEWL was observed after treatment for the skin with ultraphil
cream, which was even lower than the value of the control site
(P < 0.05). The extent of the SC barrier disruption in vitro can thus
be ranked as ME > GE/Control > ultraphil.
3.1.2. Inﬂuence of application time on in vitro skin penetration
Different application times of 1 and 4 h were tested in corre-
sponding experiments with the curcumin-loaded microemulsion,
the hydrogel and the ultraphil cream. The results of these studies
are given in Table 2. No signiﬁcant differences in penetration depth
or recovered drug amounts were found for the microemulsion or
the hydrogel after 1 and 4 h of application time (P > 0.05, respec-
tively). However, a slight tendency towards lower values of
penetration depth and drug amounts was generally observed. This
indicates that the prolonged application time in vitro does not
necessarily yield higher skin penetration. On the contrary, lateral
diffusion of the drug may occur [27–29] and dehydration effects
may take hold. It was thus decided that 1 h of application time
was sufﬁcient for the envisioned experiments. Comparable work-
ing protocols have been successfully employed in previous
in vitro studies [2]. The phenomenon of the potential lateral
spreading effect after prolonged application will be subject of
further studies.
In case of the ultraphil cream, the extent of skin penetration
was highly unsatisfying after 1 h. Merely, a prolonged application
time of 4 h led to noticeable skin penetration of the drug while a
signiﬁcant amount of formulation still remained on the skin
surface. It was apparent that the penetration depth of curcumin
when applied in this vehicle was signiﬁcantly lower even after
4 h of application time than from the other formulations
(P < 0.05, respectively). Besides, remnants of the formulation still
impaired the tackiness of the ﬁrst adhesive ﬁlms. Due to its lack
of penetration and spreading, ultraphil cream was thus excluded
from further experiments. Modiﬁcation of the working protocol to-
wards cleaning of the skin surface was not deemed appropriate
within the context of the envisioned comparative studies, but this
aspect will be investigated separately at a later point.
Regarding the rank order of penetration depth of the compared
formulations, an obvious tendency was apparent, namely micro-
emulsionP hydrogel > ultraphil cream. Both the microemulsion
and the hydrogel yielded signiﬁcantly higher skin penetration
depths than the ultraphil cream (P < 0.05). A statistically signiﬁ-
cant difference between the penetration depth of the microemul-
sion over the hydrogel was only reached after 4 h of application
time (P < 0.05).
Summarising our experiences with different application times,
only a slightly longer treatment for the skin than for in vivo exper-
iments seemed most appropriate. The excised porcine ear lacks cir-
culation and is subjected to constant dehydration during the
experiment. Insufﬁcient application times might lead to errone-
ously low penetration depths, which do not represent the in vivo
situation. Prolonged application times may yield representative re-
sults, but may also promote unphysiological dehydration of the tis-
sue and lateral spreading [27,30]. The decreased skin hydration,
accompanied by lower TEWL values, leads to decreased skin diffu-
sion of drugs. This effect might annihilate the positive effect of a
longer application time [31]. Although the isolated porcine ear is
a suitable and representative model for short-time studies, it ap-
pears to be less adequate for longer application periods, especially
for highly lipophilic drugs. Appropriate sink conditions may not be
reached due to the lack of cutaneous circulation [9]. Thus, de-
creased penetration rates of model drugs after prolonged penetra-
tion times may occur [32].
3.1.3. In vitro skin penetration proﬁles
The results of the in vitro tape stripping experiments for both
curcumin and ﬂuorescein sodium after 1 h of application time
are summarised in Table 2. Overall, the amount of penetrated drug
was highly comparable for all in vitro experiments irrespective of
the lipophilicity of the investigated drug and the type of formula-
tion (P > 0.05). In contrast, the penetration depth of the different
drugs was inﬂuenced by both the excipients of the formulations
and the logP value of the drug. The hydrophilic ﬂuorescein sodium
achieved deeper skin penetration than the lipophilic curcumin
from the corresponding microemulsion (P < 0.05), reaching values
around 50% of the entire SC. This might be due to the different
solubilities of the drugs within the microemulsions. After
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Fig. 1. TEWL of porcine ear skin in vitro measured before and after tape stripping.
The inﬂuence of the applied formulation on the extent of SC barrier disruption is
demonstrated. The TEWL before and after tape stripping of the area treated with the
microemulsion containing curcumin is given on the left (ME-C, 20 tapes), followed
by the corresponding data for the curcumin-loaded hydrogel (GE-C, 20 tapes) and
ultraphil (UL-C, 20 tapes). The respective values represent the means ± SD of at
least seven experiments (nP 7). An untreated skin site, respectively, served as a
control (20 tapes, n = 23).
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application of the formulations, volatile compounds evaporate and
the drugs may re-crystallise due to the destruction of the formula-
tion structure. Since crystallised drug is no longer available for
penetration, this might hinder the achieved penetration depth
especially in case of lipophilic drugs that are mainly dissolved by
the involved solvents (verbal communication with Dr. Thomas
Franz, 2011). In case of the different curcumin-loaded formula-
tions, an effect of the vehicle on the penetration depth of the lipo-
philic drug was noticeable. As already discussed, higher
penetration of curcumin was obtained with the microemulsion
than with the hydrogel. After 1 h of application time, these differ-
ences did not quite reach signiﬁcant levels due to the strong inter-
individual variability within the experiments (P > 0.05, with
P = 0.0505). Nevertheless, the general tendency was apparent.
3.1.4. Inﬂuence of the formulation on the amount of removed SC
proteins in vitro
An additional aspect that was investigated was the inﬂuence of
the applied formulation on the amount of removed SC proteins.
Fig. 2 shows the comparison between the amount of SC proteins
removed from untreated porcine skin as a control and the amount
of SC proteins that was removed after application of the different
formulations. As can be seen in Fig. 2a, the microemulsion rapidly
penetrated into the skin without leaving signiﬁcant traces of for-
mulation on the skin surface. Thus, the removal of SC proteins
was not hindered by the application of the formulation when com-
pared to the control (P > 0.05). In case of the hydrogel (Fig. 2b), a
signiﬁcant inﬂuence of the formulation on the amount of removed
corneocytes was found until the 7th removed adhesive ﬁlm
(P < 0.05, respectively). Slightly lower amounts of SC were re-
moved, possibly due to decreased tackiness of the tapes. Interest-
ingly, no weakening of the cohesion between corneocytes caused
by the ethanol within the microemulsion and the hydrogel was ob-
served, which would have led to higher amounts of removed cor-
neocytes [30]. The subsequent tapes were not impaired in their
tackiness by the remnants of the formulation when compared to
the control (P > 0.05). In case of ultraphil, signiﬁcantly less cor-
neocytes were removed with all 20 adhesive ﬁlms as opposed to
the control (P < 0.05, Fig. 2c). This pronounced inﬂuence of the for-
mulation on the tape stripping process can be ascribed to the insuf-
ﬁcient penetration of the formulation, in particular the lipophilic
compounds, which remained on the skin surface and impaired
the tackiness of the tapes [30]. In such cases, cleaning of the skin
surface prior to the tape stripping process appears essential to ob-
tain reliable results. The cleaning of the skin surface with solvents
may likewise inﬂuence the results obtained with the ﬁrst adhesive
tapes. Thus, an acceptable compromise has to be found in accor-
dance with the respective formulation properties.
3.2. In vivo experiments: human forearm skin
3.2.1. Transepidermal water loss (TEWL)
The TEWL can be employed to characterise the skin barrier
function of human volunteers in vivo [25,26]. The results of the
long-term in vivo monitoring of the TEWL of human volunteers
are given in Table 3 panels a and b. The TEWL of each volunteer
was determined over the course of 4 months in regular intervals
both on the forehead as well as the left and right forearm. At least
29 independent measurements were taken for each person
Table 2
In vitro skin penetration data for the different investigated formulations after application of 2 mg/cm2 on porcine ear skin. The inﬂuence of different application times of 1 and 4 h
on skin penetration of curcumin is shown. The given values are means ± SD of at least six individual experiments for each formulation (nP 6).
Formulation Application time (h) Penetrated drug amount (lg/cm2) Penetration depth (lm) Penetration depth (% of SC)
ME curc 1 7.48 ± 1.32 2.26 ± 0.85 27.56 ± 10.37
ME curc 4 6.71 ± 1.76 1.82 ± 0.65 22.20 ± 7.93
GE curc 1 8.25 ± 3.84 1.26 ± 0.69 15.37 ± 8.41
GE curc 4 7.26 ± 1.97 0.91 ± 0.36 11.10 ± 4.39
UL curc 1 Not feasible
UL curc 4 6.58 ± 1.57 0.39 ± 0.14 4.76 ± 1.71
ME ﬂuor 1 7.65 ± 1.56 3.82 ± 0.88 46.59 ± 10.73
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Fig. 2. Inﬂuence of the applied formulation on the amount of removed porcine SC
proteins in vitro. The black bars, respectively, represent the amount of SC proteins
removed from untreated skin areas (control). The grey bars, respectively, represent
the amounts of SC proteins removed after the application of a microemulsion (a,
after 1 h), a hydrogel (b, after 1 h) or ultraphil cream (c, after 4 h). The given values
represent the mean of at least six experiments (nP 6).
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(nP 29). The mean of these TEWL values was considered as repre-
sentative for each volunteer. The resulting ﬁnal TEWL values of the
volunteerswere then evaluated in regard to different criteria to elu-
cidate the potential inﬂuence of parameters such as sex, age, the use
of skin care products, sweating, skin type (Table 3 panel a) or the
season (Table 3 panel b) on the skin barrier function.
As expected, the TEWL of the different investigated skin regions
varied for the forehead and the forearm regions. The determined
absolute values were around 11–12 g m2 h1 for the forearm skin
and around 25 g m2 h1 for the thinner skin region covering the
forehead, which is in accordance with previous ﬁndings [26]. The
higher TEWL of regions with increased permeability can be related
to the smaller corneocytes size [26,33], the smaller number of SC
cell layers [20] and the density of eccrine sweat glands [16].
No signiﬁcant difference was found between the TEWL of the
left and right forearm (P > 0.05). Likewise, no signiﬁcant difference
was found between the TEWL of the respective regions for male
and female or younger and older volunteers (P > 0.05, respectively).
This indicates that neither gender nor age inﬂuence the TEWL,
which is in accordance with previous reports dealing with the ef-
fect of ethnicity, age and sex on the TEWL [26,34]. However, other
opinions can be found [35]. None of the other investigated criteria,
such as the regular use of skin care products, the inclination to
sweating or the skin type of the participants according to the Fitz-
patrick scale [36] proved to be of signiﬁcance regarding the TEWL
(P > 0.05 in all cases).
Monitoring of the TEWL results for all volunteers as determined
during the course of several months revealed a slight, if signiﬁcant
variation of the TEWL during this time (P < 0.05, Table 3 panel b). In
case of the forehead, it may be assumed that the increasing exter-
nal temperature might have an effect on the TEWL despite air con-
ditioned laboratory surroundings. In case of the forearms, however,
no clear tendency in this respect could be observed, which indi-
cates that a slight variation of the TEWL values can be regarded
as normal during long-term observation. The results of evapori-
metric methods even with closed-chamber systems may be inﬂu-
enced by the microclimate near the skin surface, which in turn is
inevitably inﬂuenced by the present overall climate at a given time
of the year [37]. In summary, no signiﬁcant effects of the different
subject-related variables on the TEWL were found in the long-term
study apart from the obvious difference between the anatomical
sites. The season of the measurements was found to have a slight
impact on the TEWL, as conﬁrmed by literature where seasonal
variations in biophysical and biological characteristics of the SC
have been reported [35,38].
Apart from this long-term observation, the TEWL before and
after tape stripping was determined as an indicator for the barrier
function of the skin [17]. The TEWL of untreated skin was in accor-
dance with the results of the long-term monitoring and previous
Table 3
TEWL of human volunteers. The TEWL of each volunteer was determined over the course of 4 months by means of at least 29 independent measurements per person (nP 29),
which were conducted in regular intervals. The mean of these TEWL values was, respectively, considered as representative for each individual. Table 2a shows the mean TEWL
values in g m2 h1 ± SD as determined for all volunteers. The data were evaluated in regard to different criteria as detailed below. Table 2b demonstrates the mean TEWL in
g m2 h1 ± SD of all measurements conducted during the course of each month.
Panel 3a
Investigated group Number of volunteers Mean TEWL (g/m2 h) ± SD
Left forearm Right forearm Forehead
All volunteers n = 26 11.67 ± 2.68 12.31 ± 2.85 24.16 ± 4.04
Female Volunteers n = 15 10.79 ± 1.85 11.11 ± 1.97 24.37 ± 3.74
Male Volunteers n = 11 12.87 ± 3.23 13.95 ± 3.12 23.89 ± 4.60
Age 18–25 n = 12 12.10 ± 3.47 12.52 ± 3.71 24.19 ± 4.09
Age 26–55 n = 14 11.42 ± 1.83 12.10 ± 2.04 24.06 ± 4.31
Skin care products n = 18 11.00 ± 2.05 11.64 ± 2.56 24.14 ± 3.54
No skin care product n = 08 13.16 ± 3.44 13.82 ± 3.04 24.23 ± 5.28
Sweating n = 15 11.90 ± 2.25 12.69 ± 2.91 24.40 ± 4.00
No sweating n = 11 11.35 ± 3.27 12.00 ± 2.94 24.35 ± 4.12
Skin type I n = 03 10.58 ± 1.11 11.67 ± 0.80 20.94 ± 1.65
Skin type II n = 10 11.69 ± 3.38 11.96 ± 3.14 23.18 ± 3.71
Skin type III n = 10 12.05 ± 2.55 13.08 ± 3.19 25.65 ± 4.26
Skin type IV n = 03 11.03 ± 0.62 11.44 ± 0.78 24.94 ± 4.96
Panel 3b
Month Number of measurements Mean TEWL (g/m2 h) ± SD
Left forearm Right forearm Forehead
February n = 85 10.81 ± 3.32 11.54 ± 3.70 22.36 ± 5.50
March n = 109 12.05 ± 3.18 12.44 ± 3.34 23.86 ± 5.61
April n = 170 11.67 ± 3.32 12.48 ± 3.74 24.43 ± 5.26
May n = 155 10.80 ± 2.88 11.60 ± 3.46 25.24 ± 5.51
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Fig. 3. TEWL of human forearm skin in vivo measured before and after tape
stripping. The TEWL before and after tape stripping of the area treated with the
microemulsion containing ﬂuorescein sodium is given on the left (ME-F, 40 tapes),
followed by the corresponding data for the curcumin-loaded microemulsion (ME-C,
20 tapes), hydrogel (GE-C, 20 tapes), macroemulsion (E-C, 20 tapes) and nano-
emulsion (NE-C, 20 tapes). An untreated skin site served as a control. Values
represent the means ± SD of six experiments (n = 6).
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studies [26,33]. Interestingly, the in vivo TEWL values observed
after the removal of 20 adhesive tapes were highly comparable
for both untreated skin and skin treated with the different formu-
lations (Fig. 3). Thus, in contrast to the in vitro results, only a slow
increase in TEWL was observed in vivo, which was not inﬂuenced
by the presence of topical formulations. Literature conﬁrms that a
slow and variable increase in TEWL of human skin is observed dur-
ing the initial tape stripping process. Only when a major part of the
SC is removed, the TEWL increases strongly [39], as can be seen for
the microemulsion with ﬂuorescein sodium where 40 adhesive
tapes were removed (Fig. 3). The initial changes depend largely
on the condition of the SC as well as on the exact tape stripping
procedure. Inter-individual variations might be related to site-
dependent differences in spontaneous desquamation and SC cohe-
sion [20].
3.2.2. In vivo skin penetration proﬁles
The results of the in vivo tape stripping experiments are given
in Table 4. As for the in vitro experiments, the skin penetration
of ﬂuorescein sodium from the microemulsion was higher than
that of curcumin from the same or other vehicles (P < 0.05). Over-
all, the same tendencies as for the in vitro experiments were found.
The penetration of curcumin tended to be higher from the micro-
emulsion than from the hydrogel or the macro- and nanoemul-
sions. However, none of these differences reached a signiﬁcant
level (P > 0.05, respectively). As already observed in previous
in vitro studies [11], the skin penetration behaviour of the macro-
emulsion and the nanoemulsion was highly comparable despite
the marked difference in particle size and rheological properties
(P > 0.05). For all formulations, no statistically signiﬁcant differ-
ences were found when comparing the results of the tape stripping
experiments performed on female and male volunteers (P > 0.05).
3.2.3. Inﬂuence of the formulation on the amount of removed SC
proteins in vivo
The observed tendencies were in agreement with previous
in vivo investigations reporting an obvious inﬂuence of the applied
formulation on the amount of removed corneocytes [29]. In case of
the microemulsion and the hydrogel, slight if signiﬁcant differ-
ences were noticeable for the ﬁrst few tapes (n = 6, P < 0.05, respec-
tively) in accordance with the effects discussed and depicted for
the in vitro data. In case of the macroemulsion and the nanoemul-
sion, signiﬁcant differences were also noticeable for the ﬁrst few
tapes (n = 6, P < 0.05, respectively). However, more corneocytes
were apparently removed with the ﬁrst few tapes after application
of these formulations when compared to the control. It may be
assumed that the cohesion of the corneocytes might have been
decreased after application of the highly hydrophilic systems.
Moisturising O/W creams can cause acute hydration of the SC, an
increase in TEWL and weakened SC cohesion. Thus, higher
amounts of protein are removed though tape stripping [16,20,22].
In summary, the amount of removed corneocytes both in vivo
and in vitro may be inﬂuenced in different ways. The applied
formulations may lead to reduced tackiness of the tapes, especially
if highly lipophilic creams with slow skin penetration or solvents
are applied. In this case, modiﬁcation of the working protocol
towards cleaning of the skin should be considered. On the other
hand, moisturising or occlusive formulations may lead to increased
skin hydration, thus causing facilitated removal of corneocytes due
to reduced cohesion. These ﬁndings once again conﬁrm the need
for the quantiﬁcation of the removed corneocytes on each individ-
ual tape.
3.3. Validity of the porcine ear model
Different in vitro models exist to mimic human skin penetration
in vivo. The beneﬁts of ex vivo investigations are manifold: ethical
approval is not required, multiple replicate experiments are more
easily performed and toxic compounds can be evaluated [9].The
difference between in vivo and in vitro data using excised human
skin may become very small if working protocols are harmonised
[40]. However, in vitro studies using excised human skin usually
rely on material obtained from the abdomen after liposuction,
while in vivo studies are conducted on the human forearm. Thus,
the obtained data will exhibit certain differences, especially if the
skin has been subjected to heat-separation [40]. Therefore, porcine
ear skin may be equally if not more suitable as an in vitro model,
delivering good correlations [41]. Pig skin shares essential perme-
ation characteristics with human skin, especially for lipophilic
components [18]. The physiological conditions of porcine ear skin
can be kept almost constant since the porcine ear skin remains
on the ear cartilage, the skin barrier is not interrupted, dehydration
is decelerated and no contraction occurs [1]. The accuracy of the
data depends on the use of proper methodology that has to be
standardised and optimised for each in vitro set-up [41]. Previous
studies have shown that porcine ear skin is a suitable substitute for
human skin when performing in vitro experiments [2,9,42].
In the present study, comparable tendencies were observed
after in vivo and in vitro tape stripping, which conﬁrms that the
porcine ear model is suitable for conducting comparative studies
to evaluate skin penetration of different vehicles. Fig. 4 shows
the respective penetration proﬁles of the curcumin-loaded micro-
emulsion in vivo and in vitro. Both penetration depth in regard
to the entire horny layer thickness and the recovered drug
amounts were highly comparable. As can be seen from the proﬁles,
very similar amounts of corneocytes were removed with every
tape during the tape stripping process from the human forearm
skin in vivo (Fig. 4A). As a consequence of this very constant re-
moval process, the drug amounts on the individual tapes were
equally homogeneously distributed, as can be derived from the
very homogeneous thickness of the individual bars in Fig. 4A. In
contrast, the corneocytes of the porcine skin surface appeared to
be less densely packed. As can be seen in Fig. 4B, large amounts
of corneocytes and, consequently, adherent penetrated drug were
removed with the ﬁrst adhesive ﬁlms. The number of removed cor-
neocytes and drug per tape decreased constantly with increasing
tape number, which might be ascribed to the increasing corneocyte
adhesion in the deeper cell layers and an increasingly homoge-
neous skin structure. Indeed, this more irregular surface structure
of the porcine skin with loose cell clusters and canyons has already
been reported [7] and is well reﬂected in the presented results.
Despite these general differences regarding corneocyte removal,
the overall trends regarding skin penetration were remarkably
comparable for in vitro and in vivo experiments (Fig. 5), especially
in the case of the microemulsions both with ﬂuorescein sodium
and curcumin. A certain level of variability in individual skin pen-
etration depths was observed both in vivo and in vitro, which
should however be acceptable for practical application [9,43].
Determination of six individual samples is generally sufﬁcient to
Table 4
In vivo skin penetration data for the different investigated formulations after
application of 2 mg/cm2 on human volar forearm skin for 30 min. Six experiments
were performed for each formulation (n = 6), values are given as means ± SD.
Formulation Penetrated drug
amount (lg/cm2)
Penetration
depth (lm)
Penetration depth
(% of SC)
ME curc 6.45 ± 2.28 3.08 ± 1.13 28.00 ± 10.27
GE curc 8.68 ± 1.08 2.70 ± 0.68 24.55 ± 06.18
E curc 7.03 ± 1.17 2.52 ± 0.47 22.91 ± 04.27
NE curc 6.60 ± 1.50 2.36 ± 0.62 21.45 ± 05.64
ME ﬂuor 12.89 ± 2.81 5.61 ± 1.35 51.00 ± 12.27
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obtain representative tendencies [2]. Regarding the penetrated
drug amounts, the respective values obtained with the curcumin-
loaded microemulsion and hydrogel were highly comparable for
the in vitro and in vivo studies (P > 0.05, respectively). This con-
ﬁrms that the delivered drug load is primarily dependent on pas-
sive diffusion, which appears to be in the same order of
magnitude for porcine and human skin at the chosen experiment
times. Merely, in case of the ﬂuorescein-loaded microemulsion, a
slight if statistically signiﬁcant difference was found between the
permeated drug amounts in vitro and in vivo (P < 0.05). The higher
penetrated drug amount in vivo might be related to the physiolog-
ical skin hydration, which is continually decreasing in the excised
porcine ear tissue and inﬂuences the penetration of hydrophilic
drugs more than lipophilic ones [17].
When regarding the numerical values represented in Fig. 5 and
detailed in Tables 2 and 4, the microemulsion with ﬂuorescein so-
dium penetrated the SC in vitro to an extent of 46.59 ± 10.73%,
while the in vivo penetration reached values of 51.00 ± 12.27%.
Thus, the in vitro penetration achieved 91.34% of the actual
in vivo values. In case of the microemulsion with curcumin, the
in vitro values represented 98.43% of the actual in vivo penetration.
In case of the hydrogel, a slight underestimation was reached
in vitro with 62.60% of the penetration depth in vivo. Such an
underestimation may be observed in vitro with porcine ear skin
especially if the follicular pathway of penetration is involved,
which is impaired in vitro due to the lack of physiological move-
ment that may favour penetration via this route [42]. Dehydration
of the tissue may play an additional role. The macroemulsion and
the nanoemulsion, which were evaluated for in vivo application,
achieved only slightly lower penetration depths than the other
formulations.
Overall, the good in vivo/in vitro correlation obtained for the
microemulsions and the hydrogel suggests that in vitro tape
stripping experiments may be sufﬁciently representative to re-
place in vivo tape stripping for further studies with these
formulations.
3.4. Skin penetration of macroemulsion vs. nanoemulsion in vivo
Colloidal systems stabilised by carbohydrate-based surfactants
possess great potential for dermal drug delivery [44,45]. Recently,
both macroemulsions and nanoemulsions stabilised by sucrose
stearate were developed [11]. Interestingly, their in vitro skin pen-
etration behaviour was highly comparable despite the signiﬁcant
differences in particle size and viscosity. Since the outcome of
in vitro studies may be inﬂuenced by the experimental set-up,
we decided to conﬁrm the obtained results by tape stripping
experiments conducted in vivo. Overall, few reports deal with the
actual skin penetration potential of submicron-sized emulsions
in vivo and no such data exist for the novel semi-solid and liquid
formulations based on sucrose stearate.
The presented in vivo results conﬁrmed the tendencies ob-
served in vitro [11], namely identical skin penetration potential
of both systems (P > 0.05, Fig. 5). This is in contrast to numerous re-
ports on the superior skin penetration of nanosized colloidal sys-
tems [46–48]. Possibly, the large droplets of the macroemulsion
exhibit a larger contact area that fosters penetration of drugs into
the skin [15]. This aspect might make up for the comparatively
smaller droplet surface area of the macroemulsion in comparison
with the nanoemulsion, which is usually held accountable for im-
proved skin penetration of nanosized vehicles. Surprisingly, both
systems achieved skin penetration rates that were comparable to
those of the microemulsion and the hydrogel (P > 0.05) although
the latter formulations contain large amounts of surfactants and
solvents. It may thus be assumed that these emulsions represent
a skin-friendly alternative to the classic vehicles.
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Fig. 4. Skin penetration proﬁles of curcumin from a microemulsion: comparison of
data obtained on human forearm skin in vivo (A) and porcine skin in vitro (B). The
depicted values are means of six individual experiments (n = 6, respectively). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
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Fig. 5. Comparison of in vivo and in vitro skin penetration of the model drugs
ﬂuorescein sodium (F) and curcumin (C) from different formulations. The penetra-
tion depth of ﬂuorescein sodium from the microemulsion is given on the left (ME-
F), followed by the corresponding penetration data for curcumin from the
microemulsion (ME-C), the hydrogel (GE-C), the macroemulsion (E-C) and the
nanoemulsion (NE-C). The given values, respectively, represent the means ± SD of 6
individual experiments for both in vitro and in vivo studies.
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4. Conclusion
The presented data conﬁrm that porcine ear skin is a highly
suitable model for in vitro tape stripping. The penetration proﬁles
of curcumin and ﬂuorescein sodium obtained after a ﬁnite-dose
application of different vehicles were in excellent agreement with
the corresponding in vivo data. The results can be regarded as a
complementary validation of the different NIR-densitometric cali-
bration data for the quantiﬁcation of human and porcine SC pro-
teins. Moreover, it was conﬁrmed that the skin penetration
potential of recently developed semi-solid sucrose stearate-based
macroemulsions is comparable to that of ﬂuid nanoemulsions of
identical composition despite signiﬁcant differences in particle size
and viscosity.
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a  b  s  t  r  a  c  t
Numerous  reports  on  the enhancement  effect  of cyclodextrins  (CDs)  on  the  skin  permeation  of dermally
applied drugs  exist,  the  majority  of  which  is  based  on in  vitro  diffusion  cell  studies.  The  speciﬁc  experi-
mental  setup  of  such  studies  may  skew  the  obtained  results,  which  is rarely  discussed  in  the  context  of  CD
studies.  Thus,  the  aim  of  this  work  was  to conduct  a systematic  in  vitro investigation  of  the  permeation
enhancement  potential  of  -CD on  a steroidal  drug  from  a nanoemulsion.  The  role  of  critical  diffusion  cell
parameters  such  as the  dose  of  application,  occlusive  conditions,  the  nature  of the  receptor  medium  and
the  skin  thickness  were  investigated.  The  results  showed  that  signiﬁcantly  enhanced  skin  permeation
rates  of  ﬂudrocortisone  acetate  were  indeed  caused  by 1% (w/w)  of -CD  at both  ﬁnite  and  inﬁnite  dose
conditions.  At 0.5%  (w/w)  of  -CD, signiﬁcant  enhancement  was  only  achieved  at  inﬁnite  dose  application.
Additional  in  vitro  tape  stripping  experiments  conﬁrmed  these  tendencies,  but  the  observed  effects  did
not  reach  statistical  signiﬁcance.  It may  be concluded  that  the full  permeation  enhancement  potential  of
the CD  as observed  in  the  franz-cell  setup  can  only  be  realised  at  inﬁnite  dose  conditions  while  preserving
the formulation  structure.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Cyclodextrins (CDs) are commonly used pharmaceutical excip-
ients which are well known for their ability to complex lipophilic
compounds. Both the natural cyclic oligosaccharides -, - and
-CD as well as their derivatives can be employed for the solu-
bilisation or stabilisation of drugs. In dermal drug delivery, CDs are
highly useful for the stabilisation of sensitive compounds which
are prone to chemical degradation (Lopez et al., 2000; Scalia et al.,
2007). In addition, they may  serve to stabilise formulations them-
selves or to inﬂuence the skin penetration of active substances by
either promoting or decreasing drug penetration (Klang et al., 2010;
Loftsson et al., 1991; Montassier et al., 1998; Rajewski and Stella,
1996; Trichard et al., 2007). This effect depends on the afﬁnity of
the respective drug to the lipophilic cavity of the employed CD and
its solubility within the vehicle. Since CDs can interact with vari-
ous lipophilic molecule structures, their use in topical formulations
has to be carefully evaluated for each new product. Such prelimi-
nary investigations frequently consist of in vitro skin permeation
experiments using diffusion chambers and excised human skin or
Abbreviations: CD, cyclodextrin; DLS, dynamic light scattering; PDI, polydisper-
sity index; ZP, zeta potential; BSA, bovine serum albumin; PEG 400, polyethylene
glycol 400; TEWL, transepidermal water loss.
∗ Corresponding author. Tel.: +43 1 4277 55 410; fax: +43 1 4277 9554.
E-mail address: Claudia.valenta@univie.ac.at (C. Valenta).
suitable substitutes. Numerous reports dealing with the effect of
incorporated CDs on the skin permeation of model drugs from dif-
ferent formulations can be found in the literature (Loftsson and
Olafsson, 1998; Loftsson and Masson, 2001; Loftsson and Bodor,
2006; Matsuda and Arima, 1999). However, the effect of the exper-
imental setup on the outcome of skin permeation studies involving
CDs has not been discussed or systematically investigated so far.
Important parameters in this context are the amount of applied
dose, the nature of the receptor medium and the effect of occlusion
conditions. Since CDs may  contribute to enhanced skin permeation
rates of lipophilic drugs by simply increasing their solubility in the
donor medium, such an effect might be severely overestimated dur-
ing in vitro diffusion cell studies where an inﬁnite dose of sample
is provided in the donor chamber. Under such conditions, the CD
might indeed facilitate the diffusion of the drug within the surplus
formulation and lead to an increased concentration of drug at the
skin surface which is available for permeation. However, such an
effect might not be reached under in vivo conditions where a ﬁnite
dose of a semi-solid sample is rubbed into the skin.
Therefore, the aim of this work was  to systematically investigate
the permeation enhancement effect of -CD on a steroidal model
drug and to elucidate the inﬂuence of different in vitro setups on
the results. To this end, skin permeation experiments were con-
ducted using established nanoemulsion formulations containing
the lipophilic drug ﬂudrocortisone acetate (Klang et al., 2011a). For
these ﬂuid submicron-sized O/W emulsions, remarkably enhanced
skin permeation rates of steroidal drugs had been observed after
0378-5173/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.ijpharm.2011.11.037
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incorporation of -CD using franz-type diffusion cells (Klang et al.,
2010, 2011a).  The validity of these results should be tested in
comprehensive in vitro skin permeation studies to address the
questions discussed above. It should be clariﬁed whether the
observed enhancement effect could be reproduced under differ-
ent experimental setups. To this end, extensive franz-type diffusion
cell studies using porcine abdominal skin were performed with
corresponding formulations containing ﬂudrocortisone acetate and
different amounts of -CD. The comparison of these different for-
mulations containing 0, 0.5 or 1% (w/w) of -CD served to elucidate
the importance of the amount of incorporated -CD for the perme-
ation enhancement effect. Experimental diffusion cell parameters
such as the dose of application, occlusion conditions, pre-treatment
of the skin, skin thickness and the nature of the receptor medium
were systematically modiﬁed and optimised for the envisioned
studies.
In addition, comparative tape stripping experiments were per-
formed to provide a different in vitro setup using a ﬁnite dose
application while avoiding the maceration effects of a receptor
ﬂuid. Thus, a more realistic estimation of the actual enhancement
potential of CDs in topically applied formulations should be gained
and the observed trends were compared to those of the diffusion
cell experiments.
2. Materials and methods
2.1. Materials
Egg lecithin Lipoid E-80 was kindly donated by Lipoid GmbH
(Ludwigshafen, Germany). PCL-liquid (cetearyl ethylhexanoate,
isopropyl myristate) was purchased from Dr. Temt Laborato-
ries (Vienna, Austria). Potassium sorbate was obtained from
Herba Chemosan Apotheker-AG (Vienna, Austria). Fludrocorti-
sone acetate (CAS: 514-36-3) and bovine serum albumin (CAS:
9048-46-8) were purchased from Sigma Aldrich (St. Louis, USA).
Polyethylene glycol 400 (CAS: 25322-68-3) was obtained from
Gatt-Koller GmbH, Absam, Austria. Cyclodextrin  (Cavamax®
W8  Pharma) was obtained from Wacker Chemie AG (Munich,
Germany). All further chemicals used were of analytical reagent
grade and used without further puriﬁcation. Standard Corneoﬁx®
adhesive ﬁlms with a square area of 4.0 cm2 were obtained from
Courage + Khazaka GmbH (Cologne, Germany).
2.2. Formulations
The model nanoemulsions were prepared as previously
described (Klang et al., 2011a).  Brieﬂy, the aqueous phase, con-
sisting of freshly distilled water and potassium sorbate, was
stirred at 50 ◦C. Lecithin E-80 was dissolved in PCL-liquid and the
lipophilic drug ﬂudrocortisone acetate was incorporated into the
resulting oil phase. Additional -CD was dissolved in the aque-
ous phase. The two phases were mixed and pre-homogenised
with an ultra-turrax (Omni 500, 4 min, 2500 rpm). Afterwards, the
mixture was stirred and heated to 50 ◦C before further homogeni-
sation with a high-pressure homogeniser (EmulsiFlex C3, Avestin)
for 20 homogenisation cycles at 750 bars. The composition of the
resulting formulations and the corresponding abbreviations are
given in Table 1.
2.3. Emulsion characterisation
2.3.1. Particle size, polydispersity index and particle surface
charge
The systems were analysed for their particle size and particle
size distribution by dynamic light scattering (DLS, photon correla-
tion spectroscopy) using a Zetasizer Nano ZS (Malvern, UK) at 25 ◦C.
Table 1
Composition of the model nanoemulsion NE with ﬂudrocortisone acetate. For the
additional nanoemulsions -0.5% NE and -1% NE, additional -CD was incorporated
at  either 0.5 or 1.0% (w/w). Abbreviations of the three formulations are detailed
below.
Excipients Composition (%, w/w)
PCL liquid 20.0
Lecithin E-80 2.5
Potassium sorbate 0.1
Fludrocortison acetate 1.0
Distilled water ad 100
Abbreviations: NE = basic nanoemulsion without additional -CD; -0.5%
NE  = nanoemulsion with 0.5% (w/w) of -CD; -1% NE = nanoemulsion with
1%  (w/w) of -CD.
Samples were diluted with freshly distilled water 1:100 (v/v) to
diminish opalescence. The measured parameters were the hydro-
dynamic diameter expressed as z-average value, i.e. the intensity
weighted mean diameter of the bulk population of oil droplets, as
well as the polydispersity index (PDI). The latter represents the
particle size distribution within the formulations; values below
0.2 indicate a narrow size distribution and thus good long-term
stability (Mueller, 1996a). All samples were analysed in triplicate
(n = 3) and each individual result was  automatically calculated as
the average of 3 measurements with 20 sub-measurements each.
In addition, the particle surface charge or zeta potential (ZP) of
the nanoemulsions was determined by laser Doppler electrophore-
sis, again using the Zetasizer Nano ZS (Malvern, UK) at 25 ◦C. The
samples were diluted with distilled water (1:100 v/v) contain-
ing sodium chloride (0.01 mmol) to ensure constant conductivity
below 0.05 mS/cm and thus reproducible measurement conditions
(Klang et al., 2011a).  The ZP was determined in triplicate for all
nanoemulsions (n = 3); again each individual result was  calculated
as the average of 3 measurements with 20 sub-runs each. Over-
all, the obtained data should ensure the use of representative and
intact formulations for all further studies.
2.3.2. Drug content and pH
The drug content of all nanoemulsions was  analysed immedi-
ately after preparation to ensure appropriate drug incorporation.
Brieﬂy, 10 mg  of each system were dissolved in 1 ml of methanol,
centrifuged for 6 min  at 12,000 rpm (Hermle Z323K, MIDSCI, USA)
and analysed by HPLC. Samples were taken at least in triplicate
(n ≥ 3). In addition, the pH of the formulations was determined
using a pH meter (Orion 420A, Bartelt, Austria) at ambient tem-
perature (25 ◦C, n = 3).
2.4. Preparation of porcine abdominal skin and porcine ear skin
For the diffusion cell studies, porcine abdominal skin was
freed from hair and dermatomed (GB 228R, Aesculap, Germany)
to a thickness of 1.2 mm.  Since full-thickness skin represents an
unphysiologically strong barrier for the diffusion of lipophilic drugs
(Bosman et al., 1998; Lehman et al., 2011), additional experi-
ments were performed using porcine abdominal skin that was
dermatomed to a thickness of 0.5 mm.  The dermatomed skin was
stored in aluminium foil and polyethylene bags at −20 ◦C and was
thawed prior to the experiments. Under such conditions the skin
is stable in regard to SC properties for diffusion studies for up to 6
months (Leveque et al., 2004; Wagner et al., 2000).
2.5. Solubility of the model drug and choice of the receptor
medium
The investigated receptor media were pure aqueous phosphate
buffer (Pharmacopoea Europea, pH 7.4, 0.012 M) as well as buffer
114 CHAPTER 3. PUBLICATIONS
Please cite this article in press as: Klang, V., et al., Effect of -cyclodextrin on the in vitro skin permeation of a steroidal drug from nanoemulsions:
Impact of experimental setup. Int J Pharmaceut (2011), doi:10.1016/j.ijpharm.2011.11.037
ARTICLE IN PRESSG ModelIJP-12264; No. of Pages 8
V. Klang et al. / International Journal of Pharmaceutics xxx (2011) xxx– xxx 3
containing 1.4% or 5% (w/v) of bovine serum albumin (BSA) or 20%
(v/v) of either propylene glycol, polyethylene glycol 400 (PEG 400)
or ethanol.
The saturation solubility of the ﬂudrocortisone acetate in the
designated receptor ﬂuids was determined by HPLC analysis. To this
end, an excess of ﬂudrocortisone acetate was dissolved in 1 ml  of
the respective medium at 25 ◦C. The dispersion was then shaken for
24 h at room temperature, centrifuged to separate undissolved drug
and was ﬁltered (Minisart RC4 0.45 m,  Sartorius stedim Biotech
GmbH, Göttingen, Germany) and analysed by HPLC. At least 4 indi-
vidual experiments were performed for each medium (n ≥ 4).
2.6. Skin permeation experiments using franz-type diffusion cells
In vitro skin permeation studies were performed using Franz-
type diffusion cells (Permegear, USA) (Franz, 1975). Porcine
abdominal skin was chosen as model membrane because of its
similarity to human skin regarding morphology and permeabil-
ity (Michniak-Kohn et al., 2005). Appropriately cut skin pieces
were clamped between the donor and the receptor chamber of the
diffusion cells having a permeation area of 0.95 cm2. The recep-
tor compartment was ﬁlled with 2 ml  of the respective receptor
medium. Pure phosphate buffer (pH 7.4, 0.012 M)  was  employed as
standard receptor medium. Comparative studies were performed
with buffer media containing 1.4% (w/v) of BSA or 20% (v/v) of
either propylene glycol, PEG 400 or ethanol to evaluate the ben-
eﬁt of an adapted receptor medium. The diffusion cells were kept
at the average skin surface temperature of 32 ± 0.5 ◦C and were
continuously stirred with magnetic bars for 24 h. The accurately
weighted formulation was placed on the excised skin in the donor
chamber. Samples of 200 l were removed at deﬁned time inter-
vals for HPLC analysis and were replaced by fresh receptor medium.
Permeation proﬁles of ﬂudrocortisone acetate were constructed by
plotting the time (hours) against the cumulative amount of the drug
(g/cm2) as determined in the receptor solution. The steady state
ﬂux (J, g cm-2 h-1) was calculated by linear regression after the
respective lag-times.
Different sets of experiments were performed. The inﬂuence
of the amount of applied formulation was tested. To this end,
respectively 5, 50 and 500 mg/cm2 of each nanoemulsion, corre-
sponding to a ﬁnite, semi-inﬁnite and inﬁnite dose application
(Henning et al., 2009), were applied onto the skin (n ≥ 8, respec-
tively). Information about the inﬂuence of the incorporated -CD
at the different amounts of formulation could likewise be obtained
in these experiments. Additional experiments served to investigate
whether pre-treatment with the CD would affect the skin perme-
ation of the drug from the applied standard nanoemulsion as well.
To this end, the skin was pre-macerated within the franz-cell setup
using 50 l of either 1% (w/w) aqueous buffer solution of -CD,
pure aqueous buffer solution or no additional solute for 16 h. These
experiments were carried at all three amounts of applied formula-
tion.
During all experiments, the donor compartment as well as the
sampling arm was occluded to prevent evaporation. For selected
comparative studies, additional non-occluded conditions with an
open donor compartment were employed.
Further experiments to optimise the setup for the standard
nanoemulsion involved variation of the model skin thickness as
well as the nature of the receptor medium. These experiments
served to identify the most suitable working protocol for general
studies of nanoemulsions containing highly lipophilic drugs.
2.7. Skin penetration experiments via in vitro tape stripping
In vitro tape stripping was conducted to elucidate whether the
enhancement effect of CD incorporation would be reproducible
under a different experimental setup. Thus, the penetration
behaviour of ﬂudrocortisone acetate into the stratum corneum of
porcine ear skin was investigated. Penetration proﬁles were con-
structed from the results of at least eight individual tape stripping
experiments for each formulation (n ≥ 8). Fresh porcine ears were
kindly donated by the Clinic for Swine, University of Veterinary
Medicine, Vienna. The ears were stored at −20 ◦C, thawed prior
to the experiments, cleaned with cold water and blotted dry. The
skin was freed from hair with scissors and the skin barrier func-
tion of representative areas was  conﬁrmed by determination of the
transepidermal water loss (TEWL) using the closed-chamber device
AquaFlux® (Biox Ltd., London, UK) (Klang et al., 2011b).  The formu-
lations were then applied to a marked area at a concentration of
6 mg/cm2 with a saturated vinyl glove ﬁnger for 30 s.
After 1 h of penetration time, Corneoﬁx® tapes were employed
to remove the superﬁcial stratum corneum layers of the porcine ear
skin (Klang et al., 2011b,c). The outline of the ﬁrst adhesive ﬁlm was
indicated with a permanent marker. Pressure was applied for 3 s
with a rolling movement of the vinyl glove-covered thumb at a con-
stant pressure of 49 N (5 kg). The tape was  subsequently removed
in a single rapid movement. This procedure was repeated with 25
tapes per experiment. The amount of adherent corneocytes was
determined using the infrared densitometer SquameScanTM 850A
(Heiland electronic GmbH, Wetzlar, Germany) (Voegeli et al., 2007).
The optical pseudo-absorption of the adhesive ﬁlms at 850 nm (A,
in %) was  employed to quantify the amount of stratum corneum
proteins by employing the equation m = A/0.41 (g/cm2) (Klang
et al., 2011b).  The mean cumulative amount of the stratum corneum
proteins removed with the tapes was employed to establish the
penetration depth of ﬂudrocortisone acetate in relation to the
complete horny layer thickness. The latter was  determined by con-
tinuous stripping of the complete stratum corneum in four of the
experiments (n = 4) until the detection limit of the IR-densitometer
was reached.
2.8. HPLC analysis
The samples were analysed for their drug content by HPLC
(Series ISS-200, Perkin Elmer, USA), consisting of an auto sampler,
a lc pump and an UV-diode array detector (235 C) using a Nucle-
osil 100-5 C18 column (250 mm × 4 mm,  Macherey-Nagel, USA)
plus pre-column (CC8/4, 40 mm × 4 mm).  The oven temperature
was set at 50 ◦C and the injection volume was 20 l for all sam-
ples. Data analysis was  performed using the TotalChrom Navigator
6.2.0 software. The quantiﬁcation of ﬂudrocortisone acetate was
performed as previously reported (Klang et al., 2011a)  at a detec-
tion wavelength of 240 nm using acetonitrile/water (40/60, v/v) as
the mobile phase. The retention time was around 11 min  at a ﬂow
rate of 0.8 ml/min. Standard solutions of ﬂudrocortisone acetate in
methanol were prepared and a calibration curve was  calculated
by plotting the analysed drug concentrations against the obtained
peak area values. The concentration range of the standard solutions
was between 0.018 g/ml and 35.88 g/ml with a coefﬁcient of
determination of R2 = 1. However, the limit of reasonable quantiﬁ-
cation was set at 0.06 g/ml since values below this concentration
showed limited reproducibility.
2.9. Statistical data analysis
All results are expressed as means of at least three experi-
ments ± SD. Statistical data analyses were performed using the
GraphPadPrism3 program. Student’s t-test or ANOVA with P < 0.05
as respective minimum level of signiﬁcance were employed for
the analysis of parametric data. Non-parametric data were ana-
lysed using the Mann–Whitney test or the Kruskal–Wallis-test with
P < 0.05 as minimum level of signiﬁcance, respectively. For the
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Table 2
Physicochemical properties of nanoemulsions with ﬂudrocortisone acetate (1%, w/w).  All given values are means of at least three experiments ± SD (n ≥ 3). The parameters
shown in Table 2a are the mean hydrodynamic diameter or mean droplet size in nm,  the PDI, the ZP values in mV  as well as the conductivity of the diluted samples. The
parameters given in Table 2b are the mean drug content in % of the originally incorporated drug amount as well as the pH of the investigated formulations.
(2a)
Formulation Size (d, nm) PDI ZP (mV) Cond (mS/cm)
NE 178.40 ± 0.66 0.040 ± 0.029 −31.27 ± 1.55 0.024 ± 0.006
-0.5%  NE 171.03 ± 0.32 0.098 ± 0.042 −33.17 ± 0.75 0.021 ± 0.001
-1%  NE 169.73 ± 2.35 0.033 ± 0.049 −31.73 ± 1.52 0.019 ± 0.001
(2b)
Formulation Drug content (%) pH
NE 96.17 ± 05.64 6.84 ± 0.02
-0.5% NE 91.93 ± 01.73 6.74 ± 0.01
-1%  NE 93.13 ± 02.11 6.78 ± 0.02
diffusion cell studies, both cumulative amounts permeated and
drug ﬂuxes were statistically evaluated in parallel. The results were
consistent in all cases.
3. Results and discussion
3.1. Nanoemulsion characterisation
The physicochemical properties of the produced nanoemul-
sions are given in Table 2. The mean hydrodynamic diameter of
the droplets showed only a slight change upon incorporation of
the CD (Table 2a). The PDI values after CD incorporation showed
slightly increased standard deviations, but largely unaltered abso-
lute values below 0.1, which represents a narrow droplet size
distribution (Mueller and Schuhmann, 1996b). The ZP values, which
characterise the surface charge of the emulsion droplets in solu-
tion, ranged slightly above −30 mV for all formulations, which
indicates sufﬁcient electrochemical stability. The low conductivity
conﬁrmed the validity of the ZP measurements (Mueller, 1996a).
Overall, these results are in good agreement with previous studies
(Klang et al., 2011a)  and the produced formulations were therefore
employed for the subsequent experiments on porcine skin.
As shown in Table 2b, both the mean drug content and the pH
values of all formulations were in a satisfying range and conﬁrmed
the representative nature of the formulations for the envisioned
studies.
3.2. In vitro skin permeation: franz-type diffusion cells
A standard nanoemulsion containing a steroidal model drug was
chosen for comprehensive diffusion cell studies in order to sys-
tematically identify the most suitable experimental setup to obtain
reliable permeation data for this and similar systems. In addition,
these basic data served as a basis for comparison with formulations
containing additional -CD.
3.2.1. Effect of the applied dose: ﬁnite vs. inﬁnite dose
The effect of the applied dose on the skin permeation of ﬂudro-
cortisone acetate into the aqueous buffer solution was investigated.
In context of this ﬁnite/inﬁnite dose comparison, two additional
formulations with different amounts of -CD were evaluated in
the same manner. The results of these experiments are given in
Table 3. Quite expectedly, the skin permeation of ﬂudrocortisone
acetate from the standard nanoemulsion could be ranked in the
order 5 mg/cm2 < 50 mg/cm2 < 500 mg/cm2. Both the cumulative
drug amount after 24 h and the mean drug ﬂux were roughly ten-
fold increased for the semi-inﬁnite and inﬁnite dose conditions
(P < 0.05, respectively). No signiﬁcant difference, however, was
observed between the 50 and 500 mg/cm2 application (P > 0.05).
This suggests that inﬁnite dose conditions were already reached at
50 mg/cm2 although different reports exist (Lehman et al., 2011).
The ten-fold increase in applied dose from 5 to 50 mg/cm2 was
nicely reﬂected in the respective permeated drug amounts and
ﬂuxes. Comparatively large standard deviations were observed in
all experiments since the overall permeated drug amounts were
very low and biological material was  involved as a model mem-
brane.
In case of both systems containing additional -CD, the ten-fold
increase in applied dose from 5 to 50 and from 50 to 500 mg/cm2
was clearly reﬂected in the permeated drug amounts and ﬂuxes
(P < 0.05, respectively). Apparently, the addition of the CD magni-
ﬁed the increase in permeation with the increasing doses.
The enhancement effects caused by the incorporated -CD were
clearly related to the amount of CD as well as the experimental
setup. When comparing the formulation containing 0.5% (w/w)
of -CD to the standard nanoemulsion, the permeation behaviour
was quite similar at applied doses of 5 and 50 mg/cm2 (P > 0.05,
respectively). A signiﬁcant enhancement effect was only observed
at inﬁnite dose conditions (500 mg/cm2, P < 0.05). In case of 1.0%
(w/w) of -CD, a signiﬁcant enhancement effect was observed at all
applied doses of 5, 50 and 500 mg/cm2 when compared to the stan-
dard nanoemulsion (P < 0.05, respectively). This indicates that an
enhancement effect can be achieved at both ﬁnite and inﬁnite dose
conditions if the amount of incorporated CD within the formulation
is sufﬁciently high.
To exclude any direct effect of the CD on the skin, additional
experiments were performed using the standard nanoemulsion.
The skin was pre-impregnated within the franz-cell setup with
50 l of either pure aqueous buffer, buffer containing 1% (w/w)  of
Table 3
Skin permeation data of ﬂudrocortisone acetate from standard nanoemulsions (NE)
and corresponding formulations with 0.5% or 1.0% of additional -CD (-0.5% NE
and -1% NE). Given values are means ± SD of at least 8 experiments (n ≥ 8). Finite,
semi-inﬁnite and inﬁnite dose conditions were tested with applied amounts of 5,
50  or 500 mg/cm2 of formulation. For each setup, statistically signiﬁcant differences
with P < 0.05 against the standard nanoemulsion (NE) are marked with a ‘*’.
Formulation Applied
amount
(mg)
Cumulative amount
after 24 h ± SD
(g  cm-2)
Mean drug ﬂux ± SD
(J, g cm-2 h-1)
NE control 5 0.12 ± 0.11 0.008 ± 0.007
-0.5% NE 5 0.11 ± 0.09 0.005 ± 0.004
-1% NE 5 0.45 ± 0.23 * 0.067 ± 0.047 *
NE control 50 1.31 ± 1.11 0.08 ± 0.07
-0.5% NE 50 1.83 ± 0.63 0.08 ± 0.03
-1% NE 50 4.68 ± 2.44 * 0.90 ± 0.64 *
NE  control 500 1.36 ± 1.10 0.09 ± 0.07
-0.5% NE 500 12.99 ± 2.53 * 0.63 ± 0.11 *
-1%  NE 500 54.23 ± 15.65 * 2.48 ± 0.68 *
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dissolved -CD or no additional solute. The skin permeation of ﬂu-
drocortisone acetate in this setup was highly comparable to that
observed in the conventional studies with untreated model skin
(n ≥ 4, P > 0.05 at all applied doses, data not shown). It may  thus be
assumed that the CD does not have a direct effect on the skin bar-
rier function, which is in accordante with previous theories (Klang
et al., 2011a)  and studies where no permeation enhancement was
observed after pre-treatment of skin with CDs in vitro (Williams
et al., 1998). It likewise conﬁrms that maceration effects, which are
known to skew the results of diffusion cell studies after extended
experiment times of over 24 h, are mainly a problem when inves-
tigating hydrophilic drugs (Otberg et al., 2008).
In conclusion, the assumed mechanism behind the enhanced
permeation of ﬂudrocortisone acetate is not related to any direct
effects on skin, but most likely to solubility effects within the
vehicle. In literature, the most frequently suggested mechanism
of action relies on the better dispersion of the drug molecules
within the vehicle through complexation with the CD and thus
better solubilisation of the drug (Loftsson and Masson, 2001;
Loftsson et al., 2007). As a consequence, more drug is available
at the skin surface to enter the SC through diffusion. The CD
molecules themselves are too large to penetrate into the skin them-
selves. As previously discussed (Klang et al., 2011a), it remains
to be clariﬁed whether this mechanism can be held responsi-
ble for the observed strong effects if only small molar amounts
of CD are present within the vehicle. CDs may  also affect the
interfacial ﬁlms of the emulsion droplets (Klang et al., 2011a).
Thus, the modiﬁed emulsion structure could also contribute to the
altered drug release from the droplets. Since we  are dealing with
dynamic systems, a combination of both mechanisms is well pos-
sible.
In summary, the amount of applied dose was conﬁrmed to
be a crucial parameter in the diffusion cell studies of the ﬂuid
nanoemulsions. For experiments with semi-solid systems, ﬁnite
dose conditions are usually recommended although certain appli-
cations for inﬁnite doses exist as well (Gillet et al., 2011). For
theoretical evaluations, inﬁnite dose conditions offer the advan-
tage of standardised kinetic conditions as the inﬂuence of the
dose on skin permeation is minimised (Wagner et al., 2002).
Thus, the permeation of different drugs might be compared more
directly. In our case, we primarily beneﬁted from more accu-
rate drug quantiﬁcation by HPLC grace to the increased amounts
of drug detected in the receptor medium. Likewise, application
of the formulation onto the diffusion cells was facilitated due
to the larger amount of sample. Thus, errors due to inaccurate
weighing are minimised (Wagner et al., 2002). Since the per-
meation data obtained for the 50 mg/cm2 dose of the standard
nanoemulsion were a very accurate upscale from the ﬁnite dose
of 5 mg/cm2, the former dose was chosen for further studies with
this system to investigate the effects of other methodological
parameters.
3.2.2. Occluded vs. non-occluded conditions
For comparative reasons, additional studies were performed
using diffusion cells with non-occluded upper chambers. The
skin permeation of ﬂudrocortisone acetate from the standard
nanoemulsion was investigated at all three amounts of applied
dose (5, 50 and 500 mg/cm2, Fig. 1). Large standard deviations
were observed under non-occluded conditions at all amounts
of applied dose. At occluded conditions, this was  primarily the
case for ﬁnite dose application. Apart from this slight trend, no
statistically signiﬁcant differences were observed between the
experiments at occluded or non-occluded conditions regarding
cumulative amounts drug amounts or drug ﬂuxes at all amounts
of applied dose (P > 0.05, respectively).
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Fig. 1. Cumulative permeated amounts of ﬂudrocortisone acetate after 24 h from
standard nanoemulsions (NE) at occluded (black bars) or non-occluded condi-
tions (white bars). Finite (5 mg/cm2), semi-inﬁnite (50 mg/cm2) and inﬁnite dose
(500 mg/cm2) application of the formulation were employed. Given values are
means ± SD of at least 8 experiments (n ≥ 8).
3.2.3. Effect of the skin thickness
Since the thickness of the employed model skin plays a major
role in diffusion cell experiments, two differently dermatomed skin
samples of 1.2 or 0.5 mm thickness were employed for compar-
ative studies. Again, the experiments were performed using the
model nanoemulsion at all amounts of applied dose (5, 50 and
500 mg/cm2, Fig. 2). Quite expectedly, signiﬁcantly higher cumu-
lative drug amounts and drug ﬂuxes were observed at a skin
thickness of 0.5 mm  for all applied amounts of standard nanoemul-
sion (P < 0.05, respectively). The use of split-thickness or strongly
dermatomed skin is indeed recommended for absorption studies
of poorly water soluble drugs (Lehman et al., 2011). However, the
drug ﬂuxes for the thin skin samples were rather irregular and
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Fig. 2. Cumulative permeated amounts of ﬂudrocortisone acetate from standard
nanoemulsions (NE) after 24 h through porcine abdominal skin at a skin thickness of
either 1.2 mm (black bars) or 0.5 mm (white bars). Finite (5 mg/cm2), semi-inﬁnite
(50 mg/cm2) and inﬁnite dose (500 mg/cm2) application of the formulation were
employed. Given values are means ± SD of at least 5 experiments (n ≥ 5).
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Table 4
Solubility of ﬂudrocortisone acetate in different receptor media. All values were
determined at least in quadruplicate (n ≥ 4).
Receptor ﬂuid Drug solubility
(g/ml) ± SD
Phosphate buffer pH 7.4 15.04 ± 2.43
Phosphate buffer/BSA (1.4%, w/v) 34.69 ± 0.19
Phosphate buffer/BSA (5%, w/v) 63.91 ± 0.16
Phosphate buffer/propylene glycol (80/20, v/v) 57.81 ± 0.66
Phosphate buffer/PEG 400 (80/20, v/v) 72.34 ± 7.65
Phosphate buffer/ethanol (80/20, v/v) 105.09 ± 1.38
hardly showed a consistent increase over time. This might be due
to the fact that producing dermatomed skin samples of such small
thickness becomes increasingly difﬁcult and already small aberra-
tions in the skin may  lead to variable results. Thus, a compromise
regarding skin thickness should be found to produce adequately
homogeneous skin samples without creating an unphysiologically
strong barrier for lipophilic drugs.
3.2.4. Effect of the acceptor medium
The solubility data obtained for the different receptor media
are given in Table 4. As expected, the solubility of ﬂudrocortisone
acetate was markedly increased in the presence of the differ-
ent additives. The strongest increase in solubility was caused by
the presence of 20% (v/v) of ethanol, followed by the respective
amounts of PEG 400, propylene glycol and ﬁnally BSA at 1.4% (w/v).
The buffer containing 5% (w/v) of BSA was excluded from fur-
ther studies due to its high foaming tendency, which rendered this
medium impractical for the envisioned studies.
Pure phosphate buffer still represents the receptor ﬂuid of
choice if undesired interactions with constituents of the skin or
the employed formulation are to be avoided. This was  particu-
larly important in our case where the speciﬁc effect of the CD
should be investigated separately and undisturbed by any addi-
tional factors. Thus, the phosphate buffer was employed for all basic
studies. The different receptor media were compared in additional
studies using the standard nanoemulsion at 50 mg/cm2 applica-
tion (Table 5). In this setup, semi-inﬁnite dose application was
employed to emphasise potential differences in drug permeation.
A comparison of the different receptor media revealed that both
cumulative drug amounts and drug ﬂuxes were highly compara-
ble for the control buffer and the buffer media containing either
BSA, propylene glycol or PEG 400 (P > 0.05 in all cases). Merely in
case of the ethanol-containing buffer a signiﬁcantly increased drug
permeation was noticeable when compared to the control buffer
(P < 0.05). This indicates that in case of this steroidal model drug,
the increased solubility in the different receptor media caused by
BSA, propylene glycol or PEG 400 was apparently not sufﬁcient to
promote its skin permeation. Comparative studies employing an
application dose of 500 mg/cm2 revealed the same tendency, at the
same time conﬁrming that no signiﬁcant difference between the
two amounts of applied dose are to be expected irrespective of
Table 5
Skin permeation of ﬂudrocortisone acetate from standard nanoemulsions (NE) at
semi-inﬁnite dose conditions using 50 mg/cm2 of applied formulation and different
acceptor media. Given values are means ± SD of at least 8 experiments (n ≥ 8).
Investigated
receptor medium
Applied
dose (mg)
Cumulative amount
after 24 h ± SD
(g cm-2)
Mean drug
ﬂux ± SD (J,
g cm-2 h-1)
Buffer 50 0.80 ± 0.88 0.29 ± 0.21
Buffer with BSA 50 0.19 ± 0.13 0.17 ± 0.13
Buffer with PG 50 0.57 ± 0.62 0.20 ± 0.17
Bufffer with PEG 50 0.47 ± 0.48 0.21 ± 0.13
Buffer with EtOH 50 5.46 ± 3.43 2.09 ± 0.98
the employed receptor medium (n ≥ 5, P > 0.05 in all cases, data not
shown). The remarkably enhanced skin permeation in context with
ethanol that was observed for both 50 and 500 mg/cm2 application
is in accordance with the solubility data given in Table 4. It may
however be assumed that the impact of ethanol on the skin itself
may  have contributed to this pronounced effect.
As commonly known, current recommendations such as the
OECD guidelines rely on the use of isotonic buffer media for skin
permeation studies with franz-type diffusion cells. The receptor
ﬂuid should provide adequate solubility of the permeant so as not
to hinder its absorption, but at the same time be innocuous to the
skin (Gillet et al., 2011). In case of lipophilic drugs, the solubility
requirements are usually not met  by standard buffer media such
as phosphate buffered saline. Thus, additives which increase the
solubility of the permeant may  be incorporated in the receptor
medium, such as surfactants, propylene glycol, bovine serum albu-
min  or even ethanol. However, these additives may  affect the skin
samples and can alter the apparent skin diffusion rates of applied
substances (Gillet et al., 2011; Lehman et al., 2011). This is fre-
quently observed for both propylene glycol and ethanol, which may
act as permeation enhancers (Megrab et al., 1995a, b). They sup-
posedly act via increasing drug solubility in the stratum corneum,
but may  also directly affect stratum corneum components. How-
ever, solvent concentrations of over 60% may  lead to dehydration
of the skin, thus decreasing drug ﬂux. Likewise, a solvent gradi-
ent across the membrane may  inﬂuence the results due to osmotic
or solvent drag effects, i.e. the co-transport of water and solvent
through the membrane and back-diffusion effects (Megrab et al.,
1995a; Sznitowska, 1996). For these reasons, we  chose to limit the
amounts of additives in the receptor medium to 20% (v/v). If the rate
of absorption of a given compound is quite low even isotonic buffer
can serve as an adequate receptor for some compounds that are
otherwise considered water insoluble (Lehman et al., 2011). In con-
text with the presented experiments, this might explain why  the
aqueous buffer medium performed equally well when compared
to other media containing BSA, propylene glycol or PEG 400.
3.3. In vitro skin penetration: tape stripping
Additional skin penetration studies without the use of buffer
media were conducted to exclude any maceration or skin hydration
effects on the outcome. Since it is well-known that a strong inter-
individual variability in SC thickness exists (Dickel et al., 2010;
Jacobi et al., 2007; Kalia et al., 2000; Schwindt et al., 1998), at least
8 individual experiments were performed for each formulation
(n ≥ 8). The experiments served to determine the skin penetra-
tion potential of the standard nanoemulsion itself. Furthermore,
the effect of additionally incorporated -CD should be evaluated
in this in vitro setup as well. Fig. 3 shows the skin penetration
proﬁle (Lademann et al., 2009) of ﬂudrocortisone acetate from the
standard nanoemulsion. The penetration depth of the three for-
mulations was  in the order of -1% NE > -0.5% NE > NE (Fig. 4).
However, these differences did not reach statistical signiﬁcance
(P > 0.05 in all cases). In case of the nanoemulsion containing 1%
of -CD, up to 87% of the total SC thickness were reached; the lat-
ter was  found to be around 8.06 ± 1.22 m (n = 4) for the employed
porcine ears. The summarised penetrated drug amounts were in
the range of 20–30 g/cm2 in all cases.
In additional studies, corresponding formulations with a dif-
ferent oil phase consisting of the commonly used squalene were
produced and investigated in identical tape stripping experiments
with ﬂudrocortisone acetate (data not shown). Again, a slightly
deeper skin penetration of the formulations containing -CD was
observed. The differences did not reach statistical signiﬁcance in
this case, either, but the same trends were observed.
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Fig. 3. Skin penetration proﬁle of ﬂudrocortisone acetate from a standard nanoemulsion (NE). The depicted values are means of eight individual experiments (n = 8). The
distances between the horizontal lines correspond to the respective amounts of removed SC while the coloured areas represent the corresponding amounts of recovered
drug  on the respective tape strips. The upper line of the proﬁles corresponds to the skin surface, the lowest line to the boundary of living cells below the SC.
When comparing these ﬁndings to the results of the diffu-
sion cell experiments, it may  be assumed that the non-destructive
manner of formulation application in the franz-cell setup might
be associated with the permeation enhancement. In diffusion cell
setups, the formulation is not massaged into the skin as during tape
stripping and the emulsion structure remains intact. This preserva-
tion of the internal formulation structure might be the underlying
cause of the disproportionately strong permeation enhancement
effect through -CD especially at inﬁnite dose conditions. Thus,
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Fig. 4. Skin penetration depth observed after in vitro tape stripping with a stan-
dard nanoemulsion containing ﬂudrocortisone acetate (NE) as well as corresponding
nanoemulsions containing additional amounts of 0.5 or 1% of -CD. The presented
values are means ± SD of at least 8 individual experiments (n ≥ 8).
the discussed solubility effects or changes in formulation structure
caused by the incorporation of the CD may  take hold.
It may  be advisable to conduct additional tape stripping experi-
ments when investigating the permeation enhancement potential
of CDs in diffusion cell studies. With a conventional ﬁnite-dose
in vivo application, the strong enhancement potential of the CD as
observed in the franz-cell setup will not be realised to its full extent.
The development of inﬁnite-dose vehicles for in vivo application,
such as matrix patches, might serve to overcome this limitation.
3.4. Optimisation of the franz-cell technique for nanoemulsion
studies with steroidal drugs: conclusive remarks
Overall, we  found that the classical franz-cell method consist-
ing of using a skin thickness of 1.2 mm,  inﬁnite dose application
of the formulation and pure phosphate buffer as acceptor medium
led to the most reproducible results and is likewise the most prac-
tical working procedure in regard to skin preparation, sampling
accuracy and quantiﬁcation limits. In the case of formulations con-
taining CDs, additional in vitro methods such as tape stripping
experiments are recommended to detect potential overestimations
caused by the conditions of the franz-cell setup.
4. Conclusion
Remarkably strong permeation enhancement effects for the
steroidal model drug were obtained with the franz-cell setup at
sufﬁciently high amounts of -CD, especially at inﬁnite dose con-
ditions. These effects were obviously related to the peculiarities of
the experimental setup, where large amounts of formulation are
applied without massaging them into the skin. The potential of this
enhancement strategy cannot be realised to its full extent upon
mechanical application of a ﬁnite dose on skin, as was  shown in tape
stripping experiments in vitro. As a next step, in vivo experiments
would be of interest. Future research should focus on the devel-
opment of novel dermal delivery systems such as matrix patches
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enforced by CDs where inﬁnite dose application may  be employed
while maintaining the formulations’ original structure.
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Abstract
Background: Despite the frequent use of porcine ear skin for tape stripping experiments
the peculiarities of this skin type have not been characterised in detail yet. Thus, di erent
techniques were employed to investigate the skin surface structure of porcine ear skin and
the changes in barrier function during in vitro tape stripping. To this end, the potential of
capacitance-based skin hydration imaging as means of skin quality control was investigated
for the first time.
Methods: The porcine ear model was characterised before and during tape stripping by
TEWL measurements, capacitance-based sensor imaging, ATR-FTIR and optical light mi-
croscopy.
Results: The capacitance-based sensor was found to deliver precise information about the
quality of the employed skin sites before and during tape stripping. The removal of stratum
corneum proteins was highly reproducible even for di erent porcine ear types. The mean
greyscale values showed an excellent linear correlation to the corresponding TEWL values and
the respective penetration depth. Optical light microscopy confirmed the presence of canyons
on the surface of porcine ear skin.
Conclusion: The results suggest that the capacitance-based sensor is a suitable tool for skin
integrity testing of porcine ear skin in vitro and for monitoring changes in skin barrier function.
Keywords: stratum corneum, porcine ear skin, capacitance-based sensor imaging, tape strip-
ping, transepidermal water loss, skin surface structure, ATR-FTIR
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1 Introduction
The tape stripping procedure is a well-
established method to determine the skin pen-
etration behaviour of active substances. Adhe-
sive films are employed to remove the upper-
most corneocyte layers of the stratum corneum
(SC) and penetration profiles can be obtained
by analysing both the amount of drug and the
amount of proteins on the individual tapes (1,
2). This technique is most frequently employed
for in vivo experiments on human forearm skin
(3). In an approach to minimise such in vivo
experiments and the associated organisatorial
e ort, the porcine ear model is increasingly in-
vestigated as an in vitro model for tape strip-
ping experiments (4). Apart from a standard-
ised working procedure and reliable methods
of protein quantification, a constant high qual-
ity of the employed porcine ear skin is of vi-
tal importance for such in vitro experiments.
However, porcine ears may be of a variable na-
ture depending on the breed and upbringing
of the sacrificed animal. The most suitable
areas for tape stripping experiments, namely
the central part of the dorsal side of the ear
(5, 6), may be damaged due to tags or in-
juries (Figure 1). Small superficial lesions or
Figure 1: Fresh porcine ears. Care has to be taken to
avoid damaged skin areas (indicated by arrows) or regions
of excessive hair growth.
diseases of the skin may not be this obvious
to the naked eye and require additional tech-
niques for quality control of the employed skin.
An established method for this purpose is the
assessment of the transepidermal water loss
(TEWL), which is related to the skin barrier
function. Low TEWL values can be consid-
ered as a sign of an intact barrier. However,
this technique originates from in vivo applica-
tions and does not o er the exact same ap-
plicability in vitro. Since excised porcine ears
lack an active circulation, the tissue as well
as the skin will invariably dehydrate over the
course of an experiment. Thus, the obtained
TEWL values cannot be considered as abso-
lute values representing the in vivo situation
since they are entirely dependent on the state
of the ear. Although the TEWL in vitro can
be employed to monitor the defrosting process
and the hydration state of porcine ears within
a set of experiments with satisfying accuracy
(4, 7, 8), the discussed limitations represent
a source of error. Thus, we decided to in-
vestigate the suitability of further methods for
the quality assessment of porcine ear skin for
tape stripping experiments. Apart from sys-
tematic TEWL measurements, a microscopic
investigation of the tapes removed from the
skin surface was performed. In addition, the
properties of the skin surface structure were
characterised by capacitance-based measure-
ments with a specifically designed fingerprint
sensor. Capacitance-based sensor imaging al-
lows for recording capacitance images of the
skin surface and is a convenient tool to de-
scribe and quantify skin surface hydration (9).
Capacitive skin images also give a high res-
olution representation of skin topography, in
terms of wrinkles and cells. In dermatology
and cosmetics, skin topography characterisa-
tion is employed to identify lesions, evaluate
the e ect of topical formulations or evaluate
skin ageing (10). Interestingly, this technique
has not been employed for skin integrity test-
ing in context with tape stripping experiments
on either human or porcine skin. Therefore,
the aim of this work was to validate the tech-
nique of capacitance-based sensor imaging for
quality control of skin samples and monitor-
ing of the changes in skin barrier function dur-
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ing tape stripping. Comparative assessment of
TEWL values should reveal whether the two
techniques deliver comparable results and are
equally suitable for an initial control of porcine
ear skin and a subsequent in-process control
during in vitro tape stripping. The latter rep-
resents an important prerequisite to obtain re-
liable skin penetration data. Irregular pro-
tein removal may occur quite suddenly during
tape stripping if large skin patches loose co-
hesion (3). As a consequence, inaccurate skin
penetration profiles may be obtained if optical
methods of protein quantification are employed
(11). Therefore, such biased data should be
identified and excluded from further evalua-
tion. In addition, attenuated total reflection
fourier transform infrared spectroscopy (ATR-
FTIR) measurements were conducted to ob-
serve the changes in SC barrier function dur-
ing tape stripping on porcine ear skin. In re-
spect to the pig ear model, a further aim of
this work was to confirm previous observations
regarding the skin surface structure of human
and porcine skin by microscopic investigation
of removed tape strips. Although the struc-
ture of porcine ear skin is highly similar to
that of human skin, the superficial appearance
of porcine and human skin may di er consid-
erably, as was recently observed during NIR-
densitometric measurements for the quantifi-
cation of porcine stratum corneum proteins
during tape stripping (4). Since the di erent
protein coverage of the tape strips was only
demonstrated in photographs, we hereby pro-
vide microscopic images for a more precise vi-
sualisation of this phenomenon.
2 Materials and Methods
Materials and preparation of the
porcine ears
Standard D-Squame® adhesive tapes with a
diameter of 22 mm and an area of 3.8 cm2
were purchased from CuDerm Corp. (Dal-
las, TX, USA). Standard Corneofix® adhe-
sive films with a square area of 4.0 cm2 were
obtained from Courage + Khazaka GmbH
(Cologne, Germany). Tesa film crystal clear
tapes (product number 57859-00000) were ob-
tained from Tesa GmbH (Vienna, Austria).
Di erent types of pig ears were investigated.
In order to ensure logistic feasibility and re-
producibility of the experiments, all porcine
ears were stored at -24¶C and thawed prior to
the experiments. The porcine ear skin may
be variable in thickness and hair growth de-
pending on the pig’s age and breed. On the
one hand, ears of fattened full grown pigs from
a local farmer were tested immediately after
slaughtering (aged 6 to 10 months). It may be
assumed that most porcine ears employed in
studies are obtained from fattened pigs (12).
These large ears possessed thick, rough and dry
skin exhibiting dense coverage with long hair.
On the other hand, small porcine ears were ob-
tained from another pig breed from the Clinic
for Swine, University of Veterinary Medicine
Vienna. These ears could be obtained at much
younger age of the pigs (3 to 4 months) directly
after sacrifice. The skin of these small ears was
very soft and almost free of hair. Nevertheless,
pigs of more than 12 weeks of age are consid-
ered adult (13). After defrosting, the ears were
cleaned carefully with purified water and blot-
ted dry with soft tissue. The skin remained
at the cartilage at all times except in case of
the separate ATR-FTIR measurements. In ad-
dition, one set of non-invasive in vivo sensor
measurements was conducted on pigs aged 3
to 4 months at the Clinic for Swine, University
of Veterinary Medicine Vienna, in accordance
with the respective regulations.
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Characterisation of the porcine skin
surface in comparison to human fore-
arm skin in vivo
The skin surface properties of the model ears
were established using TEWL measurements,
capacitance-based sensor measurements and
optical light microscopy for analysis of individ-
ually removed tapes. For the latter task, both
Corneofix® and DSquame® tapes were tested.
The same techniques were applied to human
forearm skin of the experimenter for compari-
son.
In vitro tape stripping
Ten individual tape stripping experiments were
performed using Corneofix® tapes (n=10).
Two di erent types of porcine ears were em-
ployed for comparison (n=5, respectively).
The pig ear skin was carefully freed from hair
with scissors. After marking the outline of the
respective first adhesive film on the dorsal skin
surface, up to 120 tapes were removed from the
same area after pressure application with the
thumb as previously described (4). The tape
stripping procedure was stopped when the de-
tection limit of the NIR-densitometer for pro-
tein quantification was reached. Both assess-
ment of the TEWL, capacitance-based sensor
measurements and microscopic analyses of the
removed tapes were performed in regular inter-
vals during the tape stripping process.
Protein quantification by NIR-
densitometry
The amount of corneocytes removed with each
tape strip was analysed using the infrared
densitometer SquameScanTM 850A (Heiland
electronic GmbH, Wetzlar, Germany) (14).
Briefly, the optical pseudo-absorption of the
adhesive films at a wavelength of 850 nm was
determined against a blank reference tape. Us-
ing previously determined calibration data for
porcine skin (4), the mass of corneocytes on the
adhesive films can be calculated by employing
the equation m = A / 0.41 (in µg·cm-2). The
mean cumulative amount of removed SC pro-
teins was employed to calculate the removed
SC thickness assuming the mean protein den-
sity of the tissue to be around 1 g·cm-3 (7).
Correlation of the removed stratum
corneum amount with the number of
tape strips
The total values of absorbance at 850 nm of
all consecutively removed tape strips were ob-
tained by adding up the individual absorption
values of these tape strips as determined by
NIR-densitometric measurements. This sum
absorbance can be regarded as representative
for the thickness of the complete SC. There-
fore, this value can be set as a standard for
100% of the SC thickness. This relation can
be used to transform the relative amount of SC
that is removed with each tape strip into a per-
centage value as demonstrated for human SC
(15). Since human and porcine skin is not en-
tirely comparable, we hereby for the first time
established this correlation for in vitro tape
stripping using porcine ear skin.
The addition of individual absorbances to
obtain a sum absorbance of the whole SC was
carried out 10 times (n=10). The mean of
the obtained sum absorbances was set as 100%
of SC thickness. This value was employed to
calculate the cumulative relative horny layer
thickness that was removed after 1 to a max-
imum of 120 tape strips, respectively. The
exponential correlation between the number
of removed tape strips and the relative horny
layer thickness as derived from sum absorbance
values was calculated using the software pro-
gram R.
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TEWL measurements
The TEWL of the investigated porcine ear skin
sites was determined before and during the
tape stripping process with the closed-chamber
device Aquaflux® (Biox Ltd., London, UK).
Determination of the TEWL is a standard pro-
cedure for assessing skin integrity before exper-
iments or during wound healing processes (16).
The TEWL is expressed in g/m2/h and repre-
sents the quantity of water that is lost via the
skin per hour and 1 m2 of skin area. If larger
quantities of water pass through the skin when
compared to established standard values, bar-
rier defects may be suspected (16).
Capacitance - based fingerprint sensor
imaging
The skin relief, i.e. the surface texture or to-
pography, is an important biophysical feature
that cannot be evaluated by the naked eye
alone. A method that was found highly use-
ful for in vivo studies due to its simplicity
and speed of data acquisition is capacitance
mapping of the skin (17, 18). Skin capaci-
tance imaging is a non-invasive and non-optical
method that can distinguish di erent levels of
stratum corneum hydration and can thus iden-
tify sites of dermal inflammation, lesions or
sweat gland disturbances in vivo (19, 20). Skin
capacitance is an electrical property of the skin
measurable at the level of the SC. The obtained
values are related to the moisture content of
the tissue (21). Changes in the SC structure
may be related to its water holding capacity
or alterations of the barrier function which af-
fect the electrical properties of the skin (20).
The capacitive pixel-sensing technology is an
area-integrating surface texture method that
images the capacitance at 50 µm intervals on
the skin surface and exposes skin pores, pri-
mary and secondary lines and wrinkles (17, 21,
22). The technique is based on silicone image
sensor technology, initially developed for the
assessment of fingerprints in biometric security
procedures (20).
In our case, a specifically designed
capacitance-based fingerprint sensor (MBF
200, Fujistu Ltd.) (23) was employed for skin
hydration imaging and surface analysis. The
employed sensor consisted of 256x300 pixels,
a 50x50 µm spatial resolution and an 8-bit
greyscale value scale ranging from 0 to 255
to represent low to high skin hydration levels
(23). This device is a hand-held probe which
is applied onto the skin for rapid assessment
of the current skin hydration properties.
The skin surface pattern of hydration and
topography is then viewed in the form of
high-resolution real-time non-optical images:
dark pixels represent hydrated areas of high
capacitance while bright pixels may represent
dry spots on the skin or depressions and lines
in the skin’s micro relief which impede the
contact between the probe and the stratum
corneum (20). Areas where skin moisture is
lost via the SC, be it via natural routes such as
sweat glands or through damaged skin areas,
can be detected. The sensor can be used to
detect subclinical irritation, acne or psoriatic
lesions or sweat gland disturbances in vivo
(19) and to monitor the e ect of moisturisers
and surfactants (24).
So far, the potential of this technique has
not been explored for in vitro tape stripping
experiments. In this context, the sensor could
be employed to assess the intactness of the skin
barrier function before experiments. This was
performed in the course of in vitro tape strip-
ping experiments to test whether the changes
in skin barrier function could be monitored and
if an in-process control during the experiment
was possible. Sensor measurements were per-
formed every 10 removed tapes at the least.
The device was closely applied to the skin sur-
face with slight pressure for a maximum of 2
seconds so as not to interfere with the water
5
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flux and water content inside the SC (20).
ATR-FTIR experiments during tape
stripping
Additional tape stripping experiments on
porcine ear skin were conducted to monitor
changes in skin barrier function by ATR-FTIR
spectroscopy. Since preliminary experiments
had shown no dependence of the data on the
employed ear type, six large porcine ears were
chosen for this study (n=6). The dorsal ear
skin was removed from the cartilage, carefully
freed from hair with scissors and cut into strips
of 1.0 x 7.5 cm that were pinned onto pieces
of styrofoam (25). Subsequently, consecutive
tape stripping was performed with 20 adhe-
sive films, this time chosing a brand suitable
for corneocyte removal on a larger piece of
skin (Tesa film crystal clear). The amount of
corneocytes removed was again determined by
NIR-densitometry using the SquameScanTM
850A. ATR-FTIR spectra were recorded be-
fore tape stripping as well as after 5, 10, 15
and 20 tape strips, which represent the antic-
ipated major changes in skin barrier function.
Infrared spectra of the skin samples were ob-
tained using a FTIR spectrophotometer (Ten-
sor 27, Bio-ATR I tool, Bruker Optics, Ger-
many) thermostatted at 32¶C. The skin sam-
ples were placed on the ZnSe crystal with the
stratum corneum facing down. To achieve re-
producible spectra of constant intensity an ex-
act weight of 100.00 g was mounted on the sam-
ples during ATR-FTIR analysis.
Microscopic analysis
Microscopic analysis of adhesive films removed
from both porcine skin in vitro and human skin
in vivo should elucidate potential di erences
in the skin surface structure and corneocyte
coverage of the tapes. As a first step, indi-
vidual adhesive films of both Corneofix® and
DSquame® tapes were taken from representa-
tive areas on the centre of the dorsal side of
excised pig ears. For comparison, the proce-
dure was applied to human forearm skin in vivo
as well. The tapes were removed according to
the respective protocols and were analysed by
optical light microscopy using a photo micro-
scope (Zeiss Axio Observer.Z1 microscopy sys-
tem, Carl Zeiss, Oberkochen, Germany). All
images were taken at 5-fold magnification in
conventional bright field mode. Apart from
these tapes for comparative investigation, se-
lected adhesive films removed during a conven-
tional tape stripping procedure were analysed
in regular intervals to monitor the changes in
protein coverage of the tapes.
Statistical data analysis
Results are expressed as means of three or
more experiments ± SD. Statistical data anal-
yses were performed with the program Graph-
PadPrism3 while using P<0.05 as a mini-
mum level of significance. Parametric data
were analysed using the Student’s t-test or
ANOVA. Non-parametric data were analysed
using the Mann-Whitney test or the Kruskal-
Wallis-Test.
3 Results and Discussion
Characterisation of the skin surface
The skin surface properties were investi-
gated by means of TEWL measurements and
capacitance-based sensor measurements. It
should be clarified whether both methods
served equally well as a means of quality con-
trol for skin integrity testing. The TEWL of
the intact dorsal porcine ear skin was found to
be around 18.36 ± 3.66 g/m2/h in 47 individ-
ual measurements on 12 porcine ears (n=47).
This corresponds well with previous findings
and can be seen as an indicator for an undam-
6
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aged skin surface and normal hydration state
of the excised tissue (4, 7). The corresponding
mean greyscale value as determined with the
capacitance-based sensor was 101.41 ± 25.72
on a scale ranging from 0 to 255. No sig-
nificant di erences between the TEWL val-
ues of the di erent ear types were found when
evaluated separately (P>0.05, 19.02± 3.44 vs.
17.09±3.84 g/m2/h, 31 measurements on large
ears vs. 16 measurements on small ears). This
indicates that the skin barrier function of the
two di erent ear types was highly comparable.
In contrast, the capacitance-based sensor led to
significantly di erent greyscale values for large
and small ears (P<0.0001, 88.02 ± 17.92 vs.
128.20± 16.16). Since the greyscale values re-
flect the water content of the skin, these dif-
ferences indicate that the skin water content
was quite di erent for the di erent ear types
despite the similar skin barrier function. Since
the contact area observed during the measure-
ments was highly comparable for the di erent
ear types before and during the tape strip-
ping procedure (P>0.05 in all cases), it may
be assumed that the skin surface texture of
the di erent ear types was nevertheless quite
similar. For optimal results of tape stripping
studies, model skin of the highest possible sim-
ilarity should be employed. In this respect,
capacitance-based sensor imaging might prove
to be a useful tool in the future to study the
homogeneity and the level of skin surface hy-
dration.
Another parameter of interest that can be
extracted from the grey-level histogram of the
images is the skin micro relief in % (9). In-
terestingly, the di erences between the ears as
observed in terms of mean greyscale values was
not reflected in the corresponding micro relief
values. The mean micro relief value of 47 indi-
vidual measurements conducted on 12 porcine
ears was 0.62±0.36 % (n=47) with a mean con-
tact area of 61.01± 15.14 %. When evaluated
separately, the values remained highly similar
for both ear types (P>0.05, respectively). This
suggests that the skin surface structure of the
ear types is highly similar and the di erences in
greyscale values, which reflect the di erent skin
water content, might be related to age-induced
di erences in skin properties of the animals.
For reasons of comparison, the capacitance-
based sensor was employed for measuring se-
lected areas of human skin in vivo and porcine
ear skin in vivo as well (Figure 2). As can
BA C
D
G H I
E F
Figure 2: Influence of skin surface properties on the
greyscale value as assessed by the fingerprint sensor. (A)
Human forearm skin in vivo; (B) Human forearm skin in vivo
with active sweat glands; (C) Human forearm skin in vivo
damaged by a scar; (D) Human forehead skin in vivo; (E)
Human forehead skin in vivo with active sweat glands; (F)
Human index finger skin damaged by a blister after thermal
damage; (G) Porcine ear skin in vivo; (H) and (I) Porcine
ear skin in vivo exhibiting small lesions.
be seen, the human forearm skin exhibits a
fine pattern of wrinkles which is only dis-
turbed if sweat glands become active (Figure
2B) or fresh or healed lesions occur (Figure
2C). The criss-cross pattern of primary and
secondary lines of the skin micro-topography
can be clearly seen (20). These preliminary
measurements may already serve to exclude
damaged or unsuitable areas from tape strip-
ping experiments in vivo. Areas with increased
sweat gland density such as the human fore-
7
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head skin (Figure 2D and 2E) are both un-
suitable and impractical for tape stripping ex-
periments. Active sweat pores appear as pin
point-sized darker regions of high conductance
(20). Whitish areas of low capacitance, such as
scars (Figure 2C) and blisters (Figure 2F) can
likewise be identified and excluded. Thus, het-
erogeneities in the quality and physical prop-
erties of the SC can be revealed (20).
In case of porcine ear skin in vivo, the larger
numbers of hair represent an obstacle to skin
hydration measurements by capacitance-based
techniques (Figure 2G, H and I). Nevertheless,
areas of increased water loss such as small le-
sions of the stratum corneum can be clearly
identified even in static measurements (Figure
2H and I). The same tendencies were observed
in the subsequent in vitro experiments using
excised porcine ears.
For in vivo studies, further comparative data
are necessary to establish a set of control val-
ues as performed for the TEWL. Our prelim-
inary in vivo measurements on human and
porcine skin in vivo revealed that the mean
greyscale values obtained by capacitance-based
sensor imaging are highly comparable for hu-
man forearm skin and porcine ear skin, namely
69.43 ± 14.99 and 63.30 ± 15.31 (n=3, respec-
tively). In vitro values for the same area ap-
pear to be increased in the porcine ear, as is the
case for TEWL values. When measuring di er-
ent areas of human skin in vivo, further analo-
gies to the TEWL are found, such as higher
values for the skin of the forehead.
These results indicate that the capacitance-
based sensor is an equally suitable tool for in-
vestigating the skin surface properties of both
human and porcine skin when compared to
the classical TEWL measurements with a con-
denser chamber. In case of in vitro experi-
ments on porcine ears, the sensor might even
be superior since the TEWL is only a rough
estimate of the hydration state of the excised
tissue. The sensor may be employed for occlu-
sive measurements of a longer duration, which
have been shown to be more sensitive to barrier
defects than measurements with a condenser
chamber (26).
Indirect characterisation of the skin
surface structure by light microscopy
The surface structure of the employed porcine
skin was likewise investigated by microscopic
analysis of tape strips removed in individual
experiments. Thus, the nature of the removed
corneocytes and their tendency to aggregate
should be elucidated. In addition, the di er-
ences between human and porcine SC surface
properties should be visualised by optical light
microscopic images. In a first step, only sin-
gle adhesive films were respectively removed
from the skin surface of human forearm skin
or porcine ear skin and were analysed with a
light microscope (Figure 3). As can be seen,
Human skin on Corneofix tape
Porcine skin on Corneofix tape
Porcine skin on Dsquame tape
Human skin on Dsquame tape
Figure 3: Microscopic analysis of the corneocyte covering
of the first adhesive films removed from the skin surface of
human and porcine skin during tape stripping. Two repre-
sentative examples of corresponding adhesive tapes are given
per row (left and right-hand side). On the adhesive films re-
moved from human forearm skin in vivo, a certain amount of
humidity is noticeable especially with DSquame® tapes. On
the adhesive films removed from porcine ear skin in vitro,
much larger aggregates as well as “canyons” are present, es-
pecially with DSquame® tapes.
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the human corneocytes were more equally dis-
tributed on the tapes than the porcine cor-
neocytes and rarely formed larger clusters. In
contrast, porcine skin was characterised by
large cell clusters interrupted by “canyons”
(27). This phenomenon, however, was primar-
ily noticeable on the first removed tape strip
of every experiment while the subsequently re-
moved tapes exhibited increasingly homoge-
neous protein coverage. Figure 4 shows micro-
Strip 1
Strip 20 Strip 40 Strip 80
Strip 5  Strip 10
Figure 4: Monitoring of the tape stripping process per-
formed on excised porcine ears of fattened pigs (age 6-10
months) with Corneofix® adhesive films. The removed tapes
were analysed by optical light microscopy (bright field mode,
5-fold magnification). For average to low corneocyte cover-
ages, optical methods of analysis give results with satisfying
accuracy.
scopic images of adhesive films removed dur-
ing consecutive tape stripping on porcine ear
skin. The looser packing and concomitant ease
of removal of the corneocytes at the skin sur-
face have been attributed to the decrease in
the number of desmosomes and presumably
explain the presence of thicker tissue layers
on the initial tape strips (28). When moni-
toring the entire tape stripping process it be-
comes clear that the overall removal of porcine
corneocytes is su ciently homogeneous to ob-
tain reproducible and reliable results. As al-
ready discussed, overlapping stacks of corneo-
cytes or inhomogeneous protein coverage of the
tapes might lead to inaccurate results when
employing optical protein quantification meth-
ods (11). However, the numerous benefits of
the highly e cient, rapid and practical meth-
ods of optical protein quantification tend to
justify the potential slight inaccuracy for the
first removed tape. As previously observed,
Corneofix® tapes appear to be less prone to
the stack e ect due to their decreased adhe-
sive power (4). Thus, they were used for the
presented tape stripping experiments. Over-
all, the obtained images confirm our previ-
ous observations and indicate that the di erent
surface structure of human and porcine skin
should be taken into consideration during in
vitro tape stripping especially when perform-
ing optical methods of skin analysis.
In vitro tape stripping: estimation of
the relative stratum corneum depth
The SC of the tested porcine ears was removed
completely during consecutive tape stripping
experiments. The entire SC thickness was de-
termined by summarising the individually de-
termined values of pseudo-absorption at 850
nm and employing the appropriate calibra-
tion data and protein density for calcula-
tion. The mean SC thickness was found to
be 7.28 ± 1.49µm for all experiments (n=10).
When evaluated separately, the large and small
porcine ears showed a significantly di erent
SC thickness of 8.83 ± 0.82 µm and 6.50 ±
1.07 µm (P<0.05, n=5, respectively). The
summarised mean pseudo-absorption values
correspond to the entire SC thickness removed
in the experiments. The experiments were
only stopped when the detection limit of the
NIR-densitometer was reached. The cumula-
tive relative horny layer thickness that was re-
moved after 1 to a maximum of 120 tape strips
was calculated in percentages for every experi-
ment. These data were employed to establish a
general correlation between the number of re-
moved tape strips (n) and the relative thick-
ness of the removed SC (y). The resulting
exponential equation is shown below (Equa-
tion 1). In conclusion, the relative thickness of
the SC removed after a given number of tape
strips can be calculated as a percentage of the
9
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absolute SC thickness.
y = 98.858≠ 99.589e≠nú0.0727 (in %) (1)
It was thus possible to correlate the amount of
removed SC with each consecutively removed
adhesive film with satisfying accuracy. For
instance, after 10 adhesive tapes a relative
amount of 50.39 ± 6.59 % of the SC was re-
moved while 87.40 ± 3.54 % were removed af-
ter 30 tapes. This corresponds quite well with
the values observed for human SC (15), con-
firming that the majority of the porcine SC
is likewise removed after comparatively few
adhesive tapes. In contrast, the removal of
the following cell layers processes quite slowly
due to the increased cohesion. The number
of tapes required for removal of the entire SC
may vary, in the present case between 80 to
120 for the large ears and 60 to 80 for the
small ears. However, these last adhesive films
only contribute a very small percentage of the
entire SC thickness. Irrespective of the type
of ear used, the removal of the SC can thus
be characterised by the presented non-linear
equation (Figure 5). This confirms that de-
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Figure 5: Correlation of the relative amounts of SC re-
moved with increasing numbers of adhesive tapes according
to Equation 1 (R2 = 0.9999).
spite the di erences in skin surface structure
between human and porcine skin and the ex-
pected inter-individual di erences, reliable and
reproducible results can be obtained in tape
stripping experiments on porcine ears. The
presented general relationship can be employed
to estimate the relative amount of SC removed
from pig ear skin by any number of tape strips.
Thus, complete removal of the SC, which is
time- and cost-intensive, can be avoided in fu-
ture experiments (15).
Changes in skin barrier function
as observed with ATR-FTIR spec-
troscopy
The changes in skin barrier function dur-
ing tape stripping experiments were addition-
ally analysed by ATR-FTIR. Table 1 shows
an overview of typical skin bands that were
observed: CH2 asymmetric and symmetric
stretching vibrations describing the conforma-
tional order of the SC lipid acyl chains, amid
I (C=O) and amid II (C–N) vibrations eluci-
dating changes in SC protein conformation as
well as CH2 scissoring mode 1 and 2 character-
ising the lateral packing of the SC lipid alkyl
chains (25, 29-31). For most bands, no qual-
itative change in the SC composition was de-
tected by analysis of the skin during tape strip-
ping. Minor if statistically significant shifts of
the symmetric CH2 stretching band and the
amide 1 vibration were recorded. After the
removal of twenty tape strips the frequency
of the symmetric CH2 stretching mode was
shifted to a higher wavenumber, namely to
2850.59± 0.08 cm≠1 (Table 1). This shift may
indicate a transition from the hexagonal to the
liquid phase resulting in a higher degree of dis-
order (29, 32). This is in good agreement with
the observed process of SC removal (Figure 5).
After removal of 20 tapes, roughly 80% of the
horny layer is generally already removed and
thus the barrier function is impaired to quite
some extent. Moreover, after five tape strips
a statistically significant shift to a higher fre-
quency was observed for the amide 1 band (Ta-
ble 1). This shift could indicate a change in
the secondary structure of keratin (33). As
10
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  asymm.CH2 symm. CH2 Amide 1 Amide 2 CH2 sciss. 1 CH2 sciss. 2 
skin before tape stripping 2918.23 ± 0.42 2850.35 ± 0.24 1637.10 ± 2.27 1541.80 ± 2.00 1466.24 ± 0.27 1454.98 ± 0.59 
skin after 5 removed tapes 2918.01 ± 0.22 2850.16 ± 0.00   1640.88 ± 1.89 * 1541.93 ± 0.88 1466.34 ± 0.07 1455.03 ± 0.48 
skin after 10 removed tapes 2917.96 ± 0.35 2850.24 ± 0.13 1639.43 ± 2.06 1542.14 ± 1.32 1466.34 ± 0.07 1454.92 ± 0.66 
skin after 15 removed tapes 2918.31 ± 0.25 2850.43 ± 0.24 1639.25 ± 1.50 1542.76 ± 0.70 1466.05 ± 0.25 1455.30 ± 0.58 
skin after 20 removed tapes 2918.60 ± 0.40   2850.59 ± 0.08 * 1639.44 ± 2.33 1543.72 ± 0.88 1466.18 ± 0.31 1455.06 ± 0.37 
 
 
 
Table 1: Wavenumbers [cm-1] of characteristic skin bands before and during tape stripping experiments on porcine ear
skin (n=6). Given values are means ± SD. Significant di erences between the tape stripped skin versus the control skin
before tape stripping are marked with *.
expected, the change in keratin structure was
most apparent in the uppermost layers of the
SC. Likewise, the subsequently recorded spec-
tra during the tape stripping procedure showed
a similar, if not statistically significant shift. In
short, the ATR-FTIR analysis of the skin be-
fore and during tape stripping confirmed the
damage in skin barrier function caused by the
tape stripping procedure while the qualitative
composition of the SC remained unchanged up
to 80% of its entire thickness.
In-process control of in vitro tape
stripping via capacitance-based sen-
sor imaging
The skin surface properties of porcine ear skin
in vitro as observed by capacitance-based sen-
sor imaging may not only serve as a quality
control of the skin, but can likewise be em-
ployed to monitor the tape stripping process.
Figure 6 shows the skin hydration profile of
porcine ear skin before (A in vivo, B in vitro)
and during removal of an increasing number of
tapes on the excised porcine ear in vitro. Ir-
regularities in protein removal as seen in Fig.
6E and 6F can thus be detected and the ex-
periment can be aborted since the optical cor-
neocyte quantification, which relies on homo-
geneous cell distribution, would produce inac-
curate results. Apart from these visual as-
pects, the mean greyscale values obtained from
a larger set of experiments on intact skin can
A B C
FED
Figure 6: Monitoring of the tape stripping process on
porcine ear skin. Image (A) shows porcine ear skin in vivo
(young domestic pig of approximately 3-4 months of age).
Remnants of dirt and moisture as well as numerous hairs
cause a slightly blurred appearance. Image (B) is a cor-
responding image in vitro with trimmed hair. Image (B)
to (F) show the skin surface structure before and during the
tape stripping process on an excised porcine ear in vitro: the
furrows become more accurately visible while the greyscale
value of the images changes after the removal of 5 (Image
C), 10 (Image D), 15 (Image E) and 20 (Image F) adhesive
films. The occurrence of dark regions (as marked by the
arrows) indicates a major disturbance of the skin barrier,
which was confirmed by visual observation: a single large
patch of skin was removed in one piece. Subsequently, the
tape stripping data gained after this occurrence will become
increasingly inaccurate.
serve as standardised control values. Thus, in-
tact representative skin areas can be identified
and the tape stripping process can be moni-
tored (Figure 7). As can be seen in Figure 7A,
the mean greyscale value shows a fairly regu-
lar increase with the first removed tapes and
reaches a plateau after 30 removed tapes. This
increase in greyscale value corresponds to an
increase in the detected skin water content and
a concomitant decrease in skin barrier func-
tion as confirmed by increasing TEWL values.
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Figure 7: Fingerprint sensor measurements on porcine ear
skin before and during tape stripping with Corneofix® tapes
(n=10). In Figure 7(A), the mean greyscale values (grey
bars) determined during tape stripping are plotted on the
left-hand side scale while the mean micro relief values in
% (black line) are given on the right hand-side scale. In
Figure 7(B), the right-hand side scale characterises the mean
contact area in % (grey line), again in relation to the mean
greyscale values (grey bars).
Since most of the barrier was removed after 30
tapes, no further changes of the greyscale value
were observed. The skin micro relief appeared
to be inversely correlated to the greyscale value
and decreased with increasing numbers of re-
moved tapes, which indicates that the skin sur-
face achieved increasing uniformity. It may
be assumed that irregularities within the up-
permost corneocyte layers, including loose cell
stacks or wrinkles, were removed with the first
few adhesive tapes and thus no more changes
were observed after the first 30 removed tapes.
The contact area recorded during the measure-
ments increased in analogy to the increasing
greyscale values, which supports this theory
(Figure 7B). As already noticed during charac-
terisation of the ear skin, the mean greyscale
values di ered significantly for the di erent
ear types when evaluated separately (P<0.05).
The greyscale values of large porcine ears were
noticeably lower than those observed for the
smaller ears. These di erences were observed
during the tape stripping process until most
of the SC had been removed with approxi-
mately 30 tapes. However, the observed mi-
cro relief values did not reflect these di er-
ences at any stage of the tape stripping pro-
cess and were highly similar for both ear types
(P>0.05, Figure 7A). When regarding the cor-
responding TEWL values determined in paral-
lel to the sensor measurements, the exact same
tendencies as for the greyscale values were ob-
served (Figure 8). After 30 removed adhesive
0
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Figure 8: Measurement of the TEWL on porcine ear skin
before and during tape stripping with Corneofix® tapes
(n=10). Given values are means ± SD.
tapes, further tape stripping resulted in little
or no change of the TEWL. Due to the pro-
longed experiment times, the recorded values
even started to decrease after more than 100
removed tapes due to irreversible dehydration
of the tissue.
Correlation of mean greyscale values
and the TEWL
The mean greyscale values and the correspond-
ing TEWL values as determined before and in
regular intervals during the tape stripping ex-
12
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periments were employed for a linear regres-
sion analysis (Figure 9). When plotting the
mean greyscale values against the mean TEWL
values measured at the same skin sites dur-
ing the consecutive removal of 100 tapes, a
highly linear correlation was obtained with R2
= 0.9249 (Figure 9A). This indicates that the
two methods lead to highly comparable con-
clusions about the state of the skin barrier
function and the TEWL. The same conclusions
were reached when correlating either the mean
greyscale values (Figure 9B) or the TEWL val-
ues (Figure 9C) to the respectively reached SC
depth. Highly satisfying coe cients of deter-
mination were obtained in both cases.
4 Conclusion
Capacitance-based sensor imaging was shown
to be a suitable tool for skin integrity testing as
means of quality control for porcine ear skin for
in vitro tape stripping. Likewise, it can be em-
ployed for in-process control during the tape
stripping process since inhomogeneous dam-
ages within the SC through irregular corneo-
cyte removal can be visualised. The mean
greyscale values obtained during tape strip-
ping were found to be highly reproducible for a
larger number of experiments. Excellent linear
correlations between the mean greyscale values
and corresponding TEWL values and the asso-
ciated skin penetration depths were observed.
This technique might represent an important
contribution towards the standardisation of in
vitro tape stripping and the involved porcine
ear skin.
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Figure 9: (A) Correlation of the mean greyscale value
as obtained via capacitance-based sensor measurements and
the mean TEWL values as determined with the Aquaflux®
device during continuous tape stripping of the entire SC.
Data points were taken before the procedure as well as after
5, 10, 15, 20 and subsequently every 10 tapes until 100 ad-
hesive films were removed. The correlated values are means
of 10 experiments (n=10). Images B and C show the cor-
relation of the mean penetration depth achieved in these
experiments to the corresponding mean TEWL values (B)
and the corresponding mean greyscale values (C).
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Abstract
Sucrose stearate blends of intermediate lipophilicity are mild surfactants with thermosensitive
gelling behaviour. Binary systems and emulsions with sucrose stearate S-970 or S-1170 were
developed and investigated by thermoanalytical and rheological measurements. The presence
of an oil phase promoted the gelling potential of the esters especially at higher production
temperatures. Semi-solid emulsions with viscoelastic properties comparable to weak gels were
obtained with di erent dermatologically acceptable oils. The complex internal structure as
visualised by fluorescence microscopy exhibited changes during storage in dependence of oil
and surfactant type. A combination of S-970 with cetearyl ethylhexanoate-based oil phases
led to superior physical stability.
Keywords: sucrose stearate, semi-solid, fluorescence microscopy
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1 Introduction
Sucrose ester mixtures are commonly employed
surfactants in the food industry, but have like-
wise been investigated as compounds of drug
delivery systems to enhance drug solubility
and to increase absorption of topically applied
actives [1-4]. Since sucrose esters are non-
ionic biodegradable surfactants of low toxic-
ity they are ideal compounds to create al-
ternative matrices for lipid-based drug deliv-
ery systems for dermal application [5]. Unlike
the more frequently investigated carbohydrate-
based alkylpolyglucoside surfactants [6-8], the
behaviour of sucrose ester surfactants in multi-
phase systems has not been thoroughly inves-
tigated yet. In recent investigations we found
that the sucrose stearate blend S-970 can be
employed to create highly viscous O/W emul-
sions [9]. Although the peculiar rheological be-
haviour of certain sucrose esters in water has
been reported in early literature [10, 11], few
studies have attempted to employ this feature
in specific formulations for dermal application.
The majority of reports deal with binary sys-
tems of the surfactant mixture in water [5, 12,
13] and it is evident that the exact processing
conditions may lead to significant changes in
the macroviscosity of the binary systems. So
far, no such investigations on the e ect of pro-
cessing conditions on the physical properties
of sucrose ester-stabilised emulsions have been
reported. The presence of an oil phase per-
mits the incorporation of lipophilic drugs [9],
but may likewise a ect the gelling properties of
the employed sucrose ester. There is a signifi-
cant need for a systematic investigation dealing
with the e ect of production conditions and
composition on the developed emulsion sys-
tems. Thus, the aim of the present work was to
elucidate the influence of the processing tem-
perature, the type and amount of sucrose ester
and the incorporated oil on the physical prop-
erties of the produced emulsions. A detailed
characterisation of the systems was conducted
to understand the internal emulsion structure
and to optimise formulation properties. Impor-
tant physical parameters were determined by
optical light microscopy and fluorescence mi-
croscopy as well as thermoanalytical and rheo-
logical investigations. To obtain an overview of
the gelling behaviour of di erent sucrose ester
blends and their suitability to form semi-solid
binary systems or emulsions, thorough prelim-
inary studies were conducted. A range of dif-
ferent ester blends was tested and only two su-
crose stearate blends, namely S-970 and S-1170
which are characterised by di erent ester com-
positions, were selected for further studies. As
a first step, a concentration range from 2.5%
up to 20% of the esters was employed to form
binary systems at di erent production temper-
atures. Having selected an appropriate surfac-
tant concentration, we moved on towards the
development of O/W emulsions. The choice of
excipients was guided by the aim of achieving
optimal skin-friendliness. The production pa-
rameters were optimised using a model emul-
sion and five di erent eudermic oils were then
investigated in a comparative study. The rheo-
logical properties of a system are of particular
importance for the stability, the processing and
the application of the final product. Thus, the
rheological properties of fresh and stored emul-
sions were compared to investigate potential
changes in the macroviscosity of the formula-
tions. It should be clarified whether all tested
oil types would produce systems of satisfying
shelf-life for practical application despite the
lack of additional gelling agents.
2 Materials and Methods
2.1 Materials
Sucrose stearate S-970 and S-1170 (Ryoto
Sugar Esters® S-970 and S-1170) were kindly
donated by Mitsubishi-Kagaku Food Corpora-
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tion (Tokyo, Japan). The exact composition
of these sucrose stearate blends as well as their
melting ranges and HLB values according to
the manufacturer are given in Table 1. Corn
oil, soybean oil, isopropyl myristate (IPM,
1-Methylethyl-tetradecanoat) and PCL® liq-
uid (cetearyl ethylhexanoate, isopropyl myris-
tate) were purchased from Dr.Temt Labora-
tories (Vienna, Austria). Tegosoft® liquid
(cetearyl octanoate) was provided by Evonik
Industries (Essen, Germany). Potassium sor-
bate was obtained from Herba Chemosan
Apotheker-AG (Vienna, Austria). Bodipy®
493/503 (4,4-difluoro-1,3,5,7,8-pentamethyl-4-
bora-3a,4a-diaza-s-indacene) was purchased
from Invitrogen (Eugene, USA) while Atto 594
and fluorescein sodium salt were purchased
from Sigma Aldrich (St. Louis, USA).
2.2 Investigation of the gelling po-
tential of di erent esters
Selection of sucrose ester blends
The gelling ability of di erent commercially
available sucrose ester blends in distilled water
was examined. The HLB value of the tested
compounds (L-195, S-270, L-595, S-970, S-
1170, OWA 1570, S-1670, P-1670 and L-1695)
ranged from 1 to 16. Each sucrose ester blend
was dissolved in distilled water at 5 % w/w,
was stirred for 30 minutes at room temperature
and homogenised with an ultra-turrax (2500
rpm, 3 minutes). Sucrose esters of HLB 1 -
5 were insoluble in water. Sucrose esters with
intermediate HLB value from 9 to 11 formed
highly viscous dispersions. Sucrose esters with
high HLB value from 15 to 16 gave highly fluid
and slightly turbid dispersions except for L-
1695 which gave a clear solution. The sucrose
esters for which a successful gelling was ob-
served, namely sucrose stearate S-970 and S-
1170, were chosen for further investigations.
E ect of production temperature
As a next step, the gelling potential of the cho-
sen ester blends was investigated in binary sys-
tems and model emulsions with PCL® liquid to
elucidate the e ect of di erent production tem-
peratures. A concentration range of respec-
tively 2.5%, 5%, 10% and 20% w/w of S-970
as well as S-1170 in distilled water was pre-
pared to investigate the influence of increasing
ester concentrations on the resulting aqueous
dispersions. The concentration ranges were
prepared at 25°C, 40°C and 60°C. All samples
were produced in triplicate (n=3). The mix-
tures were characterised by optical light mi-
croscopy as well as thermoanalytical and rhe-
ological measurements. In addition, represen-
tative model emulsions with PCL® liquid as
the oil phase (A S-970 and A S-1170, Table
2) were chosen to investigate the e ect of the
production temperature on emulsions in gen-
eral. Emulsions were prepared in triplicate by
incorporating the respective sucrose ester into
the oil and stirring of the resulting mixture for
30 minutes at di erent temperatures (25°, 40°,
50° and 60°C) until the water phase was added.
After further stirring for 5 minutes, homogeni-
sation with an ultra-turrax (2500 rpm, 3 min-
utes) was performed. These emulsions were
additionally produced with small amounts of
fluorescent dyes (section 2.4).
2.3 Final emulsions
Di erent emulsions were produced to investi-
gate the e ect of the oil phase. Their com-
position and abbreviations are given in Table
1. After testing a large number of derma-
tologically acceptable oils, the following were
chosen: tegosoft® liquid, PCL® liquid, corn
oil, soybean oil and isopropyl myristate (IPM).
The final emulsions were prepared according
to an optimised protocol based on the prelim-
inary studies. The respective sucrose ester/oil
3
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 S-970 % w/w S-1170 % w/w 
sucrose monostearate 31 - 33  sucrose monostearate 37 - 39 
sucrose distearate 20 - 22 sucrose distearate 20 - 22 
sucrose monopalmitate 11 - 13 sucrose monopalmitate 14 - 15 
sucrose tristearate 9 - 10 sucrose dipalmitat 7 - 8 
other sucrose alkylates 18 - 25 other sucrose alkylates 13 - 19 
ash, moisture, residual      
fatty acids, free sucrose < 10  ash, moisture < 3 
melting point (DSC) 49°C - 56°C   49°C - 55°C 
HLB 9  11 
 
 
 
Table 1: Composition of the employed sucrose stearate blends.
mixture was stirred and only briefly heated
to 40°C. Then the aqueous phase was added,
the resulting emulsion was further stirred for 5
minutes and homogenised with an ultra-turrax
(2500 rpm, 3 minutes). The final emulsions
were stored in sealed glass containers at 8°C
until a follow-up investigation after 3 months.
The pH value of the emulsions was likewise
monitored at 25°C using a pH meter (Orion
420A, Bartelt, Austria).
2.4 Optical light and fluorescence
microscopy
The microscopic analyses were performed us-
ing a photo and fluorescence microscope (Zeiss
Axio Observer.Z1 microscopy system, Carl
Zeiss, Oberkochen, Germany) equipped with
phase contrast and LD Plan-Neofluar objec-
tives. A small amount of sample was placed
on an object slide, covered and analysed imme-
diately. Images of binary systems and emul-
sions were taken in conventional bright field
mode and with phase contrast at 10- and 20-
fold magnifications. In addition, polarisation
microscopy (Optiphot 2, Nikon GmbH, Aus-
tria) was employed to detect the presence of
lyotropic liquid crystalline phases. Both bi-
nary systems and emulsions were investigated
by optical light microscopy. In addition, rep-
resentative model emulsions with PCL® liquid
as the oil phase (A S-970 and A S-1170, Ta-
ble 2) were investigated by fluorescence mi-
croscopy after incorporation of di erent fluo-
rescent dyes to visualise the lipophilic and hy-
drophilic domains. The coloured reagents were
chosen according to their excitation and emis-
sion maxima as well as their aqueous solubil-
ity. The hydrophilic Atto 594 (590 nm / Ø 615
nm) and fluorescein sodium (470 nm / 525 nm)
were respectively incorporated into the aque-
ous bulk phase. The lipophilic Bodipy® (470
nm / 525 nm) was employed to stain the oil
phase. These emulsions were prepared at both
40°C and 60°C and with or without treatment
with an ultra-turrax to reveal whether the en-
ergy input had any impact on the distribution
of the fluorescent dyes. It should be clari-
fied whether structures other than oil droplets
were present in the systems. In particular, the
presence of aqueous network structures which
might account for the increased emulsion vis-
cosity should be investigated.
4
140 CHAPTER 3. PUBLICATIONS
 (2a) Composition % w/w 
oil 20 
sucrose stearate blend 5 
potassium sorbate 0.1 
distilled water to 100 
  
(2b)  Oil type Abbreviations 
PCL® liquid A S-970 
 A S-1170     
tegosoft® liquid B S-970  
 B S-1170 
corn oil C S-970  
 C S-1170 
soybean oil D S-970  
 D S-1170 
isopropyl myristate E S-970 
  E S-1170 
 
 
Table 2: Basic composition of all investigated emulsions (a)
and abbreviations of the di erent formulations according to
the employed oil type (b).
2.5 Thermoanalytical Measure-
ments
Thermoanalytical measurements were per-
formed with the pure emulsifier, the aqueous
binary system and the emulsions. The sucrose
ester blends in powder form were analysed
by di erential scanning calorimetry (DSC) us-
ing a DSC-7 (Perkin Elmer, Austria) working
with a continuous flow of dry nitrogen and
an indium calibration. About 5 mg of sam-
ple were sealed within aluminium pans and
heated from 25 to 80°C. For analysis of the re-
crystallisation process, the samples were sub-
sequently cooled down again to 25°C and re-
heated to 80°C. The heating and cooling rate
was 1°C/min in all cases. For the thermal
analysis of the sucrose ester dispersions and
emulsions, microcalorimetry (micro di eren-
tial scanning calorimetry, microDSC) was em-
ployed using a Setaram III microcalorimeter
(Setaram, Mainz, Germany). About 500 mg
of each sample containing 25 mg of sucrose
ester were sealed in batch cells and scanned
against a reference sample of distilled water.
The samples were heated from 25 to 80°C at
a constant heating rate of 1°C/min. Again,
subsequent cooling back to 25°C and another
heating cycle to 80°C were additionally per-
formed at 1°C/min to gain information about
re-crystallisation phenomena and potentially
irreversible changes in the formulation struc-
ture. Thermal transitions were calculated us-
ing Setsoft 2000 Setaram software. The ob-
tained thermograms were analysed in terms of
linear onset, transition or peak maximum tem-
perature and total enthalpy.
2.6 Rheological experiments
Continuous and oscillatory measurements were
performed in triplicate on a Bohlin CVO
Rheometer (Malvern Instruments, UK) with a
thermostatic control system (Bohlin KTB30,
Malvern, UK). A cone and plate tool with 40
mm in diameter and a 4° angle (CP 4°/40 mm,
2 g of applied sample) was employed for all vis-
cous systems. A coaxial cylinder system with
25 mm in diameter (cup and bob C25, 15 g
of applied sample) was employed only for dis-
persions prepared at 60°C that were too fluid
for the cone/plate tool. The temperature was
maintained at 21 ± 0.5 °C with a gap size of
0.15 mm. Additional experiments were per-
formed for the final emulsions at 32 ± 0.5°C,
thus simulating the skin surface temperature
in vivo. Flow curves were established for all
systems. The flow properties of both disper-
sions and emulsions were investigated by mea-
suring the dynamic viscosity ÷ (in Pas) un-
der shear stress. Rheological experiments in a
controlled-rate mode were performed. A con-
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trolled shear rate “ was employed at a constant
temperature to determine the viscosity of the
samples as a function of the shear rate rang-
ing from 0.1 s-1 to 100 s-1 and back from 100
s-1 to 0.1 s-1. Moreover, oscillatory shear ex-
periments were performed for all systems, i.e.
a sinusoidal stress was applied to the sample
and the induced strain was measured [14, 15].
Beforehand, the linear viscoelastic region of all
samples was determined by performing an am-
plitude sweep at a frequency of 1 Hz (stress
ramp from 0.1 to 20 Pa or higher if neces-
sary). Subsequently, a frequency sweep test
was performed over a frequency range of 1 –
40 Hz at a constant shear stress of 2 Pa. Thus,
important formulation parameters such as the
elastic modulus G’, the viscous modulus G’’,
the complex modulus G* and the dynamic vis-
cosity ÷Õ were determined as a function of the
oscillatory frequency (v, in Hz). The elastic
modulus (storage modulus) G’ is defined as
GÕ = Gú cos(”) and describes the recoverable
energy that is stored within an elastic system.
The viscous modulus (loss modulus) GÕÕ is cal-
culated by GÕÕ = Gú sin(”) and represents the
energy that is dissipated in the viscous flow
and transformed into heat. These moduli rep-
resent the parts of the complex dynamic shear
modulus G* [14-16].
2.7 Statistical data analysis
Results are expressed as means of at least
three experiments ± SD unless stated other-
wise. Statistical data analyses were performed
using the software program GraphPadPrism3.
Parametric data were analyzed using the Stu-
dent’s t-test while non-parametric data were
analyzed using the Mann-Whitney test or the
Wilcoxon signed rank test with P<0.05 as a
general minimum level of significance.
3 Results and Discussion
3.1 Optical light and fluorescence
microscopy
Morphology of binary systems and e ect
of production temperature
The e ect of increasing sucrose stearate con-
centrations of 2.5%, 5%, 10% and 20% w/w in
aqueous dispersions prepared at di erent tem-
peratures was visualised by optical light mi-
croscopy. In general, air bubbles were observed
after preparation at 25°C (Figure 1a and 1c).
At 60°C, the mixtures became more fluid and
less prone to foaming. In case of S-970, increas-
ing amounts of undissolved surfactant were ob-
served for all concentrations after preparation
at 25°C. In contrast, preparation at 60°C led to
complete dissolution of S-970 at all concentra-
tions except for 20% w/w. This phenomenon
is demonstrated in Figure 1a and 1b on disper-
sions with 5% w/w of S-970. Sucrose stearate
S-1170 exhibited a completely di erent be-
haviour (Figure 1c and 1d). A dense internal
structure was observed for all concentrations
after preparation at 25°C. After preparation at
60°C, a similar structure was observed for all
concentrations except for 2.5% w/w. These ob-
servations suggest that the gelling-behaviour of
S-970 is more temperature-sensitive than that
of S-1170 and that S-1170 forms specific struc-
tures irrespective of the temperature.
Morphology of emulsions and e ect of
production temperature
Conventional microscopic analysis confirmed
a crowded interior emulsion structure [9].
The fluorescence microscopic investigations of
model emulsions with PCL® liquid (A S-970
and A S-1170) with additional fluorescent dyes
provided more accurate information. The vi-
sual observations were complemented by cal-
culations with the software program ImageJ®
6
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Figure 1: Morphology of binary systems: Light microscopic images of aqueous dispersions of 5% w/w of sucrose ester.
The binary systems were produced with sucrose stearate S-970 at (a) 25°C and (b) 60°C and with sucrose stearate S-1170
at (c) 25°C and (d) 60°C. The large spherical structures marked by arrows are air bubbles. Images were obtained using
phase contrast mode at 10-fold magnification. (e-g) Morphology of emulsions: Fluorescence microscopic images at 20-fold
magnification of model emulsion A S-970 after incorporation of (e) fluorescein sodium (bright bulk phase), (f) Atto 594
(bright bulk phase) or (g) Bodipy® (bright droplets). The respective small image parts have been enhanced in contrast to
emphasise the structural details.
(open source) using the automatic particle
count and size determination functions. After
incorporation of fluorescein sodium salt into
the aqueous phase, dark oil droplets were ob-
served in front of a bright green fluorescent
background (Figure 1e). Within this fluores-
cent aqueous bulk phase, numerous fluorescent
vesicles could be distinguished which were ap-
parently of hydrophilic nature. Oil droplets,
vesicles or air bubbles were frequently encircled
by a brighter fluorescent ring. This might ei-
ther represent an artefact caused by the illumi-
nation or the accumulation of the hydrophilic
dye on interfacial surfactant films. Fluores-
cein sodium might be incorporated into or ad-
sorbed onto the interfacial films through an in-
teraction with surfactant molecules. The Im-
ageJ® analysis of the dark oil droplets indi-
cated a mean droplet size of 28.43 ± 11.65 µm
while the analysed droplet area corresponded
exactly to the incorporated oil phase volume
(19.38 ± 1.30 %, n=5). After incorporation
of Atto 594 into the aqueous phase (Figure
1f), dark oil droplets could be distinguished in
front of a bright red fluorescent background.
In this case, it was even more apparent that
the fluorescent aqueous bulk phase consisted
of numerous small aqueous vesicles. The in-
corporated air bubbles again showed strong
fluorescent rings at the interface, caused ei-
ther by illumination artefacts at the air/water
interface or adsorption of the dye to the in-
7
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terfacial film. Incorporation of Bodipy® into
the oil phase led to bright green fluorescent
oil droplets in front of a dark aqueous bulk
phase (Image 1g). However, the amount of
fluorescent spherical structures appeared too
high for the incorporated oil volume of 20%
w/w. ImageJ® calculations confirmed this as-
sumption. The calculated area fraction of flu-
orescent structures amounted to 40%, which
represents an overestimation of the amount of
oil droplets. This indicates that not only oil
droplets were a ected by the fluorescence dye
and thus included in the calculations. Presum-
ably, spherical vesicular structures composed
of surfactant aggregates or bilayers were asso-
ciated with Bodipy® as well, e.g. due to solu-
bilisation of the lipophilic dye within the fatty
acid chains of the surfactant molecules. To
clearly distinguish between the oil and aque-
ous phase and to detect overlapping regions,
both Bodipy® and Atto 594 were incorporated
into a model emulsion A. Preparation at 40°C
led to numerous air bubbles due to foaming
for both sucrose stearate blends (Figure 2a, b).
The bright green fluorescent oil droplets in S-
970 emulsions were homogeneously distributed
while a network-like aggregation was observed
for S-1170 emulsions. An ImageJ® analysis re-
vealed a mean droplet size of 26.22 ± 19.52
µm with an accurately analysed area of 20.66
± 3.68 % (n=7). These data are in agreement
with the fluorescein sodium data. The analysis
of the oil droplets containing Bodipy® was ap-
parently facilitated due to the overlapping flu-
orescent regions of the aqueous vesicles; better
contrast between strongly and slightly green
fluorescent structures was obtained. Omitting
the homogenisation step with the ultra-turrax
did not a ect the distribution of the fluores-
cent dyes within the emulsions, but led to a de-
crease in air bubbles and an increase in droplet
size. Increasing the preparation temperature
from 40°C to 60°C led to an overall fluidisa-
tion during preparation and also an increase in
Figure 2: Influence of production temperature on emul-
sion morphology: Fluorescence microscopic images at 20-
fold magnification of model emulsion A prepared at 40°C (a,
b) or 60°C (c,d) including homogenisation with an ultra-
turrax. The employed surfactants were S-970 (on the left,
a and c) or S-1170 (on the right, b and d). The aqueous
phase was coloured red (Atto 594), the lipophilic phase was
coloured green (Bodipy®). The large dark fields encircled
by a brightly fluorescent film are air bubbles (arrows).
droplet size (Figure 2c, d). At 60°C, the sys-
tems were mostly free of air irrespective of the
homogenisation step. Additional fluorescence
microscopic tests on modified emulsions A with
a decreased surfactant content of 2.5% w/w re-
vealed a much less crowded structure. Mainly
oil droplets were formed while no surplus sur-
factant was available to form additional vesic-
ular structures. These systems with 2.5% w/w
of surfactant were much more fluid than their
counterparts with 5% w/w of sucrose ester. It
may thus be concluded that the internal vesic-
ular structure is indeed responsible for the in-
creased viscosity of the emulsions.
8
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Morphology and stability of the final
emulsions
The microscopic investigation of the final emul-
sions A to E (Table 2) was focused on the e ect
of the oil phase. The microscopic appearance
of the final emulsions was highly similar for all
oils except in case of IPM. Numerous air bub-
bles and a dense network of small vesicles were
generally observed [9]. In case of emulsions E
S-970 and E S-1170 with IPM the structure
was denser and darkened by even larger num-
bers of small air bubbles. Undissolved surfac-
tant appeared to be present in all fresh and
stored systems irrespective of the ester blend,
suggesting a certain re-crystallisation of the su-
crose esters after preparation. Light micro-
scopic investigation after 3 months of storage
revealed that most of the air bubbles were gone
from the systems. The stored systems showed
a less crowded internal structure than the fresh
ones. The spherical aqueous structures form-
ing the gel network appeared to have increased
in size, indicating slow separation of the aque-
ous phase. These phenomena appeared to have
the strongest impact on the physical proper-
ties of emulsions E with IPM, especially in
case of E S-1170. Interestingly, the mean oil
droplet size showed only a slight increase af-
ter the storage period. Comparison of fluo-
rescent microscopic images of fresh and stored
model emulsions A containing Atto 594 and
Bodipy® confirmed that the incorporated air
bubbles had mostly vanished and the average
droplet size had only increased slightly (Fig-
ure 3). The pH value of the final emulsions was
quite comparable around 6.48 (S-970) and 6.45
(S-1170) for all oil phases except for IPM. For
the latter, slightly higher values around 6.70
were observed for both esters. After 3 months
of storage, all emulsions showed a decrease in
pH to values around 6.41 (S-970) and 6.38 (S-
1170). In case of IPM, a decrease to values
around 6.57 was observed. This can be con-
sidered as the normal ageing process due to
chemical degradation [17]. The overall pH was
suitable for dermal application and indicated a
mild surfactant nature [6].
3.2 Thermoanalytical characterisa-
tion
Melting behaviour of pure ester blends
Investigation of the two ester blends in pow-
der form led to similar thermograms. Upon
heating, an endothermic transition was ob-
served with positive enthalpy values, which
represents physical changes induced by melt-
ing or softening of the esters when reaching
their glass transition temperature [12]. The
obtained heating thermograms did not show a
single sharp peak corresponding to a specific
melting point since the ester blends are com-
posed of mono-, di- and poly-esters of sucrose
and fatty acids [18]. Thus, a melting range
was observed that consisted of a smaller and a
larger peak. This first peak occurred around
40°C for S-970 and around 35°C for S-1170.
The maximum peak temperatures Tm of the
main peak were highly comparable for the two
ester blends and were located at 44.66 ± 0.08
°C and 44.79 ± 0.09 °C (n=3, respectively,
P>0.05). The observed melting enthalpy ( H,
J/g) was significantly larger for S-1170 than
for S-970 (P<0.05) due to the di erent com-
position of the ester mixtures. It may be as-
sumed that the observed transition represents
the transformation of an amorphous phase into
a liquid crystalline mesophase [12]. This tran-
sition may be explained by the intermolecu-
lar hydrogen bonding network between the hy-
droxyl groups of the sucrose molecules, which
is the driving force for the thermotropic self-
organisation of the sucrose ester [12].
A subsequent cooling and second heating of
the samples was performed. After the first
melting and solidification process, the struc-
9
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Figure 3: E ect of storage on emulsion morphology: Fluorescence microscopic images at 20-fold magnification of model
emulsion A S-970 (a) directly after preparation and (b) after 3 months of storage. The aqueous phase is coloured red
(Atto 594), the lipophilic phase is coloured bright green (Bodipy®). The dark spheres encircled by a brightly fluorescent
film are air bubbles (arrows).
tures of the sucrose esters were rebuilt to vary-
ing extents. During the second heating of
both esters, the shape of the transition changed
to a sharper single peak, i.e. only the large
endothermic peaks were respectively observed
while the preceding smaller peaks had van-
ished. The T0 and Tm of the main peaks re-
mained largely unchanged. However, the over-
all enthalpy values were respectively smaller
than during the first heating process (P<0.05),
indicating that irreversible changes had been
induced. Re-crystallisation during cooling was
possible to a certain extent for both esters of
intermediate HLB values [19], indicating better
physical stability of the material than reported
for esters of higher HLB value [18].
Melting behaviour of binary systems: ef-
fect of production temperature
In the microDSC heating thermograms of
aqueous dispersions of 5% w/w of the two su-
crose stearate blends, endothermic transitions
were observed as a result of the melting pro-
cess of the dispersed ester molecules. Unlike for
the pure ester mixtures, single melting peaks
were observed during the first heating process
irrespective of the preparation temperature of
the dispersions. For systems prepared at 25°C,
the obtained thermograms were quite similar
for the two sucrose stearate blends showing
a single sharp melting peak with T0 around
45°C and 46°C, Tm at 48°C and comparable
enthalpy values (P>0.05). Compared to the
crystalline ester powders, the T0 and Tm of
these dispersions were located at higher tem-
peratures, which could be ascribed to the hy-
dration of the surfactant molecules [7]. These
findings are in good agreement with previous
reports; the exact transition temperatures are
dependent on the ester concentrations within
the binary systems as well as the heating rate
[5, 12]. In case of dispersions prepared at 50°C,
the single peaks had a slightly broader shape
especially in case of S-1170. The T0 and Tm of
S-970 dispersions were located at slightly lower
values than S-1170 dispersions (P<0.05). In
case of S-970, the elevated preparation tem-
perature led to a shift of T0 from 45°C to 43°C
and of Tm from 48°C to 47°C when compared
to the dispersions prepared at 25°C. In case
of S-1170, only a slight shift of T0 from 46°C
10
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to 45°C was observed. For both ester blends,
the enthalpy values were significantly smaller
for the pre-heated dispersions than for those
prepared at room temperature (P<0.05). This
indicates that the sucrose ester mixtures only
re-crystallised to a certain extent after heat-
ing and cooling of the produced binary sys-
tems. Hydrophilic monoesters might remain
dissolved after preparation [5]. In summary,
heating induced irreversible changes within the
sucrose ester dispersions although their struc-
ture has been reported to be restored with
time [18]. The exact composition of the em-
ployed ester blends has an immense impact
on the structure of the dispersions and thus
the observed phase transitions [12, 18]. At
low sucrose ester concentrations, both micel-
lar systems [10] and bilayer formation have
been reported [12]. In our study, as reported
by Sadtler et al., the employed sucrose ester
blends were not able to form micellar struc-
tures due to their comparatively low aqueous
solubility [12]. Likewise, no liquid crystalline
structures such as lamellar phases were ob-
served in the polarisation microscope. It may
be assumed that the formation of bilayers or li-
posomal vesicles is the most likely explanation
for the increased viscosity.
Melting behaviour of emulsions: e ect of
production temperature
MicroDSC measurements of the model emul-
sions A prepared at di erent temperatures
were performed. When comparing the melt-
ing behaviour of S-970 and S-1170 emulsions
prepared at 25°C to the melting behaviour of
the pure esters, T0 and Tm of the ester blends
within the emulsions were located at slightly
higher values around 42°C and 47°C, respec-
tively. The shift to higher temperatures was
not as pronounced as for the binary systems,
suggesting that the ester is not present in a
purely hydrated state, but associated with the
oil phase as well. As the production tem-
perature was increased, the observed transi-
tion was shifted to lower temperatures and the
enthalpy values became progressively smaller.
The comparatively broad transition peak ob-
served for emulsion A S-970 prepared at 25°C
also became more inhomogeneous with increas-
ing preparation temperature. A smaller shoul-
der peak preceding the large main peak was
observed which became more pronounced with
increasing preparation temperatures. In case
of emulsion A S-1170, the same tendencies were
observed. The thermograms generally showed
higher enthalpy values and smaller shoulder
peaks. As observed for the binary systems,
a second heating cycle mostly led to a minor
peak shift to higher temperatures while en-
thalpy values were generally lower than in the
first heating cycle.
Melting behaviour of the final emulsions:
influence of oil type
The microDSC measurements of the final
emulsions revealed that the nature of the oil
phase had a definite impact on the endother-
mic transitions observed during heating (Fig-
ure 4). Overall, the mean T0 and Tm in-
creased in the order E<A<B<C<D for emul-
sions with both ester blends while the oppo-
site trend was observed for the correspond-
ing enthalpy values. The shape of the en-
dothermic peaks changed with the di erent
oil phases. For emulsions with PCL® liquid
and tegosoft® liquid, a smaller shoulder peak
preceding the main peak was observed with
both ester blends. For emulsions with corn
oil and soybean oil, a comparatively sharp sin-
gle peak was respectively observed. The heat-
ing thermograms of emulsions with IPM exhib-
ited a very early onset and a broad irregular
transition. A second heating cycle after cool-
ing back to room temperature only induced
minor changes of the transitions, mostly to
11
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Figure 4: Heating curves of the emulsions
higher values. The enthalpy values were signifi-
cantly lower for all emulsions during the second
heating cycle (P<0.05), confirming irreversible
structural changes induced by heating.
3.3 Rheological studies
Rheological behaviour of binary systems
Aqueous sucrose ester dispersions exhibited a
power-law decrease in dynamic viscosity with
increasing shear rate, i.e. shear-thinning flow
behaviour. The dynamic viscosity of the sys-
tems increased with increasing sucrose ester
concentrations (Table 3). As expected, a cer-
tain viscoelasticity was observed which likewise
increased with increasing sucrose ester concen-
trations (data not shown). This concentration-
dependence of the gelling potential of sucrose
esters is in agreement with literature [13].
Likewise, the preparation temperature had a
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Figure 4: Heating curves of the emulsions: Endothermic
transitions of the final emulsions A, B, C, D and E with (a)
S-970 or (b) S-1170. The influence of the preparation tem-
perature of 25°, 40°, 50° or 60°C can be derived from the
changes in peak onset temperature, peak maximum temper-
ature, peak shape and heat flow.
marked influence on the rheological properties
of the aqueous dispersions. Both esters exhib-
ited a strong gelling ability both at room tem-
perature and after heating [19]. For systems
prepared at 25°C, sucrose ester S-1170 exhib-
ited a significantly stronger gelling ability than
S-970 at all tested concentrations (P<0.05, Ta-
ble 3). At a preparation temperature of 40°C,
these di erences in gelling potential between
the two esters became negligible (P>0.05). Af-
ter a preparation at 60°C, the gelling e cien-
cies of the esters were reversed with signifi-
cantly stronger gel networks formed by S-970
than by S-1170 (P<0.05). It is noteworthy to
emphasize that small di erences in production
may strongly influence the physical properties
12
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 Dynamic viscosity  (Pas) 
 
 Sample 25°C 40°C 60°C 
2.5% S-970 0.19 ± 0.03 0.40 ± 0.08 0.011 ± 0.001 
 5%   S-970 1.30 ± 0.12 1.05 ± 0.42 0.06 ± 0.01 
10%  S-970 3.38 ± 0.42 3.89 ± 1.29 1.76 ± 0.28 
20%  S-970 12.18 ± 0.74 18.57 ± 1.16 21.00 ± 1.66 
    
2.5% S-1170 0.47 ± 0.09 0.27 ± 0.09 0.008 ± 0.0003 
 5%   S-1170 1.77 ± 0.31 0.80 ± 0.21 0.01 ± 0.001 
10%  S-1170 6.36 ± 0.73 3.39 ± 0.42 0.28 ± 0.03 
20%  S-1170 24.18 ± 1.86 15.43 ± 0.97 13.27 ± 0.58 
Table 3: Influence of sucrose ester concentration and production temperature on the dynamic viscosity of binary systems.
The aqueous sucrose ester dispersions of either S-970 or S-1170 were prepared at 25°, 40° or 60°C and their dynamic
viscosity was compared at a shear rate of 50 s-1. Values are given as means ± SD of at least three experiments (nØ3).
of the produced systems when sucrose esters
are employed [5]. The underlying cause for the
changes in viscoelastic properties with surfac-
tant concentration and temperature might be
related to di erent aspects. On the one hand,
micelle formation has been reported to play a
role in this context [13]. However, the type of
surfactant association depends on the molecu-
lar geometry and the packing parameter and
micelle formation has not been observed for
sucrose esters of intermediate HLB value [12].
It may be assumed that the gel network is
rather formed by H-bonds between ester and
water molecules which form an aqueous gel
network at ambient temperatures due to steric
hindrances [7]. A temperature rise may pro-
gressively break down these H-bonds, finally
leading to fluidisation. For sucrose esters of
higher HLB, a temperature rise may lead to hy-
dratisation of the polar head groups and favour
the growing of micelles, which may in turn in-
crease the viscosity of the systems [13]. Over-
all, S-1170 exhibited a far more linear gelling
behaviour than S-970. The dynamic viscos-
ity decreased with increasing temperature at
all investigated concentrations of S-1170 (Ta-
ble 3). In case of S-970, the dynamic viscosity
remained largely constant or increased slightly
at 40°C at all tested concentrations. At 60°C,
the viscosity decreased strongly at all concen-
trations except at 20% w/w, which clearly rep-
resents an exception in terms of physical prop-
erties due to the high content of undissolved
sucrose ester. In summary, a concentration of
5 % w/w of sucrose ester was confirmed to be
su cient for the formation of semi-solid sys-
tems. Thus, this concentration was employed
for the development of emulsions.
Rheological behaviour of emulsions: in-
fluence of production temperature
The e ect of di erent production tempera-
tures on the dynamic viscosity of the model
emulsions A S-970 and A S-1170 at a shear
rate of 50 s-1 is depicted in Figure 5. The
gelling ability of S-1170 at 25°C was signifi-
cantly stronger than that of S-970 (P<0.05).
These di erences decreased upon an increase
in temperature during production. At 40°C,
50°C and 60°C, no significant di erences be-
tween the dynamic viscosity of the di erent
13
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Figure 5: Influence of production temperature on emulsion
viscosity: Influence of the production temperature on the
dynamic viscosity of the model emulsions A S-970 (black
bars) or A S-1170 (grey bars). The dynamic viscosity values
were compared at 21°C and a shear rate of 50 s-1. The
depicted values are means ± SD of at least three experiments
(n Ø 3).
esters was observed (P>0.05). At 40°C, both
sucrose ester blends appeared to reach a max-
imum in terms of gelling ability. A stronger
increase in production temperature led to a de-
crease of the dynamic viscosity for both esters.
The model emulsions exhibited shear-thinning
flow behaviour and viscoelasticity, i.e. a semi-
solid appearance, irrespective of the prepara-
tion temperature. This might be ascribed to
the formation of a weak gel-like network. As
indicated by the microscopic images, the sur-
plus sucrose ester appears to form a continu-
ous matrix interdispersed with oil droplets [20].
Upon application of shear, this matrix is dis-
rupted. After su ciently long shear times, the
sucrose ester might even separate into cluster
domains that disturb the microstructure of the
emulsions, thus decreasing the overall viscos-
ity [20]. Thus, the mixtures should not be
subjected to mechanical shearing during pro-
ductions for prolonged periods of time. When
comparing the dynamic viscosity of these emul-
sions with corresponding binary systems after
preparation at 25°C, the dispersions exhibited
slightly higher dynamic viscosity values. At in-
creasing production temperatures of 60°C, the
presence of the oil phase apparently reinforced
the gelling potential of the sucrose esters, lead-
ing to systems of higher viscosity than observed
for the aqueous dispersions (P<0.05, respec-
tively). This aspect renders the sucrose esters
highly useful for the formation of semi-solid
multicomponent emulsion systems, since many
compounds require elevated production tem-
peratures. In addition, oscillatory frequency
sweep tests were conducted for the model emul-
sions. Oscillation tests are dynamic meth-
ods for determining the viscoelastic proper-
ties of the investigated material in its rheo-
logical basic state. Unlike continuous shear
techniques, oscillatory techniques do not dis-
rupt static structures [21]. For both esters, the
model emulsions exhibited gel characteristics
at all tested preparation temperatures, i.e. the
elastic moduli were significantly higher than
the viscous moduli at all frequencies (P<0.05).
When comparing the elastic and viscous mod-
uli at a frequency of 1 Hz, the highest values
for both parameters were reached at 40°C for
S-970 and at 50°C for S-1170. When directly
comparing the gelling potential of the di erent
sucrose esters at 25°C, S-1170 exhibited signifi-
cantly higher values of both the elastic and the
viscous modulus than S-970 (P<0.05, respec-
tively). At 40°C, no di erences between the
elastic and the viscous moduli of S-970 and
S-1170 were observed (P<0.05, respectively).
At 50 and 60°C, S-1170 exhibited higher val-
ues for the elastic and viscous moduli than S-
970. Overall, the investigated emulsions ex-
hibited properties of a weak gel, i.e. the viscous
and elastic modulus were slightly dependent on
the oscillatory frequency and the elastic mod-
ulus G’ was larger than the viscous modulus
G’’ at all times [13]. A slight increase in elas-
tic behaviour with increasing frequencies was
observed, as is common for viscoelastic sub-
stances [5]. Under strong deformation or con-
tinuous flow conditions, the weak gel network
breaks down into smaller flow units and may
flow homogeneously [13]. This might explain
14
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why the elastic and viscous moduli of S-1170
model emulsions at 50°C and 60°C were higher
than that of S-970 emulsions although the dy-
namic viscosity data indicated otherwise. If a
system is more structured in the gel state, it
is also more sensitive to shear that induces an
alteration of the microstructure [12]. In case
of S-1170 emulsions prepared at higher tem-
peratures, the gel network apparently broke
down earlier during the continuous shear ex-
periments.
Rheological behaviour of the final emul-
sions: influence of the oil type
The dynamic viscosity of the final emulsions
at a shear rate of 50 s-1 at 21°C is given in
Figure 6. Values are given for both fresh and
stored emulsions with S-970 (Figure 6a) and
S-1170 (Figure 6b). As can be seen, S-1170 led
to higher viscosity values than S-970 with all
employed oil phases (P<0.05) except for IPM
(P>0.05). Regarding the influence of the oil
type, di erent trends were observed for the
two ester blends. In case of the fresh S-970
emulsions, the viscosity was ranked in the or-
der E > C > A / B / D. In case of fresh S-
1170 emulsions, the ranking was D > A / B /
C > E. The only oil phase that showed the
strongest dependency on the employed ester
type was IPM. When regarding the changes
in the dynamic viscosity of the formulations
after storage, interesting trends were revealed
(Figure 6). In case of A S-970 and B S-
970 emulsions, the dynamic viscosity showed
a significant increase after 3 months of storage
(P<0.05, respectively). In case of the other
three oils, a more or less strong decrease of
the dynamic viscosity was observed. In case
of S-1170 emulsions, all systems showed a pro-
nounced decrease of the dynamic viscosity af-
ter 3 months. This suggests that only the
combination of sucrose stearate S-970 with oil
phases based on cetearyl ethylhexanoate, as is
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Figure 6: E ect of storage on emulsion viscosity: Compar-
ison of the dynamic viscosity of emulsions A, B, C, D and E
stabilised by (a) S-970 or (b) S-1170 at a shear rate of 50 s-1
at 21°C. Values were determined on fresh emulsions (black
bars) and after 3 months of storage (grey bars). The de-
picted values are means ± SD of at least three experiments
(n Ø 3).
the case for PCL® liquid and tegosoft® liquid,
leads to systems that exhibit thickening dur-
ing storage. This thickening e ect presumably
occurs as air bubbles leave the system, as con-
firmed by the microscopic images. In case of
the other oil phases, however, fluidisation of
the emulsions occurs especially in case of IPM,
indicating slow destabilisation. In case of S-
1170, no thickening e ects were observed, in-
dicating that the exact composition of the sur-
factant blend plays an important role in this
context. Additional oscillatory measurements
confirmed the observed trends. For the deter-
mined elastic modulus G’ and viscous modulus
G’’, the same orders of ranking for the di er-
15
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ent emulsions were observed as for the viscosity
values, thus confirming the e ect of the di er-
ent oil phases (Figure 7). The elastic modulus
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Figure 7: E ect of storage on emulsion viscoelasticity:
Comparison of the elastic modulus G’ (a) and the viscous
modulus G” (b) at a frequency of 1 Hz at 21°C of the model
emulsions A and B stabilised by S-970 or S-1170. Values
were determined on fresh emulsions (black bars) and after
3 months of storage (grey bars). The depicted values are
means ± SD of at least three experiments (n Ø 3).
was significantly higher than the viscous modu-
lus for all formulations (P<0.05, respectively),
i.e. all semi-solid emulsions exhibited a gel-like
structure with a prevailing elastic component
similar to standard dermal preparations [21].
The orders of magnitude of the elastic and vis-
cous moduli were respectively comparable for
all emulsions. When comparing the di erent
ester blends, higher values of the elastic mod-
ulus G’ and the viscous modulus G’’ were gen-
erally obtained with S-1170 except in case of
IPM-emulsions. Figure 7 shows the elastic and
viscous moduli of representative emulsions and
the changes observed after 3 months of storage.
As observed for the viscosity values, both the
elastic and the viscous moduli of A S-970 and
B S-970 emulsions show a significant increase
after storage (P<0.05, respectively). In case of
C S-970 and D S-970, the parameters remained
largely constant or showed a slight decrease.
The strongest decrease in the elastic and the
viscous modulus was observed for E S-970 with
IPM. In case of S-1170, all formulations showed
a more or less pronounced decrease in both the
viscous and elastic moduli after 3 months of
storage; no thickening e ects were observed.
As another aspect of interest, the e ect of dif-
ferent measurement temperatures on the rheo-
logical properties of the fresh systems was in-
vestigated by performing additional measure-
ments at the skin surface temperature of 32°C.
At this temperature, all emulsions exhibited
noticeably decreased dynamic viscosity values.
In case of S-970 emulsions, the determined val-
ues at 32°C were highly comparable for all
emulsions irrespective of the oil type (P>0.05),
ranging around 1 Pas at 50 s-1. In case of
S-1170 emulsions, the dynamic viscosity val-
ues at 32°C were in the same ranking order as
at 21°C, but were likewise reduced to values
only slightly above 1 Pas at 50 s-1. This indi-
cates that the rheological di erences in emul-
sion properties observed at 21°C might play a
role during processing and storage, but might
be minimised upon application in vivo. At
a measurement temperature of 32°C the gel
strength of the emulsions based on the di er-
ent sucrose ester blends becomes largely com-
parable. Slightly higher viscosity values for S-
1170 emulsions were merely observed in case
of tegosoft® liquid and soybean oil (P<0.05,
respectively). The corresponding oscillatory
frequency sweep tests confirmed these tenden-
cies. Both the elastic and viscous moduli were
decreased for all emulsions at a measurement
temperature of 32°C. In general, the elastic
16
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modulus G’ showed a more pronounced de-
crease than the viscous modulus G’’. The elas-
tic moduli were reduced by up to 50% of their
initial values. The strongest decrease of both
G’ and G’’ was observed for IPM-emulsions.
Overall, all emulsions exhibited shear-thinning
flow behaviour with slightly to moderately pro-
nounced thixotropy, which is desirable for cos-
metic and pharmaceutical emulsions [7]. The
observed gel-like structure of the model emul-
sions might be related to the hydrogen bond-
ing of water molecules to the sucrose hydroxyl
moieties, causing specific conformation and the
formation of an aqueous gel network due to
steric hindrances [7].
4 Conclusion
Both sucrose stearate S-970 and S-1170 are ex-
cellent surfactants for the formation of skin-
friendly semi-solid emulsions with a com-
plex aqueous bulk phase. The temperature-
dependent gelling potential of the ester blends
within multiphase systems was higher than in
aqueous binary systems especially at elevated
preparation temperatures, rendering them in-
teresting additives for emulsion preparation.
The nature of the oil phase played a major role
in terms of emulsion stability. Interestingly,
formulations with sucrose stearate S-970 and
oil phases containing cetearyl ethylhexanoate
showed an increase in viscoelasticity with stor-
age time. These findings indicate a remark-
able potential of these conveniently applicable
dermal formulations. The exact nature of the
interactions responsible for the beneficial phys-
ical properties remains to be clarified.
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CHAPTER 4
Conclusions
Colloidal carrier systems offer useful properties for dermal drug delivery. Contin-
uous research has promoted the development of formulations with optimised long-
term stability which can nevertheless be produced with the help of skin-friendly
biodegradable compounds. The focus of this work was placed on formulation
development as well as on methodological approaches to characterise the novel
formulations regarding their skin penetration potential.
As a first step, lecithin-based nanoemulsions for the delivery of lipophilic drugs
were successfully optimised by introducing skin-friendly natural co-stabilisers in-
stead of polyethoxylated surfactants. Sucrose stearate mixtures of intermediate
HLB value proved to be useful co-surfactants to improve nanoemulsion stability
and morphology. The incorporation of natural CDs contributed to an improved
physical stability of selected formulations, but was mostly found to improve the
skin permeation rates of lipophilic steroidal drugs. This effect was particularly
pronounced in case of γ-CD. A comparative study investigating lecithin and su-
crose stearate mixtures as sole surfactants in nanoemulsions indicated that sucrose
stearate mixtures are more suitable to form curved surfaces and thus homogeneous
nanoemulsion droplets. In addition, better electrochemical stabilisation was ob-
served for sucrose stearate nanoemulsions. In terms of skin permeation potential,
both emulsifiers performed equally well. The incorporation of additional γ-CD
again led to higher skin permeation rates in combination with a steroidal model
drug. This effect was more pronounced for lecithin-based nanoemulsions than for
sucrose stearate-based nanoemulsions, which indicates that synergistic mechanisms
are involved. Cryo TEM studies revealed improved nanoemulsion homogeneity and
more spherical droplet structures of lecithin-based systems after addition of γ-CD.
The permeation enhancement effect of γ-CD on steroidal model drugs under infi-
nite dose conditions was confirmed separately in a follow-up study using diffusion
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cell techniques. The effect can most likely be attributed to solubility effects within
the vehicle that come into play under infinite dose application. Under finite dose
conditions during in vitro tape stripping, only a slight tendency towards higher
skin penetration was observed.
During the development of sucrose stearate-based nanoemulsions a tempera-
ture-dependent gelling effect was observed. The peculiar rheological properties of
sucrose stearate blends of intermediate HLB value were thus employed to create
semi-solid sucrose stearate-based o/w emulsions of identical composition as the
nanoemulsions. Comparative diffusion cell studies as well as tape stripping exper-
iments revealed that despite the differences in mean droplet size and viscosity the
systems exhibited comparable skin permeation and penetration rates for different
model drugs. Further studies revealed that the exact composition of the sucrose
stearate blend as well as the employed oil phase had a noticeable influence on
the physical properties and stability of the resulting semi-solid emulsions. The
complex internal structure of the emulsions could be visualised by fluorescence
microscopy. Oil droplets suspended within a dense matrix of aqueous structures
were revealed. This matrix was presumably composed of excess surfactant and
water, causing temperature-dependent gelling upon preparation of the emulsions.
As a second major aspect of this work, the tape stripping technique was adapted
and optimised for in vitro experiments using porcine ear skin. Important parame-
ters such as tape brand as well as duration, mode and intensity of pressure applica-
tion were optimised for the porcine ear model. The technique of NIR-densitometry
was calibrated for the quantification of porcine SC proteins using an established
protein assay for conducting a linear correlation analysis. Determination of the
TEWL was found useful as a means of skin integrity testing. Likewise, skin hy-
dration mapping with a capacitance-based sensor was found to be a useful tool
to identify intact porcine skin areas or to visualise irregularities during the tape
stripping process. Finally, comparative tape stripping experiments using model
formulations such as microemulsions and hydrogels revealed that the porcine ear
is indeed an appropriate model for preliminary in vitro tape stripping experiments.
In conclusion, the presented consecutive publications served to develop, char-
acterise and optimise novel nanoemulsion and emulsion systems stabilised by eud-
ermic biodegradable raw materials. The observed strong permeation enhancement
effect of CDs could be attributed to solubility effects due to infinite dose exper-
imental setups; different approaches in formulation development are required to
exploit this enhancement potential under in vivo conditions. The tape stripping
technique was successfully adapted for in vitro experiments on porcine ear skin and
was further employed for the characterisation of the skin penetration potential of
the different developed systems.
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CHAPTER 6
Abstracts
6.1 Abstract
Lecithin-based nanoemulsions are skin-friendly and efficient vehicles for the de-
livery of lipophilic drugs. Since lecithin alone is a comparatively poor stabiliser,
a primary aim of this work was to improve the physical stability of o/w nano-
emulsions with eudermic additives such as natural cyclodextrins and sucrose ester
surfactants. The nanoemulsions were characterised by dynamic light scattering,
laser Doppler electrophoresis, cryo transmission electron microscopy and thermo-
analytical measurements. The skin permeation rates of incorporated drugs were
investigated with the help of in vitro skin diffusion studies. In this context, cy-
clodextrins were found to exert a certain positive influence on nanoemulsion sta-
bility. Moreover, they strongly enhanced the skin permeation of steroidal drugs
under infinite dose application. Solubilisation effects as well as interactions at
the o/w interface may be held responsible for this enhancement. The investi-
gated sucrose stearate mixtures were found to be valuable co-surfactants, but also
superior main surfactants. The peculiar rheological behaviour of the employed
sucrose ester mixtures was additionally employed to create appealing semi-solid
o/w emulsions without the use of gelling agents or polymers. Interestingly, the
droplet size of these emulsions had no impact on the skin permeation of model
drugs when compared to nanoemulsions of identical composition. Extensive rheo-
logical, thermoanalytical and fluorescence microscopic investigations revealed that
the composition of the employed sucrose stearate blend and the nature of the oil
phase strongly influenced the physical properties of these novel emulsions.
To further investigate the skin penetration potential of all developed vehicles,
the tape stripping method was adapted for in vitro experiments on porcine ear
skin. As a second major aim of this work, near infrared-densitometry was vali-
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dated for quantification of the removed corneocytes. A condenser chamber and a
capacitance-based sensor were successfully introduced for skin quality testing in
vitro. Conclusive comparative in vivo experiments confirmed the suitability of the
porcine ear model for skin penetration studies.
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6.2 Zusammenfassung
Nanoemulsionen auf Lezithinbasis sind hautfreundliche und effiziente Vehikel für
lipophile Arzneistoffe. Die Verwendung von Lezithin als alleiniges Tensid führt je-
doch meist zu unbefriedigender Stabilität der Formulierungen. Daher war es ein
Hauptziel dieser Arbeit, die physikalische Stabilität von O/W-Nanoemulsionen mit
hautverträglichen Additiva wie natürlichen Cyclodextrinen und Sacharoseester-
Tensiden zu optimieren. Die Formulierungen wurden mittels verschiedener Techni-
ken wie Dynamischer Lichtstreuungsmessung, Laser Doppler-Elektrophorese, Kryo-
Transmissionselektronenmikroskopie und thermoanalytischer Untersuchungen cha-
rakterisiert. Die Freisetzung eingearbeiteter Modellarzneistoffe wurde mittels in
vitro-Hautdiffusionsstudien untersucht. Cyclodextrine konnten in der Tat zu ei-
ner Verbesserung der Nanoemulsions-Stabilität beitragen; wesentlich ausgeprägter
und spezifischer war jedoch ihr permeationsfördernder Effekt auf steroidale Arznei-
stoffe unter infinite dose - Bedingungen. Hierfür könnten sowohl Löslichkeitsef-
fekte als auch eine Beteiligung der Cyclodextrine am O/W-Grenzflächenfilm der
Öltröpfchen verantwortlich sein. Die untersuchten Saccharosestearat-Mischungen
erwiesen sich sowohl in Kombination mit Lezithin als auch alleine als höchst vor-
teilhafte Stabilisatoren für Nanoemulsionen. Das beobachtete starke Quellvermö-
gen dieser Tenside wurde zusätzlich genutzt, um durch geringfügige Modifikatio-
nen im Herstellungsprozess halbfeste O/W-Emulsionen von ansprechender Konsis-
tenz und guter Stabilität ohne Verwendung zusätzlicher Gelbildner herzustellen.
In vergleichenden Hautpermeationsstudien mit Modellarzneistoffen erzielten diese
Emulsionen interessanterweise ebenso hohe Permeationsraten wie die entsprechen-
den Nanoemulsionen mit identischer Zusammensetzung. Ausführlichere rheologi-
sche, thermoanalytische und licht- sowie fluoreszenzmikroskopische Untersuchun-
gen zeigten, dass die Zusammensetzung der Saccharoseester-Mischungen sowie die
Art der Ölphase eine bedeutende Rolle für die physikalischen Eigenschaften dieser
neuartigen Emulsionen spielten.
Um die Hautpenetration aller entwickelten Formulierungen genauer zu un-
tersuchen wurde als zweiter Hauptpunkt dieser Arbeit die Methodik des Tape
Stripping für in vitro - Experimente an porziner Ohrenhaut adaptiert. Für die
Quantifizerung der abgezogenen porzinen Korneozyten wurde die Methode der
NIR-Densitometrie erstmals validiert. Eine Kondensor-Kammer-Methode sowie
ein kapazitanzbasierter Sensor wurden erfolgreich für die Qualitätskontrolle der
Haut eingesetzt. Abschließend bestätigten vergleichende in vivo-Studien, dass das
porzine Ohrenmodell ein geeignetes in vitro-Ersatzmodell für aufwändige in vivo-
Studien darstellt.
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